178 results on '"Ngugi E"'
Search Results
2. Trends in TB and HIV care and treatment cascade, Kenya, 2008–2018
- Author
-
Weyenga, H., primary, Onyango, E., additional, Katana, A. K., additional, Pathmanathan, I., additional, Sidibe, K., additional, Shah, N. S., additional, Ngugi, E. W., additional, Waruingi, R. N., additional, Ng´ang´a, L., additional, and De Cock, K. M., additional
- Published
- 2022
- Full Text
- View/download PDF
3. Reproductive Tract Infections in Kenya: Insights for Action from Research
- Author
-
Maggwa, A. B. N., Ngugi, E. N., Segal, Sheldon J., editor, Germain, Adrienne, editor, Holmes, King K., editor, Piot, Peter, editor, and Wasserheit, Judith N., editor
- Published
- 1992
- Full Text
- View/download PDF
4. Can isoniazid preventive therapy be scaled up rapidly? Lessons learned in Kenya, 2014–2018
- Author
-
Weyenga, H., primary, Karanja, M., additional, Onyango, E., additional, Katana, A. K., additional, Ng´ang´a, L. W., additional, Sirengo, M., additional, Ondondo, R. O., additional, Wambugu, C., additional, Waruingi, R. N., additional, Muthee, R. W., additional, Masini, E., additional, Ngugi, E. W., additional, Shah, N. S., additional, Pathmanathan, I., additional, Maloney, S., additional, and De Cock, K. M., additional
- Published
- 2021
- Full Text
- View/download PDF
5. HLA class I associations with rates of HIV-1 seroconversion and disease progression in the Pumwani Sex Worker Cohort
- Author
-
Peterson, T. A., Kimani, J., Wachihi, C., Bielawny, T., Mendoza, L., Thavaneswaran, S., Narayansingh, M. J., Kariri, T., Liang, B., Ball, T. B., Ngugi, E. N., Plummer, F. A., and Luo, M.
- Published
- 2013
- Full Text
- View/download PDF
6. Identification of molecular markers linked to a gene conferring resistance to coffee berry disease (Colletotrichum kahawae) in Coffea arabica
- Author
-
Gichuru, E. K., Agwanda, C. O., Combes, M. C., Mutitu, E. W., Ngugi, E. C. K., Bertrand, B., and Lashermes, P.
- Published
- 2008
7. Reducing HIV Transmission in Developing Countries
- Author
-
Jha, P., Nagelkerke, N. J. D., Ngugi, E. N., Willbond, B., Moses, S., and Plummer, F. A.
- Published
- 2001
8. Anal and dry sex in commercial sex work, and relation to risk for sexually transmitted infections and HIV in Meru, Kenya
- Author
-
Schwandt, M, Morris, C, Ferguson, A, Ngugi, E, and Moses, S
- Published
- 2006
9. Genotype × environment interaction in carbon isotope discrimination and seed yield in cowpea (Vigna unguiculata L. Walp.)
- Author
-
Ngugi, E. C. K., Galwey, N. W., and Austin, R. B.
- Published
- 1993
- Full Text
- View/download PDF
10. Sexual patterning and condom use among a group of HIV vulnerable men in Thika, Kenya
- Author
-
Ferguson, A, Pere, M, Morris, C, Ngugi, E, and Moses, S
- Published
- 2004
11. Response of a sexually transmitted infection epidemic to a treatment and prevention programme in Nairobi, Kenya
- Author
-
Moses, S, Ngugi, E N, Costigan, A, Kariuki, C, Maclean, I, Brunham, R C, and Plummer, F A
- Published
- 2002
12. Sexually transmitted infections and vaginal douching in a population of female sex workers in Nairobi, Kenya
- Author
-
Fonck, K, Kaul, R, Keli, F, Bwayo, J J, Ngugi, E N, Moses, S, and Temmerman, M
- Published
- 2001
13. A randomized, placebo-controlled trial of monthly azithromycin prophylaxis to prevent sexually transmitted infections and HIV-1 in Kenyan sex workers: study design and baseline findings
- Author
-
Fonck, K, Kaul, R, Kimani, J, Keli, F, MacDonald, K S, Ronald, A R, Plummer, F A, Kirui, P, Bwayo, J J, Ngugi, E N, Moses, S, and Temmerman, M
- Published
- 2000
14. WEAA0103: Production and characterization of human anti-V3 monoclonal antibodies from Indian clade C human immunodeficiency virus type-1 (HIV-1) infected patients
- Author
-
Sargeant, D., Deverasetty, S., Luo, Y., Villahoz-Baleta, A., Zobrist, S., Rathnayake, V., Russo, J., Muesing, M., Schiller, M., Andrabi, R., Kumar, R., Bala, M., Nair, A., Biswas, A., Wig, N., Kumar, P., Luthra, K., Gonzalez, N., McKee, K., Yuste, E., Mascola, J.R., Alcamí, J., Vojnov, L., Martins, M., Bean, A., Veloso de Santana, M., Sacha, J., Wilson, N., Bonaldo, M., Galler, R., Stevenson, M., Watkins, D., Aziz, M., Mata, M., Mahmood, F., Durkin, H., Liu, C., Greenblatt, R., Nowicki, M., Golub, E., Anastos, K., French, A., Baum, L., Wacleche, V.S., Chomont, N., Gosselin, A., Monteiro, P., Goupil, M., Kared, H., Tremblay, C., Bernard, N., Boulassel, M.-R., Routy, J.-P., Ancuta, P., Jadlowsky, J., Baiduc, C., Richardson, M., Bennett, A., Jakobsen, B., Riley, J.L., Vingert, B., Benati, D., Lambotte, O., de Truchis, P., Slama, L., Jeannin, P., Perez-Patrigeon, S., Boufassa, F., Kwok, W.W., Lemaître, F., Delfraissy, J.-F., Thèze, J., Chakrabarti, L.A., French, M., Center, R., Wilson, K., Fleyfel, I., Fernandez, S., Kelleher, A., An, P., Goedert, J., Donfield, S., Buchbinder, S., Kirk, G., Detels, R., Winkler, C., Lajoie, J., Juno, J., Burgener, A., Rahman, S., Mogk, K., Wachihi, C., Mwanjewe, J., Plummer, F.A., Kimani, J., Ball, T.B., Fowke, K.R., Fowke, K., Dieye, T.N., Chentouffi, A., Camara, M., Sarr, S., Tran, M.V., Seydi, M., Dasgupta, G., Fall, M., Daneau, G., Diaw, P.A., Kestens, L., Sow, P.S., Mboup, S., Benmohamed, L., Asmuth, D.M., Ma, Z.-M., Albanese, A., Devaraj, S., Hodzic, E., Garcia, J.-C., Knight, T.H., Flynn, N.M., Mann, S., Yotter, T., Tsuchida, E., Miller, C.J., Pallikkuth, S., Micci, L., Ende, Z., Iriele, R., Cervasi, B., Else, J., Silvestri, G., Villinger, F., Pahwa, S., Paiardini, M., Solomon, S., Murugavel, K.G., Vignesh, R., Bella, D., Shoba, R., Poongulali, S., Kumarasamy, N., Landay, A., Solomon, S.S., Swathirajan, C.R., Balakrishnan, P., Cu-Uvin, S., Mayer, K.H., Shacklett, B.L., Palmer, C.S., Zhou, J., Saleh, S., Lam, L., Hearps, A., Maisa, A., Pereira, C., Lewin, S., Jaworowski, A., McCune, J.M., Crowe, S., Doitsh, G., Galloway, N., Monroe, K., Yang, Z., Zepeda, O., Greene, W.C., Patel, M., Jenabian, M.-A., Lebouché, B., Brouillette, M.-J., Kema, I., Al-Ghazawi, F., Faller, E., Parmar, P., Kakal, J., MacPherson, P., Sugden, S., Sant, N., Vinton, C., Brenchley, J., Tabb, B., Hao, X.P., Hirsch, V.M., Lifson, J., Estes, J.D., Bushman, F., Sherrill-Mix, S., Ocwieja, K., Mukherjee, R., Brown, M., Chin, J., Custers-Allen, R., David, P., Olson, J., Travers, K., Schadt, E., Sánchez del Cojo, M., López-Huertas, M.R., Mateos, E., Coiras, M., Sampey, G., Van Duyne, R., Guendel, I., Gregg, E., Shafagati, N., Tyagi, M., Easely, R., Klase, Z., Romerio, F., Iglesias-Ussel, M., Nekhai, S., Kehn-Hall, K., Kashanchi, F., Kumar, N., Evans, V., Pereira, C.F., Ellenberg, P., Cameron, P.U., Lewin, S.R., Gray, L., Cowley, D., Crespan, E., Welsh, C., Mackenzie, C., Gorry, P., Wesselingh, S., Churchill, M., Marchionni, L., Weber, S., Burger, H., Kemal, K., Weiser, B., Korn, K., Doerfler, W., Vatakis, D., Cameron, P., Harman, A., Cunningham, A., Ma, D., Cillo, A., Xu, C.L., Kristoff, J., Fang, J., Haret-Richter, G., Mellors, J., Pandrea, I., Apetrei, C., Trinité, B., Ohlson, E., Rana, S., Alster, J., Levy, D.N., Victoriano, A.F.B., Hibi, Y., Tan Gana, N., Asamitsu, K., Okamoto, T., Marsden, M., Kovochich, M., Suree, N., Shimizu, S., Mehta, R., Cortado, R., Bristol, G., An, D.S., Zack, J., Madrid-Elena, N., Hernandez-Novoa, B., Lamas, M., Garcia-Bermejo, L., Moreno, S., Ruel, T., Achan, J., Huang, W., Cao, H., Li, P., Eller, L.A., Killian, M., Sinclair, E., Charlebois, E., Havlir, D.V., Wong, J., Henrich, T.J., Sciaranghella, G., Li, J.Z., Gallien, S., Ho, V., Lacasce, A.S., Kuritzkes, D.R., Del Prete, G., Kiser, R., Trubey, C.M., Smedley, J., Coalter, V., Oswald, K., Shoemaker, R., Fast, R., Li, Y., Lara, A., Wiles, A., Wiles, R., Macallister, R., Sanchez, R., Wai, J., Tan, C., Keele, B., Estes, J., Piatakjr, M., Hazuda, D., Symons, J., Deeks, S., Hutter, G., Wensing, A., Martin, J., van Ham, P., Vandekerckhove, L., Nijhuis, M., Kline, C., Ndjomou, J., Franks, T., Piatak, M., Ambrose, Z., Josefsson, L., Eriksson, S., Ho, T., Epling, L., Tan, A., Lemey, P., Faria, N.R., Shao, W., Hunt, P., Somsouk, M., Douek, D., Bacchetti, P., Loeb, L., Custer, J., Poole, L., Hecht, F.M., Palmer, S., Kikuchi, T., Iwabu, Y., Kawana-Tachikawa, A., Koga, M., Hosoya, N., Nomura, S., Brumme, Z.L., Jessen, H., Markowitz, M., Pereyra, F., Trocha, A., Walker, B.D., Iwamoto, A., Tokunaga, K., Miura, T., Bacchus, C., Hocqueloux, L., Avettand-Fenoël, V., Saez-Cirion, A., Mélard, A., Descours, B., Samri, A., Blanc, C., Autran, B., Rouzioux, C., Zink, M.C., Graham, D.R., Gama, L., Queen, S.E., Meulendyke, K.A., Mankowski, J.L., Clements, J.E., Beima-Sofie, K., Bigham, A., Lingappa, J.R., Wamalwa, D., Mackelprang, R.D., Maleche-Obimbo, E., Richardson, B., John-Stewart, G., Mackelprang, R., Celum, C., de Bruyn, G., Beima, K., Ronald, A., Mugo, N., Rainer, A., Buckingham, K., Bamshad, M., Mullins, J., McElrath, J., Lingappa, J., Madlala, P., Singh, R., Werner, L., Sibeko, S., Karim, S.S.A., Winkler, C.A., Ndung'u, T., Peterson, T., Bielawny, T., Mendoza, L., Thavaneswaran, S., Narayansingh, M., Kariri, T., Liang, B., Ngugi, E., Plummer, F., Luo, M., Kajaste-Rudnitski, A., Marelli, S., Poli, G., Berkhout, B., Das, A.T., Vicenzi, E., De Pasquale, M., Kourteva, Y., Allos, T., D'Aquila, R., Blackinton, J., Thompson, M., Mukherjee, N., Freel, S., Tomaras, G., Keene, J., Roan, N., Muller, J., Gawanbacht, A., Zirafi, O., Chu, S., Kirchhoff, F., Munch, J., Greene, W., Chandra, N., Thurman, A., Anderson, S., Cunningham, T., Mauck, C., Doncel, G., Introini, A., Vanpouille, C., Lisco, A., Grivel, J.-C., Munawwar, A., Singh, S., Margolis, L., Dinh, M., Anderson, M., Gioia, C., McRaven, M., Okocha, Z., Cianci, G., Hirbod, T., Kigozi, G., Prodger, J., Kaul, R., Kong, X., Gray, R., Hope, T., Nawaz, F., Cicala, C., Van Ryk, D., Wei, D., Pascuccio, M., Shrestha, S., Knox, J., Schwing, C., Hiatt, J., Chang, J., Jelicic, K., Fauci, A., Arthos, J., Fecek, R., Mailliard, R., Rinaldo, C., Martinez-Maza, O., Magpantay, L., Phair, J., Bream, J.H., Rinaldo, C.R., Jacobson, L.P., Chahroudi, A., Carnathan, D., Carnathan, P., Christ, F., Pickford, C., Demeulemeester, J., Shaw, S., Desimmie, B.A., Smith-Burchnell, C., Butler, S., Westby, M., Debyser, Z., Johnson, T., Clark, M., Clark, J., Shelke, N., Friend, D., Kiser, P., Hofmann-Sieber, H., Hauber, I., Chemnitz, J., Grundhoff, A., Chusainow, J., Schambach, A., Baum, C., Ziegler, P., Manz, M., Buchholz, F., Hauber, J., Kitchen, S., Levin, B., Rezek, V., Kim, S., Aguilera-Sandoval, C., Balamurugan, A., Yang, O., Chang, L.-J., Alkhatib, G., Huang, L.-M., Chen, Y., Yeh, Y., Dey, A., Kassa, A., Nandi, A., Sarkar, P., Sun, Y., Hartog, K., Labranche, C., Montefiori, D., Srivastava, I., Carfi, A., Barnett, S., Gulzar, N., Montero, M., Klaric, K.-A., Lepik, C., Donald, J., Tsai, S., Wu, S., Wang, S., Degrado, W., Lu, S., Scott, J.K., Tang, D., Capina, R., Yuan, X.-Y., Prego, C., Pinto, J.C., Alonso, M., Barry, C., Pilon, R., Daniuk, C., Tuff, J., Pillet, S., La, D., Czarnecki, C., Lacap, P., Peters, H., Wong, G., Kimani, M., Ball, T., Sandstrom, P., Kobinger, G., Vaccari, M., Cameron, M., Liyanage, N., Pegu, P., Gordon, S., Doster, M., Sekaly, R.-P., Franchini, G., Tran Thi Thanh, H., Van den Bergh, R., Massinga-Loembe, M., Colebunders, R., De Baetselier, P., Raes, G., Santos-Oliveira, J., Giacoia-Gripp, C., Regis, E., Alexandrino-Oliveira, P., Amato, V., Lindoso, J.A., Goto, H., Guerra, J., Mattos, M., Oliveira-Neto, M., Grinzstejn, B., Morgado, M., Da-Cruz, A., Tugizov, S., Herrera, R., Veluppillai, P., Greenspan, D., Palefsky, J., Thaisri, H., Moriuchi, M., Tsuchiya, N., Rojanawiwat, A., Pathipvanich, P., Sawanpanyalert, P., Ariyoshi, K., Moriuchi, H., Fitzgerald, W., Ngwende, S., Mudenge, B., Madzimure, D., and Mudenge, G.
- Subjects
A53 - Mycobacteria and tuberculosis ,AIDS2012 Abstract Supplement ,A32 - Host restriction factors including APOBEC, TRIM and others ,A10 - Mucosal immunity/defenses: responses and dysfunction ,A38 - Mother-to-child transmission ,A40 - Preclinical development of microbicides ,A57 - Novel assays for virological monitoring ,A14 - Pathogenesis in gut, lymphoid tissues and bone marrow ,A39 - Preclinical HIV drug development ,A34 - Mucosal transmission ,A12 - Mechanisms of activation / inflammation and impact in pathogenesis ,A25 - Cellular elements necessary for HIV replication ,A42 - Nucleic acid-based HIV and SIV therapies ,A56 - Novel assays of immune responses ,A31 - Host genetics of resistance and susceptibility ,A8 - Virus-specific cellular immunity ,A37 - Highly exposed seronegative individuals (HESN) ,A9 - Immune responses in resistant cohorts: elite controlers and exposed uninfected ,A4 - Bioinformatic analysis of viral diversity in natural ,A27 - Viral mechanisms of persistence and latency ,A55 - Interactions with other pathogens ,A23 - Regulation of gene expression and latency ,A28 - Mechanisms of eradication ,Public Health, Environmental and Occupational Health ,Infectious Diseases ,A7 - Virus-specific humoral immunity ,A33 - Systems biology approaches to HIV infection ,A44 - T cell-based vaccines ,A43 - B cell-based vaccines ,A29 - Tissue reservoirs ,A30 - Host cellular factors and latency ,A36 - Acute and early HIV infection ,A13 - Mechanisms of T cell depletion and dysfunction ,A45 - Novel vectors and strategies - Abstract
Background Many HIV databases and applications focus on a limited domain of HIV knowledge. Since even a “simple” organism like HIV represents a very complex system with many interacting elements, the fractured structure of existing databases and applications likely limits our ability to investigate and understand HIV. To facilitate research, therefore, we have built HIVToolbox, which integrates much of the knowledge about HIV proteins and presents the data in an interactive web application. HIVToolbox allows quick and convenient hypotheses generation, experiment interpretation, and potential new drug structure creation. Methods HIVToolbox was built as a standard three-tier J2EE web application, consisting of 1) an underlying relational MySQL database, 2) a set of standard Java data access objects that pull data from the database, and 3) a set of dynamic web pages the user interacts with. HIV-1 data from external sources such as the Protein Data Bank, NCBI, Los Alamos, etc. was collected, curated, and stored in the HIVToolbox database. Additional data, such as homology and position statistics matrices, was generated from existing data. Since version 1, drug binding site and drug resistant mutation data has also been added. Results HIVToolbox was used to create several new hypotheses about HIV-1 integrase, including predicting the location of a CK2 phosphorylation site, which was later confirmed by experiment. A new version of HIVToolbox support display of the 3D locations of drug resistant mutations on surface plots of HIV proteins and the drug binding sites for structures of complexes of HIV proteins with drugs. Conclusion HIVToolbox is an open-access web application that allows virologists and structural biologists to access detailed information about HIV-1 proteins, such as sequence, structure, functional sites and relationships, homology, drug binding sites, and drug resistant mutations, and to immediately see the relationships between any or all of them. Weblink: [http://hivtoolbox.bio-toolkit.com], Background Analysis of human monoclonal antibodies (mAbs) developed from HIV-1 infected donors have enormously contributed to the identification of neutralization sensitive epitopes on the HIV-1 envelope glycoprotein. The third variable region (V3) is a crucial target on gp120, primarily due to its involvement in co-receptor (CXCR4 or CCR5) binding and presence of epitopes recognized by broadly neutralizing antibodies. Methods Thirty-three HIV-1 seropositive drug naive patients (18 males and 15 females) within the age range of 20-57 years (median=33 years) were recruited in this study for mAb production. The mAbs were selected from EBV transformed cultures with conformationally constrained Cholera-toxin-B containing V3C (V3C-CTB) fusion protein. We tested the mAbs for their binding with HIV-1 derived proteins and peptides by ELISA and for neutralization against HIV-1 viruses by TZM-bl assays. Results We isolated three anti-V3 mAbs, 277, 903 and 904 from the cells of different individuals. The ELISA binding revealed a subtype-C and subtype-A specific binding of antibody 277 and 903 while 904 exhibited cross reactivity also with subtype-B V3. Epitope mapping of mAbs with overlapping V3 peptides showed exclusive binding to V3 crown. The antibodies displayed high and low neutralizing activity against 2/5 tier 1 and 1/6 tier 2 viruses respectively. Overall, we observed a resistance of the tier 2 viruses to neutralization by the anti-V3 mAbs, despite exposure of the epitopes recognized by these antibodies on the native viruses, as determined by intact virion binding assay with two representative subtype-C and B viruses (Du156.12 and JRFL). Conclusion Our study suggests that the anti-V3 antibodies derived from subtype-C infected Indian patients display neutralization potential against tier 1 viruses. Defining the epitope specificities of these mAbs and further experimental manipulations will be helpful in identification of epitopes, unique to clade C or shared with non-clade C viruses, for immunogen design., Background One major obstacle to induce bNAbs resides in the high variability of the viral envelope and structural mechanisms hiding crucial epitopes. Besides, maturation of bNAbs against HIV represents a difficult process that can be impaired by the immunodeficiency associated with HIV infection. We have explored the hypothesis that preserved B cell function in LTNPs could result in the production of bNAbs at higher frequency and increased affinity in comparison with HIV progressors. Methods Samples (142) from the cohort of LTNPs (median RNA copies/ml: 87, median CD4+: 802 cells/µl) were kindly provided by the HIV BioBank integrated in the Spanish AIDS Research Network (RIS). A control population of 191 untreated patients (median RNA copies/ml: 10,241, median CD4+: 567 cells/µl) from Hospital Clinic, Barcelona, was analyzed. Sera at 1/200 and 1/2000 dilutions were preincubated with Env recombinant viruses harboring a luciferase gene and then added to U87.CD4.CXCR4/CCR5. bNAbs specificities were studied by ELISA using mutated gp120 that abrogates antibody binding, competition ELISA with biotinylated antibodies, neutralization assays with mutated viruses and peptide competition neutralization assays. Results The percentage of elite neutralizers was higher in the LTNPs (9.3%) than in the control population (3.7%). Broadly neutralizing sera were screened for the presence of epitope-specific antibodies. CD4 binding site antibodies were detected in several sera. To determine whether these antibodies were responsible for broad neutralization, competition neutralization assays using RSC3 (antigenically resurfaced glycoprotein containing the CD4bs) were performed. RSC3 addition inhibited neutralization mediated by 16.7% of sera in LTNPs and 12.5% sera of the control population. Anti-MPER antibodies were detected in 50% individuals of both populations, including several sera with 4E10-like antibodies. Glycan-dependent HIV-1 NAbs were more abundant in LTNPs (66%) than in control population (37%). Conclusion Broad humoral immune responses against HIV-1 were more common among LTNP than a control population of untreated HIV-1-infected donors., Background HIV/SIV primarily infect activated CD4+ T cells, but can infect macrophages. Because of the relatively small percentage of infected macrophages, the interaction between antigen-specific CD8+ T cells and infected macrophages in HIV/SIV infection has been poorly studied. We, therefore, sought to determine whether SIV-specific CD8+ T cells could control viral replication in infected macrophages. Methods We wanted to ascertain whether ex vivo tetramer-sorted SIV-specific CD8+ T cells could suppress viral replication in SIVmac239/316e- and SIVsmE660-infected macrophages using a recently developed 48-hour viral suppression assay. We reasoned that freshly sorted CD8+ T cells might be more representative of the in vivo properties of CD8+ T cells than in vitro cultured cell lines and clones. Results Surprisingly, both ex vivo tetramer-sorted SIV-specific CD8+ T cells and bulk CD8+ T cells that eliminated and suppressed viral replication in SIV-infected CD4+ T cells were inefficient at controlling viral replication in SIV-infected macrophages. Our data suggest that macrophages may be an important reservoir for SIV because it may be difficult for SIV-specific CD8+ T cells to suppress viral replication in this particular cell type. Conclusion It is possible, therefore, that while AIDS virus-infected macrophages only constitute a small percentage of all virus-infected cells, they may be relatively resistant to CD8+ T cell-mediated lysis and continue to produce virus over long periods of time. Thus, macrophages could actually be contributing significantly to viral production. Induction of HIV/SIV-specific CD8+ T cells capable of killing infected macrophages or preventing establishment of the macrophage reservoir HIV might be critical for controlling viral replication., Background The potential role of ADCC in prevention of infection is suggested by the RV144 HIV vaccine trial where non-neutralizing antibodies contributed to protection against infection with HIV. Studies from Kenya showed that HIV specific IgA in cervical fluid was present in uninfected sex workers. We aimed to analyze cervicovaginal lavage fluid(CVL) from 2 seroconverters (SC) and 10 highly exposed seronegative women who had unprotected sex with known positive partners. Methods A 51Cr-release assay with natural killer cells or monocytes as effectors was used to measure IgG or IgA mediated ADCC against clade specific gp120 coupled target cells. We analyzed CVL from ESN at one visit, and SC at intervals from one yr pre-seroconversion (PSC) to 6.5 yr after seroconversion (ASC). We evaluated activity at 4, 10 fold serial dilutions starting with a 1/10 dilution. Results Figure 1 (top)shows shows minimal to no activity of IgG mediated ADCC in the CVL of 10 ESN. Figure 1(bottom) shows IgA mediated ADCC in the CVL of the same 10 ESN. 4 patients show significant activity above background activity. At the peak dilution, patient 4 shows 27.3% Specific Release (SR), patient 6 shows 14.5 %SR, patient 8 shows 17.9 %SR and patient 10 shows 17.6 %SR. Figure 2 and 3 shows no IgA mediated ADCC activity in CVL of 2 seroconverters from PSC to 6.5 years ASC even while IgG activity is present in later visits. Conclusion HIV IgA in CVL samples was associated with ADCC and lack of HIV infection in exposed women, indicating that genital HIV IgA may contribute to protection from infection. Further studies need to be done to determine if IgA mediated ADCC antibodies may be protective in ESN., Background CD4+ T-cells from gut-associated lymphoid tissues (GALT) are major HIV-1 targets. Recruitment of excess effector CD8+ T-cells in the proximity of target cells is critical for the control of viral replication. We investigated the colocalization potential of HIV-specific CD8+ and CD4+ T-cells into the GALT and explored the role of retinoic acid (RA) in regulating this process in a cohort of HIV-infected subjects with slow disease progression (SP). Methods Five SP subjects were available for this study: median CD4 counts 670 cells/µl, plasma viral load 3.27 log10 HIV-RNA copies/ml, and 15 years of infection. PBMC were exposed to HIV peptides or CMVpp-65 protein in the presence or absence of all-trans RA (ATRA) or the RA antagonist LE540. The expression of trafficking molecules on antigen specific T-cells was analyzed by flow cytometry using the CFSE assay. Results The expression of the gut-homing molecules integrin β7, CCR6, and CXCR3 was identified as a “signature” for HIV-specific but not CMV-specific CD4+ T-cells, thus providing a new explanation for their enhanced permissiveness to infection in vivo. HIV-specific CD8+ T-cells expressed high levels of integrin β7 and CXCR3; however CCR6 was detected at superior levels on HIV-specific CD4+ versus CD8+ T-cells. ATRA upregulated the expression of integrin β7 but not CCR6 on HIV-specific T-cells. Conclusion HIV-specific CD8+ T-cells may colocalize in excess with CD4+ T-cells into the GALT via integrin β7 and CXCR3, but not CCR6. Considering our previous findings that CCR6+CD4+ T-cells are major HIV targets, a limited ability of CD8+ T-cells to migrate in the vicinity of CCR6+CD4+ T-cells may facilitate HIV dissemination at mucosal sites. In addition to other previously described T-cell features (e.g., antiviral properties, poly-functionality, and exhaustion), the colocalization potential of CD4+ and CD8+ T-cells represents a new parameter to consider for predicting the efficacy of anti-HIV responses., Background An attractive approach for restoring CTL activity to HIV-1 infected individuals is the adoptive transfer of autologous CD8 T cells that have been transduced with an HIV-1 specific TCR. Previously, we described an HLA-A2-SL9 specific TCR that when introduced into CD8 T cells could control HIV-1 replication in an in vitro suppression assay. Given that the success of HAART is based, in part, on attacking multiple targets, we isolated an additional HLA-A2 restricted, HIV-1 specific TCR targeting the HIV-1POL sequence YQYMDDLYV. This epitope is of great clinical relevance because it lies within the active site of Pol and is a target of many reverse transcriptase inhibitors. Methods By surface plasmon resonance, we defined the Kd of this wild type TCR to be 6.7µM and t1/2 to be 2.7s. Using phage display, a panel of affinity enhanced A2-YV9 TCRs were obtained with Kd values ranging from 5.1 to 0.3µM. Results When introduced into CD8 T cells by lentiviral vectors, the A2 YV9 specific TCRs were highly specific for the wild type epitope. In contrast to what we previously determined for CD8 T cells transduced with the wild type A2-SL9 specific TCR, we observed that the A2-YV9 specific T cells could respond in a polyfunctional manner by simultaneously producing TNF-α, IFN-γ, IL-2, and MIP1-β when presented with a wide range of peptide concentrations. Moreover, affinity enhanced A2-YV9 specific CD8 T cells were able to recognize and respond to several variants of the wild type sequence, including those responsible for resistance to NNRTI and NRTI such as Nevirapine, Didanosine and Efavirenz. Conclusion Together, our data suggest that adoptive transfer of these A2-YV9 specific CD8 T cells presents great potential for augmenting available treatments and imparting additional control to HIV-1 infected individuals experiencing drug resistance., Background HIV Controllers are rare individuals who spontaneously control HIV replication in the absence of antiretroviral therapy. To identify parameters of the CD4 response that may contribute to viral control, rather than merely reflect a persistently low viremia, we compared the T helper profile in two groups of patients with more than 10 years of viral suppression: HIV Controllers from the ANRS CO18 cohort (n=26) and efficiently treated patients (n=16). Methods Cells specific for immunodominant Gag and CMV peptides were evaluated for the production of 10 cytokines and cytotoxicity markers, and were also directly quantified ex vivo by MHC class II tetramer staining. Results HIV Controller CD4+ T cells were characterized by a higher frequency of IFN-γ production, perforin+/CD107a+ expression, and polyfunctionality in response to Gag peptides. While IL-4, IL-17, and IL-21 production did not differ between groups, treated patients cells produced more IL-10 in response to Gag and CMV peptides, pointing to persistent negative immunoregulation after long-term antiretroviral therapy. Gag293 tetramer-positive cells were detected at high frequency (0.15%) and correlated positively with IFN-γ producing CD4+ T cells in the Controller group (R=0.84; P=0.01). Tetramer-positive cells were fewer in the HAART group (0.04%) and did not correlate with IFN-γ production, supporting the notion of a persistent immune dysfunction in HIV-specific CD4+ T cells of treated patients. Conclusion HIV Controllers maintained a population of highly efficient Th1 effectors directed against Gag in spite of a persistently low antigenemia, while patients treated in the long-term showed a loss of CD4 effector functions. We previously reported that HIV Controllers harbored a unique population of CD4+ T cells expressing high avidity TCRs directed against Gag293. We propose that high avidity drives continuous Th1 effector differentiation in response to low antigen concentrations and explains the persistence of an activated antiviral response in HIV Controllers., Background Natural control of HIV infection is associated with CD8+ T cell responses to HIV core antigens, encoded by Gag, restricted by ‘protective’ HLA-B alleles (HLA-B27, -57, -58). Slower progression of HIV infection is associated with antibodies to HIV core proteins but mechanisms are unclear. Antibody responses that have isotype switched to IgG2 may be particularly effective. We have investigated this further. Methods Plasma from 32 HIV controllers (HIV RNA2SD of non-HIV sera for rp55 antibodies. Antibodies to rgp140 were titred. Controllers were HLA typed by sequenced-based typing using genomic DNA. Results Controllers had a positive IgG1 or IgG2 antibody response to one or more core protein (p17, p24) on WB more often than non-controllers (75% vs 28.6%, p=0.0016 and 22% vs 0, p=0.034, respectively). Also, 12.5% of controllers but no non-controllers had a positive IgG2 antibody to rp55 (p=0.14). When results of WB assays and ELISA were combined, 34% of controllers but no non-controllers had positive IgG2 antibodies to core antigens (p=0.04). Positive IgG2 antibodies to core antigens were more common in patients without ‘protective’ HLA-B alleles (57%) than patients with these alleles (16.5%) (p=0.026). Positive IgG1 antibodies to Pol-encoded proteins were also more common in controllers (p=0.0003) but IgG2 antibodies were not detected. IgG1 and IgG2 antibodies to envelope antigens showed few differences. Conclusion An isotype switched IgG antibody response to HIV core antigens is associated with control of HIV infection in patients without ‘protective’ HLA-B alleles., Background A recent genome-wide association study (GWAS) of host determinants for HIV-1 disease revealed that single nucleotide polymorphisms (SNPs) near genes HLA-C and ZNRD1 were associated with setpoint HIV-1 viral load and disease progression. ZNRD1 has also been identified as a host protein required by HIV-1 life cycle in a genome-wide functional genomic study. Methods We investigated the effects of 13 SNPs in the ZNRD1 region on HIV-1 infection and progression in five U.S-based treatment-naive HIV-1 longitudinal cohorts consisting of homosexuals, hemophiliacs and injection drug users (IDUs) (n=1028). Allelic frequencies were compared between HIV-1 seronegatives (SN) and seroconverters (SC) with further analysis focusing on high-risk exposed HIV-1-uninfected individuals (HREU) compared to HIV-1 seroconverters (SC). Among HIV- 1 seroconverters, variation in time to clinical AIDS was assessed by haplotype. Electrophoretic mobility shift assay (EMSA) was used to assess the associated SNP's potential to alter DNA-protein interactions. Results A haplotype in the ZNRD1 gene showed significant association with decreased risk of HIV-1 acquisition (OR=0.65, 95% CI 0.47-0.89), independent of the effect of HLA-C rs9264942. The tag SNP allele in the ZNRD1 promoter region causes a loss of nuclear factor binding, as revealed by EMSA. This differential binding was further shown to be cell-specific, occurring in Hela epithelial cells instead of Jurkat T-cells (stimulated or unstimulated), suggesting its regulatory role in mucosal epithelial barriers influence HIV-1 transmission. Indeed, this infection effect was not observed in HIV-1 infected IDUs (OR=0.82, 95% CI, 0.44-1.54). On the other hand, SNPs and haplotypes for ZNRD1 modestly affect progression rate to AIDS. Conclusion This study provided novel evidence supporting a direct role of ZRND1 in modulating HIV and identified a ZNRD1 allele as a host resistant factor to HIV-1 acquisition. (Funded by NCI HHSN26120080001E), Background Understanding the early events during heterosexual HIV transmission at the genital mucosa is necessary to develop a safe and efficacious HIV microbicide or vaccine. A recent workshop highlighted the benefits of studying Highly Exposed Seronegative (HESN) individuals in order to identify and describe correlates of HIV protection. In an HESN cohort of commercial sex workers in Nairobi, Kenya, we have described a state of reduced systemic T cell immune activatio termed Immune Quiescence. However, the extent of Immune Quiescence at the genital mucosal is not known. This study characterized the female genital mucosal profile of cells, cytokines and chemokines involved in immune activation and lymphocyte recruitment among HESN. Methods CVL and plasma from commercial sex workers from the Majengo clinic in Nairobi, Kenya (57 HIV- followed for7 years) were analysed for the presence of 22 cytokines/chemokines and five antiproteases previously associated with resistance to HIV infection. Activation of cervico vaginal cells was analysed by multiparametric flow cytometry. Results HESN women have a unique pattern of mucosal chemokine/cytokine expression. HESN subjects showed lower expression of MIG, IP-10 and IL-1a as well as higher levels of antiproteases. Among the HESN women there was a distinct chemokine gradient between the blood and genital mucosa relative to control women. Conclusion MIG and IP-10 are important regulators of T cell trafficking to the genital mucosa while IL-1a is an indicator of immune activation. The reduced levels of these cytokines/chemokines together with the unique correlations observed with antiprotease expression among HESN women suggest that the Immune Quiescent phenotype extends to the female genital tract. Reducing the number of activated CD4+ T cells in the FGT could limit cellular targets for HIV infection and may be an important component to resisting HIV infection., Background For 26 years a group of HESN women from Nairobi, Kenya who can be epidemiologically described as relatively resistant to HIV infection have provided clues towards the identification of natural correlates of protection against HIV-1 infection. Studies of these HIV-1-resistant women suggest they posses a unique mucosal environment which includes the overexpression of specific antiproteases and a unique proinflamatory cytokine expression patern. Here we describe how these factors contribute to protection against HIV infection during mucosal transmission. Methods Cervical lavage fluid (CVL) from 277 women were collected from 76 HIV-1-resistant, 120 HIV-1 uninfected, and 97 HIV-1 infected women. CVL protein was analyzed both independently by SELDI-TOF MS and as pooled groups by 2D-LC-FTICR MS. Of the more than 350 unique proteins identified 29 proteins were differentially expressed (> 2-fold cutoff) between HIV-1-resistant women and controls. These findings were confirmed by traditional ELISA and quantitative Western Blot (WB) analysis. Results The majority of overexpressed proteins were serpins, their breakdown products (p=2.2 x 10−8), and other antiproteases, as well as innate factors with known anti-HIV-1 activity. The overexpression of specific serpins and an epithelial-derived antiproteases was confirmed by ELISA and WB (p=0.004, p=0.05, and p=0.02). Underexpressed proteins in HIV-resistant women included inflammatory proteases and immune response factors. Cytokine/chemokine analysis revealed that antiprotease expression correlated with pro-inflammatory cytokines (p, Background Herpes simplex virus type 2 (HSV-2), the most frequent cause of genital ulcer disease (GUD), has been shown to play a more important role than any other sexually transmitted infections (STIs) in driving HIV prevalence in Africa. In turn, HIV-1 infection leads to more frequent HSV-2 reactivations and shedding. The exact immune mechanisms involved in this virological negative immuno-synergy are unknown. In the present study we sought to assess whether HIV co-infection would affects HSV-specific T cell immunity. Methods Nineteen HSV peptides, derived from HSV-2 glycoproteins gB and gD, were used to analyze the frequency and the magnitude of HSV-2-specific IFN-γ-producing CD4+ and CD8+ T cell responses in 30 HSV-2 seropositive patients and 17 HSV-2 seronegative individuals in a cohort of heterosexual Senegalese HIV-discordant couples, using ELISpot assay. HIV RNA viral load has been run for HIV infected subjects and CD4 count ran for all subjects using a flow cytometry method. Results The magnitude and frequency HSV-2-specific T cell responses was compared between 21 HSV-2 co-infected with HIV-1 and 9 HSV-2 mono-infected individuals. A significantly higher magnitude of IFN-γ-producing T cell responses were observed in HSV-2 infected patients compared to seronegative individuals (median, 61 vs. 0 spots/106 PBMC, P=0.001). Moreover, twenty-four (80%) out of 30 HSV-2 seropositive patients showed significant HSV-2-specific IFN-γ-producing T cell responses compared with only 6 (35%) out of 17 HSV-2 negative subjects (P, Background HIV-infection leads to GALT CD4+ T-cell depletion that persists despite prolonged antiretroviral therapy (ART). SBI is a medical food that neutralizes bacterial antigens and reduces gut inflammation in animal models. Methods Subjects on ART with diarrhea and a thorough negative GI-workup received SBI (EnteraHealth, Ankeny,IA,USA) 2.5 grams BID for 8 weeks. 4-hour urine disaccharide gut permeability and absorption test and duodenal biopsies were obtained before and at 8-weeks. Immunohistochemistry for CD3/CD4 was performed on biopsies and flow cytometry was performed on duodenal single-cell suspensions and PBMCs for lymphocyte subsets. Markers of bacterial translocation and cytokine levels were measured in plasma. Stool was collected for 16S rDNA quantification and sequencing. Median values (interquartile ranges) and nonparametric analysis are reported. Results All 8 subjects experienced resolution of GI-related symptoms. D-xylose absorption increased in 7/8 subjects and in those with improvement, the absorption levels increased from 31.4 mgs (28.5, 38.8) to 41.5 mgs (33.7, 45.2)(p=0.016). Gut permeability was normal before [0.024% (0.0, 0.048)] and after [0.032% (0.0, 0.047)] intervention (normal, Background Interleukin (IL)-21 regulates three immunological functions - Th17 cell homeostasis, differentiation of memory B cells and antibody-secreting plasma cells, and long-term maintenance of functional CD8+T-cells - that are compromised in pathogenic HIV and SIV infections. Since IL-21 availability is reduced during infection, we hypothesized that in vivo administration of IL-21 might be beneficial for HIV infected humans. Methods We infected 12 rhesus macaques with SIVmac239 (i.v.), and then treated 6 of them with rhesus rIL-21-IgFc (50mg/kg, s.c., once weekly for 5 weeks) during the early infection (from day 14 to 42 post-infection). Effects of IL-21 on viral load, immune activation, homeostasis of T-cells and their main subsets as well as T-cell cytotoxic potential have been evaluated in blood and mucosa by q-PCR, IHC, and flow cytometry up to 6 months post-infection. Mann-Whitney test and Spearman correlation were used for statistical analyzes. Results IL-21 treatment was safe and did not increase plasma viral load or systemic immune activation. Compared to untreated animals, IL-21 treatment resulted in (i) increased expression of Perforin and GrB in total and virus specific CD8+T-cells of various anatomical sites (P, Background The majority of new HIV infections are acquired via heterosexual transmission. Certain individuals remain seronegative despite repeated high-risk exposure to HIV. The correlates of protection in exposed seronegative(ESN) individuals remain unclear. The purpose of this study was to determine the breadth and persistence of HIV-specific CTL responses in blood and cervical mucosa of ESN women. Methods The ESN cohort included 30 female partners of antiretroviral naïve HIV+ men. ESN women were followed longitudinally for 3-6 months. Controls included sero-concordant couples (n=17) and low-risk seronegative women (n=30). PBMC and mucosal mononuclear cells (MMC) from cervical cytobrush were stimulated with HIV Gag and Env (Clade C) peptide pools; IFN-g production was measured by intracellular cytokine staining. IFN-g production by>0.1% of cells after background subtraction was considered positive. Samples with, Background A characteristic feature of the early phase of mammalian cells to metabolic stress is an increase in the rate of glucose uptake and metabolism. Glucose transporter 1 (Glut1) is the major glucose transporter in T cells and its expression is increased on CD4+T cells during chronic HIV-1 infection in vivo (Palmer et al., Abstract 1, IAS, 2012). We therefore seek to determine the impact of increased Glut1 expression on glucose metabolism in CD4+T cells from HIV-1-infected subjects. Methods The cell surface expression of Glut1 and glucose uptake (2-NBDG) was monitored in CD4+T cells from HIV-1 infected treatment naïve or HIV- controls subjects by flow cytometry. Hexokinase and glycolytic activity was measured by the intracellular concentrations of Glucose-6-phosphate (G-6-P) and L-lactate, respectively. Intracellular PTEN, pAkt (T308) and pAkt (S473) levels determined PI3K-mTOR activity. In vitro HIV-1 infection was performed on PBMCs activated with anti-CD3/CD28 microbeads and IL-7 and incubated with the CXCR4-using NL4.3-GFP virus. Results Basal glucose uptake, G-6-P, L-lactate, intracellular p-Akt (T308) and p-Akt (S473) were significantly higher in CD4+Glut1+ vs CD4+Glut1- cells. This corresponded with an overall increased glucose uptake and glycolysis and lower levels of PTEN expression in CD4+T cells from HIV-1+subject vs seronegative individuals. Anti-CD3/CD28-induced Glut1 expression on CD4+ T cells was sensitive to specific inhibition of the Class1B PI3K-y and mTORC1 pathways which also blocked HIV-1 infection of CD4+T cells in vitro. Conclusion CD4+T cells from HIV-1 infected patients have increased glucose uptake and glycolytic activity mediated at least in part by the PI3k-y-mTORC1 pathway. Increased Glut1 cell surface expression and glycolysis in CD4+T cells may increase their susceptibility to HIV-1 infection and foster their depletion due to hypermetabolism. Approaches to normalize Glut1 expression or glycolysis in CD4+T cells may offer a platform for interventions to slow HIV-1 disease progression., Background Progressive depletion of CD4 T cells is a hallmark of AIDS yet the underlying mechanism remains poorly understood. In human lymphoid cultures, most of the dying cells correspond to abortively infected resting CD4 T cells (Cell 143:789-901,2010). We have now studied how these cells die. Methods Human lymphoid aggregated cultures (HLACs) prepared with human tonsil and spleen were used to recapitulate many of the conditions encountered by HIV in vivo. CD4 T cell death is prominent in HLAC following viral infection. Results >95% human lymphoid CD4 T cells that die in HLAC are abortively, not productively, infected. These nonpermissive resting cells accumulate incomplete cytosolic viral transcripts that trigger an innate immune response resulting in interferon-beta production and activation of caspase-3 and caspase-1. Most cells die as a consequence of caspase-1-mediated pyroptosis, an intensely inflammatory form of programmed cell death where cytoplasmic contents and pro-inflammatory cytokines (IL-1b) are released. Unexpectedly, HIV-induced CD4 T-cell death and release of inflammatory mediators can be blocked by addition of certain oral sulfonylureas like glimepiride that inhibit P2X7 ion channels, and are FDA-approved for the treatment of type II diabetes. Conclusion 1. Abortively infected lymphoid CD4 T cells do not die due to the action of an HIV virulence factor(s), but rather because of host innate immune response launched against viral DNA produced in these cells. 2. This response likely evolved to protect the host from spread of infection, but the involvement of pyroptosis appears to trigger additional rounds of cell recruitment, infection, cell death, and inflammation. 3. CD4 T-cell depletion is blocked by P2X7 inhibitors that may interfere with pyroptosis. Such agents might be clinically useful in combination with classical antiretrovirals, particularly in HIV-infected subjects displaying rapid progression of disease or broad drug resistance., Background Increased Tryptophan (Trp) catabolism into kynurenine (Kyn) and/or 3-hydroxykynurenine (3OH-kyn) by indoleamine 2,3 dioxygenase (IDO), contributes significantly to the persistent immune activation during HIV infection and plays a detrimental role in T cell responses in advanced AIDS. We herein studied Trp catabolism in elite controllers comparing to other well established groups of HIV patients with different disease outcomes. Methods Plasma samples from elite controllers (EC) (n=21), ART-naive (n=96), ART-successfully treated (ST) (n=18), and healthy controls (n=51) were collected. All these groups were standardized for nutritional status (albumin levels and body mass index). Levels of Trp, Kyn and 3OH-kyn were measured using isotope dilution tandem mass spectrometry and the markers of Trp catabolism (Kyn/Trp and 3OH-kyn/Trp ratios) were correlated to clinical data. Results In ART-naive patients, viral load was positively associated with Kyn, 3OH-kyn levels and the markers of Trp catabolism (p, Background In view of the role interleukin (IL)-7 plays in T-cell survival, homeostasis and function it is no surprise expression of the IL-7 receptor alpha-chain (CD127) is tightly regulated. We previously showed that expression of CD127 is suppressed on CD8 T-cells in HIV+ patients and that this suppression is mediated by both IL-7 and the HIV Tat protein. IL-7 down-regulates CD127 transcripts and surface protein through two distinct mechanisms. In this study we examine the mechanism by which IL-7 down-regulates the CD127 gene at the level of transcription. Methods CD8 T-cells from HIV-negative volunteers were treated with IL-7 (0.1−10 ng/ml) in the presence or absence of various inhibitors. CD127 transcripts were quantified by qPCR. STAT-5 phosphorylation was measured by flow cytometry. Nuclear run-on assays were utilized to measure the rate of CD127 gene transcription. Candidate CD127 repressors were identified using PCR arrays, qPCR, Western and siRNA-mediated gene knock-down assays. Results IL-7 attenuates levels of CD127 transcripts in CD8 T-cells in a time- and dose-dependent manner. Both the full-length transcript and the splice-variant encoding the secreted isoform of CD127 are suppressed by IL-7. We show by nuclear run-on assay that IL-7 suppresses the rate of transcription of the CD127 gene and found no evidence that IL-7 affects the stability of CD127 mRNA. Further, the suppression of CD127 transcripts is dependent on JAK kinase activity and phosphorylation of STAT-5 but not STAT-3. Notably, cycloheximide blocked IL-7's ability to down-regulate CD127 transcripts suggesting IL-7 stimulates the de novo synthesis of a transcriptional repressor which in turn suppresses CD127 gene transcription. We recently identified several candidate repressors using PCR arrays and are currently examining their involvement in the transcriptional suppression by siRNA-mediated knockout experiments. Conclusion Upon binding to its receptor, IL-7 activates the JAK/STAT-5 signaling and induces the expression of a transcriptional repressor which suppresses CD127 gene transcription., Background Interleukin (IL)-7 plays essential roles in T-cell development, homeostasis and activation. Disruption of this cytokine pathway likely contributes to HIV-induced immune deficiency. We previously showed that IL-7 and the HIV Tat protein reduce the half-life of the IL-7 receptor alpha-chain (CD127) in human CD8 T-cells but the mechanism directing CD127 to the proteasome is not yet understood. In this study we examined roles of SOCS proteins in regulating CD127 expression. Methods CD8 T-cells isolated from healthy HIV-negative volunteers were treated with IL-7 (0.1–10 ng/ml) in the presence or absence of various inhibitors. SOCS1-7 and CIS transcripts were examined by qPCR and protein expression was measured by Western. The interaction of SOCS proteins with CD127 was examined by Co-IP. Surface CD127 protein expression was measured by flow cytometry. Intracellular localization of SOCS and CD127 protein was examined by confocal microscopy. Results IL-7 induces the expression of SOCS1-3 and CIS transcripts in CD8 T-cells via the JAK/STAT-5 signaling pathway in a time- and dose-dependent manner with SOCS2 transcripts increasing 300-fold within 3 hours. While induction of SOCS2 and SOCS3 mRNA was transient, SOCS1 and CIS transcripts remained elevated over baseline for at least 48 hours. Western blot analysis confirmed increased protein expression of the induced SOCS genes. Preliminary data on CD8 T-cells isolated from HIV+patients indicate that the IL-7-mediated up-regulation of SOCS transcripts is significantly decreased compared to healthy controls. IL-7 induces rapid phosphorylation and internalization of CD127 followed by proteasomal degradation. By Co-IP we show SOCS proteins induced by IL-7 physically interact with CD127 and study their cellular localization by confocal microscopy. We hypothesize this interaction directs the receptor to the proteasome. Conclusion IL-7 induces the expression of SOCS1-3 and CIS genes through the JAK/STAT-5 pathway. Through physical interaction with CD127, SOCS proteins may direct CD127 to the proteasome for degradation., Background Nonhuman primate natural hosts for simian immunodeficiency viruses (SIV) develop a non-resolving chronic SIV infection, but do not develop AIDS. While several hypotheses, such as down-modulation of immune activation and differential surface expression of SIV receptors, have been suggested as putative mechanisms to explain the nonprogressive nature of SIV infection in natural hosts, mechanisms underlying high and maintained levels of plasma viremia without apparent loss of target cells in natural hosts remain unclear. Methods Here, we have used flow cytometric sorting, quantitative real-time PCR, immunohistochemistry, and in situ hybridization to study viral infectivity and production within subsets of peripheral blood and lymph node-resident CD4+ T cells in cohorts of chronically SIVsmm-infected sooty mangabeys and SIVsmE53-infected rhesus macaques. Results We find: (1) infection frequencies among PB and LN-resident CD4+ T cells in chronically SIVsmE543-infected RM are significantly higher than those in SIVsmm-infected SM; (2) differential virus targeting is observed among anatomical LN niches and among individual CD4+ T cell subsets in SIV-infected RM and SM; (3) lymph node resident TFH cells are preferentially SIV-infected in RM, but these cells are not preferentially infected in SM and; (4) infectivity of central and effector memory CD4+ T cells is associated with plasma viremia in RM while infectivity of only effector memory CD4+ T cell infectivity is associated with plasma viremia in SM. Conclusion These data provide mechanistic insights into the maintenance of immunological function among chronically SIV-infected natural hosts for SIV, provide an explanation as to how natural hosts are able to maintain high levels of plasma viremia without apparent loss of target cells, and may lead to novel gene therapy interventions to recapitulate the natural host phenotype to animals that are susceptible to SIV-induced disease., Background Transcription of the HIV-1 genome yields an initial pre-mRNA which undergoes complex alternative splicing to produce over multiple spliced mRNAs. Analysis of host cell factors important for HIV replication by genome-wide siRNA screens has emphasized that HIV replication is extremely sensitive to the complement of available splicing factors, suggesting that HIV splicing may be an attractive target for therapeutic intervention. Here, we have used single molecule amplification and third generation sequencing to characterize splice patterns for the patient isolate HIV89.6 under different conditions. Methods We infected HOS cells or primary T-cells and carried out single molecule PCR in emulsionsto minimize competition among amplicons. We then used Pacific Biosciences single molecule sequencing to analyze message populations. Results Primary sequence read lengths averaged 1.6 Kb, and 5% of reads were over 3.8 Kb. Over 100 different messages was documented, more than doubling the previous number. The HIV sequence reads confirmed all of the known major splice junctions and identified new splice junctions, which create new ORFs in the 89.6 isolate. The presence of these new transcripts was confirmed using RT-PCR. The ORFs encode a novel form of Tat with an altered carboxy terminus and a Rev-Nef fusion (dubbed “Ref”) containing the amino terminal helix of Rev and the carboxy terminal portion of Nef. Using this assay, we found that HIV splicing differed between different cell types, differed between different human donors, and changes over time after infection. Conclusion These data illustrate how the diversity and promiscuity of splicing in HIV allows the virus to respond to different cellular environments and provides a continuous supply of evolutionary novelty that can potentially serve as a substrate for natural selection., Background HIV-1 infected cells have evolved strategies to delay apoptosis but the exact mechanism is unknown. One explanation could be the enhancement of Bcl-2 levels. MicroRNAs (miRNAs) are small non-coding RNAs that participate in the innate immune response. Several cellular miRNAs target viral mRNAs, leading to a decreased viral replication, but viruses may also counteract this effect. In the case of HIV-1, Tat has been described as an RNAi suppressor, although this statement remains controversial. To get better insight into this issue and into the effect of Tat in protection to apoptosis, we have analyzed the miRNA expression pattern in Jurkat cells expressing different forms of Tat. Methods The miRNA expression profile of Jurkat cells with stable expression of HIV-1 full-length Tat101 (two-exon protein) or Tat72 (exon 1 isoform) was analyzed with a two color-based array of miRNAs (Exiqon). Differences in miRNA expression were then confirmed by qRT-PCR. Results Global down-regulation of cellular miRNAs due to the expression of Tat was not observed. Instead, several specific miRNAs were dis-regulated due to the expression of Tat101 or Tat72, although the expression of the second exon granted a higher modification. We confirmed that cellular miR-21 and miR-222 were up-regulated in Jurkat Tat101 cells. miR-21 plays an important role in apoptosis. Since a higher resistance to FasL-mediated apoptosis was observed in Jurkat Tat101, we established a correlation between this protection and the increased levels of Bcl-2 in Jurkat Tat101. Regarding miR-222, it regulates cell cycle progression. In agreement with this, Jurkat Tat101 cells showed less proliferation capacity than control cells. Conclusion HIV-1 Tat does not show a general RNAi suppressor activity but it increases specifically several human miRNAs, conferring cells protection to apoptosis. This phenomenon was dependent on the expression of full-length Tat., Background Throughout the years many labs have discovered important factors that contribute to the transcription of HIV-1. Most of these factors have been well characterized and their significance has been validated. Some of the critical factors involved in Tat activated transcription include RNA Pol II (associated with LTR), chromatin remodeling complexes (i.e. SWI/SNF), acetyltransferases (i.e. CBP, p300, pCAF), NFκB and components of pTEF-b. Surprisingly, almost none of the published literature has focused on finding these factors as complexes from genuine HIV-1 infected cells. Here we show presence of undiscovered complexes unique to HIV-1 infected cells which may serve as targets of inhibition. Methods We utilized a combination of HIV infected cell lines and primary latent cells (both T-cells and monocyte/macrophages) to define changes of protein complexes in infected cells. We utilized large quantities of infected cell lysates for size-exclusion chromatography to find novel kinases (i.e. cdk9/T complexes), and chromatin remodeling complexes, among others in presence of high salt (500 mM). Results We found that there are novel cdk9/T complexes ranging from 2 MDa to ~300 KDa present only in T-cells that produce virus. Other components of the pTEF-b are also examined and found to be mostly unchanged in infected vs uninfected cells. Other novel complexes present only in infected cells included kinases for the NFkB pathway and SWI/SNF proteins. Many of these proteins are extremely stable and are targets of drug inhibition. Using a small panel of drugs, we find that many of the kinases utilized for transcription of HIV-1 have varying IC50s depending on the size of the complex and their protein partners. Conclusion HIV-1 infected cells contain many novel protein complexes that are yet to be discovered. Here we use a simple method of size exclusion to discover novel complexes that could potentially be used as targets of inhibition in therapeutics., Background Latently-infected resting CD4+ T-cells are a major barrier to the eradication of HIV infection. These cells are enriched in lymphoid tissue compared to blood. We hypothesized that interactions between dendritic cells (DC) and resting CD4+ T-cells are critical for the establishment and maintenance of HIV latency. Methods Resting CD4+ T-cells labelled with eFluor670 were cultured alone or with syngeneic DC for 24h prior to infection with a CCR5-tropic, EGFP-reporter virus. Non-proliferating (eFluor670hi), non-productively-infected (EGFP-) CD4+ T-cells were sorted on day 5 post-infection. Latent infection was re-activated and amplified by co-culturing sorted cells with mitogen stimulated PBMC. Results Infection of resting CD4+ T-cells in the presence of myeloid (m)DC significantly increased latent infection of non-proliferating CD4+ T-cells compared to infection of T-cells cultured alone (p=0.0005, n=11). Latent infection was not increased in resting CD4+ T-cells co-cultured with plasmacytoid DC (n=11) or monocyte-derived-dendritic-cells (n= 2). Co-culture of mDC with memory (CD45RO+) CD4+ T-cells but not naïve (CD45RO-) CD4+ T-cells resulted in latency (n=6). eFluor670hiEGFP- CD4+ T-cells that had been co-cultured with mDC showed a significant increase in the expression of CD69 (p=0.01, n=8) and PD-1 (p=0.007, n=10), but did not express HLA-DR or Ki67. Treatment of the mDC-T-cell co-cultures with blocking antibodies to the chemokines CCL19 and CXCL10 (shown to induce latent infection in resting CD4+ T-cells); the chemokine receptor CXCR3; or the adhesion molecule LFA-1 (binds to ICAM) led to no changes in the frequency of latently-infected CD4+ T-cells (n=5). When mDC-T-cell contact was prevented using transwells the number of latently-infected CD4+ T-cells was reduced (n=3). Conclusion mDC play a key role in the establishment and/or maintenance of HIV latency in resting memory CD4+ T-cells. Our results suggest this is likely to be mediated through DC-T-cell contact via alternative pathways to ICAM-LFA-1 binding., Background HIV-1 penetrates the central nervous system (CNS) during early infection, establishing a viral reservoir. While macrophages and microglia represent the sites of productive HIV-1 infection, astrocytes undergo a restricted/latent infection. We recently demonstrated that astrocytes are extensively infected and may therefore constitute a significant potential reservoir of HIV-1 within the CNS. Here, we analyzed HIV-1 promoters (LTR) from matched CNS and non-CNS compartments to determine their role in virus restriction within CNS-derived cells. Determining the regulatory mechanisms of CNS-derived LTRs is essential to understanding the CNS as a HIV-1 viral reservoir, and in developing strategies aimed at HIV-1 eradication. Methods HIV-1 LTR sequences from a cohort of HIV-1 autopsy subjects consisting of matched CNS- and non-CNS-derived isolates were examined and their activity was determined in T-cells and SVG astrocyte cells. Electrophoretic mobility shift assays (EMSA) were used to analyze transcription factor binding activity within the core and basal promoter regions of the LTR. Results CNS-derived LTRs demonstrated restricted basal transcriptional activity in both T-cells and SVG cells, and non-CNS-derived LTRs showed decreased activity in SVG cells. Restricted basal activity mapped to the three Sp binding motifs, previously shown to be essential for both Tat-independent and Tat-dependent activation of the LTR in T-cells. Further repression in astrocytes was observed due to elevated levels of the repressor Sp3 in SVG cells. Conclusion The reduced transcriptional activity observed for CNS-derived HIV-1 promoters was found to correlate with a reduction in Sp1 binding, which mapped to mutations within the core Sp binding motif. Transcriptional activity in SVG cells was further regulated by Sp3, which outcompeted Sp1 for Sp-motif binding. These data suggest that CNS-derived viruses have a reduced capacity to initiate viral transcription in astrocytes and highlights that unique transcriptional mechanisms exist within the CNS, ultimately affecting the fate of viral infection and the development of latency., Background Latent reservoirs of HIV-1 consist of cells harboring dormant, stably integrated viral genomes that can be reactivated after cell stimulation. Latent HIV-1 evades immune responses and resists anti-retroviral therapy. CD4+ T cells are the major reservoir of latent HIV-1. These cells are very rare and lack distinctive markers, which has hindered their characterization. Methods We developed an in vitro model suitable to investigate HIV-1 latency in CD4+ T cells. In our system CD4+ T cells are activated with dendritic cells and antigen, infected in vitro with HIV-1, and then brought back to quiescence through a resting phase in the presence of interleukin-7. During the resting phase, the latently infected cells generated with our system lack expression of activation markers; do not undergo cellular proliferation and do not sustain viral replication. We sorted latently infected and uninfected cells from the same cell culture at the end of the resting phase, and profiled their entire transcriptome. Results The results of this microarray analysis revealed profound differences between latently infected and uninfected cells derived from the same culture. First, a number of genes involved in all major cellular metabolic pathways are down-modulated in latently infected cells. Second, several messengers involved in gene expression (including chromatin organization, transcription, translation, post-translational modification, transport and assembly) are also down-regulated in latently infected cells. Third, genes involved in signal transduction, cell activation, cell proliferation and cell cycle progression are down-modulated in latently infected cells. Finally, several genes encoding cell surface molecules are differently expressed in latently infected vs. uninfected cells. Conclusion The establishment of HIV-1 latency does not simply entail suppression of HIV-1 expression, and the return to cell quiescence. Rather, HIV-1 appears to exploit and/or promote suppression of all cellular functions, leading to cell quiescence and viral latency. These results may have therapeutic implication for viral eradication., Background HIV-1 cure remains elusive despite HAART due to the reservoirs of proviral DNA integrated into the human genome. Efforts to cure HIV-1 therefore need to aim at eliminating proviral DNA from cellular reservoirs. The first epigenetic signal identified in virus infected and uninfected cells has been promoter methylation. Compelling evidence confirms that specific promoter methylation can lead to gene silencing. Previous studies have examined HIV-1 epigenetics mostly in vitro. Methods We determined methylation patterns in HIV-1 proviral genomes from PBMCs obtained from 21 individuals with a spectrum of disease progression. The CpGs in the long terminal repeats (LTRs) of proviral DNA were investigated by bisulfite sequencing in up to 85 genomic variants per individual. This approach facilitates the study of the full range of CpG methylation and sequence variability of HIV-1 proviruses under conditions of natural selection in human populations. Results In patients with advanced disease, the HIV-1 proviruses remained essentially unmethylated in their LTRs. In one long-term nonprogressor, the percentage of methylated proviruses varied from 0–77% at different times after infection. More important and unexpected was the detection of three specific LTR-located CpG dinucleotides that had been selectively mutated to TpAs in>20 out of the 32 samples analyzed. Comparison to 11 HIV-1 LTR sequences in the Los Alamos HIV database demonstrated that mutations in the sites identified by our study occurred more frequently than at other locations, although the mutations were different from TpAs. Conclusion These specific CpGs, possibly including their abutting sequences, might indicate weak spots in the proviral genomes whose sacrifice by mutation to TpAs could enhance the HIV-1 potential for long-term proviral survival. These data suggest that the sites of the mutated CpGs occurring at conserved sites may serve as potential targets for therapeutic interventions to eliminate integrated proviruses. Grants: DFG-DO165/28-1; NIH-UO1-AI35004, Background We have demonstrated that HIV latency can be established in resting CD4+ T-cells infected after incubation with the CCR7 ligand, CCL19. The aim of this study was to identify the sites of viral integration in this model and to determine the relationship of integration sites to transcription factor binding sites and cellular gene expression. Methods Resting CD4+ T-cells were incubated with either IL2/PHA, CCL19, or in media alone (unactivated). After 2 days, cells were infected with NL4.3 and the presence of integrated DNA was confirmed at day 4. Total cellular DNA was purified and provirus-host junctions cloned and sequenced and mapped on the human genome using the UCSC Genome Browser. Gene expression in each cell type was determined using Illumina microarrays. Comparisons were made between these in vitro conditions and CD4 T-cells from HIV-infected patients on antiretroviral therapy (ART). Gene ontology was analysed using ClueGo. Results We identified unique integration sites in infected CCL19-treated (n=247), IL2/PHA (n=432) and unactivated (n=133) T-cells. Integration occurred in transcriptionally active genes and most were involved in cellular housekeeping and cell signalling pathways. Integration sites were a similar distance from CpG islands, CTCF, pol II and histone methylation and acetylation sites. Compared to IL2/PHA-activated and unactivated cells, integration in CCL19-treated cells was further away from regions with high transcriptional activity (including transcriptional start sites (TSS); (p< 0.0001)) and closer to Long Interspersed Nuclear Elements (p< 0.0001), H4K20me3 (p< 0.0001) (a methylation site mapped to heterochromatin) and H4R3me2 (p< 0.0001; involved in priming gene expression). CCL19 treated cells and patient derived cells were similar in some but not all integration site patterns. Conclusion HIV integration occurred in transcriptionally active genes in all culture conditions although integration patterns in CCL19-treated latently infected cells were distinct. The significance of unique integration site selection in the setting of latency warrant further investigation., Background SIVagm infection of rhesus macaques (RMs) provides a model of functional cure: initial high level viremia (108 copies/ml) and massive mucosal CD4+ T cell depletion are followed by durable control of SIVagm replication, complete recovery of CD4+ T cells, normalization of T-cell activation and seroreversion. The advantage of this model is that the functional cure occurs in all SIVagm-infected RMs. Immune control of SIVagm replication can be temporary reversed by experimental CD8-cell depletion. Methods Our objectives were to further characterize the RM/SIVagm model of functional cure by: (i) assessing the level of persistent chronic SIVagm viremia using qPCR with single copy sensitivity (SCA); (ii) determining whether rebounding virus after CD8-cell depletion is replication-competent by inoculation of uninfected RMs; and (iii) characterizing the diversity of rebounding virus using single genome sequencing (SGS). Results SCA revealed low level viremia, averaging 20 copies/ml (range 10–30), in RMs 9 month after viremia became undetectable by conventional qPCR. Inoculation of new RMs with plasma collected during virus rebound after CD8 cell depletion resulted in peak viremia of 108–109 SIVagm RNA copies/ml, followed by control of viremia with kinetics similar to that following infection with high titer SIVagm stock virus. SGS of rebound plasma virus after CD8 cell depletion revealed sequence homogeneity consistent with clonality. Rebound virus was genetically similar to unpassaged SIVagm used to infect RMs, suggesting that the viral reservoirs that were the source of the rebounding virus were seeded early after infection. Conclusion These findings further validate SIVagm-infected RMs as a model of functional cure of replication-competent retrovirus infection. Deciphering the mechanisms of control may identify new strategies to achieve functional cure. This model is well suited to assess new therapeutic strategies to deplete viral reservoirs without the complexity of multidrug antiretroviral therapy., Background Integration into host cell chromosomal DNA is considered an essential step in the replication of retroviruses, yet HIV-1 replication in vivo or in vitro generates one to two orders of magnitude more copies of unintegrated viral DNA (uDNA) than successfully integrated proviruses (iDNA). These extrachromosomal species are reported to possess limited capacity for gene expression and to be a replicative dead end. Resting CD4+ cells are the major targets of early infection following mucosal transmission, and resting memory CD4+ T cells constitute the major reservoir of latent infection. The cytokine environment in mucosal and lymphoid compartments facilitates HIV-1 infection of CD4+ T cells in the absence of TCR mediated activation. Methods We employed a combination of HIV-1 reporter viruses, flow cytometry and quantitative PCR to analyze HIV-1 early and late gene expression and virus production in purified peripheral blood CD4+ T cells. Results We find that resting CD4+ T cells rendered permissive to HIV-1 replication by cytokines IL-2, IL-4, IL-7 or IL-15 provide a reservoir for the persistence of unintegrated HIV-1 DNA. Nonproliferating cells containing uDNA could generate de novo HIV-1 and transmit virus efficiently to uninfected cells, resulting in recombination between viruses. uDNA generated an order of magnitude less virus than integrated proviruses, but cells generating virus from uDNA survived and produced virus longer. Vpr packaged in virions was necessary for initial gene expression from uDNA. Subsequent T cell receptor/coreceptor-mediated activation substantially increased early viral gene expression from uDNA, but an increase in virus production was observed only when activation-induced cell proliferation was inhibited by de novo Vpr generated from the uDNA template. Activation through the T cell receptor or HDAC inhibitors in combination with Prostratin efficiently activated latent uDNA several weeks after infection of resting T cells. Conclusion We propose unintegrated HIV-1 as a potential reservoir of inducible virus., Background A thorough understanding of the molecular mechanisms governing HIV-1 latency is essential in the development of rational therapeutics for the eradication of the virus. Evidence is accumulating that histone methylation regulates HIV latency. The multi-domain protein UHRF1 (ubiquitin-like, containing PHD and RING finger domains 1), a key epigenetic regulator for maintaining DNA methylation patterns, has also been reported to interact with histone 3 lysine 9 methylated histones. This study investigates the role of UHRF1 in the transcriptional silencing of latent HIV-1 provirus. Methods 293T cells were co-transfected with wild type HIV-1 long terminal repeat (LTR) and either with constructs encoding wild type or mutant forms of human UHRF1, treated with tumor necrosis factor alpha (TNF-α) and the promoter activity was determined by the dual luciferase assay. The presence of UHRF1 at the LTR was assessed by chromatin immunoprecipitation assay using sheared chromatin lysates from latently infected cells, ACH-2 and J-Lat 6.3. Small interfering RNA (siRNA) experiments were conducted using TZM-bl cells, which contain a chromatin-integrated HIV-1 LTR, to confirm the influence of UHRF1 on the HIV-1 LTR. Results We observed that UHRF1 inhibited both basal and the induced HIV-1 gene expression by TNF-α. Chromatin immunoprecipitation assay revealed the presence of UHRF1 at the vicinity of the HIV-1 LTR and UHRF1 occupancy was reduced upon activation. Meanwhile, knockdown of UHRF1 expression modestly increased basal LTR activity. Conclusion Results suggest that UHRF1 contributes to the transcriptional silencing of latent HIV-1 provirus and further elucidate the underlying molecular mechanisms that maintain latency., Background Replication-competent HIV persists in patients who are treated with highly active antiretroviral therapy (HAART). One significant reservoir of this persistent virus is within rare latently infected CD4+ T cells. However, the infrequent nature of these cells makes them challenging to study directly in infected patients, and clinical attempts to completely eliminate this viral reservoir have not been successful. Therefore improved models for HIV latency and eradication strategies are needed. The humanized bone marrow-liver-thymus (BLT) mouse provides robust multi-lineage immune reconstitution with human cells. When infected with HIV, these mice can also serve as an in vivo model for investigating HIV latency. Methods BLT mice were infected with HIV and assessed for the presence of latently-infected cells. Cells were stimulated ex vivo with a variety of canonical and novel latency activators. Infected mice were also treated with HAART and then assessed for the presence of activation-inducible virus. Results Up to 3% percent of human cells in spleen, peripheral blood, and thymus/liver implants in HIV-infected BLT mice harbored latent HIV. This virus was integrated, activation-inducible, and replication competent. The latently-infected cells were also responsive to stimulation with protein kinase C activators and latency-activating nanoparticles. Furthermore, activation-inducible virus was detectable in HAART-treated mice, although at lower frequencies than in untreated mice. Conclusion The humanized BLT mouse provides a versatile system for ex vivo and in vivo investigation of HIV latency., Background In a previous ART intensification study with MVC we detected episomal 2-LTR-DNA in all patients at week 24, while undetectable at baseline (Gutierrez C, et al. PLoS ONE, 2011). A residual agonistic effect of MVC on CCR5 receptor through calcium flux has been discarded. Activation of CCR5 intracellular signaling pathways leading to transcription factors activation, including NFkB, could promote HIV-1 transcription in resting CD4 T cells. We aimed to study if MVC could trigger this effect. Methods TROPISMVC (NCT01060618) is a clinical trial of 10 days MVC monotherapy in naïve HIV-1-infected patients. Blood samples were drawn at baseline, after 10 days of MVC and 18 days after MVC withdrawal (day 28). PBMCs were isolated from nine patients, bearing CCR5 (n=6) and D/M (n=3) tropic viruses. Resting CD4+ T cells were separated by MACS® Technology and aliquots of 5 million cells were frozen. Nuclear proteins were obtained using the Actif Motif Nuclear Extract Kit. NFkB activation was detected by ELISA plates coated with oligonucleotides mimicking the specific consensus binding sites (TransAMTM NFkB family, Actif Motif), following the manufacturer's instructions. NFkB activity was estimated measuring target genes' expression by real-time PCR of the extracted RNA. Results NFkB activity was detected in 4/6 patients with R5 tropic viruses and in 2/3 patients with D/M tropic viruses; results expressed in fold change (FC) compared to baseline according to HIV-1 tropism. The presence of MVC increased NFkB activity consistently, as summarized in the following table. Upregulation of at least one NFkB targeted gene was observed in all but one cases with available RNA sample. Conclusion MVC can activate NFkB, and the expression of targeted genes, in resting CD4 T cells from HIV-infected patients regardless of the viral tropism. Through this pathway, MVC could trigger HIV-1 transcription in resting cells thus accelerating the decay of the HIV-1 cell reservoir., Background Children have large populations of naive CD4+ T-cells that characteristically express high levels of CXCR4 and low levels of CCR5, compared to memory CD4+ T-cells. We hypothesized that HIV+ Ugandan children infected with CXCR4-tropic virus would exhibit larger HIV-DNA reservoirs in naïve CD4+ T-cells, compared to children infected with CCR5-tropic (R5) virus. Methods Cryopreserved PBMC from a convenience sample of 12 HIV+ Ugandan children receiving antiretroviral therapy (ART) with undetectable plasma HIV-RNA (< 400 copies/ml, Amplicor, Roche) were sorted into naïve (CD27+CD45RA+) and memory (CD27-CD45+ and CD45-CD27±) CD3+CD4+ T-cells. HIV-DNA levels were determined using a Taqman assay targeting gag, normalized to cellular-DNA content (tert, ABI). Co-receptor tropism was determined using a commercial phenotypic assay (Trophile, Monogram). We calculated 1) the ratio of the prevalence of infection (copies per 106 cells) in naïve to the prevalence in memory CD4+ T-cells and 2) the proportion of the total peripheral CD4+ T-cell HIV-reservoir that is contained in naïve CD4+ T-cells, and compared them between children with R5- and dual/mixed(CXCR4/CCR5, DM)-tropic virus using non-parametric statistics. Results Median age was 4.9 (interquartile range 3.5-8.1) years, CD4+T-cell number 743 cells/ul (565-1089), CD4+ T-cell percentage 25 (21-29), and ART duration 95 days (95-147), with 6 subjects each with HIV-envelope-subtypes A and D. R5 virus was identified in 8 and DM virus in 4 children. Conclusion In ART-treated adults, the vast majority of persistently infected CD4+ T-cells are memory cells. By contrast, we found that a significant proportion of the reservoir resides in the naïve CD4+ T-cells among Ugandan HIV+ ART-treated children. Infection with DM virus was associated with preferential naïve T-cell infection. In developing strategies to eradicate HIV, it will be important to take into account the high levels of naïve T-cell infection in children, particularly among those with DM virus., Background Functional HIV-1 cure has been described in the setting of myeloablative allogeneic stem cell transplant (alloSCT) with ccr5▵32/ ccr5▵32 donor cells, but the effects of alloSCT on viral reservoirs are largely unknown. We studied the longitudinal effects of reduced-intensity conditioning (RIC) alloSCT on HIV-1 peripheral blood reservoirs in two infected male patients with hematologic malignancies who previously underwent autologous SCT. Methods Analysis of peripheral HIV-1 reservoirs was performed on banked samples (1 pre- and 3 post-RIC-AlloSCT) for both patients, including: 1) quantification of HIV-1 DNA from peripheral blood mononuclear cells (PBMCs), 2) quantification of 2-LTR circles from PBMC episomal DNA, 3) full-length envelope amplification and phenotypic coreceptor usage prediction from proviral DNA, 4) quantification of plasma viremia by a single-copy assay, 5) flow cytometric characterization of lymphocyte subsets and coreceptor expression, and 6) CCR5 genotyping. Results No HIV-1 DNA was detected 8 to 17 months after alloSCT in PBMC from both patients despite presence of modest levels of total PBMC-associated HIV-1 DNA prior to and 2-3 months after SCT (87–271 copies/106 PBMCs). 2-LTR circles were not detected at any time-point despite excellent recovery of episomal mitochondrial DNA. Both patients were heterozygous for ccr5▵32 mutation prior to transplant; a transient reduction in CXCR4 expression was observed following transplant. Pseudoviruses incorporating envelopes from early time-points used predominately CCR5 for entry. Both patients remained virologically suppressed on ART, but were either started on prednisone or continued on tacrolimus/sirolimus immunosuppressive therapy for chronic graft-versus-host disease (GVHD) near the time of loss of HIV-1 reservoir detection. Conclusion PBMC HIV-1 DNA became undetectable 8 months after RIC-alloSCT. This finding may be due to a dilutional effect of donor cell engraftment in the setting of protective ART, the additive effect of cytotoxic therapies, and/or GVHD. Confirmation of results by sampling large-volume blood collections and other tissue compartments is warranted., Background Nonhuman primate (NHP) models are needed for evaluation of proposed but unproven, and potentially dangerous strategies targeting residual virus and latent reservoirs in AIDS virus-infected subjects receiving suppressive antiretroviral drug treatment (ART), but such models have proven challenging to develop. Methods We treated a cohort of 6 Indian rhesus macaques with a novel three class (NRTI, PI, IN-STI) six drug (PMPA/FTC/DRV-RTV/L-870812/L-870564) ART regimen beginning at 4 weeks post-infection with SIVmac239. Peripheral blood CD4+ T cells from ART-treated animals with suppressed viremia were evaluated ex vivo for responses to SAHA, including changes in histone acetylation patterns and induction of expression of SIV. Beginning approximately 26 weeks post infection, animals received four 21 day courses of daily treatment with SAHA, with each course of SAHA separated by an approximately 3 week interval, with continuous ART throughout and longitudinal sampling of blood and lymph nodes for immunological, virological, and pharmacodynamic evaluations. Animals were euthanized and necropsied after the final SAHA dose, while still on ART, and tissues studied virologically. Results The ART regimen was feasible, safe and well tolerated over one year of treatment and allowed suppression of plasma viremia to, Background The “Berlin patient” is the first patient functionally cured of HIV. He received stem cell transplantation from a homozygote CCR5-Δ32 donor. The reconstituted CD4+ T-cell population should be susceptible to infection with CXCR4-using viruses. According to gp120-V3 deep sequencing analysis of plasma-derived variants present before transplantation, the patient harbored a minority (2.9%) of viruses predicted to be CXCR4-tropic (geno2phenocoreceptor FPR 10%). It remains puzzling why these variants failed to emerge post-transplant. We hypothesize that these CXCR4-predicted variants depend on CCR5 for replication. Methods Patient-derived viral constructs were generated by cloning V3-sequences of the CXCR4-predicted viruses (pX1-pX7) and the dominant CCR5-predicted strain (pR5) into HXB2-ΔV3. As controls V3-sequences of HXB2 (cHXB2; CXCR4-tropic) and BaL (cBaL; CCR5-tropic) were cloned. Co-receptor preference was investigated in U-373-MAGI-cells expressing CD4+CCR5+ or CD4+CXCR4+, PBMCs from healthy donors and patient-derived post-transplant CCR5-Δ32 PBMCs. Results Three pre-transplant CXCR4-predicted strains had an amino acid substitution in the V3 glycosylation-motif and one had a lysine at position 25, all associated with CXCR4-tropism. Five of the 7 viral clones were infectious. As expected cHXB2 infected CD4+CXCR4+-MAGI-cells and was inhibited by AMD-3100 (CXCR4-inhibitor) in donor PBMCs. Remarkably, the CXCR4-predicted viruses (FPR 2.7–9.3) depended on CCR5 for replication in MAGI-cells and were inhibited by maraviroc (CCR5-inhibitor) in donor PBMCs similar to pR5 and cBaL. As an ultimate proof it was shown that CXCR4-predicted strains could not replicate in the post-transplant derived CCR5-Δ32 PBMCs, whereas cHXB2 replication was observed. Conclusion The minority population of CXCR4-predicted viral strains which the patient harbored pre-transplant were fully dependent on CCR5 for replication in vitro. This could explain lack of rebound after treatment discontinuation. This provides a strong rationale for the further development of CCR5-targeted gene therapy and suggests that successful reconstitution of CCR5-depleted immune system may work, even if there is some evidence of CXCR4-predicted variants., Background Although HIV-infected individuals can suppress plasma viremia to undetectable levels with antiretroviral therapy, infected cells remain in the body and can contribute to viremia when therapy is discontinued. Macaque models allow investigators to more easily characterize viral reservoirs. Methods Twelve male macaques were infected with RT-SHIV, an SIV virus containing HIV-1 reverse transcriptase, and monitored for plasma viremia and CD4 counts. After 10-14 weeks post-infection, 6 animals were not treated and 6 animals were treated for 17–20 weeks with 3 drugs (tenofovir, lamivudine, and efavirenz) or 4 drugs (tenofovir, lamivudine, efavirenz, and an integrase inhibitor). Viral RNA and viral DNA were measured longitudinally in the blood and at necropsy in over 20 different tissues by quantitative PCR and normalized for cellular RNA and DNA. Results In untreated and treated animals, RT-SHIV DNA was highest in lymphoid and gastrointestinal tissues and very low to absent in the brain, genital tract, and kidney. The amount of viral DNA detected in multiple lymphoid tissues correlated with the level of plasma viremia 1 week post-infection. RT-SHIV RNA was abundant in the lymphoid tissues of untreated macaques with detectable viremia, but was detected variably in different regions of the gastrointestinal tract. Little or no viral RNA was detected in the tissues from animals after 17-20 weeks of therapy. There was no obvious difference in RT-SHIV RNA levels between animals treated with 3 or 4 drugs. Conclusion Our results suggest that the majority of virally-infected cells are located in lymphoid tissues with variable levels in the gastrointestinal tract. The number of infected cells in these reservoirs correlates with viremia one week after infection, suggesting that viral reservoirs are seeded within days of infection. Little viral RNA is evident in tissue after suppressive therapy with either 3 or 4 antiretroviral drugs., Background The role of ongoing virus replication in HIV persistence during long-term antiretroviral therapy is unknown. Since residual replication should result in detectable evolution, we investigated the degree of sequence evolution in blood-derived and rectal tissue-derived CD4+ T cells. Methods Using single-genome and single-proviral sequencing techniques, we obtained 20-50 single viral genomes from pre-therapy plasma samples from 5 subjects who initiated therapy during acute infection and 3 subjects who initiated therapy during chronic infection. Pre-therapy plasma viral sequences were compared to single proviral HIV-1 genomes derived from HIV-1-infected T-cells (naïve, memory, central- and effector-memory) from peripheral blood (PB) and gut-associated lymphoid tissue (GALT) samples collected after 4-12 years of suppressive therapy. Maximum likelihood phylogenetic trees were constructed using the general time reversible model incorporating rate variation among sites. Evolutionary divergence was explored using root-to-tip analysis (Path-O-Gen). Results The geometric mean infection frequency of memory and naïve CD4+ T-cells in the PB was 13- and 24-fold higher respectively in subjects treated during chronic compared to acute infection. This was also true for effector memory CD4+ T-cells from the GALT (6-fold higher). Phylogenetic analysis revealed clear evidence against any substantial evolution between the pre-therapy plasma-derived HIV RNA sequences and on-therapy intracellular HIV DNA sequences. Numerous intracellular HIV sequences identified after long-term therapy contained replication-incompetent virus. One patient had a predominant intracellular clone in both memory and effector memory T-cells containing a 380bp deletion after >9 years of therapy. Conclusion Early initiation of effective therapy results in substantially lower reservoir size in blood and gut. The lack of HIV-1 genetic evolution in the HIV-1 infected CD4+ T-cell populations after years of therapy argues against virus replication as a major cause of persistence in these cell populations. The role of replication in other tissues and cell types however remains to be defined., Background HIV-1-infected individuals who control viremia to below the limit of detection without antiviral therapy have been termed elite controllers (EC). Functional attenuation of some HIV-1 proteins has been reported in EC. However, little is known about role of the HIV-1 accessory protein Vif function in EC, which enhances HIV-1 infectivity through APOBEC3G degradation. In this study, the anti-APOBEC3G function of Vif was compared between EC, chronic progressors (CP) and individuals with acute infection (AI). Methods Forty-nine EC, 49 CP and 44 AI were studied. vif genes were amplified by nested RT-PCR using concentrated plasma. To compare anti-APOBEC3G activity of Vif proteins among those groups, VSV-G-pseudotyped viruses were generated by co-transfecting 293T cells with expression plasmids encoding patient-derived Vif, APOBEC3G, VSV-G, together with a vif/env-deficient HIV-1 proviral DNA clone carrying a luciferase reporter gene. VSV-G-pseudotyped viruses were normalized for p24 antigen and used to infect 293T cells and luciferase activity was measured at 48 h postinfection. Results Anti-APOBEC3G activity of Vif from EC was significantly reduced compared to those from CP or AI (Figure 1). These results remained significant after excluding individuals expressing protective HLA alleles B*27 and/or B*57. No significant difference was observed between CP and AI. Significant differences in amino acid usage in vif genes were found at 7 residues between CP and EC, and at 13 residues between AI and EC. However, there were no common polymorphisms (away from consensus B) that could explain reduced anti-APOBEC3G activity of Vif derived from EC. Conclusion Anti-APOBEC3G activity of Vif proteins derived from EC was reduced. This reduced activity was independent of presence or absence of known protective HLA alleles. Common Vif mutations in EC unlikely explain the observed reduction; rather it might be attributable to unique mutations to each EC Vif protein., Background Repressive epigenetic modifications have been shown to induce and maintain HIV latency; however underlying molecular mechanisms are not yet clear. We have previously demonstrated the critical role of CBF-1 (Latency-C-promoter binding factor 1) in establishing repressive chromatin structures at HIV LTR during latency establishment. The knockdown of CBF-1 results in the reactivation of latent proviruses and overexpression of CBF-1 facilitates latency establishment. Here we extend these studies to show that multiple repressive epigenetic modifications that CBF-1 induces are the result of recruitment of Polycomb Group (PcG) corepressor complex at HIV LTR by CBF-1. Methods Both transformed and primary T cells were infected with lentiviral vectors expressing Tat in cis to study the underlying molecular mechanisms regulating HIV latency and via running various molecular assays, including Chromatin Immunoprecipitation (ChIP) assays. Results In this study, we demonstrate that CBF-1 induces repressive chromatin structures at HIV LTR by recruiting Polycomb Group (PcG) corepressor complex at HIV LTR. The knockdown of endogenous CBF-1 results in the dissociation of PcG complex components from HIV LTR. Furthermore, knockdown of the individual components of PcG complex leads to the reactivation of latent HIV proviruses demonstrating the direct role of PcG complex in establishing HIV latency. Overall our results demonstrate that the CBF-1 induced various epigenetic modifications are the result of recruitment of Polycomb Group (PcG) corepressor complex at HIV LTR, which carry a variety of epigenetic factors that repress HIV gene expression via generating several layers of repressive epigenetic modifications. Conclusion We have established that analogous to the transformed T cell lines in primary T cells CBF-1 induced repressive chromatin structures play important role in establishing HIV latency. Additionally by recruiting PcG corepressor complex at LTR, CBF-1 not only facilitates HIV latency establishment also play critical role in maintaining and stabilizing the latent proviruses., Background Virological and Immunological Studies in CONtrollers after Treatment Interruption (VISCONTI) are required to understand the benefits of an early treatment at acute HIV-1 infection on the HIV reservoir. We studied the distribution, magnitude and inducibility of the HIV reservoir in VISCONTI patients. Methods The prospective VISCONTI study included twelve patients controlling HIV for a median of 76[IQR:67.5–84.5] months after interruption of a 3[IQR:1.7–5.9] years long HAART initiated within 10 weeks post-infection. Circulating resting CD25-CD69-HLADR- CD4+T cell subsets were sorted as naive (TN), central-memory (TCM), transitional-memory (TTM) and effector-memory cells (TEM) for further cell-associated HIV-DNA quantification by ultrasensitive real-time-PCR, and viral inducibility by culture with anti-CD3/anti-CD28/IL-2/IL-7. Reservoir distribution was compared to the one observed in 8 untreated Elite-Controllers for whom 90% of HIV-RNA measures was undetectable (below 200 copies) over 12[9–14] years. Results In the VISCONTI group, activated CD4+T cells had significantly higher HIV-DNA levels than resting ones (median 2.7[IQR:2.4–3.4] and 2[IQR:1.8–2.5] log copies/million cells, p=0.005). HIV-DNA was detected in all subsets from all patients except for 8 out of 12 TN-sorted cells, which were 10 fold less infected than all memory subsets (median TN:1.5[IQR:1.2–1.6], TCM:2.5[IQR:1.8–2.9], TTM:2.6[IQR:2.2–2.8] and TEM:2.4[IQR:2–2.8] log copies/million cells, p< 0.007). TTM was the major subset contributing to 56% of this reservoir. The same HIV reservoir characteristics were observed in Elite-Controllers in term of magnitude and distribution, except that both TCM and TTM equally contributed to the Elite-Controllers HIV reservoir. The VISCONTI HIV reservoir was inducible after TCR-stimulation in all sorted memory subsets from all patients, except in TN where no virus was recovered in 6 out of 8 patients. Conclusion In VISCONTI patients, treatment initiated at primary HIV-1 infection leads, after treatment interruption, to a low -but inducible- durable HIV reservoir distributed mainly in short-lived memory CD4+T cells that mimicks the natural distribution observed in Elite-Controllers., Background A major hurdle toward curing HIV is the establishment of long-lived latent reservoirs such as the CNS. Using an SIV model of HIV infection we examined the effect of combination antiretroviral therapy (cART) on immune and inflammatory gene expression in the periphery and CNS that leads to virus downregulation. Methods To examine the effect of cART on acute and long-term systemic and CNS immunopathogenesis, groups of SIV-infected macaques were untreated and euthanized at 21 postinoculation (dpi) or end stage disease, or treated with cART starting at 4 or 12 dpi and euthanized at 21 or 175 dpi, respectively. RNAs for immune and inflammatory genes were quantified in the spleen and brain by non-amplification Nanostring technology or by qRT-PCR. SIV replication and viral DNA were also measured. Results cART initiation at 4 or 12 dpi did not prevent SIV seeding of the brain; brain viral DNA levels were the same as in untreated animals. cART treatment initiated at 4 dpi had little effect on peripheral and CNS immune and inflammatory gene expression profiles as compared to responses mounted in untreated macaques after acute infection, as indicated by similar levels of IL17A, IL17F, and CCL5 in the periphery and IL-6, IFNß, and TNFa in the CNS. Conclusion The CNS is a latent reservoir for SIV that is seeded early after infection regardless of cART initiation at 4 or 12 dpi. The innate and adaptive immune responses are nearly as effective as early cART treatment at returning the host to peripheral and CNS immune homeostasis by 21 dpi. However, at the same time those responses likely promote the establishment of latent reservoirs by suppressing viral replication, not eliminating the reservoir., Background Toll-like receptors (TLRs) are critical proteins of the innate immune system. We evaluated association of single nucleotide polymorphisms (SNPs) in 6 TLR and 2 TLR-associated genes with infant HIV-1 acquisition and progression. Methods HIV-outcomes were assessed from birth to 1-year of age among infants from a Kenyan perinatal cohort in which HIV-infected women were enrolled during pregnancy and received short-course zidovudine. Infants were genotyped for 6 candidate and 118 haplotype-tagging polymorphisms in TLRs 2, 3, 4, 7, 8, and 9, MyD88 and TIRAP, and 144 ancestral informative markers. Cox proportional hazards and linear regression were performed to assess TLR polymorphism associations with HIV-1 acquisition, peak HIV-1 RNA levels, and infant mortality. Sex-stratified analyses of TLR7 and TLR8 were conducted due to their X-chromosome location. Results Among 368 mother-infant pairs, 56 (15%) infants acquired HIV-1 by month 1 and 17 (4.6%) between 1 and 12 months. Infants with the TLR9 1635A (rs352140) variant were more likely to acquire HIV by 1 month (HR=1.49, 95% confidence interval [CI] =1.04–2.38, p=0.028) and by month 12 (HR=1.40, CI=1.02–1.92, p=0.038) in additive models adjusted for maternal plasma HIV-1 viral load (VL) and genetic ancestry. Among 56 HIV-1 infected infants infected at, Background The Toll-like receptor (TLR) genes mediate the innate response to viral infections and may impact HIV-1 pathogenesis. We evaluated TLR polymorphisms for association with plasma HIV-1 RNA set-point in HIV-1 infected individuals from East and Southern Africa. Methods Analyses included prospective data and DNA from 500 Africans with heterosexually-acquired HIV-1 (125 incident, 375 prevalent). For incident HIV-1, set-point was defined as the median plasma HIV-1 RNA level ≥4 months after the estimated infection date. For prevalent HIV-1, set-point was the average of ≥2 consecutive plasma HIV-1 RNA measurements before ART initiation or CD4 decline to, Background Human cyclophilin A (CypA) encoded by peptidyl prolyl isomerase A gene (PPIA), is an important cellular co-factor for efficient human immunodeficiency virus type 1 (HIV-1) infection. In this study we investigated the effect of genetic variation in the regulatory region of PPIA on HIV-1 disease progression and CypA mRNA expression levels in HIV-1 South African cohorts. Methods A total of 603 black South African participants from these cohorts were genotyped for single nucleotide polymorphism (SNP) A1650G in the regulatory region of CypA using PCR-RFLP. 247 (195 HIV-1 seronegative participants [SNs] and 52 primary infected participants [SPs]) participants were from the CAPRISA acute infection (AI) 002 cohort and 356 HIV-1 chronically infected participants were from the Sinikithemba cohort. CypA mRNA expression was quantified in 30 SNs and 28 SPs from the CAPRISA AI 002 cohort by real-time RT-PCR. Lastly, we assessed the effect of SNPA1650G on viral (NL4.3) replication in PBMCs isolated from HIV-1 negative individuals. Results The minor allele (G) of SNP A1650G (referred to as 1650G) was significantly associated with higher viral load (p, Background Class I Human Leukocyte Antigens (HLA) play an important role in the adaptive immune response by presenting antigens to CD8+ T-cells. Previous studies have reported multiple HLA associations with rates of disease progression in HIV infected individuals, while few class I associations with resistance or susceptibility to HIV-1 infection have been reported. Methods HLA-A, -B, and -C were typed for more than 1000 women enrolled in the Pumwani sex worker cohort using a sequence-based typing method. Kaplan-Meier analysis was used to identify alleles influencing seroconversion and disease progression to AIDS (CD4+ decline to, Background We have recently shown that the IFN-inducible Tripartite motif-containing protein 22 (TRIM22) suppresses basal HIV-1 LTR-mediated transcription through a Tat-and NF-κB-independent mechanism [Kajaste-Rudnitski et al., J Virol 2011, 85(10):5183–96]. In the absence of Tat/TAR RNA complex, HIV-1 transcription can occur through the positive elongation factor (P-TEF) b function and Sp1. We have here investigated whether TRIM22 interferes with Sp1-mediated transcriptional activation of the HIV-1 LTR. Methods 293T cells, devoid of endogenous TRIM22, were transfected with increasing amounts of a TRIM22-expressing plasmid together with a fixed amount of an HIV-1 LTR reporter construct that contains a TAR sequence unresponsive to Tat and two tet-O motifs that bind to rtTA in the presence of doxycycline (Dox). Constructs containing the deletion of one, two or three Sp1 sites were also tested. Results TRIM22 efficiently inhibited Dox-induced WT HIV-1 LTR transcription. Interestingly, this inhibitory effect was progressively lost with the LTR reporters lacking one, two or all three Sp1 binding sites, respectively. In line with these observations, addition of three Sp1 sites into a reporter construct based on a CMV-derived promoter element, normally insensitive to TRIM22, renders it susceptible to TRIM22 transcriptional repression, indicating that TRIM22 could have a broader regulatory role in Sp1-mediated gene expression. Although TRIM22 does not alter overall Sp1 expression levels when transfected into 293T cells, immunoprecipitation experiments performed on 293T cells transfected with a FLAG-tagged TRIM22 revealed that TRIM22 directly interacts with Sp1. Conclusion These results suggest that TRIM22 may inhibit HIV-1 LTR-driven transcriptional initiation through interference with the Sp1-mediated signaling and activation of early HIV-1 gene expression, rendering it an attractive candidate for novel therapeutic approaches., Background We hypothesized that APOBEC3G (A3G) was associated with provirus burden in resting memory CD4+ T cells, and infectivity of HIV produced from them. Methods Cells from antiretroviral-naïve, long-term non-progressor (LTNP, n=7) and HAART-suppressed (HS, n=11) subjects were negatively selected from PBMCs (Robo-Sep). Sorting (FACS Aria, BD) separated activated cells (CD25+, CD69+, CD38+ and HLA-DR+) from resting central memory (Tcm: CCR7+, CD45RO+), resting effector memory (Tem: CCR7-, CD45RO+, which includes resting transitional memory) and resting naïve (CCR7+, CD45RO) T cells. A3G was quantified by immunoblotting (Odyssey, Li-Cor). Provirus was quantified by alu-PCR. Reactivated HIV was recovered from cells treated ex vivo with anti-CD3,8 bispecific monoclonal antibody and IL2. Virus p24 levels in culture supernatants were quantified by ELISA. Infectivity of virus produced from ex vivo activated cells was assessed using TZM-bl indicator cells. Results Tcm and Tem from LTNP had less provirus in vivo than the same cell type from HS subjects (p= 0.01 for Tcm and 0.02 for Tem). A3G protein levels were higher in Tcm and Tem from the LTNP, in comparison to Tcm and Tem from the HS, subjects (p=0.02 for Tcm and p=0.02 for Tem). Virions were recovered from ex vivo activated Tcm from 5 of the HS subjects. Infectivities of normalized virion amounts were inversely associated with the A3G levels in virions produced from them (Spearman r=-0.99, p=0.01) Conclusion Resting central and effector memory CD4+ T cells from LTNP had less provirus and higher levels of A3G protein than the same cell types from HS subjects. Infectivity of HIV reactivated ex vivo from Tcm of HS subjects was inversely associated with virion A3G levels. A3G appears able to restrict viral spread from proviruses reactivated from resting memory CD4+ T cells, suggesting that improving this restriction may contribute to 'curing' HIV., Background The immediate and early dynamic cellular response to an HIV virion entering the cell is not well understood, particularly at the post-transcriptional level where known rapid immune responses occur. Several RNA-binding proteins (RBPs) are known to be important in infection, including HuR, which is known to bind to and regulate the mRNA transcripts of several of the known early entry co-factors such as PPIA, TRIM5, APOBEC3G and CUL5. Methods We have previously integrated three global methods to measure post-transcriptional regulation in Jurkat T cell activation and examine relationships between ribonucleoprotein (RNP) interactions, transcription, RNA stability and translation. Dynamic changes in association with HuR caused measurable effects on RNA stability and translation of mRNAs. Transcripts that increased in association with HuR during activation showed increased stability and translation while those that decreased show decreased stability and translation. Furthermore, these changed transcripts fell into relevant functional groups, where cell cycle regulators were largely decreased in association, stability and translation, and DNA/RNA regulators were largely increased in association, stability and translation. Results To test the effect of post-transcriptional regulation in HIV infection, we used the C8166 T cell line for a near complete and synchronous infection and measured global changes in RNA stability and rates of transcription using 4-thiouridine stability profiling at five time points over the initial 24 hours of infection. Simultaneously, we measured dynamic changes in mRNA association with HuR during the same infection time points. Comparing the two datasets, we observed several mRNA transcripts, including myc mRNA, a known target of HuR, showing dynamic regulation at the level of stability during the infection time course. Conclusion Elucidation of these events supports the involvement of the post-transcriptional response early in HIV infection and suggests that potentially modifying or amplifying the post-transcriptional response may be able to reduce the efficiency of infection., Background Semen, the most common vector for HIV transmission, enhances HIV infection in vitro. We recently identified amyloid fibrils comprised of fragments from semenogelins, the predominant component of the semen coagulum. Semenogelin amyloids interact with virions (Figure 1) and potently enhance HIV infection of target cells. During semen liquefaction, semenogelins are fragmented and eventually completely degraded by PSA. We hypothesized that if semenogelins are important for the viral enhancing activity of semen, then the change in the levels of these proteins during liquefaction should affect the ability of semen to enhance infection. Methods Seminal fluid liquefied for different amounts of time were assayed for viral enhancing activity and semenogelin levels in the absence or presence of PSA inhibitors. We also tested the effect of purified PSA on the activity of amyloids formed from chemically-synthesized semenogelin peptides. Results The viral enhancing activity of semen decreases with increasing liquefaction time in a manner that parallels the degradation of semenogelins. Semenogelin degradation and loss of viral enhancing activity in semen are both prevented in the presence of a PSA inhibitor. Finally, PSA specifically cleaves and inhibits the viral enhancing activity of semenogelin fibrils. Conclusion Seminal fluid's viral enhancing activity is retained for several hours and then progressively decreases during prolonged liquefaction. We found a correlation between activity and semenogelin levels during liquefaction. These findings underscore the importance of semenogelins for the viral enhancing activity of semen. We also provide evidence that PSA directly regulates the activity of semenogelin fibrils, suggesting that these amyloids are regulated by liquefaction. As such, mechanisms to enhance the natural liquefaction process may be a useful approach to limit the ability of semen to enhance viral transmission., Background The relationship between exogenous contraceptive hormones and permissiveness of the female genital tract to human immunodeficiency virus type 1 (HIV-1) remains the subject of intense debate, due to a recent study showing a two-fold increase in the rate of acquisition and transmission in serodiscordant couples using depot medroxyprogesterone acetate (DMPA)[1]. In order to better characterize the effect of DMPA on the vagina, we compared the leukocyte populations and density of epithelial junction proteins in vaginal tissue biopsies of women at baseline (during both the follicular and luteal phases of the menstrual cycle) and 12 weeks after receiving one DMPA injection. Methods Vaginal biopsies were obtained from 20 healthy women in the follicular and luteal phases of the menstrual cycle, and approximately 12 weeks after receiving a 150 milligram intramuscular injection of DMPA. Leukocyte populations, activation phenotype and epithelial thickness and tight junction and adherens proteins were measured by immunohistochemistry and integrated optical density. Statistical analyses were performed using Wilcoxon signed rank tests. Results After DMPA administration, CD3, CD8, CD45, CD68, HLA-DR and CCR5 bearing lymphocytes were all significantly (p0.05). Epithelial thickness and tight junction and adherens proteins were not statistically different between sampling times (p>0.05). Conclusion After exposure to DMPA, vaginal leukocyte populations significantly increase in the vaginal mucosa. In absence of changes in epithelial integrity, the increase in vaginal T cells, activation markers, and HIV-1 receptors point to a possible immunological basis for the observed effects of DMPA on HIV-1 acquisition and transmission in women., Background Semen is the main carrier of sexually transmitted viruses, including HIV-1. However, semen of HIV-infected men is not merely a passive transporter of HIV-1 but, because of its richness in biologically-active compounds, including chemokines, may facilitate HIV-1 transmission. To test this hypothesis and to study HIV-1 transmission under controlled conditions, we evaluated HIV-1 loads and the cytokine milieu in semen and blood from infected men as well as, the role of these cytokines in HIV transmission to cervicovaginal tissue ex vivo. Methods We measured 21 cytokines/chemokines with a multiplex bead assay and evaluated the loads of HIV-1 in seminal and blood plasmas from 50 HIV-1-infected and 28 uninfected Indian men. Results We found that semen and blood are two separate immunological compartments, in which concentrations of cytokines and loads of coinfecting herpesviruses are profoundly different. Upon HIV infection, the levels of blood and semen cytokines were significantly altered, thus facilitating cytokine network compartmentalization. HIV-1 infection changes the seminal cytokine spectrum by upregulating 16 of the 21 measured cytokines, while in blood 2 cytokines were downregulated and 7 were upregulated. One of the most prominent cytokine in semen was IL-7, which was significantly upregulated in semen of HIV-1-infected individuals. IL-7 in concentrations similar to that in semen of HIV-1-infected individuals facilitates HIV-1 infection in cervicovaginal tissue ex vivo. This facilitation is associated with a suppression of apoptosis of infected CD4 T cells. Conclusion HIV-1 infection results in an aberrant production of cytokines, changing the seminal cytokine network. The altered seminal milieu is an important determinant of HIV-1 sexual transmission: Cytokines altered by seminal infection facilitate HIV-1 transmission to cervicovaginal tissue ex vivo. Cervicovaginal tissue infected ex vivo provides a platform to study the mechanisms of this phenomenon and to develop new preventive strategies by targeting the seminal microenvironment., Background Male circumcision has been shown to decrease rates of HIV acquisition in African men. The STEP vaccine trial also demonstrated that vaccinated, uncircumcised men were at increased risk for HIV acquisition. We sought to identify the mode(s) by which HIV infection may occur in uncircumcised men. Methods Foreskins were obtained from consenting male donors receiving prophylactic male circumcision in Rakai, Uganda. Whole penile specimens were obtained from tissue donation organizations (ScienceCare and NDRI). Using fluorescent immunohistochemistry, foreskin keratin layers were labeled with filaggrin and involucrin markers. Penile tissues were incubated with ex vivo with photo-activatable GFP-linked-Vpr HIVBal for 4 hours, snap-frozen, and cryosections stained for target cells and keratin. Images were obtained with epifluorescent microscopy and analyzed for keratin thickness, viral particles, and viral penetration into penile epithelia. Results We found no significant differences between inner and outer foreskin keratin layers from 19 foreskin samples obtained in Uganda, indicating that reduced keratin thickness is not likely to make the inner foreskin more susceptible to HIV. Preliminary data from whole penile specimens (uncircumcised n=7, circumcised n=7) shows no significant difference in number of visualized virions per image captured, but more virions entering uncircumcised as compared to circumcised glans tissue (uncircumcised:circumcised=2:1). Virions were found at distances from the epithelial surface (mean±SD=33.5±22.3 µm) in the range where CD4+ cells are also localized (mean±SD=53.6 ±32.3 µm), in the absence of trauma to the epithelium. Finally, we visualize virions interacting with the male urethral pseudo-stratified columnar epithelia, though to a lesser degree than seen with stratified squamous epithelia (n=5, glans:urethra=2:1). Conclusion These preliminary results suggest preferential routes by which HIV-1 may enter the male genital tract in female-to-male HIV sexual transmission., Background Our laboratory previously reported that HIV binds and signals through Integrin-α4β7, the gut homing receptor, on the surface of CD4+ T-cells. This interaction may be critical during the earliest events of HIV transmission, when the virus rapidly homes to the gut and a massive depletion of gut CD4+ T cells ensues. Understanding the precise manner by which the virus engages α4β7 may therefore provide insights into the earliest events in HIV infection and the design of novel therapeutics. Both its natural ligands (MAdCAM and VCAM) and gp120 bind α4β7 in a cation-dependent manner. In each case a divalent cation bound to the integrin coordinates an aspartic acid (Asp) residue in the ligand. We previously described a highly conserved Asp in the V2-loop of gp120 that mimics the natural ligands of α4β7, and plays a critical role in this interaction. However, MAdCAM and VCAM utilize a second Asp residue and a second coordinating cation to mediate recognition of both α4 and β7 chains in a complex way. Our data suggests that gp120 interactions with α4β7 are similarly complex. Methods To identify critical residues in HIV-gp120 that mediate α4β7-reactivity we designed site-directed Asp mutants in recombinant gp120s, and measured the binding of each mutant to α4β7. Results By this approach, we identified two sites that mediate gp120-α4β7 interactions. A single Asp mutant at either position reduced reactivity with α4β7 by~2-fold relative to the wildtype, while the double Asp mutants diminished α4β7 binding to near-undetectable levels. Conclusion This observation reveals the discontinuous nature of the gp120-a4 7 epitope and suggests gp120 interactions with a4 7 closely mimic MAdCAM and VCAM. These results advance upon our previous understanding of the molecular basis of α4β7-gp120 interactions and lay the groundwork for further structural studies., Background Highly exposed seronegative (HESN) individuals have had repeated exposures to HIV-1 yet remain virus and antibody negative. We evaluated HIV-1 specific NK cell responses in men who have sex with men (MSM) defined as HESN based on high-risk sexual activities engaged in the early 1980's. Methods Fresh, whole blood samples from HIV-1 seropositives on ART (HIVpos), HIV-1 seronegatives (HIVneg), and HESN subjects in the Multicenter AIDS Cohort Study were cultured with overlapping 15-mer peptide pools representing consensus sequences of HIV-1 Gag, Env, and Reg (Tat, Rev, Vif, Vpu, Vpr), or peptide diluent (Tiemessen, et al., JID 2010). The cultures were analyzed for CD3-CD56+ NK cell and CD3+CD8+ T cell responses by flow cytometry. Results HIV-1 peptide-specific NK cell IFN-g and TNF-a responses were present in 19/23 (83%) HIVpos, 6/13 (46%) HESN and 4/21 (19%) HIVneg (P< 0.001 and P=0.07 compared to HIVpos and HESN, respectively). The IFN-g response magnitudes ranged from 1% to 20% of all NK cells: HIVpos=5.6±1.1%, HESN=1.5±0.7%, and HIVneg=0.47±0.1% (P< 0.001 and P=0.065 compared to HIVpos and HESN, respectively). HIVpos NK cells predominately responded to Env peptides, whereas HESN NK cells responded to both Env and Reg peptides. While both HIVpos and HESN demonstrated CD8+ T-cell responses to Env and Reg, only HESN had CD8+ T-cell IFN-g reactivity to Reg in association with NK cell responses. Conclusion We show for the first time that contemporaneous blood samples from MSM defined as HESN exhibit relatively robust, innate NK cell immunity, and less common CD8+ T cell immunity, specific for HIV-1 proteins. These presumably long lasting, NK cell responses to Env and Reg peptides could be due to prior exposure to HIV-1, or to an inherited genetic resistance. In-depth assessment of these virus-specific NK cell responses could be important in designing effective HIV-1 therapeutics and vaccines., Background Marked differences are seen in individuals’ susceptibility to HIV infection. Inflammation and immune activation are critical factors contributing to initial infection with HIV. The objective of this study was to define serum levels of cytokines and biomarkers of inflammation in participants in the Multicenter AIDS Cohort Study (MACS) who were at high risk for acquiring HIV infection but remained HIV seronegative (HESN), and in those at lower risk who did (LRSC), or did not (LRSN), subsequently undergo HIV seroconversion. Methods Serum levels of cytokines, and biomarkers for inflammation were quantified using Luminex multiplexed assays, in 188 HESN, 125 LRSC, and 197 LRSN. LRSC were tested at a study visit preceding HIV seroconversion. HESN were defined as persistently seronegative participants who were multiply-exposed (>45 anal sexual partners in the 2.5 years prior to MACS visit 2). The LRSC and LRSN groups had, Background Mother-to-infant transmission (MTIT) of HIV results in ~400,000 infected children each year, with a transmission rate of 35–40%. In contrast, nonhuman primate species that are naturally infected with SIV in the wild (“natural hosts”, including sooty mangabeys, SMs) rarely transmit SIV from mothers to infants. The mechanisms underlying this protection are unknown. In this study we tested the hypothesis that limited target cell availability protects SMs from MTIT. Methods The availability of target cells (CD4+CCR5+ and CD4+Ki67+ T-cells) for SIV infection in seven uninfected SM infants was measured by flow cytometry among naïve and memory T-cell subsets obtained from tissues (lymph nodes, spleen, tonsil, and multiple sites along the gastrointestinal tract) at necropsy. Results We found that, in infant SMs, the median percentage of CD4+Ki67+ T-cells ranged from 3.2%-10.3% depending on the anatomic site analyzed, with lower values found in CD95-CD28+ naïve CD4+ T-cells. In contrast, the CD95+CD28+CCR7+ central memory and CD95+CD28+CCR7- transitional memory CD4+ T-cells displayed higher median levels of Ki67 (10.4%-49.3%). The percentage of Ki67+CD95+CD28-CCR7- effector memory CD4+ T-cells tended to be between that of the naïve cells and other memory subsets. Despite this increased level of proliferation (compared to adult SMs), CCR5+T-cells comprised, Background Current HIV-1 integrase inhibitors target the catalytic activity, which is vital for sustained viral infection. Integrase mediates the critical step of proviral DNA integration. Efficient integration also requires a crucial cellular co-factor of HIV-1 integrase, LEDGF/p75, that tethers the viral DNA to the host chromatin. LEDGINs, small molecules designed to bind to the LEDGF/p75 interaction site on IN and to disrupt the interaction, have recently been shown to act as potent inhibitors of HIV replication in cell culture. Methods We have now analyzed the detailed mode of action of LEDGINs, dissecting the allosteric nature of inhibition in vitro and analyzing phenotypically their activity in cell culture. Mechanistic studies and combination experiments shed light on potential synergy of LEDGINs with known integration inhibitors. Analysis of the inhibition of a broad spectrum of HIV strains allows predictions on combinations with other drugs such as entry, RT and protease inhibitors. Results Biochemical evaluation of LEDGINs demonstrates in addition to a potent inhibition of the integrase-LEDGF/p75 interaction, a block of the catalytic integrase activities. This allosteric inhibition is promoted by the stabilization of the dimer-interface of IN upon LEDGIN binding most likely by affecting interaction with viral DNA. These properties of LEDGINs result in potent inhibition of HIV replication in both MT2 and PBMC cells. Moreover, LEDGINs are active across a broad range of HIV clades. LEDGINs retained full activity against a panel of viruses containing mutations that confer resistance to integrase strand transfer inhibitors. Combining LEDGINs with strand transfer inhibitors demonstrates a synergistic effect of these classes of integration inhibitors. Conclusion The biochemical data together with the lack of cross resistance and the observed synergistic effects of LEDGINs in combination with strand transfer inhibitors support the potential for combined use of LEDGINs with strand transfer inhibitors in HIV therapy., Background Tenofovir (TFV) is the only microbicide antiretroviral that has shown clinical effectiveness when dosed pericoitally in a vaginal gel. There remains a need to improve TFV delivery by providing long-lasting, coitally-independent, effective drug levels. Intravaginal rings (IVRs) offer this capability; however TFV is hydrophilic and demonstrates inadequate delivery from conventional IVR technologies. Our objective was to develop a novel IVR technology capable of releasing ≥10 mg/d TFV for ≥90 days, alone or co-delivered with 10 or 20 µg/d of the contraceptive levonorgestrel (LNG). Methods IVRs were designed using single (TFV-only) or dual (TFV-LNG) reservoir-type polyurethane (PU) segments. TFV segments comprised water-swellable PU tubing filled with a high density TFV paste. LNG segments comprising a LNG-loaded non-swellable PU core with a rate controlling membrane were cut to 1 and 2 cm lengths to obtain target release rates of 10 and 20 µg/d, respectively. In vitro release testing (IVRT) and 3-month pharmacokinetic (PK) studies in rabbits and sheep evaluated device performance. Results IVRT revealed time-independent and tunable TFV and LNG release rates which were optimized to achieve our target 10 mg/d TFV and 10 or 20 µg/d LNG. In sheep, TFV and LNG release rates were estimated at ~12–17 mg/d and ~14–31 µg/d, respectively. TFV vaginal tissue and fluid levels were ~104 and 106 ng/g, respectively, similar to levels reported after clinical dosing of TFV 1% gel. In rabbits, LNG PK demonstrated 2-fold differences in plasma and cervical tissue concentrations between the two dose groups, as predicted by in vitro release. Conclusion We developed a unique IVR technology that met our target product profile delivering a high flux of a hydrophilic antiretroviral (TFV) alone or with a low flux of a hydrophobic drug (LNG) in a controlled, time-independent manner. PK results are highly encouraging and warrant a Phase I clinical study. [Picture of prototype TFV and TFV/LNG IVRs], Background HIV-1 integrates into the host chromosome and persists as a provirus flanked by long terminal repeats (LTR). To date, treatment regimens primarily target the virus enzymes or virus entry, but not the integrated provirus. Therefore, HAART requires lifelong treatment which is frequently accompanied by the occurrence of substantial side effects and/or the development of drug-resistant viruses. Previously, we engineered a LTR-specific recombinase (Tre-recombinase) that effectively excises integrated HIV-1 proviral DNA from infected human cell cultures, suggesting that customized enzymes might someday help to eradicate HIV-1 from the body. Therefore, we here analyzed the potential of Tre-recombinase to reverse HIV-1 infection in vivo. Methods We constructed an advanced lentiviral self-inactivating (SIN) vector that expresses Tre-recombinase conditionally in HIV-infected cells. We monitored Tre functionality and potential Tre-related cytopathic effects over time in tissue cultures. Moreover, the effect of Tre activity on HIV-1 infection was investigated in humanized mice. Results It is shown that Tre-recombinase is efficiently delivered into cells and accurately excises HIV-1 proviral DNA from chromosomal integration sites. Apparently, prolonged overexpression of Tre-recombinase does not induce undesired cytopathic effects in the transduced cells. Finally, we demonstrate pronounced antiviral activity of Tre-recombinase in HIV-1 infected Rag2−/−?c−/− mice, which were either engrafted with Tre-transduced human CD4+ T cells or with Tre-transduced human CD34+ hematopoietic stem cells (HSC). Conclusion The presented data suggest that Tre-recombinase may be a valuable component of future antiretroviral therapies of the post HAART era that aim at virus eradication, thereby providing a cure for AIDS., Background In HIV infection, the HIV-specific cytotoxic T lymphocyte (CTL) response is a critical component in controlling viral replication that ultimately fails in its ability to eradicate the virus from the body. Our primary aim is the development of a way to enhance the HIV-specific CTL response to allow long-term viral suppression or viral clearance. Methods In our approach, we sought to genetically manipulate human hematopoietic stem cells (HSCs) such that they differentiate into mature CTLs that will kill HIV infected cells. To perform this, we utilized molecularly cloned HIV-specific T cell receptors (TCRs) derived from CD8+ T cells. These TCRs were used to genetically transduce HSCs that were introduced into a humanized mouse and were allowed to differentiate into mature human CD8+ CTLs. Mice expressing the transgenic HIV-specific TCR and, separately, control mice were then infected with HIV-1 and functional cellular responses, viral suppression, and viral and T cell dynamics were assessed. Results We found that genetic modification of human HSCs with a cloned TCR allows proper differentiation of the cells to occur in vivo and these cells migrate to multiple anatomic sites, mimicking what is seen in humans. We observed that the genetically modified HIV-specific CTLs form a functional antiviral response in vivo that results in the significant suppression of HIV replication in multiple organs. In addition, we found significant correlations between the levels of reconstitution with cells bearing the HIV-specific TCR, antigen-driven T cell expansion, and the control of viral replication. Conclusion We have developed a system to closely characterize the engineering of antiviral immunity and HIV-specific CTL responses. Our results strongly suggest that stem cell based gene therapy may be a feasible approach in the treatment of chronic viral infections and provide a foundation towards the development of this type of strategy., Background Treatment of HIV infection by antiretroviral therapy is effective but costly and often associated with numerous side effects. The key to a permanent treatment to chronic HIV infections is to elicit potent host resistance to viral infection and to restore immune functions. The prolonged incubation period of HIV-1 provides a good opportunity for applying non-conventional interventions such as gene therapy. For HIV gene therapy to be effective, the combination of an efficient gene transfer vector and a powerful anti-HIV strategy is necessary. Methods HIV resistance will be established in patients′ hematopoietic stem cells (HSCs) by lentivector (LV) transduction of (i) a microRNA to block endogenous CCR5 expression, (ii) a sequence-modified CCR5Δ32 gene to interfere with the function of native CCR5 and CXCR4 and (iii) effective multiple anti-HIV shRNAs to target viral RNAs. Results We generated LVs encoding the native and a codon-optimized CCR5Δ32 gene. Ectopic expression of CCR5Δ32 in HOS-R5 and Magi-R5 cells established protection against R5-HIV-1 infection. Unexpectedly, we observed severe cytotoxicity in HOS-R5 cells and primary CD4 T cells when CCR5Δ32 was expressed. In a second approach, we generated a LV expressing an H1-promoter driven CCR5 miRNA and demonstrated marked protection against R5-HIV-1 infection. In a third approach, we generated a novel LV expressing three miRNA intronic cassettes (miR155-19a-30a) targeting HIV-1 pol, int and vpu, respectively, and demonstrated marked protection against HIV-1 infection. LV transduction of adult CD34+ HSCs had no adverse effect on hemopoiesis for dendritic cell development but T cell development appeared to be impaired based on an in vitro assay. Conclusion We conclude that ectopic expression of CCR5Δ32 in adult CD34+ HSCs using a constitutive expression promoter is cytotoxic because the CCR5Δ32 transgene can activate uncontrollable intracellular T cell signaling. However, miRNAs targeting endogenous CCR5 and multiple HIV sequences is highly effective against HIV infection without cytotoxicity., Background The transition from native to receptor-bound and eventually to the fusion-competent conformation of HIV-1 envelope glycoprotein (Env) Env requires a tightly choreographed interaction among highly conserved structures within the viral envelope glycoprotein. Recent structural information has revealed that these conformational transitions are regulated by three conserved but highly mobile layers stacked between the receptor-binding domain (gp120) and the fusion arm (gp41) of Env. We hypothesized that limiting the mobility of these layers by artificially insertion of covalent bonds will capture Env in a conformation where conserved sites are stably exposed. Methods We scanned residues that lie at the interface of gp120 layers (layers 1, 2 and 3) and identified targets that are predicted to form disulfide bonds if substituted with paired cysteines. We substituted a pair of residues between layers 1 and 2 with cysteine & expressed and purified the disulfide-stabilized gp120 (and gp140) antigens and analyzed them using Surface Plasmon Resonance (SPR) assay. Following in vitro analysis, we immunized rabbits with both the wild-type and disulfide-stabilized gp120 (and gp140) antigens, adjuvanted with Carbopol+MF59, and evaluated serum antibodies for binding, neutralization and epitope-specificity. Results A single disulfide bond inserted between the highly conserved layers 1 and 2 led to enhanced stability of the receptor bound conformation of gp120. This was revealed by lower dissociation constant (Kd) of the mutant gp120 binding to 17b antibody, which recognized a conserved CD4 induced (CD4i)-epitope on gp120. Upon immunization in rabbits, the disulfide-stabilized gp120 (and gp140) antigens, in comparison to wild-type antigens, elicited higher level of antibodies directed to CD4-binding site and CD4i-site. Conclusion We demonstrate that structure guided stabilization of inter-layer interactions within Env can be used to improve and stabilize the exposure of conserved epitopes on the antigen and elicit improved antibody response, with the aid of a potent adjuvant, upon immunization., Background The limited success of vaccines targeting the MPER of HIV-1 gp41, we hypothesize, may in part reflect the difficulty of mimicking its neutralization-competent structure (NCS). We have developed DNA-vaccine candidates meant to emulate the NCS of the MPER, and report on their ability to elicit MPER-specific, neutralizing (Nt) antibodies (Abs). Methods DNA vaccines encoding various gp41 ectodomain fragments, and the transmembrane region (TM) of either the platelet-derived growth factor receptor (PGDFR), or that of gp41 were engineered, transiently expressed in COS-7 cells, and tested for antigenicity. Rabbits were immunized with plasmid DNA of select candidates; sera were collected and tested for MPER reactivity. Results Work with the protein products of these vaccines has shown they mimic the NCS of the MPER by several criteria, including the ability to be bound tightly by well-characterized Nt MAbs, but weakly by their non-neutralizing mutant-MAb counterparts. Immunizations with plasmids expressing the MPER tethered to the PDGFR-TM elicited MPER-specific Abs that targeted the epitope of the 2F5 NtAb. Immunization with DNA vaccines encoding the MPER and gp41 TM, elicited low-titre Abs that cross-reacted weakly with the MPER, and strongly with regions outside the MPER. Both sets of immunizations failed to produce Abs that cross-reacted with the 4E10 epitope, or neutralized pseudoviruses bearing HIV-1 Env. We found that the presence of the PGDFR-TM significantly reduced MPER-binding to 4E10 MAb, but not by 2F5. Putative models suggest that in the PDGFR-TM fusions, the 4E10 epitope faces into the lipid bilayer, thereby altering its exposure. Conclusion Our work reveals key structural features involved in promoting the NCS of the MPER. While the gp41 TM is vital in properly exposing neutralizing epitopes on the MPER, it was also found to elicit Abs against sites outside the MPER. Current work is focused on engineering the gp41 TM to optimally expose MPER epitopes., Background The classical vaccine approach for combating other viruses has failed so far in dealing with HIV-1, a virus infecting a key component of immune system and with greater diversity and rapid mutation. New approaches are needed to develop a preventative vaccine. The protease of HIV-1 is a small 99-amino acid aspartic enzyme mediating the cleavage of Gag, Gag-Pol and Nef precursor polyproteins. The process is highly specific, temporally regulated and essential for the production of infectious virions. A total of 12 proteolytic reactions are required to generate a viable virion. Therefore, a vaccine targeting the 12 protease cleavage sites(PCS) could be effective. The PCS of HIV-1 are highly conserved, direct immune responses against these sites would yield several advantages. First, the immune response could destroy the virus before its establishment in the host. Second, it could force the virus to accumulate mutations eliminating the normal function of the HIV protease. Third, restricting the immune responses to these sites can avoid distracting immune responses that often generate unwanted inflammatory responses, induce excess immune activation, and attract more targets for HIV-1 infection, establishment and spread. Methods We conducted a pilot study to investigate the feasibility and effectiveness of this approach. The recombinant VSV-peptides were used to immunize cynomolgus macaques and nanopackaged peptides were used to boost the immune response to the 12 PCS of SIVmac239. The controls and immunized macaques were repeatedly challenged intrarectally with an increased dosage of SIVmac239. Results Antibody and T cell responses to the 12 PCS can protect macaques against higher dosage of SIVmac239 challenge (p=0.0005, R=0.8005) and the vaccine group maintains significantly higher CD4+ counts (p=0.0002) than the controls weeks after being infected. Population coverage analysis showed that this approach can be applied to >95% populations in the world. Conclusion Targeting 12 PCS of HIV-1 is a viable approach., Background A strategy combining Canarypox based vaccine, ALVAC-HIV with gp120 protein has resulted in limited but significant protection from HIV infection in The RV144 vaccine efficacy trial. We have previously tested a similar strategy in the non-human primate model of HIV infection obtaining a similar efficacy to what observed in humans. Methods To study the contribution of innate immune responses as correlate of protection, we have performed microarray analysis in the blood collected from 6 macaques at 16, 24 48 and 72 hours after the first two immunizations with ALVAC (V1 and V2 respectively) and the 3rd immunization with ALVAC/gp120 protein (V3). Results Our results show that 1) 24h after the 1st immunization with ALVAC-SIV (V1) genes with antiviral activity were up regulated (MX1, HERC-5, CD79b), but interestingly inflammatory genes where down regulated (IL1, IL18RAP, IFNR1), suggesting a reciprocal regulation of genes for IFN type I and II; 2) similar patterns of gene expression where observed earlier, at 16h from V2, suggesting the presence of "memory -innate" anti viral responses; 3) the 3rd boost with ALVAC, given simultaneously to the gp120 protein adjuvanted in Alum (V3), resulted in significant changes in the gene expression profile when compared to the first two vaccinations. At 24h from this immunization there were a far less number of IFN-related genes that were significantly up regulated (V3=3) when compared to the first and second immunization (V1= 17; V2=27), and the IFN-responses still up regulated were associated with NK cells, B cell- (CD79B) and T cell- (PKC, CD28 TCR) responses. Conclusion These results suggest that each component of vaccination could have contributed to the protection from infection underscored the ALVA/gp120 strategy. Understanding how to induce different types of immune responses that are protective for HIV may be relevant for the generation of more effective vaccine strategies., Background One of the most frequent complications associated with antiretroviral therapy (ART) in HIV-tuberculosis (TB) co-infected patients is the Immune Reconstitution Inflammatory Syndrome (IRIS). While monocytes/macrophages play a major role in both HIV- and TB-infection individually, the putative contribution of monocytes to the development of TB-IRIS remains uncharacterized. We therefore applied a parallel approach of genome-wide microarray analysis and focused gene expression profiling in monocytes from Ugandan HIV-TB co-infected patients before and shortly after ART initiation, to investigate the possible functional contribution of monocytes to the development of IRIS. Methods Monocyte gene expression of TB-IRIS patients and non-TB-IRIS patients was analyzed by Affymetrix GeneChip® Human Gene 1.0 ST Arrays and was confirmed using the nCounter system; datasets were analyzed for overrepresented pathways using Ingenuity Pathway Analysis. Expression levels of and enzymatic activities of proteins of interest were characterized in the isolated monocyte fractions and in the plasma of IRIS patients. Results Pathway analysis indicated that the complement system was significantly modulated in monocytes of TB-IRIS patients, both before initiation of therapy (baseline) and after two weeks of therapy. At baseline, expression of both C1q and C1-inhibitor was higher in TB-IRIS patients. After two weeks, the C1q mRNA levels in the majority of TB-IRIS patients increased, whereas C1-inhibitor mRNA levels decreased pronouncedly. Additionally, the inhibitory activity of C1-inhibitor was significantly higher in TB-IRIS patients compared with non-TB-IRIS patients at baseline but reduced to the level of C1-inhibitor activity in non-TB-IRIS patients at week 2. Conclusion For the first time, we provide evidence that monocytes at least partially contribute to the development of TB-IRIS, probably through the complement system response. An intriguing possibility is that the relative balance between C1q and C1-inhibitor may be affecting the inflammatory function of C1q in the complement cascade., Background We have shown that leishmaniasis contributes to heightened T-cell activation in HIV-1/Visceral leishmaniasis (AVL) patients. Now we investigate whether lipopolysaccharide (LPS) has a crucial role in the pathogenesis of this co-infection. Methods 10 healthy volunteers, 17 AVL/HIV-1 and 16 HIV-1/AIDS patients were recruited. CD4+T counts and CD8+T cells expressing CD38 were analyzed by flow cytometry. LPS and sCD14 levels were measured by enzymatic assays. Plasmatic pro-inflammatory cytokines (IL-1/IL-6/IL-8/IL-17/IFN-γ/TNF-a) were assessed by multiplex analysis. The macrophage migration inhibition factor (MIF) and intestinal fatty acid binding protein (IFABP) were quantified by ELISA. Mann-Whitney and Spearman correlation test were employed for statistical analysis. Multivariate linear regression was used to determine influence of intervenient factors over T-cell activation. Results AVL/HIV-1 patients in leishmaniasis remission presented equal CD4+T counts or T-cell activation levels in comparison to patients in the active phase of leishmaniaisis. Higher levels of CD8+/CD38+ were seen independently of leishmaniasis clinical phase when compared to HIV/AIDS cases (p< 0.05). Viral load levels had no influence in CD8+/CD38+ levels. Co-infected and HIV+ patients presented similar LPS and IFABP levels, but higher than healthy donors (p< 0.001). Pro-inflammatory cytokines levels, but not MIF were significantly augmented in co-infected cases. LPS levels were positively correlated with MIF (r=0.40;p< 0.05). We found positive correlation between LPS levels and CD38 on CD8+ T lymphocytes(p, Background The incidence of HPV-associated lesions is higher in HIV-infected than in HIV-uninfected individuals. Oral and anogenital mucosal epithelia of HIV/AIDS-positive individuals contain infiltrating HIV-infected immune cells that express viral tat and gp120, and proinflammatory cytokines TNF-a and IFN-g. These proteins may disrupt tight junctions (TJ) of mucosal epithelium, facilitating HPV penetration. Our aims were to investigate how HIV-associated disruption of mucosal epithelium promotes HPV infection. Methods Polarized oral and cervical epithelial cells and tissue explants from HIV-uninfected individuals were treated with recombinant HIV-1 tat, gp120, TNF-a and IFN-g independently and together. The cells and tissue explants were exposed to HPV 16 pseudovirions labeled with fluorescent dyes. Paracellular HPV penetration through disrupted epithelium was evaluated by confocal microscopy. Results Treatment of oral and cervical epithelial cells with tat, gp120, TNF-a, or IFN-g independently for 24 h did not induce significant disruption of TJ but the combination of all 4 proteins caused disruption of TJ in about 90% of cells. Prolonged treatment of cells with these proteins independently for 5 days also induced substantial disruption of TJ. Epithelial disruption mediated by these proteins facilitated paracellular PsV passage through polarized cells-30-45% of apically applied virions were detected in the basolateral compartment. Treatment of oral epithelial explants with HIV tat, gp120, TNF-a, and IFN-g led to disruption of epithelial TJ with paracellular HPV penetration into epithelium and entry of HPV into basal cells. Conclusion Our data indicate that HIV tat, gp120, TNF-a, and/or IFN-g in the epithelial microenvironment disrupt epithelial TJ in a time-dependent manner. Alone or together, they potentiate HPV penetration into basal epithelial cells where HPV infection is initiated. Interference with the effects of these proteins may be useful to reduce the risk of HPV infection when applied topically to at-risk genital mucosal epithelium prior to sexual exposure., Background TT virus is genetically variable and widespread among the general population without apparent pathological effects. It has been detected in the peripheral blood and a variety of body fluids such as semen and cervical fluids. Studies from North America and Europe have reported that TTV infection is more prevalent in HIV-1-infected individuals than in healthy control, but its prognostic significance has been controversial. No study has been reported for TTV co-infection in HIV-1-infected Asian people. This study was aimed to demonstrate prevalence, genotypic variability and prognostic significance of TTV coinfection in northern Thailand HIV cohort. Methods A total of 756 HIV-1-infected adults were enrolled in the Lampang HIV cohort in northern Thailand, and their blood samples were collected. HIV-1 plasma viral loads and CD4 counts were measured at enrollment, and their clinical courses had been monitored. 40 healthy Japanese adults were also tested as controls. DNA of 5 TTV genogroups (G1 to G5) was detected by PCR using genogroup-specific primer pairs. Results 753 (99.9%) of 754 HIV-1-infected adults were infected with any genogroup of TTV: G1 (700/754, 93%), G2 (0/754, 0%), G3a (740/754, 98%), G3b (732/754, 97%), G4 (601/754, 80%) and G5 (562/754, 75%). On the other hand, 38 (95%) of 40 healthy Japanese adults were infected with any TTV genogroup: G1 (63%), G2 (3%), G3a (70%), G3b (68%), G4 (63%) and G5 (20%). Infection with more than one genogroup is more common in HIV-1-infected adults (99%) than in controls (68%). 62% HIV-1-infected and only 13% healthy adults were infected with all of G1, G3a, G3b, G4 and G5. Conclusion TTV infection is highly prevalent in both HIV-1-infected and uninfected Asian adults; however, mixed genogroups were much more common in the former. Correlations between certain TTV genogroup or TTV loads and CD4 counts or HIV-1 load will be determined., Background Secreted proteins play an important role in intercellular interactions, especially between cells of the immune system. Infection of human lymphoid tissues by HIV-1 may alter secretion patterns. Here, we describe a novel, easy, inexpensive, and versatile method, which allows the identification and isolation of a living cell actually secreting any protein of interest. Methods We coupled carboxylated magnetic iron oxyde nanoparticles (IONPs) or quantum dots to polyclonal goat anti-mouse IgG(H+L) antibodies (GAM) and used them as a platform to bind a cell-specific antibody, conferring cell targeting, and an antibody specific for a secreted protein. Purified complexed IONPs form an affinity matrix on the cell surface and capture the cell-secreted product, which can then be detected on the surface of the secreting cell by another secreted-protein-specific labeled antibody. Results GAM-IONPs complexed with anti-CD45 antibody and either anti-IL-2 or anti-IFNgamma. This capture assay was as efficient as a commercial assay and intracellular cytokine staining in identifying cells that secrete IL-2 and IFNg. Respectively, these assays detected IL-2 secretion on 16.9±4%, 14.7±1.8% and 16.3±1.4% of T cells (N=6, P, Background Monitoring of antiretroviral treatment (ART) with human immunodeficiency virus (HIV) viral loads, is rarely available in resource-limited settings because of the high costs, stringent requirements for storage and transport of plasma. Monitoring of antiretroviral therapy (ART) with HIV-1 viral load assays to determine virological treatment failure and to decide when to change to second line therapy is highly recommended. Requirements for -80 degrees Celsius freezers for sample storage prohibit implementation of this level of care in resource poor settings. Dried blood spots (DBS) can be used as an alternative to plasma, but the use of DBS for HIV-1 assays has not been assessed in Zimbabwe. This study investigates the performance of DBS for HIV viral load monitoring of patients on ART in Zimbabwe. Methods Parallel forty eight (48) plasma samples and 48 DBS samples were used in this study. They were selected from samples stored at Flow Cytometry Laboratory, Zimbabwe, collected from patients with ART failure and who were being monitored for HIV drug resistance. Viral load assays were performed on 48 samples using plasma and dried blood spots methods. Plasma was separated and frozen at -80 degrees Celsius and DBS were kept at room temperature for 30days. Results The correlation between plasma and DBS viral load was high (R2=0.75). Mean difference was 0.05 log10 copies/mL (SD 0.58), and only 8 samples showed >1 log10 difference. Sensitivity and specificity of DBS to detect virological failure (plasma viral load >400 copies/mL) was 82.5 and 93.1%, respectively. Conclusion There was a very good correlation between DBS stored at room temperature for 30 days and plasma viral load assays. The evaluation shows that DBS can be a feasible and reliable method for virological monitoring of patients on ARVs in rural areas with transport facilities for referring samples to a central laboratory. Abstract Coding GuideExample: MOAA01=(Weekday) MO – (Session type) AA – (Session order) 01 Weekdays: SU (Sunday), MO (Monday), TU (Tuesday), WE (Wednesday), TH (Thursday), FR (Friday) Session types: oral abstract sessions – AA (Track A), AB (Track B), AC (Track C), AD (Track D), AE (Track E), AX (Cross-Track), LBA (Late Breaker Track A), LBB (Late Breaker Track B), LBC (Late Breaker Track C), LBD (Late Breaker Track D), LBE (Late Breaker Track E), LBX (Late Breaker Cross-Track); oral poster discussions sessions – PDA (Track A), PDB (Track B), PDC (Track C), PDD (Track D), PDE (Track E) PDX (Cross-Track) Session order: 01, 02, 03, 04, etc.
- Published
- 2012
15. WEAD0302: Total Control of Epidemic (TCE) program of Humana People to People: a community driven response to the fight against AIDS
- Author
-
Strathdee, S., Lozada, R., Martinez, G., Rangel, G., Staines, H., Abramovitz, D., Vera, A., Magis-Rodriguez, C., Patterson, T., Bärnighausen, T., Bloom, D., Humair, S., Lichtenberg, M., Hansen, I., Mukhopadhyay, S.M., Irizarry, C., Jones, C., West, C., Adjei, B., Nordlund, D., Ilic, D., Nyagero, J., Wangila, S., Kutai, V., Olango, S., Matseke, G., Simbayi, L., Wabiri, N., Ncitakalo, N., Bekalu, M.A., Eggermont, S., Godwaldt, M., Handa, S., Pettifor, A., Thirumurthy, H., Halpern, C., Bogart, L., Skinner, D., Thurston, I., Toefy, Y., Klein, D., Wachman, M., Schuster, M., Bendezu, J., Berger-Greenstein, J., Richardson, M., Reid, K., Wolfe, J., Mainville, C., Bacic, J., Brady, S., Sakovych, O., Balakireva, O., Bondar, T., Ochieng, R.M., Cobbler, M.-A., Matungwa, D.J., Chenha, C., Kachuchuru, J., Visser, T., van Reeuwijk, M., Maro, G., Massawe, A., Kalongola, I., Francis, J., Changalucha, J., Mshana, G., Itaka, A., Makokha, M., Campbell, C., Nhamo, M., Nyamukapa, C., Madanhire, C., Scott, K., Skovdal, M., Sherr, L., Gregson, S., Kiiza, C., Babu Ndyabahika, A., Castro, D., Keatley, J., Gutierrez-Mock, L., Sevelius, J., Rebchook, G., Njom Nlend, A.E., Bagfegue Ekani, B., Tchouamo, A., Mbi, A., the Mother & Child Djoungolo Network, Brewster-Lee, D., Suba, M., Deering, K., Feng, C., Amram, O., Montaner, J., Chettiar, J., Shannon, K., Rao, D., Desmond, M., Andrasik, M., Rasberry, T., Lambert, N., Cohn, S., Simoni, J., Chaitha, W., Jiraphongsa, C., Khumthong, S., Lili, L., Sung-Jae, L., Isaranun, W., Kaeworasan, S., Pibulniyom, R., Chaitha, I., Reif, S., Whetten, K., Wilson, E., Legrand, S., Kelso, G., Cruise, R., Dale, S., Weber, K., Cohen, M., Brody, L., Phillips, J.C., Webel, A., Dawson Rose, C., Holzemer, W.L., Chen, W.-T., Johnson, M.O., Kirksey, K., Voss, J., Sefcik, E., Eller, L.S., Corless, I.B., Wantland, D., Portillo, C., Tyer-Viola, L., Sullivan, K.M., Nicholas, P.K., Iipinge, S., Nokes, K., Kemppainen, J., Rivero-Mendez, M., Chaiphibalsarisdi, P., Reid, P., Brion, J., Gschwend, A., Wespi, K., Amman, P., Langhaug, L., Lim, T., Go, V., Ha, T.V., Minh, N.L., Viet Anh, C., Davis, W., Quan, V.M., Hargreaves, J., Davey, C., White, R., Fielding-Miller, R., Mnisi, Z., Dlamini, N., Baral, S., Kennedy, C., O'Laughlin, K.N., Faustin, Z.M., Rouhani, S.A., Ware, N.C., Marukutira, T., Letamo, G., Mabikwa, V., Karugaba, G., Makhanda, J., Marape, M., Seleke, R., Anabwani, G.M., Knight, L., Hosegood, V., Timaeus, I., Schneider, J.A., Michaels, S., Bouris, A., Tun, W., Keesbury, J., Simmonds, F.N., Sheehy, M., Moyo, T., Rathner, C., Kalibala, S., Cole, S., Agniel, D., Schwartz, R., Anastos, K., Burke-Miller, J., Young, M., Golub, E., Dunkle, K., Jewkes, R., Murdock, D., Sikweyiya, Y., Morrell, R., Muldoon, K., Akello, M., Muzaaya, G., Simo, A., Jain, A., Nuankaew, R., Oranop na Ayuthaya, P., Richter, K., Hardon, A., Bongololo-Mbera, G., Cherutich, P., Gomez, G.B., Kahega, E., Ky-Zerbo, O., Vernooij, E., Wanyenze, R., Obermeyer, C., Bezabih, T., Wang, B., Li, X., Stanton, B., Chi, P., Logie, C., James, L., Tharao, W., Loutfy, M., Urada, L.A., Strathdee, S.A., Schilling, R.F., de Guia, B., Morisky, D.E., Rivero-Méndez, M., Portillo, C.J., Sanzero Eller, L., Nicholas, P., Williams, J., Gómez-Olivé, F.X., Angotti, N., Kabudula, C., Menken, J., Clark, S., Klipstein-Grobusch, K., Tollman, S., Kuteesa, M., Bautista-Arredondo, S., Lazar, F., Buzducea, D., Santamaria, E.K., Elkington, K.S., Alicea, S., Dolezal, C., Leu, C.-S., Mellins, C.A., Gibbs, A., Washington, L., Mbatha, N., Hechter, R.C., Wang, J.Q., Sidell, M.A., Towner, W.J., de Wet, K., Wouters, E., Teh, M.F., Wagner, G.J., Aunon, F.M., Rana, Y., Khouri, D., Mokhbat, J., Stephenson, R., Finneran, C., Shaikh, S., Lonappan, S., Kumarikunta, G., Biswas, K., Rakesh, S., Aher, A., Mehta, S.M., Robertson, J., Santos, G.-M., Beck, J., Wilson, P., Hebert, P., Ayala, G., Chakrapani, V., Boyce, P., Dhanikachalam, D., Manilal, N.R., Ha, D., Fujimoto, K., Ross, M., Adams, M., Johnson, H., Lundgren, R., Panchanadeswaran, S., Hwahng, S., Chacko, S., Barrington, C., Fleming, P., Moya, M., Rosario, S., Perez, M., Donastorg, Y., Broxton, C., Kerrigan, D., Zalwango Kabuye, F., Nakamanya, S., Nalugya, R., Nnalusiba, B., Seeley, J., Auerbach, J., Banyan, A., Riordan, M., West, B.S., Choo, M., El-Bassel, N., Kamarulzaman, A., Wu, E., Gilbert, L., Wang, J., Kelly, B., Ostrow, D.G., Stall, R.C., Jantz, I., Berona, J., Herrick, A., Carrico, A., Swartz, J., Long Term Effects of Meth Use Study Group, Ahmed, A., Reichenbach, L., Alam, N., Arumugam, V., Sharma, C., Das, M., Matheson, T., Demicco, E., Vittinghoff, E., Dilley, J., Colfax, G., Hayashi, K., Ti, L., Kaplan, K., Suwannawong, P., Wood, E., Kerr, T., Bridge, J., Hunter, B.M., Atun, R., Lazarus, J.V., Latypov, A., Bidordinova, A., Khachatrian, A., Han, L., Li, Z., Luo, W., Bulterys, M., Yang, F., Li, R., Shen, L., Fuller, S., Wu, Z., Harper, G., Ngugi, E., Riplinger, A., Gikuni, A., Lemos, D., Hosek, S., Hooks, K., Kuo, C., Casale, M., Cluver, L., Lane, T., Sello, L., Manikandakumar, T., Grote, S., Pal, K., Mehta, S., Caceres, C.F., Salazar, X., Ceccarelli, M.A., Anamaria, P., Prada, P., Villayzan, J., Bracamonte, P., Cataldo, F., Malunga, A., Rusakaniko, S., Umar, E., Teles, N., Musandu, H., Power, L., Brough, G., Bell, M., Partridge, N., Stuart, A., Reijer, D., Bryant, M., Bhatia, A., Mann, C., Li, L., Liang, L.-J., Lin, C., Guan, J., Jia, M., Rou, K., Ekstrand, M.L., Bharat, S., Ramakrishna, J., Shah, S., Perumpil, S., Srinivasan, K., Benkirane, M., Lohiniva, A.-L., Abdelrahman, E., Kamal, W., Talaat, M., Mugo, L., Chirchir, B., Njuguna, P., Kirui, M., Kinuthia, P., Ombam, R., Yorick, R., Suvorova, S., Sukovatova, O., Buchelnikova, L., Shutova, M., Melyakh, A., Hodgdon, S., Harutyunyan, A., Grigoryan, M., Zaqaryan, N., Dewo, Z., Tollera, G., Trivelli, M., Gebremariam, M., Wagner, A., Oladapo, O.O., Akinyosoye, S.A., Ayoola, J.K., Omoniyi, A.F., van der Grinten, E., Mwakangalu, D., Robertson, L., Mushati, P., Belton, S., Gómez-Ramírez, O., Carr, M., Lehman, J.S., Purcell, D.W., Kampango, G., Caswell, G., Aburto Hernández, K.E., Yuan, W., Furaha Kalumire, V., Uwimpuhwe, S., Doyle, K., Dunkeyson, L., Briggs, E., Mulumba, M., Russell, A., Kwagalah, P., Musisi, N.N., Csete, J., Kanon, S., Baye, M., Bissek, A.C., Noba, V., Akondeng, L., Kembou, E., Ebogo, M., Kamenga, C., Oulare, M., Seye, A., Popotte, F., Tchendjou, P., Sakho, L., Rodriguez-Garcia, R., Kayode, O., Manteuffel, B., Simms, B., de Zalduondo, B., Bonnel, R., Njie, N., Schaefer, N., Valadéz, R., Man, W.Y.N., Worth, H., Wilson, D., Kelly, A., Siba, P., Wong, Y., Gupta, S.S., Granich, R., Suthar, A.B., Smyth, C., Baggaley, R., Sculier, D., Date, A., Desai, M.A., Lule, F., Raizes, E., Blanc, L., McClure, C., Hirnschall, G., Olinyk, S., Yager, A., McLemore, M., Lebega, O., Islam, Z., Filippovych, S., Talalayev, K., Nixon Thompson, J.A., Valladares Cardona, R.D., Guatemala, NASA Teams, Belize, El Salvador, Nicaragua, Costa Rica, Panama, Kunaka, D., Mashamba, M., Fisher, K., Donaldson, E., Gobet, B., Green, L.M., Harmon, T., Harrison, P., Lande, R., Warren, M., Zhai, W., Burke-Shyne, N., Patterson, D., Guilland, R., Kalugampitiya, A., Meite, N., Perez, O.L., Nardicchia, S., McCracken, J., Clay, C., Dorsey, K., Coplen, L., Libertine, S., Shields, A., Thomas, R., Hahn, S., Weidmann, J., Gomes, T.M., Akter, M.H., Begum, S., Rasin, S., Bhardwaj, K., Burrone, E., Boulet, P., Moon, S., Park, C., 't Hoen, E., Shen, J., Sunderji, N., Kameni, E., Metheny, N., Viegas Neves da Silva, F., Hallal, R., Guimarães, A., Himmich, H., Maguet, O., Essalhi, M., Caldéron, C., Alaoui Hasnouni, R., Kandil, A., Shterjova Simonovikj, H., Tosheva, M., Roose-Snyder, B., Johnson, V., Hanssens, C., Positive Justice Project, Mykhalovskiy, E., Peck, R., Kazatchkine, C., McCaskell, T., Betteridge, G., Symington, A., Elliott, R., Ka Hon Chu, S., Golichenko, M., Patel, P., Berger, P., Schlecht, H.P., Awuoche, H., Kiringa, G., Nduba, V., Mitchell, E., Ruzario, S., Mavhu, W., Rossouw, T., Guta, A., Switzer, S., de Prinse, K., Chan Carusone, S., Strike, C., Salazar Ramirez, D., Salazar, P., Garcia Cordova, A., Villani, J., Geffroy, L., Lowenstein, W., Bourdillon, F., Celse, M., Rozenbaum, W., Musso, S., Hesnault-Pruniaux, N., Dozon, J.-P., Cadoré, B., Briand, Y., Bernard, E.J., Nyambe, M., Lax-Vanek, J., Rans, S., Greene, B., Chung, K., Shorkey, A., Wilson, M., Hoppe, T., Simon, S., Acaba, J., Maseko, S., Ndlovu, S., Caouette, A.-A., Schoepp, A., Fielden, S., Fergusson, P., Anema, A., Young, S.L., Natamba, B.K., Luwedde, F.A., Plenty, A.H.J., Mwesigwa, J., Natureeba, P., Osterbauer, B., Achan, J., Clark, T.D., Ades, V., Robine, M., Nzarubara, B.K., Ruel, T.D., Kamya, M., Charlebois, E.D., Havlir, D.V., Cohan, D.L., Bernard, D., Koenig, S.P., Riviere, C., Bertil, C., Severe, P., Pape, J.W., Cornier, N., Schilperoord, M., Spiegel, P., Haskew, C., Njogu, P., Yiweza, D., Doraiswamy, S., Mendelsohn, J.B., Burton, J.W., Okonji, J.A., Muhindo, B., Larke, N., Grant, A., Mohamed, I.M., Mukui, I.N., Ross, D.A., Balasundaram, S., Radhakrishnan, A., Lee, C., Njogu, P.M., Tuot, S., Sopheab, H., Oum, S., Connelly, C., Booysen, F., De Walque, D., and Over, M.
- Subjects
Economic growth ,AIDS2012 Abstract Supplement ,D24 - Those growing up with HIV ,D75 - Impact of service delivery on providers, coping strategies, burn-out and motivation ,D92 - Impact of the law, law enforcement and/or access to justice on the HIV response ,D109 - Education and child welfare ,D45 - Positive health, dignity, psychological well being, mental health and prevention ,D53 - Ageing with HIV - social, behavioral and mental health issues ,D76 - Social factors determining use of HIV and AIDS, tuberculosis (TB), hepatitis and other related services ,D95 - Ethics (including research, clinical, public health and professional ethics) ,D9 - Counseling and testing (HIV counseling and testing (HCT) and voluntary counseling and testing (VCT)), social, psychological and behavioral aspects of HIV testing and counseling ,D21 - Sex and gender ,D37 - Sex work and sex cultures ,D15 - Violence and conflict: political, gender, social, structural, interpersonal and family-based ,D26 - Caregiving ,D22 - Age ,D110 - Social welfare ,D42 - Sexual transmission and drug use ,D30 - Sexual minorities and HIV vulnerability and/or resilience (e.g., gay and other men who have sex with men (MSM), lesbians and other women who have sex with women (WSW), bisexuals, transgenders, transsexuals ,D88 - Monitoring and evaluation of policies and their impact on PLWHA, affected communities and vulnerable populations ,D71 - Stigma and discrimination in health care settings ,D72 - Family-centered approaches ,Public good ,D16 - HIV-related stigma, layered stigmas and marginalized identities ,D47 - Seropositivity: social identity, disclosure and vulnerability ,D80 - Evidence-informed policy development ,D23 - Incarceration ,Infectious Diseases ,D56 - Improving social and behavioural data collection, triangulation of data sources and analysis in HIV research and programmes ,D35 - Reproductive health, fertility, family planning ,D4 - Community, social and political mobilization and building of social capital ,D27 - Disability ,D2 - Behaviourial and social research on risk reduction interventions ,D44 - Harm reduction programmes, including syringe exchange, substitution therapy and supervised injection facilities ,D85 - Policies addressing social and economic determinants of vulnerability ,D98 - Punitive laws and practices around HIV transmission, sex work, drug use and homosexuality ,D10 - Other behavioural, social and structural interventions, including in the context of biomedical interventions ,D7 - Child care, infant feeding, pre-chewing of food (premastication) ,D89 - Impact of policies on health systems ,D74 - Community involvement and outreach in service delivery ,D83 - Histories of policy responses to the epidemic ,D8 - Prevention with HIV-positive people ,D78 - Policy determinants and constraints ,D105 - Human and food security ,D38 - Sex, gender and new prevention technologies ,D84 - Policies regarding HIV prevention, diagnosis, treatment and care ,D12 - Socio-economic vulnerability and stratification (e.g., inequality, poverty, wealth, social status) ,D91 - Analysis of resource allocation and monitoring of their use ,Acquired immunodeficiency syndrome (AIDS) ,Environmental health ,D94 - Human rights and legal protection and empowerment of PLWHA and key populations at higher risk ,medicine ,D43 - Criminalization of drug use and people who use drugs and its impact on HIV ,Production (economics) ,D33 - Relationships, concurrency, sexual networks and partnerships ,D86 - Policies addressing HIV and AIDS in the workplace and educational institutions ,D46 - Adaptation to living with HIV for individuals, families and communities ,business.industry ,D1 - Combination prevention programmes ,D31 - Effects of homophobia and transphobia ,Public Health, Environmental and Occupational Health ,D48 - Growing up with HIV: early infection, children and youth ,D14 - Family structures, kinship, and social safety nets for widows, orphans and other vulnerable groups ,D41 - Social networks of drug users ,D79 - Advocacy and lobbying by civil society, affected communities and PLWHA ,medicine.disease ,D106 - Disasters and HIV ,D68 - Available capacity, capacity building and organizational development ,D17 - Racism and other forms of social exclusion ,D32 - Young people and sexuality, intergenerational sex ,D93 - Intellectual property and trade regimes and access to HIV treatment and diagnostic medical devices ,D96 - Children's rights and HIV ,D13 - Migration, social movements and population dislocation: mobile and immigrant populations (including people living with HIV) ,D3 - School-based sexuality education, life skills, gender equality education ,business ,D29 - Sexualities: meanings, identities, norms and communities - Abstract
Background We evaluated brief combination interventions to simultaneously reduce sexual and injection risks among female sex workers who inject drugs (FSW-IDUs) in Tijuana (TJ) and Ciudad Juarez (CJ) Mexico during 2008-2010, when harm reduction was expanding in TJ, but not CJ. Methods FSW-IDUs≥18 years reporting recently sharing injection equipment and unprotected sex with clients participated in a randomized factorial trial comparing four brief, single-session combinations of active motivational-interviewing and didactic interventions focused on negotiating safer-sex in the context of drug use and safer-injection skills. The injection intervention included a video made by FSW-IDUs. Women underwent quarterly interviews and testing for HIV, syphilis, gonorrhea, Chlamydia and Trichomonas. Poisson regression with robust variance estimation and repeated measures ordinal logistic regression via GEE examined effects on HIV/STI incidence and receptive needle sharing frequency, respectively. Results Of 599 initially HIV-negative FSW-IDUs (TJ: N=296; CJ: N=303), quarterly retention was≥90%. After 12 months, HIV/STI incidence decreased >50% in the active vs. didactic sex intervention (TJ: AdjRR:0.41, 95%CI: 0.18–0.91, p=0.03; CJ: AdjRR: 0.44, 95%CI: 0.19–0.99, p=0.05)-see tables. In CJ, women receiving active vs. didactic injection risk interventions decreased receptive needle-sharing by 84% vs. 71%, respectively (p=0.05); in TJ, receptive needle-sharing declined by 95%, but was similar in active vs. didactic groups (p=0.54). TJ women reported significant increases in access to syringes and condoms, but CJ women did not-see figure. Conclusion In both cities, a 30-minute intervention promoting safer-sex in the context of drug use significantly reduced HIV/STI incidence with sustained effects at 12 months. Expanding free access to sterile syringes coupled with brief, didactic education on safer injectionwas both necessary and sufficient in achieving dramatic, sustained injection risk reductions in TJ. In the absence of expanding syringe access in CJ, the injection risk intervention still achieved significant, albeit more modest reductions, suggesting that community-level interventions incorporating harm reduction are more powerful than individual-level interventions for reducing injection risks. Figure 1Plot of proportional odds of higher receptive needle sharing for intervention group by visit. Table 1Intervention effects on HIV/STI incidence after 12 months, excluding women who were HIV-positive or had active STIs at enrollment, TiujanaPredictorAdjusted Relative Risk95% CIIntervention Group (ref-Didactic Sex Rick intervention-Diadactic injection Risk intervention)Active Sex Risk Intervention and Didactic Injection Risk Intervention0.410.18, 0.91Active Injection Risk and Didactic Sex Risk Inetevention0.840.38, 1.84Active Sex Risk Intervention+Active Injection Risk Intervention0.360.15, 0.85=of unprotected sex acts with non-regular clients for month poor to enrollment1.011.01, 1.02Anested during the six months poor to enrollment2.611.38, 4.91 Table 2Intervention effects on HIV/STI incidence after 12 months, excluding women who were HIV-positive or had active STIs at enrollment, Ciudad JuarezPredictorAdjusted Relative Risk95% CIIntervention Group (ref-Didactic Sex Rick intervention+Diadactic injection Risk)Active Sex Risk Intervention and Didactic Injection Risk Intervention0.440.19, 0.99Active Injection Risk and Didactic Sex Risk Inetevention1.150.58, 2.28Active Sex Risk Intervention+Active Injection Risk Intervention1.120.56, 2.25Amount earned per unprotected sex act (USD)1.021.00, 1.05Used cocaine the months poor to enrollment1.660.98, 2.80, Background The results of the HPTN 052 study, which showed antiretroviral treatment (ART) is highly effective in reducing HIV transmission, have been hailed as a “game-changer” in the fight against HIV, leading to calls for significant scaling up of treatment-as-prevention (TasP). But it is unclear how TasP could be financed, given flat-lining support for global HIV programs. We assess if TasP is indeed a game-changer against HIV, or if comparable benefits can be obtained at a lower cost by scaling up existing interventions such medical male circumcision (MMC). We also assess the impact of TasP in combination with MMC. Since MMC is currently being scaled up in many countries in sub-Saharan Africa, the effectiveness of TasP in conjunction with MMC is a highly policy-relevant question. Methods We formulate a new mathematical model to overcome challenges in predicting the effectiveness of untried mass interventions (lack of a historical epidemic trajectory) and in predicting the combined effectiveness of different prevention interventions. Our model uses simple behavioral assumptions to estimate new HIV infections instead of estimating parameters by fitting a curve to a disease history. Results For South Africa, a combination of high ART coverage at CD4< 350/ml and circumcision coverage provides approximately the same HIV incidence reduction as TasP (defined as universal ART for all HIV-infected persons) at a cost ~ $5 billion less over 2009–2020. Circumcision outperforms high ART coverage at CD4, Background The Total Control of Epidemic (TCE) Program of Humana People to People aims to reduce spread of HIV and its impact by systematically engaging individuals and communities to take control of their own risk factors, while increasing access to prevention, treatment and support services. Implemented in close partnership with respective Ministries of Health and National AIDS Councils across Sub-Saharan Africa and Asia, TCE has made major impact in HIV control. Methods The TCE model works through two primary strategies: a) Individual HIV Counselling to Prevent New Infections: Every person in target areas was provided with counselling for behaviour change and was assisted to develop individual risk reduction plans. Home-based testing consistent with country guidelines was conducted as an integrated part of the process. b) Community Mobilization to Change Social Norms: To change social norms across the full range of HIV related issues (stigma, discrimination etc.), community-wide mobilization was carried out with local leaders, activists, PLHIV to project them as role models for others along with intensified promotion of existing services. Results Since the first TCE pilot in Zimbabwe in 2000, 11 million people were covered in 11 countries. 28 million individual HIV counselling sessions were delivered. As a result, 2 million people were tested for HIV and received their results. Over 500,000 women attended PMTCT services. More than 600,000 community activists were trained and engaged in community mobilization activities. In Blantyre District of Malawi, 4 times increase of PMTCT utilization within 3 years and in Ehlanzeni District of South Africa, 6 times increase of PMTCT utilization within 4 years after TCE implementation were observed. Conclusion With an average cost of U$ 2/person/year, the TCE model represents a cost effective community-based intervention for HIV control and care with proven results, that should be replicated across the most HIV affected countries., Background Traditional HIV Prevention Programs have not adequately addressed the issues of women in substance abuse recovery. In response, Greenhope Services for Women, Inc developed “Phenomenal Woman”, an HIV prevention program for women recently released from prison and/or mandated to receive residential substance abuse treatment. Methods The target population for “Phenomenal Woman” is African-American and Latina women demonstrating relatively high HIV risk behaviors receiving residential substance abuse treatment at Greenhope. The development of “Phenomenal Women” involved incorporating key components from “SISTA”, other HIV prevention programs, the “Helping Women Recover” curriculum, and newly created components. Formative research including: three focus groups, one key informant interview and two pilot cohorts were conducted to identify and pretest curriculum components and participant retention strategies. Results “Phenomenal Woman” is comprised of 5 group sessions and a booster session held 45 days after program completion. Its primary aims include: enhancing women's sense of self, increasing HIV/STI knowledge, as well as attitudes, self-efficacy, and behaviors related to sexuality, safe and sober sex practices, and spirituality. Utilizing the formative feedback received (n=42 participants), the program creatively uses tangible objects (music, affirmation sheets, and meditation rocks) to reinforce the key messages of strength, resilience, and making healthy decisions regarding safe and sober sex behaviors. The program was implemented with 76 participants with retention rate of 100% across the five initial sessions and 72% at the booster session. Conclusion Greenhope's “Phenomenal Woman” is an example of effectively developing and delivering curricula through the adaptation of evidence-based curricula and the creation of new components to address a target population's needs for HIV prevention and substance abuse relapse prevention. Through high levels of administrative support, participant retention rates were maximized. Accordingly, “Phenomenal Woman” holds considerable promise for dissemination to other agencies with similar target populations., Background Research among transgender persons is rare in Serbia. The emergence of HIV infection led to an increase in stigma and discrimination, but not to an increase in professional interest. Sex work in Serbia is illegal and sex workers are highly discriminated against, especially those of ‘different sexual orientation’. This paper presents research of HIV prevention needs of transgender sex workers in Serbia. The research study is meant to be a baseline study for designing special prevention strategies for this population group. Methods By snowball sampling methodology, 250 sex workers were incorporated into the research study, of those 40 were transgender, 55 male and 155 female. Results A high level of multiple stigmatization and marginalization is the result of a combination of the following characteristics: gender, ethnicity (mainly Roma), very low education levels and high levels of auto-stigma. Moreover there is a statistically significant difference between transgender sex workers and male/female sex workers in terms of being victims of violence much more frequently, perpetrated by their peers, clients, police and citizens. Transgender persons differ also in terms of low levels of prevention knowledge, the presence of misconcepotions about HIV and inadequte assessments of risk to themselves. Clearly, the preventive needs of this group cannot fully be met through programs designed for sex workers in general (such as outreach work, drop-in centers, mobile medical units, etc). Conclusion It is necessary to develop additional preventive strategies, such as:Behavior Change commmunication interventions, which are aimed at increasing self-efficacy, self-confidence which should result in an increase in visibility and affirmation of the transgender identity.raising public awareness about human rights regardless of gender differences.education of health care workers about the needs of this group., Background Initiatives aimed at behaviour change of key populations such as the female sex workers (FSWs) are pivotal in reducing the transmission of HIV. A 5-year implementation research to establish the predictor factors of behaviour change among FSWs in Kenya was initiated by the African Medical Research Foundation (AMREF) with Sida and DfID support, whose follow up results are presented in this paper. Methods This cross-sectional survey interviewed 156 female sex workers (FSWs) identified through snowball sampling. The measurement of behaviour change was based on: the consistent use of condoms with both regular and non regular clients, reduced number of clients, routine checks for STIs, and involvement in alternative income generating activities. The adjusted odds ratios at 95% confidence interval computed during binary logistic regression analysis was used to determine the behaviour change predictor factors. Results Most FSWs (84%) had participated in AMREF's integrated intervention programme for at least one year, with 4.4 years as the average duration. The results indicated that 59.1% had gone through behaviour change during the project's life cycle. The adjusted odds ratio showed that the FSWs with secondary education or more were 2.23 times likely to change behaviour, protestants were 4.61 times, being in sex work for>4 years were 2.36 times, FSWs with good HIV prevention knowledge were 4.37 times, and those engaged in alternative income generating activities were 2.30 times more likely to change their behaviour compared to respective counterparts. Conclusion Behaviour change among FSWs was possible and is associated with the level of education, religious affiliation, number of years in sex work and one's level of HIV prevention knowledge. A re-orientation on the peer education programme to focus on HIV preventive measures beyond use of condoms is emphasized., Background Condom use as a means to prevent HIV infection has significantly increased over the past decade among all age groups in South Africa. However, little is known about what motivates the behaviour in South Africa. This study investigated the prevalence and demographic, psychosocial, and behavioural determinants of condom use among people aged 15 years and older in South Africa who were sexually active over the 12 months prior to the survey. Methods Data from the 2008 national HIV population-based survey was used. This was a cross-sectional survey which was conducted using a multi-stage stratified sampling approach. Univariate analysis and multiple logistic regression were used to identify factors associated with condom use at last sexual intercourse. A total of 5072 respondents, 46.0% males and 54.0% females, who indicated having had sex in the last 12 months were involved in the study. Results Overall, there was no gender difference found in condom use: males (64.6%) vs females (60.4%). The multiple logistic regression analyses indicated that youth aged 15–24 years and students’ learners were more likely to use condoms at last sex. (AOR=2.2528, AOR=2.4358, p< 0.05). Whites, Coloureds and Indians were less likely than Africans to use condoms (AOR=0.2125, AOR=0.3000, AOR=0.4511, p< 0.05). Likewise, married people and those whose current relationships exceeded a year were less likely to use condoms (AOR=0.2782, AOR=0.3239, p=0.00). Finally, having only one regular sexual partner significantly reduces the odds of condom use (AOR=0.2855, p=0.021). Conclusion It is important to understand more about the nuances of condom use so that programmes can target those at greatest risk of infection such as African adults and people in stable relationships, especially those that might also be involved in other risky behaviours such as multiple concurrent sexual relationships., Background Given their epidemiological and socio-ecological differences, urban and rural contexts may require differently designed prevention messages. Utilizing messages framed in terms of the benefits (gains) or costs (losses) associated with a particular HIV/AIDS-related behavior could be one viable strategy to address urban-rural differences. Methods Based on relevant literature, urbanity vs. rurality, experience with HIV testing and concern about and information needs on HIV/AIDS were tested as moderators of framed HIV testing messages’ effectiveness. Gain- vs. loss-framed brochures were distributed to 394 participants (199 Urban: 46.2% male, 53.8% female; 195 Rural: 79% male, 21% female). Through pretest-posttest measures of intention to test for HIV, the relative persuasiveness of gain- and loss-framed messages was determined. Results Urbanity vs. rurality, experience with HIV testing and concern about and information needs on HIV/AIDS significantly moderated the effects of gain- vs. loss-framing on Intention to Test for HIV, F(1, 385)=9.28, p, Background Botswana's HIV prevalence is 17.6% among the general population and the incidence rate is 2.9%. In 2009, Botswana's Tertiary Education Council, recognizing that HIV interventions for College/University (tertiary) students were few/fragmented, conducted a study to understand student behaviours, needs and gaps in services. Born in the 1990s, this generation of youth is the first of its kind-a generation who has grown up with HIV-infected, heavily affected and message-fatigued. Methods Between 2009–2010, TEC conducted a study of 10% of tertiary students using self-administered surveys (N=4312). Classes were randomly selected from 32 institutions and surveys were augmented by 28 post-survey FGDs. Participation was voluntary, anonymous and counselling was offered. Survey questions were qualitative and quantitative. Results 57.0% of participants were female and 63.0% were aged 20–24. HIV knowledge was high (over 90% responded correctly to 9/11 knowledge questions) but satisfaction with current HIV interventions was low (44.9%) and 38.5% said condoms are never available on campus. 82.5% were sexually active and 45.0% had already engaged in unprotected sex. 53.9% knew their HIV status and 49.4% knew their partner′s status. 33.7% reported that they were engaging in MCP. Key findings from the FGDs include: a) campuses are sexualized spaces b) students are involved in transactional relationships c) students do not perceive themselves to be at risk for HIV and d) campus interventions are few and irrelevant. Conclusion Irrespective of increased knowledge and impact from AIDS deaths within their families while they were young children, the sexual practices that gave rise to the current HIV epidemic in Botswana persist among tertiary youth. The study raises serious reservations about the assumption that youth are making behaviour changes. It also exposes gaps in service provision and questions the strength and relevance of current interventions to youth in a country with a staggering incidence rate., Background Cash transfer programs may reduce the risk of HIV transmission among young people from poor households by providing economic security. The Cash Transfer for Orphans and Vulnerable Children (CT-OVC) is the Government of Kenya's flagship social protection program, reaching 150,000 poor families with OVC age 17 or below. Households are provided a flat unconditional cash transfer of US$25 per month. The objective of this study is to assess whether the CT-OVC reduces HIV related behavioral risk among adolescents. Methods We use data from the third wave of the impact evaluation of the CT-OVC collected in 2011. The design is a cluster-randomized trial. 1912 households in seven districts across Kenya were part of wave three; two-thirds were in the program and the remaining third were randomized out at baseline in 2007. Data on sexual behavior and other risk related behaviors were collected in wave 3 only for residents age 15-25. We analyze data for residents age 21 and below who had not had sexual intercourse at baseline (N=1516, Females=41%). We use multivariate analysis with controls for age, sex, Nairobi residence, and relationship to household head. Results Main study findings indicate that the CT-OVC has reduced the probability of sexual debut by 6.73 percentage points off a proportion of 0.37 who had ever had sex after the program began in 2007. This result appears to be driven by males. The program has also reduced the proportion of adolescents with 2 or more partners in the last 12 months, by 7.2 percentage points , and reduced the probability of 2 or more unprotected sex acts in the last 3 months for females (p=0.10). Conclusion A large scale, national cash transfer program may prevent HIV among adolescents by postponing sexual debut, reducing the number of partners and reducing the number of unprotected sex acts.Table 1Main Results Age, Background In South Africa, adolescents are at high HIV risk, yet few prevention interventions have been effective. Parents can play a pivotal role in youths’ healthy sexual development. We tested whether Let's Talk!, a pilot worksite-based parenting program, could improve parent-child communication about HIV and sexual health. Methods A small randomized pilot test was conducted at a large public worksite in Cape Town. The intervention consisted of five weekly two-hour group sessions for parents of children aged 11–15. Sixty-six parents [64% female, mean age 43 years (SD=7), range 23–59] and their 64 children [41% girls; mean age 13 years (SD=1)] completed surveys before and immediately after the intervention; surveys assessed HIV knowledge, comfort with talking about sex, communication about 16 HIV- and sex-related topics (e.g., steps of condom use, how to prevent HIV), and condom use self-efficacy. Thirty-four Black-African (Xhosa-language) and 32 Coloured (mixed-race; Afrikaans-language) parent-child dyads participated. Thirty-four parents were randomized to one of two intervention groups stratified by language, and 32 to one of two control groups. Results Multivariate regressions indicated that the intervention significantly increased parents’ comfort with talking to their child about sex, b(SE)=0.98 (0.39), p=0.02, and the number of sex- and HIV-related topics discussed with their child, b(SE)=3.26(1.12), p=0.005 (Table 1). Compared to control parents, intervention parents were more likely to discuss new sex- and HIV-related topics that had not been discussed before the intervention, b(SE)=2.85(0.80), p< .001. The intervention also significantly increased parents’ self-efficacy for condom use, b(SE)=0.60(0.21), p=0.007, and showed marginally significant effects on parent and child HIV knowledge [b(SE)=0.60(0.32), p=.066, b(SE)=0.85(0.43), p=0.052, respectively].Table 1Effects of Intervention on Parent & Child OutcomesAdjusted CoefficientsIntervention Pre M (SD)Intervention Post M (SD)Control Pre M (SD)Control Post M (SD)Comfort Talking to Child about Sex (Parent)0.98 (0.39), p=.203.39 (1.84)5.01 (1.70)4.07 (2.15)4.32 (1.91)Number of Sex & HIV Topics Discussed (Parent)3.26 (1.12), p=.0057.79 (4.84)12.38 (4.27)8.34 (5.75)9.28 (5.68)Number of New Sex & HIV Topics Discussed Since Baseline (Parent)2.85 (0.80), p, Background There is a general consensus that people with severe mental illness(SMI) are more likely to have a history of childhood sexual abuse and are at increased risk for HIV. For this study, we hypothesized that our homeless, mentally ill participants reporting CSA would be more likely to report current engagement in HIV-risky behaviors, history of STI's, and associated psychopathology than their non-CSA counterparts. Furthermore, we hypothesized that those who had experienced CSA in early to middle childhood (EMCSA) would be more likely to report these challenges than those who had experienced CSA in adolescence (ACSA). Methods As part of a NIH-funded RCT(1R01MH084696-01A2 PI Brady) primary and secondary prevention trial for adults with SMI at-risk for HIV transmission, ninety participants were administered an assessment battery which included the Structured Clinical Interview for DSM-IV, Demographic Inventory, and Timeline Followback. Chi-square analyses were used to test our hypotheses and analyze the relation between our variables of interest. Results There were no significant differences in current HIV-risky behaviors between CSA/non-CSA participants nor for EMCSA/ACSA participants. However, CSA participants were more likely to present with PTSD{χ2(1, 90)=12.95, p, Background The numbers of street children vary from 30,000 to 100,000 in Ukraine. Their vulnerability to health-related risks, including HIV/AIDS, substance and drug abuse, was a subject of the baseline study in 2008. Based on its findings, UNICEF implemented a comprehensive approach to HIV-service delivery in four pilot cities and repeated the survey to assess the effectiveness of interventions in 2011. Methods Behavioral survey among street-based adolescents (N=805, age 10–19, 565 boys, 240 girls) was conducted using location-based network and convenience sampling. Data were disaggregated by age and gender. Comparative data analysis was applied to learn the behavioral and knowledge changes. The client satisfaction questionnaire was used to define the service access barriers. Results Street adolescents are highly vulnerable to HIV-infection: 22% injected drugs, 65% of girls provided commercial sex services; 7% of boys had sex with men; only 13% always used condom with casual sexual partners. Social vulnerability factors hinder access to medical and social services: two-thirds of respondents didn't have a permanent place of residence and were not covered by medical services. 46% didn't have an ID, 54% didn't have an education certificate. The piloted interventions caused the positive behavioral change and knowledge increase: a share of those, who correctly identified the ways of HIV transmission, has increased for 10%; a share of those, who were tested for HIV during the last year and received the result, has almost doubled. The biggest increase in HIV-testing is among girls: every sixth tested in 2008, every third in 2011. Conclusion Study confirmed effectiveness and sustainability of implemented interventions and suggested a roll-out-strategy to the country. This is of critical importance as a significant number of street children remains uncovered by services and has a low level of knowledge about HIV/AIDS, HIV-service organizations and places, where support is provided and testing is available., Background This study investigated how gender, multicultural and multi-religious factors influenced the teaching and learning of HIV/AIDS education. Methods The qualitative case study utilised 6 primary schools from Kakuma Refugee Camp and its host community. The sample had 617 respondents from 9 nationalities, including 356 male and 160 female pupils. Interviews, observation, FGDs, documentary analysis and drawings generated data. The research proposal and tools underwent ethical review. Results Cultural and religious tendencies of same gender clustering denied Muslim Somali pupils an opportunity to work together as partners in addressing pertinent and effective strategies in HIV/AIDS education. Unlike the Christian Turkana and Ugandan girls who seemed open and outgoing in HIV/AIDS education activities, Somali and Ethiopian Muslim girls remained quiet, reserved and shy as a way of showing respect to the male, a behaviour that jeopardised HIV/AIDS education. Christian Sudanese and Turkana boys and girls interacted more freely, hence learnt better. Gender influenced perceptions of pupils on HIV/AIDS education content and pedagogy. While boys seemed vocal, uncontrolled and eager to discuss sex and condoms, girls preferred discussing love and care of people living with HIV/AIDS. Refugee boys produced culturally and linguistically diverse resource materials that were easily understood across the cultural groups while portraying males as innocent victims and females as potentially responsible for the spread of HIV. Notably, pupils received different and conflicting messages on similar topics depending on the teacher's religious background. While older teachers were perceived as ‘parents’, young male teachers were seen as having a hidden ‘sex agenda’. Conclusion In conclusion, gender, culture and religion, influence the learning of HIV/AIDS education in refugee schools in a complex manner, which if not understood and controlled could have negative implications. The study recommends pre-service multicultural teacher education and training on how to make HIV/AIDS education gender-responsive., Background From 2005, the Québec Ministry of Education cut what was five (5) hours of sex education (STIs, HIV/AIDS, gender, sexual diversity, etc.) per year from the secondary school curriculum. Consequently, in the context of the education reform, teachers holding specializations in English and Art, Science & Technology and Moral and Religious Education were persuaded to integrate sexuality in their course. Methods Being highly sexualized sites, high schools act as a channel for sexual initiation and exploration. Thus, teachers can be catalysts to providing valuable and life altering information around HIV/AIDS to their students. Through a qualitative case study, teacher narratives were collected to identify their classroom structure; strategies; awareness of HIV/AIDS; and the challenges encountered when discussing the subject in their classroom. Overall, implicating communication processes were an essential factor in uncovering the subtle, yet, uncomfortable silences found in this study. Results The surface-level understanding around HIV/AIDS and a lack of consistent training and access to accurate resources identified how teachers understood and valued HIV/AIDS information. Ultimately, such familiarity corresponded to how their students comprehended the virus and viewed the marginalized communities most affected. Conclusion Theoretical frameworks connected to Paulo Freire's Engaged Pedagogy and Nel Noddings's Pedagogy of Care, were considered as tools for empowering teachers when imparting knowledge on HIV/AIDS., Background School-based, teacher led Sexuality Education (SE) is effective in promoting and protecting young people's sexual health. In sub-Saharan Africa, much of SE is provided through school-based, teacher-led programmes. The aim of this study was to find out what topics in Comprehensive Sexuality Education (CSE) were acceptable and not acceptable to the teachers. Methods This study was part of an assessment of the status of Sexual and Reproductive Health and Rights in three regions (Tanga, Singida and Iringa) in Tanzania. Respondents were purposively obtained from 6 purposively selected primary and secondary schools in three purposively selected wards. A total of 45 teachers participated in Focus Group Discussions and Group Interviews. Data were analyzed using Nvivo software. Results Six topics in CSE were consistently rejected by teachers. These are homosexuality, masturbation as an alternative to sexual intercourse, condom use, sexual pleasure and enjoyment, sexual behavours other than intercourse and appropriate and inappropriate touching. Three major reasons were given to why they rejected these topics. First, they explained that if students are taught about these topics, they may practice them and that would fuel sexual activity among them. Second, since they have to teach practically, teachers explained that demonstrating these topics would be an embarrassment to them and to the students. Third, they reported that these topics are against sexual norms of the communities where they (teachers) and students come from. Conclusion With these findings, it is important to rethink the position of teachers in the delivery of CSE. Being “teachers” does not exclude individuals from abiding by sexual norms of their community. The rejection of these topics indicates that teachers still adhere to sexual norms of their communities. In order to strengthen CSE programmes, programmes need to work on sexual norms that may hinder the delivery and success of CSE in schools., Background Coastal people of Tanzania practice a rite of passage (unyago) for girls when they enter puberty (wali). Unyago is conducted by respected, mature women (manyakanga) who use local art forms and idioms to address family life and sex education. Unyago is sometimes faulted for encouraging early sex, teenage marriage, early child-bearing, and multiple concurrent partnerships (MCP). Methods We conducted a participatory learning-and-action exercise with manyakanga in the Coast region. We assessed: 1) manyakanga's knowledge of SRH and 2) manyakanga′s potential to serve as promoters of SRH. In 2011, 28 manyakanga (who were involved in small-scale pilot activities since 2008; about 50% of the manyakanga at the program sites) received a five-day training. PAYODE (a community-based organization) conducted eight monthly forums, and FHI 360 provided 28 person-days of on-site technical assistance. Results Training improved manyakanga's knowledge of SRH.Pre-training testPost-training test Score Persons Score Persons Difference (+/−) 100%4100%12+8>50%17>50%14−3, Background Interpersonal communication has been implicated as a key factor in HIV declines in Zimbabwe (Halperin et al., 2011), but little is known about the social networks through which it might have taken place. In the quantitative component of a World Bank sponsored study, Gregson (2012) found associations between community group memberships and HIV avoidance. Our qualitative component elaborates on these findings through mapping out possible psycho-social pathways between group participation and more effective community responses to HIV/AIDS. Methods We used Nhamo's (2010) conceptualisation of the ‘HIV competent community' to frame thematic analysis of the Manicaland Project's qualitative dataset. 481 people participated in 30 children's draw-and-write, 100 interviews and 55 focus groups exploring local responses to HIV/AIDS. These included people on ART; healthcare workers; workers; community group members; sex workers and clients; and participants in cash transfers, home-based care, support groups and peer education. Results Community group memberships are often associated with lower HIV incidence amongst women, and higher incidence amongst men. Group memberships impact directly through facilitating or hindering healthy behaviours, and indirectly through impacting service access, and the effects of peer education, home-based care and cash transfers. Gendered group communication styles often make women more likely to engage in positive health-related dialogue, and to entrench macho stereotypes and health-damaging behaviours in men, although this is not always the case. Conclusion Growing evidence suggests indigenous community groups could become a useful focus for enhanced HIV/AIDS prevention, care, treatment and impact mitigation. Efforts might focus on enhancing the beneficial effects of groups (mostly on women) and limiting their damaging effects on men. Parallel efforts should facilitate contexts that are supportive of beneficial group effects, including a wider comprehensive response with empowering support from funders and community partnerships with supportive service providers., Background In Western Uganda, high HIV prevalence, poverty, and abuse/exploitation threaten children's wellbeing and can contribute to high HIV transmission risk for vulnerable children. A comprehensive approach is needed to address the key drivers of vulnerability and improve child welfare for highly vulnerable children. World Education (WEI)'s Western Uganda Bantwana Program (WUBP) builds the capacity of nine community-based organizations (CBOs) to provide comprehensive services and referrals strengthening to 3,100 vulnerable children and their families to improve child welfare. Methods Using the following methods, Bantwana and local partners gathered evidence suggesting that an integrated package of psychosocial support (PSS), livelihoods, and child protection (CP) interventions can effectively contribute to reducing child vulnerability and improve children's overall wellbeing: Child profiling baseline and follow-on survey: of 132 children, measuring child wellbeing across a range of internationally accepted vulnerability indicators;CP case study: focus group discussions with districts, children, schools, and other protection stakeholders to assess school and community child protection interventions;PSS assessment: interviews/focus group discussions with volunteers, caregivers, CBO partners and children, exploring effects of a household approach to PSS on child wellbeing; andQualitative evaluation study (with Columbia University): of 247 households, to determine benefits of livelihoods/protection interventions on child wellbeing. Results Preliminary results from the Columbia study suggest that an integrated protection/livelihood intervention can improve outcomes in child wellbeing. The CP case study and PSS assessments reveal that strengthening linkages among CP stakeholders (school, community, government and household)—improves child protection outcomes, while the child profiling survey reinforces the importance of a household approach. Conclusion Preliminary evidence suggests that an integrated package of PSS, livelihoods, and CP intervention may reduce vulnerability and improve child wellbeing which could have implications for HIV prevention approaches for vulnerable children in regions with high HIV prevalence., Background The Center of Excellence for Transgender Health (CoE) has been mobilizing transgender (trans) community throughout the United States utilizing a coalition building approach since 2007. The CoE along with its National Advisory Board (NAB) has identified and supported community leaders, health departments and key stakeholders in engaging the transgender community, identifying gaps and developing strategies for addressing identified unmet needs in the U.S. The CoE supports local community efforts in organizing conferences, symposiums, and summits that are focused on transgender specific health and well being. Methods In the CATCH model, with support from staff of the CoE, local coalitions guide the community mobilization process and lead data collection and analysis efforts, prioritize HIV prevention and health care needs, develop a comprehensive plan to strengthen community access to and utilization of HIV prevention and health care services, and decide how to evaluate these efforts. Results Community mobilization is a very empowering process that can provide participants with a sense of control, self esteem, self determination and increased capacity for changing systems to be transgender inclusive.Both providers and community members are able to create meaningful, sustainable linkages for capacity building and increasing access to services.Social networks created through CATCH are sustainable and increasingly multiplying.CATCH is a groundbreaking national network that ensures that community members have a voice in the transgender HIV and human rights movement through a coordinated effort. Conclusion CATCH increases transgender community capacity to access services by supporting advocacy efforts, creating networking opportunities, and increasing visibility of trans HIV prevention and health care needs., Background The dilemma of infant feeding in HIV context of poor resource setting remains unresolved and the practice of replacement feeding may happen to be a curse by lowering child survival. Appropriate infant feeding counseling can reverse such risk as well as limiting spill-over (WHO, 2010.) Objective to describe infant feeding intents of HIV positive women and determine the appropriateness of choice of those opting for formula-feeding after the counseling process. Methods Routine infant feeding counseling of HIV positive mother offered by short-course trained counselors during the pregnancy or in the early-post partum. Intents were assessed using a generic acceptable, feasible, affordable sustainable, secure (AFASS) score composed of 7 variables grading from 0 to 2:type of energy, source of water, kind of latrines, disclosure to the partner, monthly income, ability to prepare bottle feeding and to give a reason for non breastfeeding. An AFASS score above 10/14 was considered as appropriate for formula feeding. Results 950 women were included for cohort characteristic. Among 924 women counseled, 63% intended to formula feed their babies while 37% planned to breastfeed. The AFASS criteria>10 was met by 87% who intent to practice formula-feeding compared to 57% of those who intent to breastfeed. Women counseled during post-partum were more likely than others to opt for artificial feeding (p< 0.001). Formula-feeding choice was more appropriate in women counseled during pregnancy vs after delivery (p=0.02). The determinants of choosing replacement feeding were tertiary education (p< 0.001), no previous exclusive-breastfeeding, HIV-status disclosure (p< 0.001) and AFASS score>10 (OR: 5; 95% CI: 3–6). Conclusion in Djoungolo, after infant feeding counseling, replacement feeding intent is mostly appropriate fitting mother's environment and livelihood. In addition, the desire to breastfeed remains real as more than 1/2 women who choose to breastfeed met the conditions to practice formula feeding., Background Although evidence reveals that most heterosexual HIV transmission in sub-Saharan Africa takes place within marriage or cohabitation, approaches for people living with HIV (PLHIV) focus primarily on individuals. The Faithful House (TFH) is a couples-based, skills-building curriculum used with 45,000 couples in twelve countries, recently modified to address PLHIV issues. Research examined the effect of TFH on attitudes and behaviors to provide evidence for a couples-based approach for more holistic PLHIV programming. Methods Participants, using convenience sampling, from HIV programs in four regions of Ethiopia were randomly distributed between intervention and control groups. The intervention group participated in TFH workshop for PLHIV. Both groups completed surveys at baseline and three months post-intervention which was analyzed using STATA. Results The study surveyed 378 individuals with a mean age of 35.2. Most couples (88%) were either married or cohabitating. All participants had been tested for HIV with 90% testing positive. Intervention participants (193) reported significant changes (p< 0.01) in the quality of their relationship, including improved communication and joint decision-making about child care, finances and sexual negotiation. Intervention participants had statistically significant improvements in medication adherence (18% non-adherent at baseline versus 10% at three-months) and percentage diagnosed with sexually transmitted infections in the past three months (7.3% decreased to 4.7%). Of males with pregnant partners, 94% in the intervention group attended antenatal care visits compared with 36% in the control. Intervention participants also reported statistically significant decreases (p, Background As part of a government-sponsored pilot initiative of ‘treatment as prevention’, recent efforts have been made to improve access to HIV prevention and care, including HIV testing, to vulnerable sub-populations in Vancouver, Canada. This study assessed the association between geographic factors measuring access to HIV testing sites and having a recent HIV test among hidden street- and off-street sex workers(SWs) in Vancouver. Methods Baseline data were used, including an interviewer-administered questionnaire, HIV/STI testing and geographic location data, from an open prospective cohort of SWs recruited in 2010 in Metropolitan Vancouver (“An Evaluation of Sex Workers’ Health Access”[AESHA]). Access was measured by density of testing sites within a catchment surrounding SWs’ place of solicitation (radius=distance travelled in 15 minutes of combined bus/walking) and time to travel to nearest testing site. Bivariate and multivariable logistic regression was used to identify if density and time were independently associated with recent HIV testing (in the last year). Adjusted odds ratios and 95% confidence intervals were reported (AOR:[95% CIs]). Results In total, 291 seronegative SWs from Vancouver City were included, with 69.4% (202) reporting a recent HIV test. In bivariate analysis, having a recent HIV test was significantly associated with a higher density of testing sites (p< 0.001) and time to nearest testing site (p=0.05). After adjusting for key confounders (recent injection drug use, age and sexual identity), having a recent HIV test was significantly associated with increased density of HIV testing sites: the probability of having a recent HIV test increased by 2% for each increase in one testing site (1.02[1.01–1.04]). Conclusion Our results highlight the importance of physical availability of HIV testing sites within sex work environments to facilitate use of HIV prevention and care among SWs. Increased mobile and safer-environment interventions that facilitate access to voluntary and confidential HIV testing at outdoor and indoor sex work venues remain a critical priority., Background HIV/AIDS is a leading cause of death for African-American women in the United States between the ages of 25 and 34 years. Studies have suggested that HIV-related stigma impacts morbidity and mortality rates because it contributes to poor treatment utilization for various groups of people with HIV. Despite these findings, there are no intervention studies investigating stigma reduction strategies for African-American women living with HIV. Methods We implemented an adapted version of the International Center for Research on Women's HIV Stigma Toolkit for African-American women living with HIV, with intervention modules led by an African-American woman living with HIV. Twenty-four participants attended workshop sessions split across 2 weekday afternoons, discussed issues “triggered” by videos that were produced specifically for the intervention, learned stigma reducing mechanisms from each other, and practiced using these mechanisms in role plays. Participants completed a measure of internalized stigma before, immediately after, and 1-week after workshop participation. Results The intervention demonstrated feasibility and the women enthusiastically accepted the intervention. The women reported decreased stigma from the start of the workshop to immediately after (p=0.05) and 1 week after workshop participation (p=0.07). Conclusion Findings suggest that the Unity workshop holds promise for reducing internalized stigma for African-American women living with HIV., Background This study examined the effectiveness of psycho-education in Family-to-Family Project on family relationship and emotional quotient (EQ) of adolescents in HIV families in two representative provinces in Thailand, Chiangrai and Nakorn Ratchasima. The intervention included core elements identified by Thai Ministry of Public Health and University of California, Los Angles, USA for improving physical and mental health, family relationship, and social outcomes for HIV-affected families. Methods The sample consisted of 194 adolescents (aged 12–17 years) in 402 HIV-affected families. A randomized controlled trial with pre-test and post-test was performed during December 2006 - January 2009. Adolescents were randomly assigned into 2 groups: (a) adolescents whose parent and caregiver(s) attended psycho-education and (b) adolescents whose parent and caregiver(s) did not attend psycho-education. The instrument was a set of questionnaire including: family relationship and EQ. Data were collected prior to the beginning of the program, and at 24-month follow-up. They were analyzed using t-test and logistic regression statistics. Results The study findings suggested, when controlled sex, age and education, family relationship and EQ of adolescents before and after the intervention in each group did not vary significantly. Family relationship had significantly positive relationship with EQ on the “happy” subscale [adjusted Odds Ratio (OR)=12.03, 95% Confidence Interval(CI)=3.21–45.02] and total EQ [adjusted OR=9.57, 95% CI=2.28–40.17]. However, it did not relate to EQ on the “good” subscale [adjusted OR=3.13, 95% CI=0.57–17.12] or the “competence” subscale [adjusted OR=1.41, 95% CI=0.158–12.57]. Conclusion Family relationship is a protective asset in happiness and total EQ of adolescents in HIV-affected families. However, larger and robust trials are needed to further determine the effectiveness of psycho-education for Thai HIV families. This study was funded by the National Institute of Nursing Research (grant NINR R01-NR009922)., Background Mental disorders are highly prevalent among individuals with HIV and are consistently associated with negative health outcomes. These disorders are often not adequately treated due to significant individual and community level barriers. Innovative approaches are needed to engage and effectively treat mental health problems among individuals with HIV. Methods The NIH-funded Collaborative HIV/AIDS Mental Health Program (CHAMP) assessed the feasibility and preliminary outcomes associated with providing 9 months of in-home mental health counseling for 40 individuals with HIV and a Major Axis I mental disorder living in Mecklenburg County North Carolina. The CHAMP treatment was guided by the HIV/AIDS Illness Management and Recovery Model (HAIMR), which was adapted from the evidence-based Illness Management and Recovery treatment model using a Community Based Participatory Research approach. Study participants were surveyed at baseline, 5 and 9 months to assess psychiatric symptoms (using the Brief Symptom Inventory (BSI)), social support, coping, and medication adherence. Results The CHAMP study participants were reflective of the HIV population in the region with respect to race (80% African-American) and gender (35% female).DEMOGRAPHIC CHARACTERISTICS Female35% African-American80% Average Age43.1 Less than High School Education28%PROBABLE MENTAL DISORDERS (Mini-International Neuropsychiatric Interview (MINI)) Depression55% Bipolar30% PTSD38%Baseline Characteristics of Study Subjects (N=40). Statistically significant decreases in the global BSI score and a number of BSI symptoms dimensions including anxiety, depression, obsessive compulsive, and hostility were detected. The sample means for anxiety, hostility, and phobia dropped below the BSI clinical significance level and the proportion of participants meeting the BSI case definition based on having a BSI Global Score of 63 or above decreased from 85% of participants to 54% of participants (p=.018). Statistically significant improvement was also found for the SF-12 mental health scale, adaptive coping, overall social support and emotional support. Baseline Survey (prior to treatment entry) Survey at 9 months (after treatment completion); **p, Background Perceived racial (PRD) and gender discrimination (PGD) relate to poorer health in African American (AA) women (Kreiger, 1990; Borell et al., 2006). Critical consciousness (CC), the awareness of social oppression, has been found to moderate the effects of discrimination stress (Kelso et al., submitted 2012). The present study explored PRD, PGD, and CC in AA women, examining their relationships to age, education, employment, and HIV status. Methods Participants were 98 AA women (73 HIV-positive, 25 HIV-negative) from the Chicago Women's Interagency HIV Study. Table 1 displays demographic information. Self-report questionnaires measured CC and its dimensions Power Discontent, Rejection of System Legitimacy (RSL), and Belief in the Need for Social Change (BNSC) on behalf of AAs, and PGD, and PRD. Pearson correlations examined age, education, employment and HIV status in relation to CC. Partial correlations examined CC in relation to PGD and PRD. T-tests examined HIV status differences in PGD, PRD, and CC. Variable Age Education Employment Identification with Women.04.19.30**Identification with African Americans.06.15.24*Power Discontent.10.21*.20*Rejection of System Legitimacy.25*.22*.17Belief in need for social change on behalf of African Americans.03.26*.27**Total Critical Consciousness.17.29**.25*Perceived Gender Discrimination.23*.04.17Perceived Racial Discrimination.22*−.20−.14*Note. p, Background Human rights approaches to managing HIV globally offer hope to vulnerable persons living with HIV (PLHIV), but structural challenges impede achievement of this goal. Little is known about the relationship between structural challenges and health promoting behavior among PLHIV. Our purpose was to describe associations between national level democracy ranking, HIV criminalization, perceived social capital, and antiretroviral therapy (ART) adherence among an international sample of PLHIV. Methods We recruited PLHIV at 16 sites in Canada, China, Namibia, Thailand, and the United States. Participants (n=2,149) completed a cross-sectional survey of demographics, social capital, and ART adherence. Data were collected between August, 2009 and March, 2012. HIV criminalization was assessed by reviewing site specific state/provincial or national laws and policies. Five aspects of a country's democracy and freedom were obtained from the World Audit (www.worldaudit.org) international database. Data analysis included descriptive statistics, correlational and regression analyses. Results Participants were primarily male (68%) with an average age of approximately 47 years. Overall, mean 3-day self-reported ART adherence was 82.6%. Strong associations were observed between medication adherence and overall democracy ranking (0.66, p< 0.01) and degree of limitation to political rights (−0.68, p< 0.01). In the final model, overall democracy ranking; HIV criminalization (e.g., HIV specific enhancements for other crimes, HIV reporting laws), and number of HIV-related prosecutions; and total social capital score were significantly associated with self-reported ART adherence after controlling for site, gender, age, time since HIV diagnosis, and adherence self-efficacy (F=132.05, p< 0.01, adjusted R 2=0.56). Conclusion Our results demonstrate the interconnectedness of the political, social and biomedical spheres in addressing PLHIV health care needs. Decontextualized biomedical advances and models of intervention efficacy are insufficient for future HIV management. Our results provide evidence for the importance of using intersectoral human rights based approaches to the management of HIV and its intersecting vulnerabilities globally., Background Across sub-Saharan Africa, the HIV pandemic has orphaned millions of children. Evidence from high-income settings on complicated grief, which precipitates psychologically and medically debilitating symptoms, is growing. However research on how orphans in rural Africa cope with their loss remains scarce. We report on prevalence and predictors of complicated grief among a rural Zambian cohort. Methods 376 rural Zambian orphans 10-18 years, (46.3%=female, 44.1%=orphaned by AIDS) were interviewed five times. Respondents were included if they had lost their parent(s) at least two years prior to the final survey. Validated scales from Western settings were translated and culturally adapted. Complicated grief was defined as experiencing above average levels of grief symptoms in the last four weeks. Cross-sectional data assessed prevalence of complicated grief and tested multiple regression models. Bootstrapping supported robust regression coefficients estimates. Results Approximately one-third (30.3%; n=114) of these orphans reported complicated grief symptoms. Independent predictors (p< 0.05) included peer bullying, daily stress (e.g. excessive household chores, looking after ill family) poor primary-caregiver relations, within household discrimination, number of primary caregiver losses, and time since loss. Together these explain a fifth of the grief found two or more years after parental death ( Radj2 =0.21). Other theoretical predictors of complicated grief including age, sex, sudden or violent death, living with the deceased parent or experiencing their prolonged illness prior to death were not associated. Expected comorbidities with depression, suicidal thoughts, PTSD, and functional impairment in everyday tasks were confirmed, underscoring construct validity. Conclusion One-third of orphans exhibit debilitating grief two or more years after parent death. While these data highlight the centrality of community-based initiatives that sensitise caregivers of orphans to alleviate stigma and discrimination, additional research on children with complicated grief suggests benefits from more focussed interventions. Screening tools and effective counselling interventions adapted for this rural African population are urgently needed., Background There is mixed evidence on the association between HIV prevalence and poverty, but an increasing number of studies have found a positive association between HIV prevalence and income inequality, especially among countries with generalized epidemics. Less is known about the association between income inequality and HIV prevalence in concentrated epidemics, such as among injection drug users in Vietnam, or whether this association holds at the community level. Methods 1674 male IDUs, and 1349 community members (40% male) living in physical proximity, were recruited throughout Thai Nguyen. Both IDUs and community members completed cross-sectional surveys. IDUs were tested for HIV. The GINI coefficient for income inequality was calculated for each commune from the self-reported incomes of non-IDU community members. Scatterplots of the communes were then constructed to compare community-level income inequality and HIV prevalence among IDU. Results The HIV prevalence among IDU in 32 communes in Thai Nguyen is 31.2% (4.3%–63.6%). There is a statistically significant positive correlation of 0.59 (p, Background A controversial aspect of HIV/AIDS epidemiology has been whether it is relative wealth or relative poverty that is a key driver of the epidemic in sub-Saharan Africa. We hypothesised that the social epidemiology of HIV in Africa is changing from a situation where more new infections are acquired by those of relatively high socioeconomic position (SEP), to one where those of relatively low SEP are at greater risk. We suggested this pattern is compatible with the inverse equity hypothesis from child heath that suggests those of higher socioeconomic position benefit first from new health interventions. Methods We analysed Demographic and Health Survey (DHS) data from sub-Saharan African countries with two surveys measuring HIV prevalence or with a second expected in the next two years. We inspected the pattern of HIV prevalence by SEP, indicated by education status. In the countries with two surveys we calculated the percentage risk difference for HIV prevalence stratified by education and sex. Results Data were available for eleven countries: four with two surveys and seven expecting a second survey within two years. In the first/only survey, higher SEP is broadly associated with higher HIV prevalence. In countries with two surveys, HIV prevalence has risen in the no education group in all cases except among women from Lesotho, and fallen among those with secondary education in all cases except women from Malawi. Conclusion Available evidence strongly suggests that in the early phase of the epidemic HIV infections were concentrated among those of higher SEP. Our analysis supports the inverse equity hypothesis that new infections will increasingly concentrate in people of lower SEP because of lower access to public health interventions. Data that will be available within the next two years will further test this hypothesis. The inverse equity hypothesis has important implications for policy and resource allocation., Background Swaziland has the highest HIV prevalence in the world. Many Swazis are chronically food insecure. Globally and within southern Africa, food insecurity has been linked to high-risk sexual behaviors, difficulty with antiretroviral (ARV) adherence, higher rates of mother-to-child transmission, and more rapid HIV progression. Methods In-depth interviews were conducted with 20 HIV+ female sex workers (SWs) in Swaziland. Interviews took place in four different regions of the country, and were designed to learn about context, experiences, and health service needs amongst Swazi sex workers. Interviews were coded in Atlas.ti. Results Hunger was a consistent, major theme in our informants' lives. Women cited their own hunger or that of their children as the impetus to begin sex work, and as a primary force in continuing to sell sex. Nearly all informants requested food-related services (parcels, grants, or education) when asked about desired programming. Good nutrition and the ability to eat “healthy” or ”balanced“ foods was seen as an important means of controlling HIV disease progression. Informants discussed difficulty in adhering to ARVs when faced with taking pills on an empty stomach. Across interviews, discussions of CD4 counts and ARV adherence intertwined with discussions of poverty, hunger and healthy foods. Food security and food sharing were also seen as important expressions of social networks, which many SWs felt they had trouble accessing as a result of both their HIV status and profession. Conclusion Informants described a risk cycle of hunger driving sex work driving HIV infection. The two latter in turn drive an increased need for ‘healthy foods' and an alienation from social networks which offer material and emotional support against hunger. Poverty and food security are concrete, vital issues in the lives of SWs living with HIV in Swaziland, issues that cannot be ignored when conceptualizing risk or designing services., Background Despite recent efforts to increase HIV testing in sub-Saharan Africa, poor testing availability and limited uptake in refugee populations persists. Refugees require additional focused efforts because many have suffered human rights violations putting them at increased HIV- risk. Our objective was to qualitatively study refugees' utilization of services in a refugee settlement where HIV/AIDS services are available. Methods Open-ended interviews were conducted with HIV-infected refugees living in Nakivale Refugee Settlement in southwest Uganda. Interviews focused on: (1) accessibility of HIV/AIDS-related testing and care; (2) experiences of ART adherence; and (3) perspectives on how to improve access to testing and care, adherence, and retention. Data were collected at the Nakivale HIV/AIDS Clinic from March to July of 2011 and included patient (N=73) and staff (N=4) interviews, and observations of clinical activities. For this analysis, category construction methods were used to analyze the data relating to HIV testing. Results Refugees, because of competing daily hardships, do not prioritize HIV testing. Refugees living with HIV/AIDS often present to clinic for testing and initial evaluation with very advanced disease. Reported barriers to HIV testing for Nakivale refugees reflected in the data include: difficulty physically accessing testing facilities; fear of stigma associated with HIV+ diagnosis; low self-perceived risk of disease, and lack of knowledge regarding the potential benefits of medical therapy. Given the competing priorities for survival, HIV tests are not obtained until special circumstances lead to temporary priority shifting. Conclusion Understanding how HIV testing fits among the survival priorities of refugees will help in designing effective interventions. To increase HIV testing for refugees, efforts should aim to intervene in the survival cycle to encourage priority-shifting. Intervention approaches may include improving accessibility, providing incentives and increasing HIV-related education., Background There is paucity of published data on ways in which HIV in children receiving Highly Active Antiretroviral Therapy (HAART) impacts other children living within the same households. We investigated the psychosocial impact of HIV on the siblings of HIV infected children. Methods Data were collected using pre-tested interviewer administered questionnaires and focus group discussions. Twelve 12 HIV treatment sites which account for over 90% of children receiving HAART in Botswana participated. HIV affected children were defined as those aged 6-18 years who were living in the same household as documented HIV-infected children. Ethical approval was obtained from the Botswana Ministry of Health and Baylor College of Medicine. Results Of the 258 HIV affected children, 251 (97.3%) were attending school; 206 (79.8%) and 52 (20.2%) had been fully or partially disclosed to respectively. 153 (59.3%) were siblings of the HIV-infected children, 79 (30.6%) were cousins and 26 (10%) were related in other ways. 223 (86.4%) had lived together with the HIV-infected children for longer than 5 years. 11 (4.3%) said that living with an HIV-infected child made them feel different because of stigma, playing caregiver roles, fear of contracting HIV, and feeling sad. 65 (25.4%) faced various problems, including: worrying about the HIV infected child; receiving less attention from caregivers; and experiencing stress due to adherence-related issues, stigma, and family disharmony. They coped by crying, talking to an adult relative, talking to the HIV-infected child or isolating themselves from others. 230 (89%) felt sad or scared/anxious whenever the HIV-infected child was sick. 254 (98.4%) reported playing caregiver roles, such as reminding or giving medications to the infected children. Conclusion Although HIV affected children are not the prime targets of paediatric HIV interventions, they face many psychosocial challenges. Programs and policies aimed at ameliorating the impact of HIV should take these findings into account., Background The last century's economic and political upheavals are widely believed to have reduced African and particularly South African families' cohesion and ability to function collectively. AIDS has compounded this threat to the resilience of households and wider family networks. We explore the resilience of families to AIDS and demonstrate that theories of social capital, family obligation and reciprocity can help to explain access to familial support in rural KwaZulu-Natal, South Africa. Methods Data were collected over a 7-month period from a small sample of households dealing with AIDS illness or death using in-depth interviews and participant observation. Retrospective and prospective data about households' experiences were analysed using framework analysis and the development of household case studies for comparisons. Results Affected households and individuals drew on family relationships for financial and material support and physical care. Close family members, often sharing a common sense of home and family, were the most important source of care and support. Their greatest motivation was a strong moral obligation to family, associated with norms of familial assistance. Support from other family varied depending on whether levels of mutual trust, investment in social capital and physical proximity, enabled negotiated reciprocal exchange. Families suffering from conflicting obligations, conflict, severe poverty or extreme illness were more likely to be excluded from these networks and suffered because of their inability to secure familial support. Conclusion Despite examples of exclusion, we demonstrate that social capital, reciprocity and a sense of family obligation persist in families responding to the impacts of AIDS, contributing to them maintaining cohesion, collective functioning and ultimately ensuring their resilience. Interventions to support the treatment, care and well-being of sick individuals need the flexibility to be able to both support families in their efforts to provide these services and address the needs of people without access to supportive family networks., Background Black men who have sex with men (BMSM) have the highest rates of HIV in the United States. Despite increased attention to social and sexual networks as a framework for biomedical intervention, the role of family in these networks and their relationship to HIV prevention has received limited attention. Methods A network sample of BMSM and their family members (N=380) was generated through respondent driven sampling of BMSM and elicitation of their personal networks. The proportion of personal networks that were family was calculated and weighted logistic regression was used to assess the relationship between this proportion and unprotected anal intercourse (UAI), sex-drug use (SDU) and group sex (GS); as well as intravention efforts to discourage these risk behaviors among their MSM social networks. Results 45.3% of respondents listed at least one family member in their close personal network. Greater family network proportion (having 2 or more family members in the close network) was associated with less SDU [adjusted odds ratio (AOR 0.38(0.17–0.87))] and participation in GS (AOR 0.25(0.10–0.67)). For intravention, BMSM with greater family proportion were more likely to discourage GS (AOR 3.83(1.56–9.43)) and SDU (AOR 2.18(1.35–3.54)) among their MSM friend network. Moreover, increased male family network proportion was associated with lower HIV-risk and greater intravention than increased female network proportion. Network Proportion* N(%) UAI AOR (95% CI) Sex-drug use AOR (95% CI) Group Sex AOR (95% CI) Discourages UAI AOR (95% CI) Discourages sex-drug use AOR (95% CI) Discourages group sex AOR (95% CI) Family Network (%) 0%111 (54.7)refrefrefrefrefref20–39%40 (19.7)1.48 (0.67–3.27)0.51 (0.24–1.05)†0.51 (0.14–1.84)1.05 (0.34–3.20)0.89 (0.42–1.90)2.12 (0.88–5.11)†>40%52 (25.6)0.68 (0.34–1.36)0.38 (0.17–0.87)‡0.25 (0.10–0.67)§1.66 (0.55–4.99)2.18 (1.35–3.54)§3.83 (1.56–9.43)§ Male Family Network 0%150 (73.9)refrefrefrefrefref20–39%33 (16.3)1.26 (0.52–3.03)0.55 (0.25–1.22)0.53 (0.14–2.02)1.07 (0.34–3.39)1.37 (0.74–2.55)1.33 (0.57–3.09)>40%20 (9.9)0.37 (0.11–1.21)†0.26 (0.06–1.22)†‖1.54 (0.39–6.10)2.98 (1.17–7.61)‡3.37 (0.95–11.9)†Black men who have sex with men (BMSM) family netw.*Proportion of close network members who are family. This is further limited to male family network proportion.Models are weighted and control for age, education, employment status, HIV status, network size and site of participant recruitment.†p, Background In Zambia, HIV prevalence in women (15–24) is twice that of same aged men. A gender perspective is critical for designing interventions that recognize gendered-risks to HIV. The Zambia-led Prevention Initiative (ZPI) is initiating community-level interventions through targeted approaches that address gender disparities and power imbalances. The baseline survey, part of the ZPI evaluation plan, identifies key areas for targeting. Methods A total of 1,060 men (aged 15–59) and 1,700 women (aged 15–49) participated in a survey conducted in 4 provinces. Provinces and districts were purposively selected; households and individuals were randomly selected. The survey included questions related to gender-based violence, rape myths that blame women for rape (i.e., If a woman doesn't physically fight back, you can't really say it was rape), and attitudes towards gender norms (measured using the Gender Equitable Men scale) and contraception. Results 68% of females ever experienced either or both physical (35%) or sexual abuse (39%); only 15% sought help. 62% of all respondents endorsed at least 1 of 4 rape myths and 37% supported inequitable gender norms. Those with 2+ partners (46%) in the last 12 months were more likely to support inequitable norms than those with 1 partner (39%) or no partners (26%) (p< 0.001). Nearly 20% of men think that contraception is women's business; 32% think women who use contraception are promiscuous. When women were asked about their last birth, 50% indicated they wanted to wait or did not want the pregnancy at all. Unintended pregnancies were highest among unmarried younger females (77–85%) compared to married women aged 25+ (50%). Conclusion Inequitable gender norms are pervasive and may affect women's vulnerability to HIV and gender-based violence. ZPI is addressing power imbalances between men and women that contribute to HIV risk and focusing on male norms and behaviors that contribute to gender-based violence., Background Gender based violence (GBV) is a human rights violation and public health problem impacting women's health globally and is interconnected with the HIV epidemic. GBV is associated with reduced adherence, poor treatment outcomes, and mortality in women with HIV. Methods Using marginal structural survival models (MSMs) we evaluated the effect of sexual, physical, or emotional abuse in the past 12 months on mortality among 2,222 (1,642 HIV-infected and 580 seronegative) participants in the Women's Interagency HIV Study (WIHS), an ongoing cohort study. Mortality data were confirmed by National Death Index Plus registry match. MSMs were used to estimate the mortality hazard ratio and survival curves from baseline (1994/95 or 2001/02) through 2007, controlling for sociodemographic, behavioral, and clinical factors. Results Overall, 437 (19.7%) women died between 1994 and 2007 and had abuse data available in the year prior to death. Compared to survivors, women who died were more likely to be older, HIV-infected and not treated with highly active antiretroviral therapy; have lower nadir and current CD4; to have engaged in transactional sex and used drugs and tobacco; be depressed, report lower cognitive function, and have a history of pre-study abuse including childhood sexual abuse. Accounting for these fixed and time-varying confounders, recent abuse was independently associated with all cause mortality (HR 1.54; CI 1.18, 2.02); findings remained significant in analyses stratified by pre-baseline abuse history, and by HIV serostatus. This effect was greater in uninfected (HR 4.39; CI 1.78, 10.82) than HIV infected women (HR 1.42; CI 1.07, 1.89). Conclusion Mortality risk is significantly elevated for women exposed to GBV and appreciable even in the context of a high death rate due to HIV infection. Interventions to address GBV should remain a public health priority. Further research is needed to identify possible biologic pathways underlying abuse related sequelae., Background Links between experience of sexual violence and HIV risk behavior among women are well established, as is the fact that male perpetrators of sexual violence against women report high levels of risk behavior. Links between sexual violence victimization and HIV risk have also been reported for MSM. However, little data has explored links between male-on-male sexual violence and HIV risk among men in the general population, and almost no such data exists from developing countries. Methods We conducted a population-based household survey of 1,738 men aged 18–45 across two provinces in South Africa. Information on sexual behavior, and experience and perpetration of male-on-male sexual violence was collected using audio-enhanced personal digital assistants. Male SV Victims Non-Victims P-Value 2+ casual partners in the past year55.9%40.6%, Background As northern Uganda emerges from decades of war and displacement, a growing number of young women engage in sex work (SW) for survival. With the escalating rates of HIV, the normalization of violence in northern Uganda creates a high occupational risk environment for young SWs. We aim to investigate the prevalence of client violence and associations with HIV risks among a cohort of SWs in Gulu, northern Uganda. Methods We conducted an analysis of baseline data (questionnaire and HIV screening) of SWs enrolled in a prospective cohort. Young women (≥14 years) who exchanged sex for resources in the last 30 days were recruited through ethnographic mapping, time-location sampling and peer outreach (current SWs) to SW venues. Bivariate and multivariate logistic regression modeled associations with physical and/or sexual violence by clients among SWs. Results Of 400 SWs, the median age was 21 (IQR: 19–25). The majority were Acholi (92.3%) with 66.5% (266) having formerly lived in displacement camps, 34.0% (136) living with HIV. In the last six months, 83.7% (335) had experienced violence by clients: 69.0% (276) forced unsafe sex, 28.8% (115) stabbed, and 18.8% (75) raped. In multivariate logistic regression, client violence was independently associated with rushing negotiations with a client due to police presence (a-OR: 3.58, 95% CI: 1.68–7.64), inconsistent condom use by regular and one time clients (a-OR: 3.53, 95% CI: 1.89–6.86), and older age (a-OR:1.08, 95% CI: 1.01–1.17). Conclusion The SW risk environment in northern Uganda is characterized by extreme occupational violence directly associated with a 3.5-fold increase risk of non-condom use. The criminalization of sex work in Uganda contributes to 3.5-fold increased odds of client violence from rushing negotiation due to police presence. Structural interventions (decriminalization and enforcement-based approaches) must be integrated into the HIV response, both as a human rights and public health imperative., Background The Population and Community Development Association implemented the Positive Partnership Program (PPP), which pairs HIV positive and HIV negative individuals and provided pairs loans for income generating businesses. Pairs also collaborated to disseminate HIV/AIDS knowledge to their community, with the objective of reducing community-level stigma and discrimination. Interventions included monthly HIV campaign events, funfairs, and production of three IEC materials (radio dramas, posters, and slips of paper with HIV messaging). Figure 1Change of HIV Knowledge Among Community Members. Characteristics Baseline (N=560) Endline (N=560) GENDER - Female 58.658.8 - Male 41.441.3 AGE - 15–29 22.520.0 - 30–39 17.919.5 - 40–49 23.023.2 - 50+ 37.137.3Community Respondent Profile, Baseline and Endline. The study goal is to evaluate the effect of interventions on reducing community-level stigma. Methods Randomly selected households and individuals were interviewed at baseline (N=560) and endline (N=560). We conducted t-tests on three stigma domains: fear of HIV infection through daily activity; shame associated with having HIV; and blame towards people with HIV. We developed three scales using confirmatory factor analysis and regressed each stigma scale on demographic characteristics, HIV knowledge, and exposure to intervention activities. B Coefficient (95% Confidence Interval) CHARACTERISTICS - Female (ref=male) 1.37(−0.36: 3.10) - Personally know a PLHIV (ref=does not know) −2.42(−4.34: −0.51) - 4–9 correct HIV knowledge responses (ref= 0–3 correct responses) −4.71(−6.35: −3.07) INTERVENTION EXPOSURES - None or one ref - Two −0.98(−2.95: 0.98) - Campaign/VDB or PPP club/IEC −2.86(−6.82: 1.10) - Campaign/Funfair/IEC −4.18(−7.74: −0.63) - Four −1.70(−6.44: 3.04)Results of Linear Regression on Fear-Driven Stigma. Results No differences were observed in respondent characteristics at baseline and endline. Significant changes were observed in HIV transmission knowledge and fear of HIV infection from baseline to endline. Respondents exposed to the monthly campaign, funfair and IEC materials were less likely to exhibit stigma along the dimensions of fear (4.2 points lower on average compared to respondents exposed to none or only one intervention; 95% CI: −7.4 to −0.6) and shame (4.7 points lower; 95% CI: −8.4 to −1.1), net of demographic controls and baseline levels of stigma. Personally knowing someone with HIV is associated with low fear and shame, and females are less likely to possess attitudes of shame compared to males. B Coefficient (95% Confidence Interval) CHARACTERISTICS - Female (ref=male) −2.17(−3.92: −0.41) - Personally know a PLHIV (ref= does not know) −1.78(−3.72: 0.15) - 4 to 9 correct HIV knowledge responses (ref= 0–3 correct responses) −3.73(−5.40: −2.06) INTERVENTION EXPOSURES - None or one ref - Two −0.88(−2.98: 1.14) - Funfair/Campaign/ VDB or PPP club 0.60(−7.84: 9.04) - Campaign/VDB or PPP/ IEC −1.11(−5.13: 2.90) - Funfair/Campaign/IEC −4.73(−8.35: −1.11) - Four −5.76(−10.59: −0.94)Results of Linear Regression on Shame Stigma. Conclusion Results suggest that a combination of three interventions is critical in shifting community-level stigma in Thailand: monthly campaigns, funfairs, and exposure to IEC materials. Knowing which interventions to invest in for maximum impact is crucial for country-wide expansion and scale-up of interventions., Background Disclosure of seropositivity within a partnership is a pre-requisite for couples counseling and the tailoring of prevention interventions, such as the use of treatment as prevention. In this study, we used a mixed methods approach to describe the rates and determinants of disclosure within partnerships. Methods The Multi-Country African Testing and Counseling for HIV study was a cross-sectional study designed to compare clients’ experiences of HIV testing services in Burkina Faso, Kenya, Malawi, and Uganda. Face-to-face questionnaires were administered and included multiple-choice and open-ended questions. Our analysis focuses on a sub-set of married/cohabiting participants reporting awareness of their seropositive status. We explore the influence of stigma through a multilevel logistic regression model. Results Of the 477 participants, 85.3% [95%CI 82.1–88.5] reported ever disclosing their serostatus. However, only 52.6% [95%CI 48.1–57.1] reported disclosing to their partners. We observed a significant variation between countries-participants in Kenya and Burkina Faso disclose at similar levels, while lower levels of disclosure were reported in Malawi and Uganda. Analysis of the open-ended responses among HIV positives who did divorce, revealed that disclosure can create serious rifts with partners. Perceived community stigma was approximately reported at same levels across the four countries, but levels of self-stigma differed. Patients were more likely to report self-stigma in Burkina Faso, while they were the least likely to report self-stigma in Malawi. However, none of our stigma indicators was associated with disclosure. At individual level, those with a lower education and member of a support group disclose less than the rest. Conclusion Seropositive patients tend to disclose to people in their support network. However, disclosure within the partnership is less common. We found no relationship between stigma and disclosure to partners. A tailored disclosure support and advice will be essential for programs looking at implementing treatment as prevention in serodiscordant couples., Background Internal stigma or self-stigmatization is a critical problem among PLHIV as it usually leads to low self-esteem, a sense of worthlessness and depression, etc. The objective of this study is to assess the level of internal stigma among HIV-positive adults in Ethiopia Methods This study utilized a nationally representative two-stage cluster sampling method to collect data from 3360 PLHIV (68% of them women) sample cases. Results More than half of the PLHIV blamed themselves and reported to have low self-esteem. More than 40 percent of the PLHIV feel ashamed and guilty because of their HIV status. PLHIV residing in rural areas have higher likelihood of feeling guilty than PLHIV residing in urban areas. One out of five of the PLHIV felt suicidal, in connection with their HIV positive status. Abandoning aspirations/life goals, in connection to their HIV-positive status was reported by substantial proportion of PLHIV. For instance, the proportion of PLHIV who took the decision not to have (any more) children was 59 percent,), not to have sex was 40 percent and not to get married 37 percent. Significantly higher proportion of female PLHIV were noted to have taken all these decisions compared to males (P=0.000). Almost one-quarter of PLHIV revealed that they have isolated themselves from their family and/or friends as a result of their being HIV-positive. Nearly equal proportion of PLHIV have decided to withdraw from their education/training and stopped working (12 percent) because of their HIV-status. Conclusion Internal stigma and its negative consequences are very common among PLHIV in Ethiopia. This may deter PLHIV from active participation in socio-economic activities of the community out of a fear of having their status revealed or being discriminated against. In order to address the problem, peer-to-peer support groups, skills building, network building, counselling, training, should be given attention., Background Previous research has revealed a negative impact of orphanhood and HIV-related stigma on the psychological well-being of children affected by HIV/AIDS. Little is known about psychological protective factors that can mitigate the effect of orphanhood and HIV-related stigma on psychological well-being. This research examines the relationships among several risk and protective factors for depression symptoms using structural equation modeling. Methods Cross-sectional data were collected from 755 AIDS orphans and 466 children of HIV-positive parents aged 6–18 years in 2006–2007 in rural central China. Participants reported their experiences of traumatic events, perceived HIV-related stigma, perceived social support, future orientation, trusting relationships with current caregivers, and depression symptoms. Results We found that the experience of traumatic events and HIV-related stigma had a direct contributory effect on depression among children affected by HIV/AIDS. Trusting relationships together with future orientation and perceived social support mediated the effects of traumatic events and HIV-related stigma on depression. The final model demonstrated a dynamic interplay among future orientation, perceived social support and trusting relationships. Trusting relationships was the most proximate protective factor for depression. Perceived social support and future orientation were positively related to trusting relationships. Conclusion We conclude that perceived social support, trusting relationships, and future orientation offer multiple levels of protection that can mitigate the effect of traumatic events and HIV-related stigma on depression. Trusting relationships with caregivers provides the most immediate source of psychological support. Future prevention interventions seeking to improve psychological well-being among children affected by HIV/AIDS should attend to these factors., Background The deleterious impacts of racism, sexism and HIV-related stigma on well-being are widely documented, yet most research has examined these forms of stigma separately. Rising HIV infection rates among Black African Caribbean women in Canada underscore the importance of understanding factors associated with quality of life (QOL). We used a feminist intersectional approach to examine the influence of racism, sexism and HIV-related stigma on QOL among HIV-positive Black African Caribbean women in Ontario, Canada. Methods We conducted a community-based multi-method study triangulating qualitative and quantitative methods. Building on qualitative findings regarding stigma from 15 focus groups with HIV-positive women (n=104) in Ontario, we implemented a cross-sectional survey with HIV-positive Black African Caribbean women in three Ontario cities. Multiple linear regression (MLR) analyses were conducted to measure associations between independent (block 1: racism, sexism, HIV-related stigma; block 2: resilient coping, social support) and dependent (total QOL; QOL domains: physical; psychological; level of independence; social relationships; environment; personal beliefs) variables. Results Survey participants (n=163; mean age=40.7 years, SD=8.8) reported frequent/everyday experiences of racism (29.4%) and sexism (22.6%) and high HIV-related stigma (disclosure: 84.4%; personalized: 54.7%; public attitudes 40.4%; negative self-image: 27.6%). In MLR analyses, racism, sexism and HIV-related stigma were associated with lower QOL scores (total; psychological; level of independence; social relationships; environment; personal beliefs). Resilient coping and social support accounted for a significant variance of higher QOL scores (total; psychological; social relationships; environment) after controlling for the effects of racism, sexism and HIV-related stigma. Conclusion HIV-positive Black African Caribbean women experience pervasive racism, sexism and HIV-related stigma associated with reduced QOL; social support and resilient coping were associated with higher QOL. Interventions tailored for HIV-positive Black African Caribbean women should aim to strengthen protective factors, such as resilient coping and social support, and challenge stigma and discrimination associated with HIV, race/ethnicity and gender., Background Female bar/spa workers in the Philippines face continued risk of sexually transmitted infections (STIs), yet Philippine Congress recently rejected a Reproductive Health Bill. Little is known about differences in condom attitudes among workers in different venues and the effects of social support on their condom attitudes. This study assesses socio-structural and individual factors associated with condom attitudes among female bar/spa workers in the Greater Metro Manila Area, Philippines. Methods Female bar/spa workers (N=498) from 54 venues underwent interview-led surveys as part of a larger intervention study. Multiple hierarchical linear regression analyses, adjusted for individuals nested within venues, were conducted to assess socio-behavioral (age, education, length of time employed as an entertainer, alcohol, and substance use) and socio-structural (venue type, manager support, peer support, establishment condom rule, condom availability at establishment, and social support) factors associated with condom attitudes. Results Participants were aged 18–60 years. Over 90% indicated using condoms every time while having vaginal and anal sex could lower their chances of contracting HIV/AIDS. However, nearly 70% considered condoms too expensive to use regularly. Over 60% said condom usage depended on males in their culture. Over half thought condoms caused pain or discomfort. A like proportion indicated that condom usage never or only occasionally went against their religion. In multivariate analyses, positive attitudes toward condoms were associated with co-worker peer support (0.35, p, Background In the third decade of the HIV epidemic in the United States, the population of persons living with HIV/AIDS (PLHIV) has aged. While 50 and older was initially created as the “older age” category, that cut-point is no longer informative. Understanding the health status of different adult age-groups of PLHIV will assist in providing the types of healthcare services needed by an aging population. Methods A convenience sample of 2,182 PLHIV was enrolled from HIV clinics and service organizations in the United States, Canada, Puerto Rico, Namibia, China, and Thailand from February 2010 to July, 2011. This subanalysis of U.S. participants (N=1293) assessed differences in PLHIV in three adult age groups: 40–49 (n=687, 53%); 50–59 (514, 40%); and 60 and older (n=92, 7%). Results Participants' mean ages were 44.7, 53.4, & 63.9 years; 71%, 73% & 79% male, no differences in race/ethnicity, 64%, 71% & 87% reported other medical conditions, 81%, 82% & 91% were taking HIV medications, and 52%, 46% & 40% were diagnosed with AIDS. No differences were found in social capital (measured by the Social Capital scale, Onyx & Bullen) or physical functioning (measured by SF-12); there were significant differences in mental functioning (measured by SF-12) in that mental health improved with age (means=43.6, 45.4, & 50.8), depressive symptoms (measured on CES-D) declined with age (means=22.2, 20.5, & 14.8) and treatment self-efficacy (measured on the HIV-ASES) improved with age (means =91.3, 96.8, & 100.5). Conclusion The oldest group of PLHIV has better mental health although they are living with multiple comorbidities, perhaps because they view themselves as survivors. Although fewer older persons have AIDS, 91% are taking HIV medications and their treatment self-efficacy is significantly higher than the younger age group (F=9.091, p=.000). It might be time to reexamine the possibility of creating peer groups between middle and older aged PLHIV., Background In 2010–2011 we conducted a HIV and non-communicable disease (NCD) prevalence and risk behavior survey (“Ha Nakekela” study) within the Agincourt Health and Demographic Surveillance System site (AHDSS) in Mpumalanga Province, South Africa (Menken P.I). We found surprisingly high levels of HIV prevalence at older ages, given in Table 1. 40–49 50–59 60–69 70–79 80–89 Women34%25.5%12.4%8%1%Men34%33%17%6%1%HIV Prevalence of Older Adults in Agincourt, SA. Older adults are either contracting HIV at earlier ages and surviving for a long period or they are contracting HIV at older ages. In this study we examine the sexual behavior and HIV risk for older adults in the two years previous to the study visit. Methods The Ha Nakekela study was based on a probability sample of 7,428 individuals aged 15 years and above. We analyze the sexual behavior survey for the 2,051 adults over age 39 in the study to investigate the prevalence of sexual behavior risk factors for acquiring HIV. Results We find evidence suggesting that older adults are at risk of acquiring HIV through unprotected sex and by having multiple partners. Fifteen percent of men over 39 report multiple partners, the majority of whom are significantly younger. Very few men (9.5%) and women (11.5%) reported condom use at last sex. We also find that older adults are not likely to know their or their partner's HIV status: only 5% of sexually active older adults said they knew the HIV status of their sexual partner. Of those that are HIV positive, 31% had never been tested and only 40% of those that had ever tested reported being on ART. Conclusion The high HIV prevalence, lack of condom use, lack of testing, and low ART uptake of known positives suggests that older adults are an over-looked but critical population for both HIV prevention and treatment programs., Background HIV/AIDS among adults 50 and older in Uganda is on the increase partly due to newly diagnosed infections in this age group as well as improved survival owing to antiretroviral therapy, for many HIV infected persons. Although national programmes are in place to ensure access to medical services, older people living with HIV have unique unmet healthcare needs. The objectives of this study were to identify the healthcare needs of older Ugandans living with HIV and to gather recommendations for improvements by health service providers. Methods Data regarding healthcare needs were collected from HIV positive adults aged 50 years and older attending two large non-governmental outpatient clinics in Kampala and Masaka districts, Uganda between March 2011 and June 2011. Individual in-depth open-ended qualitative interviews focus group discussions were conducted. Observations of clinic interactions were also recorded. Interview transcripts were analyzed using thematic content analysis. Results The mean age of the respondents was 65 years, 50% were female, (n=40). Respondents expressed multiple age-related healthcare needs that may differ from their younger counterparts. Needs increased with higher age. Both men and women attributed double stigma from HIV and old age as a major factor affecting disclosure and seeking healthcare for HIV. 60% of the respondents expressed anxiety about their future access to healthcare, the lack of social services and end of life care. Lack of transport and food access issues compromised respondents’ adherence to antiretroviral therapy. Conclusion Older people living with HIV have unique healthcare needs which health promotion programmes should consider meeting through appropriate and innovative approaches such as preventing and managing age-related chronic illnesses, palliative care, developing age-friendly services and settings. Research to further explore the impact of these healthcare needs on the quality of life of older PLWHA is required., Background The health of prisoners is an issue of global concern. Increased socio-demographic and behavioural risk factors prior to incarceration and poor prison living conditions contribute to increased prevalence of transmissible infections. Little is known about the health of prisoners in Mexico City. This study sought to establish prevalence data and risk factors to identify those currently needing healthcare and to inform future policy. Methods This cross-sectional study was carried out in 4 Mexico City prisons, June to December 2010. Ethical approval was granted prior to starting; participation was voluntary, confidential and based on informed consent. Participants were offered HIV, Hepatitis B, C and Syphilis testing. A representative sample completed a questionnaire on socio-demographic characteristics and risk behaviours. Positive results were delivered with counselling and treatment or referral with consent. Data was analysed using Stata. Results 76.8% (15,517/20,196) men and 92.9% (1,779/1914) women participated. Complete data sets were available for 98.8%. Prevalence of HIV (0.7%), syphilis (Anti-TP Ab 4.1%; VDRL 2.0%), Hepatitis B (HBcAb 3.0%; HBsAg 0.2%) and Hepatitis C (3.2%) was higher in the study population compared with national data. The relative increase was greater for HIV and syphilis amongst women, Hepatitis C in men, and all infections in younger participants. Questionnaire data (1934 men, 520 women) demonstrated lower educational levels, increased smoking and substance use compared to national data. High levels of unsterile tattoing, physical abuse and a history of sexual violence were found. Conclusion The study identified that health screening is acceptable to Mexico City prisoners and feasible on a large-scale. It demonstrated increased prevalence of HIV and other infections compared to national data, though low rates compared to international data. Individual participants benefited from earlier diagnosis, treatment and support. The data collected will also enable the formation of improved policy for this vulnerable group of individuals., Background After two decades of living with HIV a generation of around 7,000 children from Romania nosocomially infected in communist era, turned into young adults. Hyper protection from the family, combined with discrimination in education services, developing social services, and a focus on medical aspects represented the environment these children grew. Between 2004 and 2010 the Global Fund financed social programs for their professional integration, increasing the percentage of those availing of cash benefits from 30% to 66%. In 2010 people living with HIV (PLHIV) and NGOs protested over ARV treatment interruptions and budgetary cuts due to economic crisis, although WHO estimated the treatment coverage at 83% in 2009. Methods A nationally representative clinic-based research among PLHIV was carried out in 2011 (March–June) to determine their access to treatment, care and support (N=618, ±4%). Measures of treatment interruptions, adherence and access to services were included, as well as demographics variables. Sample was weighted according to subjects’ surveillance center registration. Results The vast majority of the sample (71.7%) is young (18–24 years), with more than 6 years of known seropositivity (82.1%), receiving ARV for more than 6 years (78.7%), with more than 2 changes in their treatment plan (80.1%), and with their main source of income as cash benefits (80.5%). Unintended treatment interruptions were spread (65.2%, average interruption lasting 38 days), resulting in more visits to regional center (49.2% more than once a month), higher expenses and the need for new combinations of ARV. Discontinuous adherence was reported by 42.2%. Access to social services was high (over 80%). Conclusion While Romania is a low prevalence country, and ensures high coverage of ARV treatment, authorities must pay attention at continuous treatment access for PLHIV, and support of treatment adherence to prevent deterioration of the health status and ensure universal access for PLHIV., Background Despite evidence that a significant number of children infected and affected by HIV (uninfected, but have HIV+family member) reside with caregivers who are not their birth parent, few studies have examined the psychological functioning of these alternate caregivers. The majority are women, typically ethnic minorities, often from impoverished communities. This study compares mental health and substance use problems in birth-mothers, and non-birth female caregivers of HIV-infected, affected, and unaffected children in the US. Methods Data come from the baseline caregiver interviews of two longitudinal studies of urban youth perinatally-HIV infected, HIV-affected, and unaffected by HIV. Caregivers (n=451) included HIV+ and HIV− birth-mothers and other HIV− female caregivers primarily of African American and Latina ethnicity. Measures of depression and anxiety symptoms and substance use problems were completed. Results Birth-mothers reported more symptoms of depression (p< .001) and anxiety (p< .001) than non-birth caregivers. Non-birth caregivers were less likely (3%) to report substance use than HIV+ (13%) or HIV− (12%) birth-mothers (p=.006) (Table 1). In multiple regression analyses, HIV+birth-mothers, but not HIV−birth mothers were significantly more depressed and anxious than non-birth caregivers, after adjusting for age, race, number of children under 18-years, and having a partner in home (Table 2). Both birth-mother groups (HIV+ and HIV−) had more substance use problems than non-birth caregivers even after adjusting for covariates. Among all caregivers in the study, those who reported either substance use or Latina ethnicity had significantly higher depression and anxiety scores (each p≤.01; data not shown).Table 1Caregiver characteristics HIV+ Birth Mother HIV− Birth Mother HIV− Non-birth Caregiver Chi-square/Anova p-value N (%)209 (46)120 (27)122 (27)Age (mean)39.238.354.4.000African-American (%)553757.006Latina (%)334835Children, Background Women's low or unpaid role in providing care for people living with HIV in the form of home-based care while central to the response to HIV been has increasingly been recognised as entrenching unequal gender relationships. Frameworks to map out the pathways have suggested that this process occurs in three domains: financial costs, opportunity costs and physical and emotional costs. Yet such a framework has a tendency to ignore the broader conceptualisation of gender inequalities that include violence against women. Methods We undertook 5 focus groups with 45 home-based carers in South Africa as part of a larger study focused on how to transform home-based care organisations from spaces of reproducing inequalities to transforming gender relationships. We conducted thematic analysis on the data exploring factors that could support or hinder gender equality. Results As with other studies, our data showed home-based carers suffered economic costs related to their work, often spending their own money to provide for their patients. In addition, few received stipends or other financial support either from donors, government or NGOs. Many carers also related the extreme physical and emotional costs of the work they did; again reflecting what is already known about providing care. However, home-based carers also spoke about the central role of gender-based and sexual violence that they feared, risked and experienced both while working and sometimes within the organisations they worked in. Such relationships of violence undermined their ability to envision their work as spaces for women's empowerment and transformation. Conclusion To move women's participation in home-based care from one of reinforcing gender inequalities to empowering women requires those supporting home-based carers to envision a wider conceptualisation of the gender inequalities home-based carers face, that includes the centrality of gender- and sexual-violence, and actively work to programme and tackle these., Background Psychiatric disorders are prevalent among HIV-infected individuals and may have deleterious effects on HIV care and outcomes. We sought to examine the impact of depression on retention in care and viral suppression among racial/ethnical diverse HIV-infected patients in a large managed care organization. Methods We evaluated a cohort of HIV- infected adults who received care and had at least 8 months' membership in health care plan in 2010 in Kaiser Permanente Southern California. History of depression prior to 2010 was identified by International Classification of Diseases, Ninth Revision Clinical Modification (ICD-9 CM) codes for depressive symptoms. Retention in care was defined as ≥ 2 CD4 and/or HIV-1 RNA tests at least 90 days apart in 2010. Viral suppression was defined as undetectable viral load or HIV-1 RNA, Background Previous research (amongst others our own published in AIDS and Social Science & Medicine) has demonstrated gender differences in various antiretroviral treatment (ART) outcomes including, adherence, quality-of-life, disclosure and retention. However, little longitudinal, in-depth research has been done to investigate the why and how of these differences. The current study firstly aims to explore the impact of masculinity and femininity on ART experiences, in both a longitudinal and in-depth manner. In addition, the study investigates the complex interrelationships between gender constructs whereby males and females potentially influence-through intricate household dynamics- the ART experiences of the other gender. Methods Based on a previous explorative quantitative study, we conducted a longitudinal qualitative study whereby 12 male and 12 female ART patients were repeatedly interviewed >over the course of 1 year in the Free State province of South Africa. Results Despite several cases of lipodystrophy and other side-effects among women due to ART, they seem to adhere and lead healthy lifestyles, often in the absence of a male partner. Male patients reported a clear notion of masculinity that required males to be in control and act strong, highly sexual and economically productive, thus conflicting with the role of ‘good patient’ that is expected to accept being HIV-positive, take instructions, and engage in health-enabling behaviors. The majority of men interviewed overcame these barriers and internalized their treatment, albeit with fewer side-effects and more support in terms of reminding and accompanying them to the clinic (mostly by females). Conclusion The study findings have both theoretical and practical relevance. Theoretically, the longitudinal impact of gender and household dynamics on the ART career draws attention to the sociological processes influencing ART outcomes. Practically, the study demonstrates that policy interventions aimed at improving long-term ART outcomes should incorporate the (interactions between) gender-specific illness and treatment experiences., Background Asian gay men make up the highest group in MSM/gay HIV notification after Anglo background, constituting a priority group for HIV health promotion in Australia (MHAHS, 2011). Multiple challenges exist as issues of stigma, migration, isolation, in addition to sexual stereotyping and homophobia within the gay and ethnic communities respectively, complicates this work.The immediacy of these issues renders HIV health promotion a second order issue. Underrepresentation in HIV health promotion work, research and general media also contributes to their invisibility. Multicultural HIV & Hepatitis C Service (MHAHS). Trends in NSW HIV notifications 1999–2010. (unpublished). Methods The “A-Men” publication was developed with an aim to engage lived experiences and visibility of Asian gay identities as an entry point to promoting sexual health and wellbeing. The approach was two-pronged: a resource production engaging broader issues facing Asian gay men - the person-centric approach; and the developmental process that involves and builds community ownership - ‘for the community, by the community'. With $5000 community arts funding from Sydney city council, the resource was developed and distributed in-print and online. Results A total of 70 volunteers from 9 different Asian ethnicities were involved in the production.1000 hard-copies were launched in March and distributed through community and service providers. 1600 users accessed the online version to date. Volunteer feedback (n=58) showed increased social-connectedness, self-esteem, pride, HIV awareness and knowledge of services. 2 community focus groups (n=62)reported similar trends: greater community engagement and dialogue around wellbeing and self-esteem. Conclusion A broader exploration of lived realities was effective in enlivening HIV messaging with Asian gay men. Through engaging intersections of identity, art and community building, a ‘biggest bang for your buck' can be achieved in a resource limited setting. Through cultural change, "A-Men" addressed the barriers to HIV awareness and wellbeing, in the process building a more resilient and empowered community., Background Evidence suggests that men who have sex with men (MSM) account for most new HIV infections in Lebanon and act as a bridge to transmission in the general population. In a region where same-sex sexual activity is highly stigmatized, a better understanding of the psychosocial factors that influence sexual risk behavior and HIV testing in MSM is essential for HIV prevention initiatives to be effective. Methods An exploratory, qualitative study was conducted with a sample of 31 MSM living in Beirut. Semi-structured interviews examined relationships with family and friends, comfort with and disclosure of sexual orientation, sexual behavior, and HIV testing. All interviews were recorded, transcribed, and coded in Atlas-ti to identify themes and extract counts. Results All men self-identified as homosexual (77.4%) or bisexual (22.6%), although 32.3% also have sex with women, and a majority (64.5%) reported some discomfort with their sexual orientation. The men described a strong heterosexual social norm, causing some to feel guilty and lead a “double life” where they conceal their sexual orientation by publically feigning attraction or dating women, or dissociating from effeminate men. Comfort with and disclosure about sexual orientation appeared to be linked with sexual risk behaviors and HIV testing. As compared to the remaining sample (n=18), the 13 participants who were both uncomfortable with their sexual orientation and had not disclosed to either parent reported higher rates of unsafe sex (69.2% versus 33.3%), more annual sexual partners (mean=36.7 versus 17.0), and lower rates of being HIV-tested (53.8% versus 88.9%) and discussing HIV risk with their sex partners (38.5% versus 88.9%). Conclusion These findings reveal the influence of sexual identity acceptance and disclosure on condom use and HIV testing in the context of high societal stigma, and suggest the need for HIV prevention interventions to facilitate progression through these psychosocial processes of sexual development., Background Evidence indicates that MSM experience higher rates of intimate partner violence (IPV) than non-MSM; however, no study has examined what defines IPV among MSM, or the associations between MSM-specific IPV and sexual risk-taking Methods Seven focus group discussions were held with 84 MSM, generating 30 types of IPV, including HIV-specific IPV. These were tested using a cross-sectional survey of 1,074 MSM. Factor analysis generated five domains of MSM-specific IPV, including a domain of HIV-related IPV. Six logistic regression models for unprotected anal intercourse (UAI) were created (n=626). Models controlled for age, race, education, employment, HIV status, and gay identity, with the key covariate being receipt or perpetration of three different IPV measurements: MSM-specific, Conflict Tactics Scale (CTS), and World Health Organization (WHO). Results The MSM-specific IPV definition included HIV-specific typologies of violence not currently included in any definition of IPV, e.g., not disclosing HIV-positivity to a partner, and captured significantly higher reporting of IPV compared to WHO (46.2% v. 13.5% receipt of IPV; 31.9% v. 8.5% perpetration of IPV). Reporting receipt of neither WHO-defined IPV nor CTS-defined IPV was significantly associated with UAI, but reporting receipt of MSM-specific IPV significantly increased odds of UAI (OR: 1.80, 95% CI: 1.27, 2.54). Two models demonstrated a significantly increased risk of UAI among men reporting IPV perpetration (WHO OR: 1.74, 95% CI: 0.91, 3.31; CTS OR: 1.67, 95% CI: 1.06, 2.63; MSM-specific OR: 1.82, 95% CI: 1.26, 2.64). Conclusion This study provides for the first time a MSM-specific definition of IPV that captures HIV-related violence not represented in standard definitions. MSM who reported MSM-specific IPV had increased odds of UAI at last sex. These findings suggest that MSM experiencing IPV are at higher risk for HIV seroconversion, although this association may not be recognized by using non-MSM-specific definitions of IPV that do not include HIV-related violence., Background HIV prevalence among MSM in India remains disproportionately high at 7.4% as compared with overall national prevalence of 0.3%. India HIV/AIDS Alliance in consortium with five other organizations implements the five-year Global Fund-supported Pehchān program in 17 Indian states to build the capacity of 200 CBOs to serve as effective HIV prevention partners with the National AIDS Control Program and reach 453,750 MSM, transgenders and hijras using a community-driven and rights-based approach. Non-disclosure of identity and low self-esteem due to internalized stigma are known to be associated with vulnerabilities that place these populations at greater risk of HIV infection. Methods A cross-sectional baseline study sampled 2,762 MSM, transgenders and hijras (TG/H: 16%) in 55 districts across 10 states to understand demographics, behavior and needs of target populations. Time and Location Cluster Sampling (TLCS) was used to identify these often hard-to-reach and relatively mobile populations. Data were analyzed using SPSS. Results Self-disclosure of sexual identity occurred least with parents (21%) for reasons ranging from fear of being rejected and rendered homeless to adverse legal consequences. Self-disclosure with siblings was also low (22%), for fear of being neglect, isolation, and verbal/physical abuse. Disclosure was highest amongst community peers (67%). Feelings of shame (33%), self-blame (28%) and feelings of guilt (26%) were associated with sexual identity among study subjects. 30% of respondents have actively attempted to avoid disclosure of their sexual identity. Conclusion Low self-esteem among MSM, transgenders and hijras and fear of rejection leads to non-disclosure of sexual identity. Based on the insights from the baseline, Pehchān developed a life skills training module that places greater emphasis on coping, communication and interpersonal skills to address sexual identity. The program plans messaging to change attitudes about homosexuality and gender identity within families and communities in India to strengthen support structures and manage conflicts more successfully., Background Globally, YMSM are uniquely vulnerable to HIV. Many are dependent on family that may not understand or accept their sexuality, forcing them to hide their sexual behavior or risk losing housing and financial support. YMSM also may have limited access to information regarding sexual health and legal rights. Despite this vulnerability, YMSM's distinct needs are often overlooked by efforts to address HIV among general youth and general MSM. Methods In 2010, the Global Forum on MSM & HIV (MSMGF) conducted a global online survey of MSM and their service providers. Among 5,066 survey participants, 1,488 were YMSM (age 30/younger). YMSM respondents were from: Asia (65%), Latin America (10%), Australasia (9%), North America (6%), Europe (4%), and Africa (3%). Chi-square and Wilcoxon rank-sum were used to evaluate differences between YMSM and other MSM. Multivariable regression was used to identify predictors of access to HIV prevention services. Results HIV-prevalence among YMSM was 14%. Most YMSM (67%) had two or more sexual partners in the past year; 33% were homeless/unstably housed. Compared to other MSM, YMSM reported lower “easy access” to evidence-based HIV prevention strategies: free HIV testing (53% vs. 37%[p, Background In India, many MSM either are married or expect to marry. The present study aimed to identify strategies for the national HIV programme to promote the health of women partners of MSM both in terms of preventing HIV transmission and in promoting early HIV diagnosis and treatment. Methods Qualitative field research used a collective case study design to collect data in 2010/11 from 11 sites in seven states among 401 MSM (HIV prevention outreach workers and beneficiaries) through 57 focus groups (n=364; 46% married) and 37 key informant interviews. Women partners of MSM could not be recruited for the study. Potential interventions proposed are based on the inferences drawn by synthesising both the literature review and qualitative data (thematic analysis). Results Both literature review and qualitative data showed that women partners of MSM can include wives, casual, regular, paid or paying partners, and they may be at higher risk of HIV due to their male partners' high-risk sexual behaviours, which include having a large number of male and/or female partners combined with inconsistent condom use. Field data revealed that self-identified MSM may enter into heterosexual marriage with willingness, under compulsion (e.g., family pressure) or with indifference. Importantly, qualitative data offer new insights into whether disclosure of sexuality and/or HIV status among MSM is significant in preventing HIV transmission to female partners. Conclusion HIV prevention messages aimed at MSM ought to explicitly promote awareness of the risks/vulnerabilities faced by female partners. Such strategies ought to particularly include counselling and HIV testing approaches that address the complexities of safer sex practices with both male and female sexual partners. Developing interventions for single MSM that raises awareness of the HIV risks faced by their women partners and implementing interventions that explicitly target married MSM and their wives are key to effective, future HIV prevention programming., Background Social network analysis has been widely used as a tool to describe and explain HIV prevalence and risk behaviors. However, the network of male sex workers is understudied. This study provided a description and graphical presentation of the social network structure of male sex workers with HIV status in Houston, Texas. Methods The study used network data from a cross-sectional network study derived from male sex workers in Houston, Texas. A convenience sampling plan was used wherein male sex workers were identified first and then were asked to refer their social, drug, or sex partners (both male and female) to the study. Netdraw, UCINET version 6, and Stata version 11 were used. Results The analysis consisted of 395 participants; with a mean age 33.1 years old (SD=9.7); 84.3% male; 31.4% gay, 44.3% bisexual, and 24.3% straight. There were 81 (20.5%) HIV positive, 253 (64.1%) HIV negative, and 61 (15.4%) unknown HIV status. Two thirds of the participants traded sex for money or drugs in the last 30 days. The network had 17 components and 32 isolates. The largest component of the network consisted of 155 people (39.2%), and the second largest consisted of 16 people. The graph below indicates that HIV positive and HIV negative people tended to be clustered together. The mean sexual network size in the last 30 days was 35.1 (SD=64.4). There was no difference in the sexual network size among HIV positive, HIV negative, and unknown HIV status.Figure 2Change in Fear of HIV Transmission Among Community Members. Conclusion Our network data showed that most network participants were connected with each other in 17 separate components, and more than a third were connected in the same network. HIV positive and HIV negative participants tended to be clustered together. These findings indicate high potential for network-level HIV interventions for HIV positive and HIV negative people., Background Northern Uganda hosts one of the highest prevalences of HIV and teenage pregnancy in the country. The Gender Roles Equality and Transformations (GREAT) Project conducted ethnographic research to understand the processes through which social norms about gender, SRH, and violence, which underlie HIV vulnerability, are transmitted in this post-conflict setting. Methods Forty life histories were collected from adolescents across the life course: very young adolescence, older adolescence, newly married, and pregnant with or parenting a first child. Forty in-depth interviews were also conducted with adults who significantly influence adolescents in study communities. Data were analyzed using AtlasTI software. Results Data reveal efforts to destigmatize HIV have been largely successful as evidenced by widespread support for youth access to HIV services, including education, testing, condoms, and treatment, as well as by the ritualization of HIV testing among young unmarried couples. The need for young people to “test their blood” before beginning sexual activity appears to have become a cultural norm, viewed by adults and adolescents as a rite of passage into sexual relationships. These efforts, however, have not translated to other aspects of adolescent SRH, namely, pregnancy prevention. Respondent Category # of Males # of Females Very Young Adolescents (ages 10–14 years)55Older Adolescents (ages 15–19 years)53Newly Married Adolescents (ages 16–19 years)56Parenting Adolescents (ages 16–19 years)56Total2020Life History Interviews (ages 10–19 years). Respondent Category # of Males # of Females Parent of adolescent girl or boy27Relative of adolescent girl or boy44Community Member (e.g. teacher, religious leader, elder)83Peer of adolescent girl or boy63Total2020In-Depth Interviews (ages 20 years and above). Results show that most respondents do not acknowledge the link between HIV prevention and family planning (FP) and oppose adolescent use of FP products. Condoms are viewed as acceptable only in the context of HIV prevention but not for pregnancy prevention. Opposition to adolescent FP use is primarily due to fear of compromised future fertility or increased promiscuity. Conclusion Severe social, economic, and medical consequences resulting from early pregnancy, particularly in low-resource settings, have been globally recognized. Efforts are needed to build on successes in HIV prevention efforts to address adolescent SRH in a more comprehensive manner., Background Few studies have documented female sex workers' (FSWs) efforts to engage in safe behaviors in the context of their multiple identities with sexual partners in India. Recognizing the intricacies of women's perceptions of risks and benefits within diverse relationships and moving beyond condom promotion are crucial for HIV prevention. Methods An exploratory qualitative study was conducted with female sex workers in India. Sixty FSWs participated in 5 focus groups and 25 semi-structured in-depth interviews in addition to completing a short questionnaire that captured basic socio-demographic information. Results The majority (60%) of FSWs was based in rural areas and was Hindu (90.3%). Respondents' mean age was 30.2 years, with an average of 6.4 years of education. Only 28% reported being legally married or living with a partner and 82% had at least one child. Further, for 58%, sex work was the main income source. Findings implied a complex interplay of factors that determined FSWs' abilities and willingness to avoid unsafe sexual behaviors with paying clients, regular/trusted clients, and non-paying intimate partners. Often, this was dictated largely by economic hardships, emotional attachments, social norms, perceived lack of power as well as the threat of violence and to a less extent by the knowledge of HIV risk. Further, discrimination and exploitation by community members including police combined with the need to hide their sex worker identities often put FSWs in situations that compromised their efforts to avoid risky behaviors. Conclusion A deeper understanding of the multifaceted exchanges between the various partner types that heighten FSWs' vulnerabilities is critical when planning HIV prevention interventions in addition to adopting a human-rights framework and recognizing women's agency in safeguarding health. Challenging popular notions of sex workers as undeserving of substantive support and individual rights would go a long way in ensuring the effectiveness of HIV prevention efforts., Background Male partners of female sex workers (FSW) have traditionally been viewed as holding power and decision-making authority regarding condom use due to the transactional nature of their relationships. The aim of this study is to explore relationship and gender dynamics between FSW and their regular partners and consider how these dynamics influence HIV vulnerability. Methods We conducted qualitative interviews with FSW (n=20) and regular partners (n=20). FSW were recruited from an ongoing cohort study and regular partners were referred by non-participating FSW in the cohort. Regular partners were defined as trusted and/or intimate partners with whom the referring FSW reported sex with at least 4 times in the last 3 months. We used narrative and thematic analysis to describe the relationship history and identify emergent themes. Results Both FSW and regular partners described emotional, sexual, and economic attachments to each other. Regular partners, however, described greater emotional and sexual attachment. While most men provided some economic support to their FSW partner, they were aware that due to their limited economic resources, they were not able to provide for all of their partner's needs. In contrast, FSW displayed more pragmatic attitudes, emphasizing the importance of both the material and emotional support provided by regular partners. Some FSW clearly stated that while they had the strongest emotional attachment to their regular partner, they had to maintain other partnerships in order to survive. Conclusion Findings challenge hegemonic norms of masculinity between FSW and their regular partners and highlight the intersection between socio-economic position and relationship power. HIV prevention efforts targeting FSW and regular partners must address both emotional and socio-economic dimensions of relationships and their influence on HIV protective behaviors., Background For some women who engage in female sex work (FSW) life remains bound up in the work as they age. We explored the reasons for entering and staying in FSW through life histories of older women (35 years and above) at high risk of HIV in Kampala, Uganda. Methods 100 women were purposively selected from a cohort of 1027 high-risk women. Life history interviews and in-depth interviews on their life and work, including sexual practices, were conducted with each woman. Data were analyzed using thematic content analysis. Informed consent and ethical clearance were obtained. Results Sixteenwomen were aged over 35, and had joined sex work as young adults usually because of financial need. They continued to take an active part in sex work. These women perceived sex work to be addictive, because of the quick access it could give to cash. Some women confided that they found their continued sex work humiliating and they really wanted to give up because they were too old and they feared that their children might find out what they did. However, faced with recurrent economic demands, paying children's school fees and buying food, these women had few alternatives. Most wished for a ‘husband’ who could help them. In the absence of such support or alternative livelihoods, giving up FSW was not an option. As they aged, they commanded lower rates from clients. Some augmented their living by selling alcohol and providing labour in the community, including child care to younger sex workers. All these women were at risk of HIV, STIs and sexual violence. Conclusion Sex work remains a key structural driver of HIV among some vulnerable older women. Sexual violence and high risk behaviour characterized sexual relations. There is an urgent need for interventions to support such middle-aged and older women., Background Findings from recent clinical trials evaluating the efficacy of antiretrovirals for pre-exposure prophylaxis (PrEP) against HIV among women are mixed, and none has included U.S. women. In addition, there is a dearth of research on knowledge, attitudes, and likelihood of use of PrEP among women in the U.S., who comprise 27% of new infections in the country. Thus PrEP′s potential as an HIV prevention strategy for American women is unknown. Methods We conducted a focus group study with 92 women in 4 U.S. cities between March and April 2012. Participants were recruited by local, woman-serving CBOs that also hosted the groups, which were led by trained facilitators. Participants completed a questionnaire with demographic and behavioral information. Focus group questions elicited basic understanding of PrEP, attitudes about its administration and uptake, barriers to use, and targeting and marketing. All sessions were digitally recorded and transcribed, and transcripts were analyzed to identify predominant themes and any demographic or site differences. Results Across sites, almost no women had heard of PrEP prior to the study; but once informed about it, nearly all found it an important option. Key considerations in deciding to take PrEP were cost (including who would pay), efficacy (most wanted 85–99%), and side effects (including interaction with contraceptives). PrEP was seen as "additional," not substitute, protection to condoms. Young women were the most commonly named target population, and schools the best venue for informing them. Mistrust of men was a main motivator for PrEP among women in Oakland and Washington; and churches were seen as a key barrier to PrEP in Memphis. Conclusion Women at risk for HIV in the U.S. are likely to use PrEP if it is known to be highly effective, doesn′t cost too much, doesn′t have significant side effects, and is promoted by peers and CBOs., Background HIV prevalence among fishermen in Malaysia is ten times that of the general population. Combining Rhodes' “risk environment” framework to assess contextual features influencing HIV risk and Berkman et al.'s comprehensive model of the mediating effects of social networks on health, this paper assesses the social relationships among drug-using fishermen in Malaysia as a key axis along which HIV risk decision-making occurs. Methods Data were collected in Kuantan, one of the busiest fishing ports on the East coast of Malaysia and from two nearby fishing villages. Twenty-eight fishermen reporting drug use during their last fishing trip or upon returning to shore participated in in-depth interviews. Fishermen were selected based on the type of fishing vessel they worked on (traditional vs. commercial) and gear used (hook/line vs. trawlers/purse seiners) to draw upon different social networks and spheres of influence. Data were coded thematically and analyzed to inform key research questions around drug use and aspects of social networks. Results Economics, occupational culture, punitive policies and stigma shaped the social networks of drug-using fishermen. Social networks, in turn, shaped HIV risk perceptions and behavior through the following pathways: 1) social influence - through the introduction to drugs, male homosociality, and peer pressure; 2) social support - drug users relied on other drug users for information and emotional needs; 3) social engagement - other drug users provided a sense of community and shared identity; and 4) access to resources and goods, like drugs. Conclusion These results suggest that aspects of social networks both constrain and enable HIV risk behavior among Malaysian fishermen by mediating the relationships between social structures and individual behaviors. Understanding the role of network influence in drug use and HIV risk among fishermen is essential to developing HIV prevention interventions that are appropriate for the unique needs of this highly interconnected population., Background Drug users often use multiple substances and are involved in sexual risk behaviors, and thus are at high risk of sexually acquiring or transmitting HIV. Studies on typologies of drug use are limited, especially those that examine the relationship between typologies of polydrug use and unsafe sex practices. Methods Using respondent driven sampling, 248 rural drug users were recruited in rural areas of the Midwest. They participated in a longitudinal, natural history study of illicit drug use and health service utilization. Latent Class Analysis was used to identify a typology of poly-drug use and assess differences in sexual risk for HIV transmission between these classes. Results All stimulant users consumed multiple drugs in the previous 30 days and many (63.7%) reported unsafe sex (condomless sex). Three latent classes were identified: Class 1 (N=107): all used powder cocaine, 90% used marijuana, 42.2% used crack-cocaine, 23.0% used heroin, and few used other stimulants and methamphetamine; Class 2 (N=67): all used crack-cocaine, 72.3% used marijuana, 20.8% used powder cocaine, 90.0% used heroin, few used other stimulants, and no methamphetamine; Class 3 (N=74): all used methamphetamine, 92.6% used marijuana, 74.2% used crack-cocaine, 88.1% used power-cocaine, 17.7% used heroin, and 49.1% used other stimulants. Although the patterns of drug use practice among the classes vary, the prevalence (64.5%, 67.2% and 59.5%, for Classes 1, 2, and 3, respectively) of unsafe sex practices was not significantly different across the classes (p=0.6213). Conclusion Rural stimulant users can be classified into three latent classes: primary cocaine users, primary crack users, and heavy multiple stimulant users. High prevalence of unsafe sex practices was reported across all classes. While much attention has been given to HIV risk reduction efforts among urban stimulant users, HIV prevention and intervention efforts for rural stimulant user are still greatly needed., Background Since 1985, research has shown that some gay/bisexual men combine specific sex-drugs and heavy alcohol use (SDA), resulting in high risk for HIV infection. Recently, we demonstrated that 2/3rds of incident HIV infections among men in the Multicenter AIDS Cohort Study (MACS) were associated with use of ≥1 sex-drug classes. However, there is little data on current prevalence and long-term SDA trajectories of MSM. Using data from 1,551 MSM in the MACS, we examined vulnerability and resilience factors (V&R) that predict adult SDA use trajectories and associated morbidities. Methods We used Latent Class Trajectory Analysis (LCTA) to assess statistically reliable patterns of SDA use over time. Classifying each participant into a distinct trajectory, we used MLR and LCTA including potential covariates to determine pre-existing V&R factors predicting SDA trajectories. Results The best fitting model yielded 5 distinct SDA use trajectories (Figure). While 10% of men were classified as high-sustained users of two SDA, the largest group (40%) never used SDAs. The next largest group (29%) used moderate (, Background Bangladesh is thus far regarded as a low HIV prevalence country with increased vulnerability due to several risk factors including high demand for commercial sex. Male clients of female sex workers (FSWs) are considered to be a potential bridge population to transmit HIV and other sexually transmitted infections (STIs) to the general population. The objectives of this paper are to describe the correlation between illicit substances (ISs), unsafe sexual behavior and self-reported symptoms suggesting STIs among male clients of FSWs in Bangladesh. Methods A cross-sectional study was conducted among 1565 male clients of FSWs during November 2005 to July 2006 in three sex trade settings (streets, hotels, and brothels) in Bangladesh. No personal identification of the clients was recorded and only verbal consent was taken in the structured questionnaire administered by male interviewers. Bivariate and multivariate data analysis was performed. Results Among the male clients of FSWs, 36.2% aged ≤24 years, nearly 30% never attended school, and above one-half (54.6%) of them were never-married. Nearly one-third (30%) used ISs. Cannabis (60.6%), alcohol (51.9%), heroin (6.8%), sleeping pills (5.7%), and injecting drugs (1.5%) were used by these clients. Consistent condom use with non-marital sexual partners in the last one month from the interview date was reported by only 13.2% of those who used ISs. Almost one-half(45%) of the IS-users experienced the symptom of STIs in the last 12 months prior to the interview date. The IS-users were 1.7 times more likely to have symptom of STIs than the non-users (adj. OR=1.70, 95% CI: 1.29–2.20). Conclusion Use of ISs was a significant risk factor for having symptom of STIs among the male clients of FSWs and they are less likely to use condoms consistently during non-marital sexual relationship. There is an urgent need to implement targeted intervention to promote safer sex behavior for male clients of FSWs in Bangladesh, especially those who use ISs., Background Injecting drug use has emerged as an important route for HIV transmission in India. The Government of India currently estimates that there are 200,000 PWID (or IDUs) in India (NACO, 2010), though other studies indicate the numbers could be much higher. Surveillance studies estimate HIV prevalence among PWID at 9.2% (NACO, 2010). Understanding the patterns of drug use and other behaviors by PWID is critical to successful intervention design. India HIV/AIDS Alliance conducted a baseline with PWID in three states (Delhi, Manipur and Haryana) on drug use and behavior patterns, as part of the Hridaya project, the India component of the five-country, Dutch government-funded Community Action on Harm Reduction program. Methods A cross sectional survey was conducted with PWID in three states. 181 respondents were selected through systematic random sampling using client information made available by partner NGOs at selected sites. Data were analyzed using SPSS software. Results 60% of PWID interviewed have injected drugs for more than 5 years; 32% inject daily and 33% at least once a week in the last 30 days. 22% of PWID have injected using needles or syringes previously used by another person. In the last 12 months, 55% of respondents had sexual intercourse with regular partners; 22.9% with casual partners; and 26.6% with commercial sex partners. During last sexual contact, 70% used condoms with regular partners; 64% with casual partners; and 51.7% with commercial sex partners respectively. Of the 100 respondents who disclosed their HIV status, 21% reported being HIV-positive. Conclusion Unsafe injection practices along with low condom usage are putting PWID at dual HIV risk. These findings support the development of focused prevention strategies that address both injection drug use and sexual behavior as part of Hridaya's harm reduction approach., Background Substance use is associated with high-risk sexual behaviors and HIV-seroconversion among MSM. Most MSM use substances episodically but research does not usually distinguish between episodic (less than weekly) and high-frequency (at least weekly) users when evaluating HIV risk. We sought to assess the relationship between engaging in serodiscordant unprotected anal intercourse with a partner of unknown or HIV-positive status (SDUA) and varying frequencies of use for different substances. Methods We screened 640 substance-using HIV-negative individuals for a qualitative study to adapt the Personalized Cognitive Counseling HIV prevention intervention for SUMSM in San Francisco from March 2009-January 2010. Data on substance use and sexual risk behaviors were collected via structured telephone interviews. We examined the association between SDUA and different frequency (episodic or high-frequency) of use for methamphetamine, cocaine, and poppers, using multivariable logistic regression, adjusting for age and race. Results Episodic use was more prevalent than high-frequency use for methamphetamine (13% vs. 6%), cocaine(26% vs. 5%) and poppers (25% vs. 9%). We observed significant dose-response relationships (i.e., greater risk with more frequent use) between episodic use and high-frequency use of methamphetamine, cocaine, and poppers; and having SDUA. Compared to non-users, the adjusted odds ratios (AOR) for SDUA among episodic and high-frequency methamphetamine users were 6.6 and 7.2, respectively. AORs for episodic and high-frequency cocaine users were 2.0 and 4.4, respectively. For poppers, AORs for episodic and high-frequency users was 1.7 and 2.8, respectively (all AORs p< 0.01; see Table 1). Substance Frequency of Use N Percent Adjusted Odds Ratio* 95% CI P-value Methamphetamineepisodic (less than weekly)80136.6(4.0–11.0), Background Thailand continues to experience dual epidemics of injection drug use and HIV/AIDS. In response, Thailand has relied on heavy-handed enforcement-based approaches. Although policing is known to contribute to the production of drug-related harm among people who inject drugs (IDU), the impact of police violence on HIV risks among IDU has not been fully characterized. Methods Using multivariate logistic regression, we identified the prevalence and correlates of experiencing police violence among IDU who participated in the Mitsampan Community Research Project (Bangkok) in 2009 and 2011. Results Among the 637 unique IDU who enrolled in the study between June 2009 and October 2011, 153 (24.0%) were female, and the median age was 37 years. In total, 239 (37.5%) participants reported having ever been beaten by police. In multivariate analyses, exposure to police beatings was independently associated with male gender (Adjusted Odds Ratio [AOR]=9.25), younger age (AOR=1.65), study enrollment in 2011 (AOR=1.95), obtaining income from illegal sources (AOR=2.12), a history of imprisonment (AOR=4.52), syringe sharing (AOR=1.91) and overdose (AOR=1.73) (all p< 0.05). Seventy percent of participants reported experiencing police violence during the interrogation process. Conclusion A high proportion of community-recruited IDU participating in this study reported being beaten by police, and this form of police violence appears to have increased in recent years. Further, experiencing police violence was independently associated with indicators of drug-related harm, including syringe sharing and overdose. These findings suggest that the over-reliance on enforcement-based approaches is contributing to ongoing human rights violations at the hands of police and the perpetuation of the HIV epidemic among Thai IDU. These findings indicate the need for greater police oversight and a shift toward the implementation of evidence-based programs focused on the HIV- and addiction-related needs of IDU., Background Injecting drug use has been documented in 158 countries and is a major contributor to HIV epidemics. People who inject drugs have poor and inequitable access to HIV services. The Global Fund to Fight AIDS, Tuberculosis and Malaria is the leading multilateral donor for HIV programmes and a major funder of harm reduction interventions. This presentation will discuss findings from the first detailed analysis of Global Fund investments in harm reduction (which is being published in the International Journal of Drug Policy during the conference, as well as in the Global State of Harm Reduction 2012 report). Methods The full list of over 1,000 Global Fund grants was analysed to identify HIV grants that contain activities for people who inject drugs. Data were collected from the detailed budgets agreed between the Global Fund and grant recipients. Relevant budget lines were recorded and analysed in terms of the resources allocated to different interventions. Results 120 grants from 55 countries and territories contained activities for people who inject drugs worth a total of US$ 361 million, increasing to US$ 430 million after projections were made for grants that had yet to enter their final phase of funding. Two-thirds of the budgeted US$ 361 million was allocated to core harm reduction activities as defined by the United Nations. Thirty-nine of the 55 countries were in Eastern Europe and Asia. Only three countries with generalised HIV epidemics had grants that included harm reduction activities. Conclusion This study represents the most comprehensive assessment of Global Fund investments in harm reduction, data which are important for policy-makers, advocates and researchers alike. This funding, while substantial, falls short of the estimated needs. Investments in harm reduction must increase if HIV transmission among people who inject drugs is to be halved by 2015., Background According to the latest update on the global state of harm reduction published in 2010, OST is available in 70 countries and territories around the world. The global coverage is estimated at the level of between 6 and 12 OST clients per 100 PWID. However, in most countries of Central and Eastern Europe and Central Asia coverage is limited due to long-term pilots and lack of systematic scale-up. The purpose of this study is to provide an up-to-date overview of the state of OST service provision in Eurasia, with a particular focus on access and quality issues. Methods Data were collected in 28 countries between August and November 2011 in order to capture some of the most recent developments related to OST service provision in Eurasia. We conducted an on-line survey using a semi-structured questionnaire in Russian and English, reviewed available literature and interviewed key stakeholders. Results Essential OST-related data including year of OST introduction, OST medications, number of clients, number of sites in prison and community settings, geographic coverage, and availability of take-home doses were analysed for all 28 countries. Based on this analysis, countries were divided into three groups: i) countries with sustained availability of OST programmes; ii) countries with limited availability and sustainability of OST programmes; and iii) countries with no OST programmes. Within each of the three groups, we identified challenges and opportunities for scaling up OST services, improving their quality and/or strategies for overcoming existing opposition. Conclusion While some progress has been made and more countries introduced OST over the past three years, numerous challenges still exist. The opportunities for increasing access to and improving quality of OST programmes are related to six areas, ranging from national ownership of OST service provision to protection from police harassment and violation of human rights of OST clients and service providers., Background Since 2004, China has rapidly scaled up Methadone Maintenance Treatment (MMT) from 8 to 716 clinics with 332,996 cumulatively enrolled drug users by September 2011. The average methadone dose is lower than the minimum recommended dose (60mg) in Chinese national guidelines. Lower methadone dosing may result in higher drop-out and continued HIV risk behavior. On average, 7.8% of MMT clients are HIV-infected. Methods A qualitative study was conducted in 2011 to determine reasons behind current dosing practices. Key informant interviews were conducted in 10 MMT clinics in 3 provinces (Guangdong, Guangxi, and Guizhou) among current and former MMT clients, their family members, and service providers. All interviews were conducted using a field guide and each interview lasted around 45 minutes. Interviews were recorded and transcripts were analyzed using a coding scheme and thematic sorting. Results Interviews with clients and their family members revealed that they did not view drug users as patients with a chronic disease in need of long-term treatment; they expected MMT to end drug use in a short time. They also thought that methadone was more addictive than heroin and that methadone withdrawal was more severe and long-lasting. This contributed to their preference for lower and tapering methadone dosing. Interviews with MMT providers revealed that many doctors did not have previous experience in drug use treatment. Lack of experience and insufficient training led to client-dominated, lower methadone dosing and the common misperception “the lower dose, the safer and better for patients.” Conclusion Factors contributing to lower methadone dosing include clients and their families’ misperceptions as well as providers’ limited experience and training in MMT. To improve the performance of MMT in China, it is recommended that capacity building for providers be improved and education and counseling of clients and their family members be strengthened., Background Rates of HIV are increasing among youth throughout Kenya. Research regarding how these youth have coped with their diagnosis and remained resilient is critical to the development of interventions that promote their health and well-being. The purpose of this study was to explore resilience among urban/slum youth newly diagnosed with HIV in Kenya. Methods Adolescents (ages 18–25) who were diagnosed with HIV within the past two years were recruited from ten villages in the Kibera informal settlement in Nairobi, Kenya. Six gender-specific focus groups (N=53; 26 female, 27 male) were conducted. Questions elicited specific and contextual data regarding participants' experiences, beliefs, and behaviors as youth newly diagnosed with HIV. Results Qualitative data were analyzed first separately, and then collaboratively, by two teams of analysts in Kenya and U.S.A. using a phenomenological framework. Seven primary thematic areas of active coping strategies were reported: 1) accepting a new HIV+ identity; 2) disclosing HIV+ status to supportive others; 3) engaging in holistic self care; 4) participating in formal support and health promotion programs; 5) advocating for other HIV+ individuals; 6) finding HIV+ role models; and 7) re-engaging with friends for social activities. Seven primary sources of social support were also revealed: 1) romantic partners; 2) friends; 3) healthcare workers/counselors; 4) people living with HIV; 5) co-workers/employers; 6) religious colleagues; and 7) affirming HIV+ media figures. Conclusion These data demonstrate that Kenyan youth who are newly diagnosed with HIV demonstrate resilience across multiple dimensions. In addition to intrapersonal-level resilience related to individual cognitions and behaviors, they also reported interpersonal-level resilience related to both seeking support and providing advocacy/support for others. Future interventions for Kenyan youth newly diagnosed with HIV should work to enhance the coping and social support of these young people through the use of creative strategies focused on developing and maintaining varying types of resilience., Background Adults caring for AIDS-orphaned children face poor psychosocial outcomes. However, we have little understanding of whether living with HIV exacerbates psychosocial outcomes. We assessed prevalence of depression and anxiety among caregivers of AIDS-orphaned children; compared prevalence among caregivers living with HIV and those not living with HIV; and tested whether social support serves as a protective factor. Methods A cross-sectional survey of 4,954 participants (2,477 children 10–17 years and 2,477 of their primary adult caregivers) was conducted in 2010 in KwaZulu-Natal Province (HIV prevalence 36.3–41.6%). Depression and anxiety were assessed using the Center for Epidemiologic Studies Depression Scale and the Beck Anxiety Inventory. HIV status was based on self-report and the verbal autopsy method. Social support was assessed using the MOS-SSS. Chi-square tested whether outcomes differed among caregivers living with HIV versus those without HIV. Multivariate logistic regressions identified whether social support was a protective factor and controlled for sociodemographic differences. Results Among caregivers, 35.6% met criteria for depression and 49.4% met criteria for anxiety. Caregivers of AIDS-orphaned children were more likely to report depression or anxiety than caregivers of other children (p, Background Evidence from India suggests that a comprehensive approach to SRHR has been lacking and that current responses have not sufficiently decreased vulnerability and sexual and reproductive ill-health among PLHIV. Previous studies with PLHIV have shown high rates of unmet contraceptive needs, untreated STIs and lack of knowledge and skills on safer sex and broader positive prevention. Methods 803 people living with HIV aged 15–49 (352 men; 401 women; 50 transgender/hijra) were interviewed in five districts in four states of India (Andhra Pradesh, Gujarat, Maharashtra and Tamilnadu). Lists of PLHIV covered by local CBOs were used as the sampling frame for the selection of respondents. The required number of respondent households was arrived at using systematic random sampling. Results Approximately one quarter of all respondents reported STI-related symptoms in the previous three months which is a cause of concern. Also, a relatively small proportion of mothers reported seeking maternal health advice during their last pregnancy (12% in Andhra Pradesh; 21% in Gujarat; 44% in Maharashtra; 27% in Tamilnadu). 10% of respondents reported having been advised against having children because of their HIV status indicating a lack of accurate or comprehensive information available at health facilities. Awareness of contraceptive methods ranged between 55% and 98%; similarly, STI-related knowledge levels ranged between 56% and 91%. Reported condom use with non-regular partners ranged between 56% and 91%. Conclusion The study highlighted unmet SRHR needs of PLHIV in the four states. While most subjects reported frequent condom use, STI-related symptoms indicate unsafe sexual behavior. SRH and HIV-related knowledge levels are low, and respondents also reported SRH-related rights violations. This study confirms the need for interventions for positive prevention along with specific SRH programming for PLHIV as part of India's HIV response., Background There is a dearth of literature on the challenges and coping mechanisms of school-age HIV infected children. The purpose of this study was to investigate challenges faced by HIV infected children in Botswana and to assess the coping mechanisms they employ to cope and survive. Methods The study was conducted among HIV-infected children and adolescents aged 6–18 years, using a cross-sectional design, in 12 antiretroviral therapy sites accounting for over 90% of all HIV-infected children receiving Highly-Active Antiretroviral Therapy in Botswana. Data were gathered using a structured pretested interviewer administered questionnaire and focus group discussions. Focus group discussions were held until saturation was achieved. Quantitative data were analyzed using descriptive statistics and cross-tabulations. Qualitative data were grouped into mutually exclusive categories according to themes emerging from the data. Ethical approval was obtained from the Botswana Ministry of Education & Skills Development, the Botswana Ministry of Health's Health and Research Development Committee and Baylor College of Medicine's Institutional Review Board. Results 984 HIV infected children participated between August 2010 and February 2011. The children were confronted with various challenges, including: poor school grades; poor school attendance due to medical appointments; poor nutrition; unanswered questions of how they became infected; and stigma or altered relationships with other children and teachers. In response to these challenges HIV infected children developed or adopted various coping mechanisms including: non-disclosure of HIV status, self-isolation; non-participation in school trips; attempting to treat HIV like any other disease; talking to close relatives or friends; and adoption of positive attitudes toward life. Conclusion HIV infected children faced many serious psychological and social challenges in living with HIV. These challenges elicit both positive and negative coping and survival strategies. Support systems for the children should aim to build on the positive coping strategies while ameliorating the negative ones., Background Approximately 70000 people are living with HIV (PLH) in Peru. Over half live in Lima-Callao and one half are gay/bisexual men and transgender people. While they are the focus of care and prevention services, not much is known about their sexuality, sexual and reproductive health (SRH) needs and access. A community-based collaborative study involving the Peru Positive Network took place to assess sexuality and SRH status and access of PLH in Peru. Methods Trained PLH volunteers in Lima-Callao and 6 inner cities conducted 814 structured interviews in 2011 (48.7% in Lima-Callao, 72% biological males). This analysis focuses on 273 males reporting being gay and bisexual (40.8%) and compares Lima-Callao (n=134) with other cities (n=139). Results Participants in Lima-Callao were slightly older; 40% in Lima-Callao and 60% elsewhere lacked health insurance. Overall 32% had regular partners-in Lima-Callao 95% of partners were men, while elsewhere 21% of those were women and 17% trans; 42% of regular partners were seropositive, but serostatus of another 20% was reported as unknown outside Lima. Participants had disclosed serostatus to 82% in Lima-Callao but 60% elsewhere. 88% reported penetrative sex in last 6 months-up to 40% unprotected outside Lima; condom use was unrelated to partner serostatus. Among those with only casual partners, 28% reported unprotected sex in prior month; disclosure was negligible. Participants recognized a shared responsibility in prevention, including through treatment adherence. 21% and 8% had heard about barebacking and serosorting, respectively, but few had practiced them. 15% had been diagnosed STIs in prior year, primarily herpes and syphilis. Sexual health advice received by participants often encouraged abstinence (30%). Conclusion HIV+ gay/bisexual men in Peru remain sexually active; serostatus disclosure is limited, particularly with casual partners; unprotected sex and STIs are common. Often sexual health services inappropriately advise abstinence and insufficiently address prevention and disclosure., Background An increasing number of children living with HIV are growing into adolescence where they face new sets of challenges. In resource constrained settings, few psychosocial and sexual and reproductive health (SRH) services provide age-appropriate support for these adolescents. Methods A large multi-country cross-sectional observational study was conducted in Malawi, Mozambique, Zambia and Zimbabwe, looking at the experience of adolescents aged 10-19 [n=1600 (boys=790, girls=810)]. Gender specific experiences from rural and urban settings were explored in each country. Data was collected using in-depth interviews with adolescents (n=150) and guardian/parents (n=46), focus group discussions (n=68), participant observation (3 months) and a knowledge, attitude and practice survey (n=1498). Data was analysed through a triangulation approach. Results Preliminary analyses reveal that key challenges for adolescents living with HIV include accessing information on SRH; disclosing their status to peers; talking about sex and HIV in the context of a relationship, within families and with health service providers; planning to have children; and emotional well-being. HIV represents a complex challenge for adolescents who lack safe and non-judgemental environments to talk about safer-sex options and pregnancy, whilst it is assumed by families and health providers that sexual activities should not start before adulthood. Few health services provide support tailored to adolescents; health providers give out inappropriate information and frequently breach confidentiality, resulting in further marginalising adolescents living with HIV. Conclusion Despite variations between the four countries and in rural vs. urban settings, the attitude of health care providers and the lack of family-centred approach result in inadequate support for adolescents when they first experience sexual and love relationships. The study provides evidence that new policies and funding for HIV in low income settings must include safer-sex advice and SRH interventions, training for health-workers and families in order to provide adolescents with skills to make choices about relationships, safer-sex and HIV disclosure., Background As HIV treatment extends the lives of people with HIV, we are learning about social as well as clinical drawbacks for the current generation over 50 with HIV. Many people with HIV express fears about the future but what is the reality and how can it be managed? Methods 410 UK-based people with HIV aged 50+were surveyed online and on paper. PLHIV were involved throughout the process advising, managing and administering the survey. Results were analysed in comparison to data on general population aged 50+ and data on all PLHIV. Results This group is highly diverse in terms of sexuality, ethnicity, gender, length of diagnosis. Compared with their peers theyReport twice as many other long term medical conditions in addition to HIV, many linked to lifestyle issues such as smoking and exerciseReport greater mobility problems and difficulty with everyday tasksAre less economically active, less likely to have savings or a pension and more reliant on state benefitsAre less likely to be homeowners, more likely to live in social or rented accommodation Many, particularly gay men, report social isolation due to age or HIV stigma, death of peers or concerns about disclosure. They also report difficulties getting primary healthcare, particularly from dentists and GPs, which are more heavily used by older people. Full results can be obtained from www.tht.org.uk/50Plus. Conclusion HIV appears to systematically disadvantage people in health, social and financial terms over a lifetime. Attention must be paid to healthcare and financial and social inclusion of older PLHIV, but also to informing long term condition management for younger and future generations of PLHIV about the greater importance of healthy lifestyle and financial planning. Work must be done to inform geriatric and generic healtcare providers about the needs of older PLHIV., Background Treatment advances and HIV transmission feed a growing population of older adults with HIV. Little attention has been given to differences within this group. Methods One in twenty UK-based over 50s with HIV (n=410) surveyed. Sample was accurate for demographics of wider group. Data from 106 heterosexual over 50s, comprised of 51 HW and 55 HBME. Results Health: HW 3x as likely be recently diagnosed. HBME diagnosed in last 6-9 years 5x HW (51.0/10.0%). HBME twice as likely to have low CD4 count when first diagnosed. HW have higher count generally. HW♂ /HBME♀ most likely to have low CD4 count now, or not know count. HW♂ more than twice as likely not to be attending a treatment centre, despite reporting significantly higher occurrence of extreme pain/discomfort. HW less likely to be taking medication for HIV (84.3/98.1%), have higher pill burden, find it harder to remember to take HIV treatment (15.5/5.7%), have side-effects from medication (20.8/13.3%) and more problems with walking, (56.0/42.6%), taking care of themselves (27.5/18.8%) and performing everyday activities (56.0/39.2%). HBME♀ have more other long-term health conditions (HBME♂ have the least), but only 50% are taking medication for these (70% HW♂ are). HBME higher levels of depression (28.8/21.6%), particularly HBME♀ (34.2%), but HW three times as likely to rate emotional/psychological health as poor. Financial/Social Exclusion: HBME all of those with no income and 3x not enough income for basic needs (45.3/15.7%). HW more likely to own their own home (47.1/18.2%). HBME more likely to be homeless, living in asylum support housing or renting council flat/house. Socially, HW more likely to disclose to Partner (16.4/4.5%), family members (16.4/12.7%) or friends (16.4/12.7%). HBME more likely to seek support from non-family. Conclusion There are major health, financial and social differences between HW and HBME. These factors need to be considered when targeting support for these groups., Background In communities severely affected by HIV many children are growing-up without their parents in skipped-generation households. Often these are headed by their grandparents. This research aims to critically examine what it means for children to grow-up in these households and which roles and responsibilities they assume. Methods The data for this qualitative and quantitative study were collected in Misangwa, a small community in the rural part of the Copperbelt Province in Zambia. Data collection was conducted by means of household surveys, in-depth interviews, Focus Group Discussions, and observational techniques. Respondents were members of the younger and the older generation found in 65 skipped-generation households. Their lives were followed over the course of thirteen months. Results Between 2001 and 2009 the number of skipped-generation households in Misangwa has increased. The proportion of children living in these households also increased significantly. The experiences and roles these children have are complex. It was found that especially older children actively impact the situation in their homes and are often wholly responsible for many aspects of daily life in the households. They work on the fields and are engaged in income-generation. Given the social isolation of many skipped-generation households a focus on households, rather than families, can be justified. Conclusion Literature often characterizes fostering as one-directional. This research examined skipped-generation households using ecological theories of child development. It found that that it is often children, and not guardians, who care for others in the households. Depending on age, personal characteristics and granted freedoms the older children provide care and support to the members of their households. In a sense these people assumes the roles and are associated with the missing middle generation. The research has brought to the surface a complexity that calls a different focus on kinship and caring with attention for diversity, historicity and experience., Background There is a high demand from donors to predict which NGOs are able to improve the health outcomes of their populations and ensure an adequate return on social investment. The principal drivers of capacity development for NGOs are often those of the donor, and promote the development of organizations contrary to achieving sustainability. This stems from insufficient knowledge of the predictors of organizational sustainability, and how to measure and prioritize capacity building efforts. These gaps must be filled since local NGOs are the backbone for services in HIV care, support, and treatment. Methods We studied three NGOs providing community based/residential care to OVC. An instrument was developed, consisting of 14 organizational domains, to enable a quantifiable and replicable assessment of an organization's level of development. Data was collected from key informants, staff surveys, record review and abstraction of routine program data. Domains were weighted in order to ascertain their relative importance in a “healthy” organization, and individual NGO performance was measured against this standard. Results The profiles generated were those of well-managed but unsustainable organizations. Financial and pharmaceutical management scored highly, while governance structures and strategic and business planning were weak. When graphed, the output revealed that only one organization's capacity was balanced while the other two curves were asymmetrical, indicating uneven capacities and ability to deliver services (Figure 1).Demographic Characteristics. Conclusion The quantitative instrument is the first tool enabling consistent, repeated assessments on the organizational capacities of NGOs providing HIV services. It guides donors on which NGOs to invest in and which capacities to build. It also enables donors to rigorously evaluate capacity building efforts of international organizations and hold them accountable. This is vital as resources for HIV/AIDS are in jeopardy and as PEPFAR increasingly emphasizes the delivery of HIV services through local organizations, investment in organizational development and country-owned capacity building., Background HIV-related stigma and discrimination is widespread in health care settings and poses a barrier for HIV prevention and control. The objective of the intervention was to reduce service providers' stigmatizing attitudes and behaviors toward people living with HIV (PLH). Methods The study was conducted in 2008-2011 in 40 county-level hospitals in two provinces of China. The hospitals were matched into pairs, with one hospital in each pair randomly assigned to the intervention condition after the baseline assessment. For intervention hospitals, we identified and trained about 20% of the popular opinion leasers (POL) among service providers to disseminate stigma reduction messages within their hospital. At the same time, universal precaution supplies were provided to all participating hospitals. A total of 1,760 participants, 44 from each hospital, were assessed at baseline, 6, and 12 months. Main outcomes of the intervention included general prejudicial attitude towards PLH, avoidance intent to treat PLH, and perceived institutional support in the hospitals. Results Significant improvements for the intervention group were observed in reducing prejudicial attitude (Estimate 2.401, SE=0.220; P, Background AIDS stigma inflicts hardship and suffering on People-Living-with-HIV (PLHIV), reducing the likelihood of HIV testing, treatment and disclosure. Stigma can be particularly harmful in health care settings. This study was designed to examine and reduce AIDS stigma among nurses and nursing students in India. Methods We interviewed 369 nurses in Mumbai and Bangalore, assessing stigma, endorsement of coercive measures and discrimination toward PLHIV. Based on these results, we developed, implemented and evaluated a 2-session stigma reduction intervention, co-facilitated by PLHIV, for 50 intervention and 50 control nursing students. Results Casual transmission misconceptions were common, with 28% of nurses believing HIV could be transmitted by sharing a glass and 26% HIV by sharing toilets with PLHIV. 70% agreed that people who were infected via sex/drugs deserved their infections. Almost all (96–99%) endorsed mandatory testing for sex workers and surgery patients and most stated that HIV-infected men (77%) and women (73%) should not be allowed to get married and that HIV-infected women should not be allowed to have children (76%). 88% said they would treat PLHIV differently from other patients, taking unnecessary precautions when drawing blood. significantly more participants worried about acquiring HIV at work (41%) than in their personal lives (14%, p, Background Stigma is a hindrance to care for people living with HIV (PLHA) in Egypt. To understand how gender affects stigma among healthcare workers (HCWs), a study was conducted to identify the differences in HIV related misconceptions and attitudes of male (M) and female (F) doctors. Methods A cross-sectional study was conducted in two tertiary care hospitals in Cairo from October–December 2010. All doctors working in surgical departments were invited to participate; three hundred thirty two accepted (210 males, 122 females). Data was collected on socio-demographic information and HIV related misconceptions and attitudes. A chi square test was used to examine the differences between male and female doctors. Results Both male and female doctors had misconceptions about HIV modes of transmission. Significant differences (p, Background Studies indicate that stigma and discrimination among health workers is higher than in other sectors. This subsequently affects service delivery and access to care and treatment for health workers living with HIV. This study aimed to determine the impact of HIV, including stigma and discrimination, on demand and supply of service delivery in order to develop health sector specific mitigation policies. Methods Data was collected from key informant interviews with 35 health facility managers and 6 focus group discussions with various cadres of facility and community based health workers in both public and faith based health facilities drawn from eight provinces in Kenya over the period June-August 2011. Content analysis of the key informant interviews and focus group discussions was done to determine health worker perceptions on the impact of stigma and discrimination on demand and supply of HIV services. Results Although stigma in the general community was reported to be reducing, the majority of the key informants felt that stigma amongst health workers was of significant concern. Stigma contributed to a high tendency of health workers to self test for HIV, avoid uptake of post exposure prophylaxis, and seek counselling and antiretroviral therapy in distant facilities. Disclosure of HIV status among health workers remained low particularly in lower level facilities. Despite high level of knowledge on HIV, it emerged from the FGDs that health workers living with HIV are discriminated against by other health workers. This manifested as a refusal to shake hands, share utensils and bias in the allocation of duties. Conclusion Policy and programmatic interventions, to support health workers living with HIV and to eliminate stigma and discrimination, are required within a comprehensive HIV workplace programme for all health workers in the country., Background Abandoned children in Russia, particularly those affected by HIV, face a grim life or death in a government institution. HealthRight and local partners developed a comprehensive MAMA+® model that includes early identification of women at risk of abandoning their children, home visits, child daycare and halfway house. Implementation of this model reduced the child abandonment rate in St. Petersburg, Russia, from 27% in 2004 to 6% in 2009. This project aimed to improve access to psychosocial services for women at-risk of child abandonment, including HIV-positive women, and reduce child abandonment in Yekaterinburg, another high HIV-prevalence city.Behavioral Characteristics. Methods In 2010–2011, HealthRight and partners replicated the MAMA+ model in Yekaterinburg, the capital of Sverdlovsk region, which leads the country in absolute number of HIV cases. The replication involved 10 training events and 12 supervision sessions; 67 government and 30 NGO service providers were trained on case management, HIV basics, psychosocial counseling, reproductive health counseling and other topics. Data were collected on the uptake of services for at-risk women delivered by the trained providers using case management records.5-Class Model fof SDA Use. Results A cross-sectoral referral network between government healthcare, social services and non-government agencies was established. An interagency referral guide was published, and an interagency protocol is being developed. A government-NGO risk screening, home visiting and case management service was institutionalized in five government social service centers, with 249 women screened and 159 (63.9%) enrolled as high risk. These women, their children and other family members received 1,201 services over 1,126 service encounters. The rate of child abandonment by HIV-positive mothers in Yekaterinburg decreased from 6.3% in 2009 to 1.9% in 2011. Conclusion Replication of the MAMA+ model offers a promising approach for decreasing child abandonment by HIV-positive mothers in urban settings. Institutionalization of psychosocial services within government agencies is key for sustainability of the MAMA+ model in Russia., Background People living with HIV (PLHIV) face various problems dealing with their relatives. Most often PLHIV in Armenia do not disclose their status to anyone. The disclosure of a childs HIV status or the parents to their children is a particularly sensative issue often leading to pshycological and interpersonal tensions, which leave influence on the health and child-parent relationships. To prevent the above “Positive People Armenian Network” NGO (PPAN) has carried psychological work with PLHIV and their children. Methods 10 trainings with HIV affected children were conducted. It was aimed at extension of the emotional and volitional spheres. 10 children 8–13 years old were selected (8 parents were HIV+, 2 HIV-). The age group was selected as the middle childhood years are significant in reviewing children-parents relationship. Children in middle childhood years are emotionally less active than teenagers. Design of meetings was planned (fables-discussions, games, art-therapeutic exercises). They were aimed at decreasing emotional tension, empathy development, value system identification, emotional harmony. Parenting works were also carried out. Results During 10 group meetings it was possible to establish psychological intimacy. Group thinking was strengthened through art-therapeutic techniques “the group tree”. Subsequent works have focused on skill development. Through discussion of Fables and art-therapy childrens vision was enlarged and turned versatile, developing the moral values. Children learned to understand their emotions properly, see themselves on the underside for understanding others’ reactions through. Parents noted the positive change in children-parents relations with and in school environment. Conclusion The values and skills obtained during the meetings will help the children for further disclosure and acceptance of parents’ status, to manage their emotions and feelings not allowing the parents illness to cause pshycological problems in themselves. Currently individual work with parents and children is still ongoing. More similar and parent-children mixed group meetings are planned for the future., Background HIV care and treatment services in Ethiopia are mostly facility based and, services are not extended to or followed up at community level. To address this challenge, AIDSRelief introduced the Community-Based Treatment Support Services (CBTS) based on the principle of continuous patient and family engagement in care and treatment to assist HIV patients achieve optimal anti-retroviral therapy (ART) adherence and maintain low rates of loss to follow-up (LTFU) at St. Luke hospital in Oromia. Methods The CBTS model is composed of adherence counselor, case managers, community nurses and community volunteers (CVs) with distinct responsibilities. This team, established at the facility level, was trained to assist establishment of community level support for HIV patients. At the facility, the team leads patients through structured treatment preparation prior to ART initiation; conduct home visits; sets up appointment system and same day follow-up for patients who miss clinic appointments; and provides supportive counseling to assist status disclosure and stigma reduction. CVs focus on providing home visits, LTFU tracing, awareness raising, early identification and counseling for OIs, and referring pregnant mothers for prevention-of-mother-to-child-transmission (PMTCT) programs. Results Following CBTS start-up in St. Luke hospital, the LTFU rate declined rapidly from 53.1 LTFU/1,000 patient months of follow-up (PMFU) in December 2010 to 47.3 LTFU/ 1,000 PMFU in March 2011. The retention rate has also shown statistically significant increase from 74.8% in March 2009 to 79.6% in March 2011.In addition, the overall patient crude retention rate has increased from 34.4% to 47.5%. Moreover, cross-directional linkages to other community-based programs supporting PLHIV have improved and community-wide disclosure among pregnant women has been promoted. Conclusion This experience proves that higher adherence rates can be attained through the CBTS model structured care programs. Such innovative community programs could to be scaled up and replicated for substantial country wide results., Background Community support systems are effective structures to provide care and support to most vulnerable children and PLWHA. However, sustainability of such initiatives can be weak. The purpose of this study was to get insight into sustainability issues of World Vision's community based care and support programming in Eastern and Southern Africa. Methods A qualitative review has recently been conducted, including 13 key informant interviews and 54 focus group discussions with community initiative members, non-governmental organization staff and government representatives in Ethiopia, Kenya, Mozambique, Uganda and Zambia. Results The study results indicate that the sustainability of community based organizations depends on several issues, one of the key factors being vertical linking to government structures. These links can take different shapes, ranging from loose cooperation between government officers and community organizations to government representatives becoming members of community organizations’ executive or coordinating boards. Such cooperation can even lead to a full adoption and institutionalization of community care and support initiatives into regional or national government structures, including further roll-out of such systems. The findings further indicate that any form of government structure cooperation with community based care and support systems can improve the community organizations’ sustainability and increase the service delivery of both sides. Conclusion As it seems, the stronger the link to government structures, the higher the community groups’ sustainability. However, sustainability also depends on the quality and availability of resources within such cooperation, as well as on the individual commitment of the partners. And finally there is also need to consider the possible pitfalls in government structure co-option, like the loss of access to external NGO funding and a politicization or restructuring of community groups, which can change their initial focus or even undermine and end volunteers’ efforts in providing care and support to vulnerable children and PLWHA., Background TB/HIV twin epidemics should be addressed jointly at community level. PLAN Foundation engaged community volunteers (CVs) for improving access to TB/HIV prevention, treatment and care services in 5 Local Government Areas (LGAs) of Ibadan, Nigeria. Methods 24 communities were selected from high TB-prone areas, high density areas and hardly-reached communities. A consensus meeting involving various community stakeholders was held during which 50 CVs were selected to facilitate active referral of TB suspects to DOTS centres and linkage with HIV testing services in ART clinics and other healthcare facilities in the areas. The CVs were trained on the basics of TB, suspects’ identification, defaulter tracing, adherence support and TB/HIV relationships. They were involved in providing support and follow-up services for smear-positive cases, linkage with HIV testing and treatment for dually-infected persons; and organizing community mobilization. Monthly CVs review meetings were held while PLAN Foundation staff provided supportive supervision to the CVs in communities. Results There were steady and significant increases in number of TB suspects referred by CVs between project onset in June 2011 and October 2011. TB clients referred to DOTS centres for screening were: June-47; July-56; August-118; September-274; October-238 totaling 733 for the period. Of these, 78 of the suspects were smear positive cases while 25 were dual infected with TB and HIV. Conclusion Engaging CVs is effective in identifying, referring, supporting and following up TB suspects and persons infected with TB and HIV. There is the need for linkage of TB and HIV services as a strategy for detecting HIV infection among people with TB. Community mobilization through CVs helps to increase awareness about TB and HIV in communities. There should be improved support and motivation for CVs as vital linkages to communities TB/HIV interventions., Background Effectively reaching PLHIV in rural, hard-to-reach areas is considered critical to improving access to health services and enrolment in care and treatment, which are needed to improve PLHIV's quality of life. Health facilities are located at least 20 kilometers from a farming population in Lamu District, Kenya. Infrastructure is poor and transport is unavailable; therefore, access to information and health services is an uphill battle. PLHIV there have had no option but to default treatment or share drugs. Methods Through Ministry of Health (MOH) structures, community sensitization was undertaken and trained clinical staff made available. Technical and financial support to conduct monthly mobile clinics was provided through AIDS, Population, and Health Integrated Assistance (APHIAplus). Comprehensive services for PLHIV were provided, including education on secondary prevention, HIV counseling and testing, provision of Septrin and HAART, adherence and support counseling, prevention with positives package, and treatment of opportunistic infections during monthly clinic days. Service delivery data was collected and summarized using standard MOH tools. Results From June 2010 to December 2011, 304 people were tested for HIV and 6% were found positive. Cumulatively 52 (48 active) patients have received HIV care (18 new) and 37 of them are actively on HAART (20 new). Patient retention is 92% and 87% have disclosed their serostatus to their sexual partners. All patients have had a CD4 test and 6-month monitoring is regularly conducted. The patients have formed a vibrant support group for psychosocial support and economic empowerment. Conclusion With structured links to health systems and community involvement, sustainable models of outreach clinics for remote and hard-to-reach areas can be developed to achieve universal access to HIV prevention, care, and treatment. The approach has the potential to promote ART adherence, patient retention on care and treatment, and stigma reduction in the community., Background There is a sense of urgency to identify instruments that can promote the health and development of children in poor resource and high HIV prevalence areas of sub-Saharan Africa. This has led to a surge in technical programmes, such as cash transfers, whose new ideas and resources may not necessarily resonate with local support structures. This paper describes the effects of a community-led cash transfer programme in Manicaland Province, Zimbabwe, and explores how community members appropriated ‘techno-fixes’ in ways that benefits them and achieve buy-in. Methods We report on data from 35 individual interviews and three focus group discussions, involving 24 key informants, 24 cash transfer beneficiaries, of which four are children, and 14 non-beneficiaries. Results A thematic network analysis found the cash transfer programme to have had a substantial effect on children's schooling and education, mainly through improved access, concentration and ultimately performance, but also on their health and well-being, primarily through improved food intake, access to healthcare and reduced levels of stress and worry at a household-level. The programme was also said to provide the beneficiaries with an important platform to reduce levels of poverty, primarily through investment opportunities arising from having greater disposable income. Encouraged by local participation in the programme, conditionalities and witnessing its positive effects, both benefiting and non-benefiting community members spoke enthusiastically about the programme and highlighted their preference for conditional cash transfers-indicating community-wide buy-in and involvement. Conclusion We conclude that despite their invasiveness, cash transfer programmes can, if implemented through local community structures, be appropriated at a community-level in ways that facilitate health-enabling and supportive social environments for vulnerable children and youth in sub-Saharan Africa., Background The advent of UNAIDS “Treatment as Prevention” policy of global antiretroviral (ARV) scale-up is not only life-saving for HIV-positive health care users, but may also hold significant potential to improve health care worker clinical practices, professionalism, and workplace morale. This research investigates the impact of ARV service delivery programming on health care workers′ clinical practices and personal and workplace morale in a rural western Ugandan setting. Methods As part of a larger community study (N=142, 48% female), individual qualitative interviews were conducted with health care workers (n=15, 47% female) from Rwimi clinic in Kabarole District, during a four-month period. Clinic practices were also assessed through 40 hours of participant observation. Findings were coded and analyzed using Attride-Stirling′s Thematic Network Analysis, and further mapped for discussion using the Social World Triad, a conceptual model developed for this study. Results ARVs are seen as being a positive, helpful force which allows health care workers to re-frame their clinical practice and professional identity to one of mastery over the illness. Their representations of HIV/AIDS are correspondingly beginning to change, to that of an illness which is manageable and controllable with drugs, thereby providing health care workers with renewed hope and a sense of clinical competence not felt since before the HIV/AIDS era. Professional practice is improving through more positive clinical interactions between health care workers and clients, which could lead to improved health service programming uptake by the community. Conclusion The clinical use of ARVs has also improved the personal coping strategies, workplace morale, and professionalism of health care workers at this clinic. Such findings encourage increased advocacy and community outreach efforts regarding ARV service provsion, and suggest that ARVs could be utilized in concert with broader social and biomedical interventions and programming, as a social change agent to reduce stigma and improve health service uptake., Background As the efforts to tackle the HIV/AIDS pandemic have become increasingly more refined, the dialogue about the ways in which the local understandings of gender and sexualities and dynamics of stigma shape the success or failure of treatment and prevention efforts has come to the fore. This presentation examines one such example in which the complex social, political, and health entanglements affect—in differing and often unexpected ways—the efforts to provide HIV-related prevention and treatment services. Specifically, it provides a qualitative socio-political analysis of the debates around the emergence of an HIV-focused clinic in Mexico City, where after the approval of a local law more comprehensive health care services for trans individuals were also to be delivered. Methods It is based on fourteen months of ethnographic research in Mexico City conducted in two phases spanning 2009–2011. It draws on qualitative interviews, observations and analysis of relevant textual documents, and provides a qualitative “bottom-up” analytical approach to the gathered data. Results The results show that the emergence of a transgender health program delivered in what is known as the HIV clinic sparked a heated controversy between supporters and detractors. Due to the intersections between structural vulnerabilities and existing dynamics of stigma around HIV, many trans women—and particularly sex workers—prevented themselves from accessing HIV-related and other health care services available to them in this hospital. Many of them did not want to be seen as potentially HIV positive individuals, as this may have brought both negative social and labour consequences into their lives. Conclusion The predicament between accessing or not health services in a clinic tainted with stigma had direct implications for the successful prevention and treatment of HIV and other illnesses. This study supports the view that local sociocultural and political dimensions need to be fully considered when envisioning HIV-specific programs., Background The Division of HIV/AIDS Prevention (DHAP), Centers for Disease Control and Prevention (CDC) Legal Assessment Project is developing interdisciplinary public health law research (PHLR) methods to assess legal frameworks that can be barriers or facilitators to effective HIV prevention. Rigorous, reproducible methodology focusing on interpreting legal data and using epidemiologic research methods can facilitate translation of legal text into data useful for making structural programmatic decisions. Methods In the U.S., state law plays a preeminent role in shaping local HIV prevention environments. We conduct 50-state legal surveys across numerous legal domains. For each domain, preliminary research identifies existing legal data from academic and legal research institutions. Research protocols (search parameters, coding schemes, codebook, pilot phase, reliability/validity checks) are developed, followed by systematic data collection (typically WestlawNext™.) Periodic legislative tracking assesses policy diffusion across states over time. These data can be combined with secondary data (census, HIV incidence, etc.) for further quantitative analysis. Results We present results from three domains. 1) Reimbursement for HIV screening: 18 states reimburse for HIV screening in all populations, and 15 reimburse in some populations (August 2011) (Map 1). 2) Reporting of all CD4 and viral load laboratory results to state HIV surveillance programs for monitoring access to care and quality of care: 26 states plus D.C. specifically require reporting of all CD4 and viral load data (January 2012) ( Map 2). 3) Previous research on consistency of state laws with CDC HIV testing recommendations was updated: 46 states plus D.C. had laws consistent with CDC recommendations (January 2012) ( Map 3).Figure 1Deviations from Norm and Prioritised Areas for Capacity Building [Prioritized areas for capacity building]. MAMA+ Model Components. MAMA+ Case Management. Conclusion PHLR data characterize important structural barriers or facilitators to effective HIV prevention environments. Methods development is ongoing and may be translatable internationally or for cross-country comparisons where countries share a regional identity and where policy diffusion across state/national lines may be expected., Background Systematic efforts to develop a national GIPA policy can help change the HIV landscape towards improving the quality of life for PLHIV in Malawi. The GIPA Report Card, a measurement tool, which assesses the application of the GIPA principle in the national response to HIV, was conducted in Malawi to identify specific barriers and opportunities to involving PLHIV in the development of policies and delivery of programmes. Methods The Malawian Network of People Living with HIV conducted a nationwide assessment. The study included knowledge about the principle, PLHIV involvement in policy development at district level, inclusion of GIPA in the National Action Framework, universal access targets, and the involvement of PLHIV in research. The data collectors, all PLHIV, also visited institutions that have HIV workplace programmes. Results The respondents represented varied institutions: 33% PLHIV; 27% Civil Society Organisations, 14% government departments or other public institutions; 5% UN agencies; 9% International NGOs, 5% parastatal organisations; and 5% private sector. Respondents stated there were fewer efforts in ensuring that the principle is practiced at local and community levels. Inclusion of GIPA in the Malawi HIV Extended National Action Framework signals the increase in efforts by the government to embrace the principle. However, there is no proactive communication and outreach campaign regarding the principle. Stigma and discrimination remain the greatest barrier to the GIPA. Conclusion Malawi must increase awareness and funding to support activities highlighting the meaningful involvement of PLHIV and to address the barriers to the effective application of the GIPA. A multi-sectoral communication's strategy and systematic efforts to develop national GIPA guidelines would help to promote the involvement of PLHIV and contribute to the quality of Malawi's HIV response., Background HIV prevention in women is a priority identified in the National Strategic Plan for STIs, HIV and AIDS 2006–2010 and the Country Programme agreed between the Government of Nicaragua and the Population Fund United Nations taking note that Nicaraguan women are being increasingly affected by HIV. In order to contribute to the national response has developed an initiative to visualize this situation and promote the active participation of women with HIV in the national response to the increased incidence departments to advocate for the promotion and defense of human rights, including reducing the stigma and discrimination, and develop preventive actions to prevent other women from acquiring HIV. Methods Qualitative evaluation. Results 6 departments have women′s organizations and local references with HIV prevention and support for the capture and defense of human rights including access to treatment, care and support.Women with HIV at 3 CONISIDA integrated departmental and national CONISIDA, 5 Commissions to Fight AIDS, from civil society (CNLCSSC) and 6 Multidisciplinary Care Teams departmental hospitals.Coordination with various stakeholders and mobilizing key social sectors, around HIV prevention in women and the promotion and defense and guarantee of the rights of women with HIV enhancing hardly a social response is obtained as quickly and effectively with other actors. Conclusion The initiative developed has been proposed as a successful model to be incorporated in the national response to HIV. Their strategies: i) Strengthening the organization of women with HIV in their communities, ii) development of their capacities in advocacy, communication and addressing HIV with other women affected by the epidemic; iii) public advocacy decision makers to influence the reduction of stigma and discrimination and vi) the exchange of experience can be replicated and adapted to different contexts to be feasible to develop successfully., Background Despite the growing number of women infected with HIV/AIDS in China, insufficient attention to women living with HIV/AIDS in the Global Fund's strategy and structure continue to increase the vulnerability and participation of women. No expenses in the budget are designated for projects focused on women, and all 11 NGO representatives in the Country Coordinating Mechanism (CCM) are men. Methods The Henan Women's Network works to mainstream gender-based approaches into China's national AIDS strategy in order to help women gain improved access to HIV/AIDS prevention, treatment and care services. The Network used three major strategies to advocate within the national Global Fund mechanism as entry point for broader national advocacy: working with female PLWHA to conduct needs assessment, and strengthen collaboration between women's health organizations; submit recommendations and mobilize international organizations including UNWOMEN and UNAIDS to incorporate gender concepts into the revision of CCM regulations; and cooperate with the All China Women's Federation on gender rights awareness trainings for health departments, the Federation and female PLWHA. Results After incorporation of a gender strategy into the CCM regulations and a targeted call for applications from women, 40% of 2011 CCM NGO consultants are women. Their increased participation in decision-making process will further the development of gender-based approaches in budget and strategy. Conclusion Actual needs of women living with HIV/AIDS have been successfully passed on through a local grassroots network. Integrated support from international organizations, the government, scholars, experts and community organizations was instrumental in achieving consensus in a gender-based strategy. Moving forward, capacity-building for women living with HIV/AIDS need to enable greater participation, and needs assessments will need to clarify suitable targets for women. Budgets promulgated by the CCM need to define specific expenses to implement gender-based strategies., Background Rwandan women and girls are disproportionately impacted by HIV and comprise the largest percentage of those infected. Progress has been made to promote gender equality and women's participation in decision-making. However, women living with HIV (WLHIV) remain underrepresented in the national HIV response. Experience shows that HIV policies and programs often fail when women are excluded from shaping their content and direction. Methods The authors examined three case studies to determine best practices for ensuring meaningful involvement of WLHIV (MIWA): (1) National Accelerated Plan for Women, Girls, Gender Equality and HIV (2010–2014); (2) EC-UN Women “Supporting Gender Equality in the Context of HIV/AIDS” program; and (3) National Strategic Plan for the Elimination of Mother-to-Child Transmission of HIV (2011–2015). Results Participatory processes (workshops, focus groups, and in-depth interviews) involving women, including WLHIV, were used to identify key priorities, activities, and HIV strategies for the National Accelerated Plan (2010) and eMTCT Strategy (2012). The EC-UN Women project fostered HIV-positive women's leadership through training, technical assistance, advocacy planning sessions, and the development of formal mechanisms within national AIDS coordinating bodies that include women. These case studies demonstrate that WLHIV's active participation in national HIV policies and strategies development increases their visibility and ensures that their needs and rights are prioritized (e.g. requirement of future participation of women and girls in national HIV decision-making). Such practices enable WLHIV to be directly involved in implementation, monitoring, and evaluation of strategies they helped to develop (e.g. by aligning their own programs and budgets to the National Accelerated Plan). Conclusion These Rwandan cases highlight MIWA's positive impact and the need for concentrated commitment to actively involve WLHIV in decision-making. Deliberate programming is needed to ensure that women and girls are empowered and equipped to transform national agendas to protect and promote their needs and rights in the HIV context in all countries., Background The UK is currently reforming its benefits system to encourage people with health conditions to return to work. However, research indicates that unscrupulous employers were using pre-employment health questionnaires to discriminate against people with health conditions in the recruitment process. Research from 2006 found that when a non-disabled person and a disabled person who disclosed their disability applied for the same job, non-disabled applicants were invited to twice as many interviews. Research also shows that fewer than 50% of people diagnosed with HIV in the UK are in employment. Methods NAT brought together a coalition of organisations including mental health and HIV charities, to campaign to prohibit the use of health questionnaires before a job offer. The Equality Bill was identified as an appropriate piece of legislation to outlaw the use of these questionnaires. Media coverage of the impact of discrimination on people living with HIV and mental health conditions raised the profile of the campaign. The coalition submitted evidence to Parliamentary Select Committees including international examples and secured cross party support for the campaign in the House of Commons. After initially rejecting the idea, the Government met with the coalition and representatives living with HIV to listen to our concerns. Results The Government accepted the evidence presented by the coalition and tabled an amendment to the Equality Bill prohibiting the use of pre-employment health questionnaires. The Equality Act came into force in October 2010 and it is now unlawful for employers to ask health related questionnaires before a job offer. This is a significant step forward in ending discrimination in recruitment for people living with HIV. Conclusion There are significant gains to be made in building coalitions with organisations supporting people with other health conditions that face similar stigma and discrimination to campaign to reform legislation., Background The crises of preventable maternal death and HIV are interrelated. In Uganda, a country with HIV treatment coverage rates of 47%, 16 women die unnecessarily in childbirth daily, one in five new HIV infections is through vertical transmission, and untreated HIV contributes to 25% of preventable maternal deaths. In addition, stigma as well as lack of basic health equipment such as gloves for midwives contributes to reluctance of health professionals to attend to HIV positive mothers, particularly in remote areas. Methods Civil society networks in Uganda formed a diverse coalition to implement a legal and advocacy strategy to challenge the epidemic of preventable maternal death in Uganda. Combining a Constitutional Court challenge with a challenge in the court of public opinion, the coalition used grassroots mobilization, media work, budget monitoring and advocacy in Parliament to create a common platform for health justice advocacy, prioritizing issues ranging from HIV treatment access to the shortage of nurses. The multiple factors that contribute to preventable maternal death, including HIV, created multiple opportunities for high impact civil society advocacy. Results This new civil society coalition has been able to break down walls between disease- and condition-specific advocacy and implement bold campaigns to scale up access to essential health services in Uganda. In one year, the coalition has supported an historic legal challenge on the right to health and preventable maternal death; has successfully advocated for increased investments in increased professional health worker recruitment, remuneration and equitable deployment; and has generated national and international press attention to the human right to health in Uganda. Conclusion We have developed an approach to advocacy in Uganda that joins civil society focusing on a wide range of diseases and conditions in synergy. Uniting around key policy opportunities has resulted in important progress in the struggle for health for all., Background The purpose of the study was to identify barriers to and opportunities for evidence-based policy on illicit drugs in four sub-Saharan African countries-Tanzania, South Africa, Nigeria and Ghana. Small-scale studies indicate that HIV transmission is linked to injection and non-injection drug use in all of these countries. Methods A policy case study for each country was developed through in-person semi-structured interviews with key informants, including policy-makers, academic experts, NGO representatives and representatives of international organizations. Results The lack of population-based data and trend data on the extent of drug use and drug injection is an impediment to policy-making, leading to denial at policy levels. In all four countries, the law allows the police wide latitude in search, seizure and arrest of people accused or suspected of committing minor drug crimes, who can receive long prison sentences. Except in Tanzania, there are very limited affordable options for evidence-based drug treatment, especially of opioid dependence. Pressure from the US and other external actors to demonstrate interdiction successes may contribute to the domination of the policing-based drug policy. South Africa's drug policy-making has been walled off from HIV policy-making bodies. Ghana is seeking to generate population-based data on the extent of drug injection as health authorities bemoan the weakness of mental health and drug treatment services. Conclusion Criminalization and policing dominate drug policy in most of these countries, impeding evidence-based responses to HIV. There is an urgent need to build capacity among policy-makers and civil society to rethink entrenched policing-based approaches to drug use and to raise awareness of affordable evidence-based services for people who use drugs. The advances made in Tanzania's methadone program, including new awareness by the police of the importance of public health approaches, should be an occasion for learning across the continent., Background Cameroon is among the 22 countries with the highest burden of PMTCT unmet needs. In response to the global commitment to eliminate new infections among children and keep their mothers alive, Cameroon decided to develop a bold PMTCT scale-up plan aligned with the global MTCT elimination targets. To develop an evidence based plan, the MoH with support from its partners conducted an analysis of programme bottlenecks, disparities using an innovative tool based on marginal bottleneck budgeting (MBB). Methods The tool was used to analyze bottlenecks and disparities on the demand and supply of MNCH and PMTC services. Key steps included: advocacy and consensus building on the methodology, key tracer interventions; consensus on bottlenecks and disparities, causal analysis and identification of corrective actions. Results Key bottlenecks are presented in table 1. Geographical, socio-cultural and economic disparities were also observed between and within regions (see fig 1 and 2). Strategies and interventions to address these bottlenecks include: 1) capacity building of community actors for the promotion of integrated PMTCT/SMNI, 2) strengthening procurement and supply management system, 3) quality assurance of PMTCT service delivery, 4) strengthening monitoring and evaluation. Conclusion The bottleneck analysis has proven to be a powerful method for identifying and analyzing disparities and factors impeding the performance of MNCH and PMTCT programmes. To generate accurate information and draw relevant conclusions quality data are a prerequisite. This was one of the major challenges which were addressed by actively collecting data by field actors. Choices and decisions on key bottlenecks should be based on their potential impact on programme performance, relevance and feasibility of corrective strategies, and availability of resources for action. Participation of all level-stakeholders from the onset of the process increases ownership, and recognition of findings. Results from the analysis were precious inputs for the development of the national mother to child transmission elimination Plan. The plan provides a framework for strategic vision and coordination for all actors and is therefore a structured road map to achieving the set targets for PMTCT by 2015., Background The demand for effectiveness swept through the international community raising expectations about results and their impact. None has been more affected than CSOs. Despite being at the front-lines of the international response to HIV/AIDS, these efforts were not always evaluated. This evaluation of the community response asked: Do communities with a strong community engagement show: (i) better knowledge, attitudes, perceptions and behavior, (ii) greater access to and utilization of HIV/AIDS services, and (iii) social transformation? Methods Given the complexity/variety of community responses, the approach selected involved several countries, studies and methods. Experimental and quasi-experimental methods measure community results looking for changes in knowledge, behaviors, utilization of services and health outcomes with indicators related to prevention, treatment, care, support and mitigation. Quantitative and qualitative data from CBO/NGOs/households were collected and analyzed to better understand social transformation and the findings. Results Eleven studies were conducted in 8 countries (2009–2011) (Burkina Faso, Kenya, India, Lesotho, Nigeria, Senegal, South Africa, Zimbabwe). Strong casual evidence shows that specific community interventions can affect the course of the HIV epidemic through increased HIV knowledge and reduced stigma, and increased condom use, testing uptake, treatment adherence and use of services. Example: (i) community empowerment increased services utilization among FSWs in India (p, Background The U.S. Food & Drug Administration prohibits men who have sex with other men (MSM) from donating blood. The policy does not consider the potential donor′s HIV status, sexual activity, or relationship status. The current policy allows other populations at elevated risk of HIV to less restrictive deferrals, or no deferral at all. This type of policy reinforces incorrect information about the spread of HIV. Most countries have permanent deferrals of MSM blood donors despite chronic blood shortages. Reform of U.S. blood donation guidelines is necessary to maximize blood donations and improve blood safety protocols. Methods Advocates, including public health and blood bank communities, blood product recipients, and NGOs, have pushed for a more equitable policy. In May 2010, GMHC joined with leading hemophilia advocates, who also represent a population disproportionately impacted by HIV, to raise awareness of blood donation guidelines in agreement that: the current deferral of all MSM results in a large number of potentially eligible blood donations; and that there are some high-risk activities permissible from heterosexual donors under the current policy. Both perspectives were presented to the Advisory Committee on Blood Safety and Availability (ACBSA) in June 2010. Results The ACBSA recommended that sufficient data were not present at that time to change the policy banning MSM, that current blood donation guidelines are “suboptimal”, and that a robust research agenda be pursued in order to carefully examine alternative policies. Government agencies are now implementing the ACBSA's recommendations to identify a subset of low-risk MSM blood donors. In tandem with U.S. momentum for reform, a number of other countries, including the United Kingdom, have made reforms to their policies to allow MSM to become blood donors. Conclusion International momentum to revise blood donation guidelines for MSM advances efforts to maximize blood safety, increases blood donation, and decreases stigma of MSM., Background Political leadership is known to affect HIV prevention and treatment. In this presentation, we aim to show the dimensions of political governance that are associated with ART coverage using country-level data. Methods Percentage of ART coverage from 2004 to 2009 as estimated by UNAIDS is analysed as the outcome measure. High-income countries as defined by the World Bank in 2009 are excluded from the analyses. Measures of political governance and GDP per capita (log-transformed) from the World Bank, adult literacy rate (UNESCO, reflected and log-transformed), gender inequality index from World Development Report 2011, skilled birth attendance at delivery compiled by World Bank (reflected and log-transformed) and disability adjusted life years (DALY) due to non-HIV causes and international (HIV and non-HIV) health funding per capita from the Institute of Health Metrics and Evaluation were fitted separately as predictors in multi-level linear models, in which year of reporting or estimation and HIV prevalence from UNAIDS are included. Missing data were imputed for fitting a final model that includes year, HIV prevalence and variables that remained statistically significant. Results Higher levels of ART coverage are significantly associated with higher GDP per capita (p< 0.001), lower gender inequality (p=0.003), higher literacy rate (p=0.011), higher percentage of births attended by skilled attendants (p=0.002) and less DALY due to non-HIV causes (p=0.033). It is also highly significantly associated with better political governance in all six dimensions( political stability, voice and accountability, control of corruption, rule of law, government effectiveness and regulatory quality) (p< 0.001). In the final model, only political stability and voice and accountability remained as statistically significantly associated with higher levels of ART coverage. Conclusion The analyses indicate that better political governance are crucial determinants of ART coverage in a country., Background The HIV and tuberculosis (TB) epidemics present unprecedented public health challenges. Antiretroviral therapy (ART) and the Three I′s for HIV/TB (isoniazid preventive treatment (IPT), intensified TB case finding (ICF), and TB infection control) are key interventions to prevent TB in people living with HIV (PLHIV). This article reviews the extent to which national HIV and TB guidelines for high HIV/TB burden African countries are consistent with current World Health Organization (WHO) guidelines. Methods The 14 African countries with 62% of the estimated global HIV/TB burden were identified from WHO estimates. Recommendations on ART initiation criteria and the Three I's for HIV/TB from national HIV, TB and HIV/TB guidelines were reviewed and compared with current WHO recommendations. Results Of the 14 countries, eight (57%) and ten (71%) follow WHO′s recommendation to provide ART at CD4 counts≤350 cells/mm3 in asymptomatic people and pregnant women, respectively. Seven (50%) countries recommend ART in people with HIV and TB irrespective of CD4 count. All countries have guidelines on the Three I's for HIV/TB. All 14 countries except Zimbabwe recommend IPT for six months, and ten of them follow symptom-based screening to rule out active TB. However, the WHO four-symptom screening algorithm is not yet widely recommended. Nine, eight and five countries have monitoring and evaluation indicators for ICF, IPT, and TB infection control, respectively. In the 14 countries, 38% of 8.4 million people eligible for ART were receiving it and 61,997 people without active TB were on IPT. Conclusion WHO and country guidelines on ART and the Three I′s for HIV/TB are largely consistent and reflect a common approach to addressing HIV and TB. However, there is a significant gap in implementation of the guidelines. Further scale-up of existing programmes and implementation of policy recommendations are required to address the HIV/TB syndemics in the countries examined., Background Gender inequalities are a key driver of the epidemic, yet despite this being recognised for many years, global policies to change these often have had little effect. Using the UNAIDS’ Agenda for Country Level Accelerated Action on Women, Girls, Gender Equality and HIV which is its flagship gender and HIV policy as a case study, we explore the barriers and facilitators of the Agenda's development and implementation, to understand the strengths and limitations of gender policy better. Methods We conducted semi-structured interviews with 16 southern African and global gender and HIV/AIDS policy makers, researchers and activists who had been involved in the development or implementation of the Agenda. We analyse their responses using thematic analysis. Results Barriers to the development and implementation of the Agenda included the lack of resources and tools to development and implement the policy; the lack of participation of women in grassroots organisations, despite this being a pillar of HIV and gender policy; and a lack of political will to see the policy translate into meaningful programmes and change on the ground, despite significant visible support from key actors in UNAIDS. Yet positively, the Agenda also provided a collaborative platform for women's organisations to develop and common language to prioritise women and girls and ensured consistent and strong language around this emerged. Conclusion Our study suggests that despite the Agenda being the ‘flagship’ policy on women and girls in the context of HIV championed by UNAIDS, there remain significant weaknesses in how the Agenda was developed and is being implemented. These challenges are reflective of the wider field of gender and HIV and reflect the limited real commitment that is often placed around challenging gender inequalities in the response to HIV., Background We reviewed the laws of the 50 states and compiled those vocational and professional licensing laws (e.g. for licensure to be an acupuncturist, barber, massage therapist, midwife, cosmetologist, nurse practitioner, doctor, dentist, etc.) that discriminate against people living with HIV/AIDS and/or those with a communicable, contagious, or infectious disease. Methods The statutes, regulations, and cases were identified in Westlaw using the following search terms: “HIV,” “Human immunodeficiency virus,” “communicable,” “contagious,” “infectious,” and “disease.” The volume includes laws that explicitly discriminate against people living with HIV/AIDS (PLWHA) as well as laws that do so implicitly through restrictions concerning communicable, contagious, or infectious diseases. While we did attempt to include all relevant state law, this does not promise to be an exhaustive list. Results The results of this survey reveal a deeply rooted HIV stigma that has been embraced by policy makers in a majority of the states. Thirty-five of the fifty states have licensing requirements that explicitly discriminate against people living with HIV/AIDS for one or more of the fifteen vocations considered here, and forty-four states have requirements that either discriminate against PLWHA or discriminate against people living with infectious, communicable, or contagious diseases. These laws lack any basis in the science of HIV transmission, and maintaining them only validates the ignorance and bias that spawned them. Conclusion Licensing criteria that discriminate against people living with HIV/AIDS violate federal law. States that allow these discriminatory laws to remain on the books are ignoring scientific consensus and promoting HIV stigma. If PLWHA in the United States are to enjoy the same employment opportunities that other individuals enjoy, then states must examine their licensing procedures and alter or remove any discriminatory requirements until all licensing practices are in compliance with the Americans with Disabilities Act and guidance from the Department of Justice., Background The southern United States has the highest numbers of adults and adolescents living with HIV and the highest death rates from AIDS. Numerous southern cities are in the top ten for HIV infection rates. Yet state laws and policies fuel the epidemic and exacerbate pervasive stigma and discrimination. Methods This long-term, multi-method investigation is based on hundreds of interviews with people living with HIV and AIDS, their advocates, public health officials, legislators, judges and medical providers, as well as extensive legal and policy analysis. Results Multiple state laws and policies create an ‘environment of risk’ that has made the South the nation′s leading region for both HIV infection and deaths from AIDS. In the South, where poverty levels are the highest in the nation and fewer people have access to health insurance state policies are contributing to the disproportionate impact of HIV on minority communities. The failure to invest in public health, Medicaid and HIV-specific programs, particularly housing and transportation for a rural population; insistence on failed abstinence-based education; criminalization of HIV exposure; homophobic laws that drive MSM and transgender people underground and away from essential health services and the highest incarceration rates in the nation are some of the human rights violations that undermine public health efforts and fuel the epidemic in southern states. Conclusion Laws and policies in the southern U.S. are undermining human rights and conflict with the goals and objectives of the National HIV/AIDS Strategy. This interactive session will identify strategies for challenging these policies at the federal, state and local level., Background Ukrainian National HIV/AIDS Prevention Program (NAPP) envisages 20,000 people on opioid substitution treatment (OST) by the end of 2013. WHO estimates 53,000 IDUs shall be placed on OST to provide adequate response to HIV/AIDS epidemic. Ministry of Health (MOH) is only organization regulating number of OST patients. MOH determines number of OST patients in its distribution orders (DO). OST targets set by MOH DO are much lower than annual NAPP indicators and indicator of GFATM Rd 6 funded Program run by ICF “HIV/AIDS Alliance in Ukraine” (AU) for 2012 as it shown on Diagram #1. Map 3. Methods 6650 patients were getting OST in 133 healthcare institutions in all regions in January, 2012. All patients receive treatment and psychosocial support for free within GFATM Rd 6 funded Program. Though OST procurement is budgeted in NAPP OST medications have never been bought from state budget. OST is regulated by MOH and other executive bodies in clumsy manner. It takes up to 7 months to issue new OST DO. State Service on narcotic control (SSNC) allowed importation of only 55% of methadone envisaged by MOH DO in 2011. SSNC is intended impose lower domestic methadone quota for 2012 than needed for OST scale up under NAPP.FigureVillages in Zimbabwe with more people in community groups have greater HCT update. 2003–2008 (N=184). Results Ukrainian State demonstrates double standard policies towards scaling up of OST. Ambitious OST NAPP targets were proclaimed but MOH applies inadequate efforts to achieve those targets. Diagram#2 demonstrates that OST expanded on 10% only over 2011 comparatively to 303% in 2008 and 131% in 2009. Conclusion AU is overcoming double standard policies towards OST scale up. AU collaborates with National AIDS Center (NAC) which is one of MOH compartments and our implementation partner within GFATM Rd 10 funded Program. This partnership is aimed to build NAC capacity for OST provision, ensure OST scale up and sustainability., Background This study examines how HIV/AIDS funds, including vertical Global Public Goods for Health (GPGH), might be leveraged to contribute to production of horizontal GPGH through health system strengthening. Specifically, it addresses the following questions: 1)How can vertical (disease-specific funds) be used to decrease the impact of funding asymmetries between vertical and horizontal GPGH and support the production of horizontal GPGH? 2)How would complementary activities be evaluated with regard to their contribution to health system strengthening? Methods Global Fund grant information was used to examine the extent to which HIV/AIDS grants are currently contributing to system strengthening and capacity building at the national level beyond their disease-specific areas and if the inclusion of health system strengthening components influences grant performance. In addition, a framework is developed to evaluate the contribution of HIV/AIDS programs to the production of GPGH through the horizontal strengthening of national health systems. Results In the bivariate analysis, the number of health system strengthening components was significantly related to performance. However, as more variables were added the significant disappears. The grant characteristics significant across the models were grant duration and region. While the results regarding the positive association between health system strengthening components and grant performance are inconclusive, the inclusion of health system strengthening components doesn′t appear to interfere with a grants ability to meet its disease specific performance targets. Conclusion The results from this analysis indicate the need for additional research to examine the relationship between health systems, health system strengthening, and HIV/AIDS program performance. The critical step would be to examine how the national subsystems are contributing to the international level through governance, financing or provision of goods and services related to GPGH. Diagram#1. Diagram#2., Background In most of the three decades since HIV appeared in Central America resource scarcity have limited the response. The HIV spending analysis it's been used for advocacy to mobilize international and public resources. National aids expenditure assessments (NASA) 2010 sheds evidence on the need to review the political agenda of resources in pursuit of higher levels of sustainability, equity and effectiveness.FigureSignificant use of prevention and any HIV Services by study communities as compared to ‘comparison’ communities. Methods NASA is a technique based on health accounting principles, extended to multi-sectoral responses to HIV, according to the resource needs model (RNM). With USAID PASCA support and by Health Ministers Council Agreement, six Central American countries developed NASA 2010, with a harmonization strategy based on research questions guiding design, data analysis and interpretation; tabular and graphical outputs, both relevant and feasible for all countries, and guidelines for data validation and participatory discussion of results.National AIDS Spending in Central American Countries. Results Except Belize, countries with higher HIV per capita spending in Central America are not those with higher HIV prevalence but those who have: a) health systems with mainly public financing, or b) large Global Fund grants. In both cases, most of the funding goes to medical interventions, people living with AIDS and general population. Spending on key populations at higher risk for HIV exposure is minimal, although the epidemics are concentrated, with high prevalence among gay men, sex workers and Trans. Antiretroviral spending is about U.S. $ 26 million, with few countries monitoring length of survival and quality of life since treatment initiation.National Aids financing by source in selected countries. Conclusion There are sharp contrasts in financial position of the response to HIV in Central America. NASA 2010 showed evidence that will put these issues on the political agenda of countries and define an updated and more effective financial strategy., Background PEPFAR South Africa saw a 2008 government policy shift in HIV opening doors to more formal collaborative planning and greater transparency in implementation of donor-supported programs. In 2010, PEPFAR commissioned a national survey to catalog i) geographic location of partners and sites and ii) human and financial resources used for implementation. This dynamic online reporting, graphing and mapping tool is called the PEPFAR Inventory and is accessible freely on the Internet. Its purpose is to provide strategic information to monitor implementation of the PEPFAR Partnership Framework between the United States and South African Governments.National Aids spending by Beneficiary Population. Methods Data were captured into a single database and 6,600 sites were geocoded using open source tools. Sites were then assigned to sub-districts, municipalities and provinces using additional open source proprietary software. A combination of open source software was used to create searchable maps. Results The Inventory is integrated with results and budget data which will be linked to targets. This will make it possible for the PEPFAR Inventory to monitor achievement and US Government investment across the country. Cluster maps enable program managers to view program coverage. MapGuide software provides an interface to display various data sets comparatively, such as population and HIV prevalence, pin-maps per agency, prime partner, site type, site ownership and program area. Viewing which partners are working in the same geographical and programme area helps to avoid duplication of effort. Conclusion The Inventory, developed by the USAID-funded Enhancing Strategic Information Project implemented by John Snow Inc., is a critical tool for monitoring the Partnership Framework. Aggregated provincial data can be integrated with other datasets at similar geographical levels to determine if PEPFAR resources are distributed to respond to the needs of the epidemic. It is envisaged that HIV/AIDS activities of other donors will eventually be linked to allow better coordination and more effective targetting., Background Since 2004, the HIV Vaccines and Microbicides Resource Tracking Working Group has employed a comprehensive methodology to track trends in R&D investments and expenditures for biomedical HIV prevention options, including HIV vaccines, microbicides, PrEP, treatment as prevention and adult voluntary medical male circumcision. Methods R&D data were collected on annual disbursements by public, private and philanthropic funders for product development, clinical trials and trial preparation, community education and policy advocacy efforts in order to estimate annual investment in HIV prevention R&D. Investment trends were assessed and compared by year, prevention technology type, funder category and geographic location. Results The period from 2000 through 2010 saw significant growth in funding support for HIV prevention research and development. However, in 2011 HIV prevention research began to see increased funding pressures as governments worldwide decreased or flat-lined budgets in global health and as philanthropic donors worked to revise their investment strategies. Funders also had to deal with greater competition among funding priorities within the field of HIV prevention and with other major global disease needs. Despite various pressures, HIV prevention research progressed significantly in 2011, with new findings and promising new trials. Conclusion Monitoring funding trends for HIV prevention research is particularly important in this time of economic uncertainty, especially as the scientific community has articulated a clear path to the end of the HIV epidemic. Such monitoring permits identification of investment needs, prioritization of research areas and assessment of the impact of public policies that increase or decrease investment. It also provides the fact base for advocacy around spending levels and allocations that will sustain investments in the research required to build on the success of recent trials; bring novel HIV prevention candidates into the pipeline; and, support follow-on clinical trials needed to assure the safety, immunogenicity, efficacy and acceptability of new HIV prevention products. Map 3., Background Sao Huang (elimination of prostitution) in China is an important public security effort to eliminate prostitution by imposing harder punishments on FSWs. Despite of the growingly intensive intervention from health department, HIV infection among female sex workers in Kunming remains high, at the level between 1.6 and 4.0% in 2009, syphilis infection at 12% and other STIs at 51% in 2006. Convincing evidences are needed to concert policies from public security and health departments. Methods The research was carried out jointly by the Kunming CDC, FSW peer workers and university volunteers, in four populated urban districts in Kunming China. In the initial phase, an estimation of FSWs was conducted. The second phase included literature review of policies, laws, regulations and practices related to Sao Huang, with special attentions drawn to Women's Education Center, a facility created under the public security system to detain FSWs arrested in Sao Huang. The third phase was a study on the lives of FSW and impact from Sao Huang particularly related to health service accessibility. Face-to-face interviews, focus group discussions and questionnaires were carried out to cover 561 FSWs. Results Extensive discrimination already hampers FSWs’ rights to health information and services. Sao Huang efforts have furthered such obstacles. Sao Huang is also a main driving factor for FSWs to move to ‘safer’ locations, increasing FSWs’ invisibility thus weakening service accessibility. Sao Huang promotes distrustful relationship and tension between FSWs and public service departments, including that of health provision, which makes it even more difficult for health department to access FSWs. Conclusion Sao Huang is a wide-spread national policy which needs to be restructured in order to adapt to the growing needs for HIV response in China. The research group is organizing evidences from the research to draft a paper advocating for changes in this particular policy., Background The enabling legal environment has long been identified as critical to rights-based responses to HIV. In the 2011 Political Declaration on HIV/AIDS, UN Member States committed to supporting legal services as well as monitoring the impact of the legal environment on HIV prevention, treatment, care and support. Research shows that legal services in developing countries remain under-resourced, of variable quality, ad hoc and reactive, often with poor case documentation and weak links with the Health and Justice Ministries. Methods A study on HIV and legal empowerment was commissioned to place the program in a broader access to justice paradigm. In each country, a comprehensive needs analysis or an environmental scan was undertaken to determine the needs, available services and gaps in HIV-related legal services. A local organization already providing legal services was given technical and financial support to improve quality and scale up, including documentation of their work. Regional and international consultations were held to promote sharing on management challenges, and substantive issues such as criminal law, needs of women and girls, and access to treatments for HIV. An independent end of program evaluation was undertaken in early 2012. Results A review of results in program countries and other contexts revealed success factors such as: engagement of outreach workers to create demand for services; women friendly and child friendly services can increase uptake; opportunities exist to mainstream HIV-related legal services into existing government services; service (such as child care) can increase access and assist sustainability, particularly for female clients; technical assistance can improve case documentation and hence advocacy for science-based policy and law reform. Conclusion Legal empowerment and access to justice approaches are essential elements of the enabling legal and policy environment for the response to HIV. They are needed to help take prevention, care, treatment and support to scale., Background Existing prostitution policies directly affect an individual's ability to protect oneself from risk of HIV/AIDS in terms of access of services and ability to negotiate safety. We examine the policies as they are written, but also from the perspectives of those they are directed toward. This panel offers an explicit analysis of policy related to sex work, prostitution, and trafficking through the perspectives of sex workers, including the criminalization of prostitution in general as well as specific policies and practices (i.e., Condoms as Evidence (DC), Prostitution Free Zones (DC), and End Demand (Chicago). Methods Our goal is to analyze policy through direct communication (in-depth interviews, surveys and case studies) related to criminalization of prostitution in general with a focus on specific policies including Condoms as Evidence, Prostitution Free Zones, and End Demand Campaigns. Our research includes 34 in-depth interviews, 50 surveys, and 6 case studies and is representative of Washington, DC, the southwest and northeast areas of the country. Results Trafficking and prostitution policies undermine HIV programs and the health of those individuals toward whom they are targeted becauseStigma and fear discourage sex workers from seeking out health services, which can further endanger the worker as well as his/her clients and partners.Quick and risky negotiations with clients because of criminalization leads a worker to operate from a less empowered place from which to negotiate specific sexual activities safelyNew anti-trafficking legislation criminalizes organizations if they provide certain services to a person they believe is trafficked but don't take the person to the police Conclusion Existing policies must be analyzed with these questions in mind and revised/reframed to place individuals' safety and health at the forefrontSex worker and sex worker rights activists must be at the forefront and integral to these discussions and reworking of policies., Background In many countries police practices are dramatically out of sync with declared government policies to prevent HIV by promoting access to condoms. Police confiscation and destruction of condoms held by sex workers and outreach workers impair sex workers’ access to condoms. Police treatment of condoms as evidence of criminal activity and as tools for extortion threatens sex workers’ ability to safely carry condoms and negotiate their use with clients. Methods In a joint research effort, community groups in Kenya, Namibia, Russia, South Africa, the United States, and Zimbabwe administered detailed questionnaires to 139 sex workers and 40 outreach workers. Results Research revealed that police routinely stop and search sex workers and confiscate their condoms. In some locations, police destroy sex workers’ condoms by burning them, cutting them up, driving on them, or throwing them in the garbage. Police confiscation and destruction of sex workers’ condoms increases their vulnerability to HIV. Sex workers reported having unprotected sex with clients after police took their condoms. In some cases, police use condom possession as justification to detain or arrest a person on charges of engaging in sex work, or as leverage to extort bribes or sexual favors. Sex workers sometimes do not carry condoms or refuse condoms from health care providers because they fear condoms will get them in trouble with police. Police further impede sex workers’ access to condoms by surveilling and harassing outreach workers and taking or destroying condoms meant for distribution. Conclusion Policing practices are undermining messages of condom accessibility and acceptability crucial for disease prevention and the promotion of individual and public health. Policing tactics and guidelines must be brought into alignment with international best practices to prevent HIV. As a first step, governments should eliminate laws that criminalize sex work and other structural obstacles to police reform., Background Due to the current legal frame work of sex work in Bangladesh sustainable HIV prevention interventions among Female Sex workers (FSWs) is a major challenge. It is clear from experience gained so far that social marginalization & disempowerment that characterize FSWs community are the key vulnerabilities that need to be addressed before any interventions related to HIV can be successfully adopted by them with ownership. Methods The first ever national congress of FSWs in Bangladesh organized by Save the Children was participated in by 1000 FSW around the country from 29 FSWs networks. They discussed legal and policy issues related to sex work and its consequences. This allowed an opportunity for shared experience from leading national, international organizations working with FSWs for last 20 years to have an analysis of the legal framework of sex work among Bangladesh. Results Hotel or Street, in any settings FSWs are not in a legal position to say no and or insist client for negotiating safe sex. According to anti- prostitution law two or more FSWs cannot work together which interferes with the ability to form collective resistance to violence, abuse & unsafe sex. On the other hand Police and Municipality law creates fear of Arrest hinders community outreach and FSW is hidden: this means it is difficult to identify, contact & build trust and avoiding arrest prevails over safer sex. Also Police powers harasses peer educators, carrying condoms seen as ‘promoting', ‘soliciting' & ‘carrying on' sex work. Due to criminalization of Brothels prevention program cannot ensure 100% condom use, frequent raids disrupt HIV services. Conclusion The legal and policy framework requires radical restructuring to reduce legal sanctions and social marginalization and allow capacity building will work for sex workers community to build a sustainable HIV AIDS program in partnership with other stakeholders including government in Bangladesh., Background In the past several years FTA negotiations have proliferated across the developing world. Why have PLHIV been protesting these FTAs and what provisions do they contain that could really impact access to medicines? Is this all conjecture or is there evidence to show the impact? Methods FTAs negotiated by the EU, US and Japan were examined. Chapters on intellectual property have been analysed. Evidence from FTAs already in existence and their impact on access to medicines was collected. FTA negotiations with India, Malaysia, Vietnam, Thailand, Brazil and South Africa were covered. Results Although there are some variations in the intellectual property provisions demanded in FTAs by the EU and US their primary aim is to decrease the space for generic production of medicines including ARVs. Provisions like data exclusivity (a new monopoly on off-patent medicines), extention of patent terms beyond 20 years, enforcement measures that will have a chilling effect on generic production, interfere with judicial independence and put shipments of medicines at risk of being seized feature in these FTAs. In addition the investment chapter puts government actions to ensure access to medicines or provision of healthcare at risk of MNC's legal cases filed in private, international arbitration. Conclusion In 2001 the price of ARVs crashed from $10,000 per person per year to $350. In 2001, governments around the world signed the Doha Declaration stating that international trade rules on intellectual property should not come in the way of providing access to medicines for all. FTAs go well beyond these international trade rules that are already resulting in higher prices of newer ARVs and medicines for Hepatitis C. Understanding the nitty gritty of the demands made in these FTAs is crucial to effective advocacy on the FTAs and for the proper involvement and consultation of PLHIV and health groups by their governments., Background There has been widespread concern about the impact of patents on access to low-cost generic antiretroviral (ARV) drugs in low- and middle-income countries (LMIC). Patents can hinder competition, which has provided sustainable price reductions for the older generation, less-widely-patented ARVs. However, until recently, limited data on patent status in developing countries hampered a full understanding of the implications of pharmaceutical patenting in these countries. Methods We compared patenting trends for 12 molecules invented pre-1995 and 12 invented post-1995, the year the WTO TRIPS Agreement came into force. We used data from the Medicines Patent Pool ARV Patent Database, the most comprehensive and regularly updated source of such information, providing information on 69 countries accounting for 84% of PLHIV in LMICs. We analyzed trends regarding: the number of molecules for which patents were applied for in a given territory, the number of LMICs with ARV patents, the expected date of patent expiration, and the implications for the development of and access to fixed-dose combinations (FDCs). Results Since 1995, pharmaceutical companies are filing for patents in a greater number of LMICs and for a greater number of molecules, such that newer ARVs are more widely-patented than older drugs. A patent on just one drug in a 2- or 3-drug FDC can pose barriers for accessing the entire FDC, and such patents can pose problems in up to 80% of territories for which data was available. Conclusion Since 1995, pharmaceutical companies are filing for patents in a greater number of LMICs and for a greater number of molecules, such that newer ARVs are more widely-patented than older drugs. A patent on just one drug in a 2- or 3-drug FDC can pose barriers for accessing the entire FDC, and such patents can pose problems in up to 80% of territories for which data was available., Background The french speaking countries of African ‘have been struck the hard by the pandemic. In recent years, however, the governments have made concerted efforts in combating the disease. With the support of international organisations programs on treatment, care and education have increased. However, a recurrent problem has been the difficulties of making HIV/AIDS medicines accessible. Stringent intellectual property laws act as a stumbling block to access to HIV/AIDS medicines. Methods Presentation of a panoramic view of the problems created by stringent intellectual property laws and how they affect access to HIV/AIDS medicines. Analysis of various approaches to facilitate access to HIV/AIDS medicines. Proffering recommendations for reforms. Results Demonstrating that the patent regime of the Bangui Agreement to which most Francophone African countries have signed is hampering access to HIV/IADS medicines and that there is an urgent need for reform. Conclusion Though the coming into force of the WTO and the TRIPS Agreement ushered in a new dynamic on when and how countries had to use certain measures to provide, promote and protect access to HIV/AIDS medicines, french speaking African countries still have certain limited policy spaces for which to manoeuver and improve access to medicines. Most of them are signatories to international and regional treaties which creates rights to health obligations. Subsequent developments after coming into force of TRIPS have tended to tilt towards supporting access to medicines. The sad problem though is regional policy incoherence and countries’ entering into treaties with TRIPS plus provisions. Fortunately, international law provides enough justification for enacting access to medicines pieces of legislation. Making maximum use of TRIPS flexibilities, incorporating human rights perspectives in intellectual property treaties, forging a strong alliance with civil society are just some of the measures needed by french African countries in increasing access to HIV/AIDS medicines., Background Over the past decade, the issue of counterfeit medicines has been seen as a burgeoning public health concern, requiring immediate action. Some decisionmakers have advocated for addressing the counterfeit issue through legislative measures targeting intellectual property enforcement. During this process, the term “counterfeit medicine” has been defined in ambiguous and confusing ways that have numerous legal interpretations, and thus intended and unintended consequences. One particular issue is the conflating of counterfeit medicine with generic drugs, which has and will continue to impede access to generic ARVs in developing countries. Methods My study consists of a political and legal analysis of three anti-counterfeiting efforts and their impacts on access to generic ARVs in developing countries, with a particular focus on East Africa. Results My analysis begins with a brief discussion and overview of some definitions of counterfeit medicine used by WHO and under the TRIPS agreement. The analysis will then explore anti-counterfeiting efforts in Kenya, in the East African Community, and in Anti-counterfeiting Trade Agreement (ACTA). I then explore an example in each context of how these measures have or will impede access to generic ARVs in developing countries. Conclusion Based on this analysis, the anti-counterfeiting measures examined pose a real and dangerous threat to accessing generic ARVs in developing countries. The counterfeit definitions used conflate generics with counterfeit medicines. Thus, a clearer and more concise definition of counterfeit is needed to avoid negative implications for generic ARVs. Finally, the real public health concern at issue here is addressing the safety quality and efficacy of medicines, and anti-counterfeiting measures do not adequately address these concerns. Therefore, rather than trying to deal with substandard medicines through intellectual property rights enforcement, other policies need to be developed that not only address the real issue, but also do not pose a threat to accessing generic ARVs., Background Since 2006, Brazil has attempted to negotiate lower prices with the patentee of Efavirenz in two grounds: a) EFZ was being sold at more affordable prices in countries with the same level of development and with less people in need of treatment than Brazil; b) generic versions were much cheaper. Considering the Brazilian policy of universal access of ART for PLWH, the offer of reducing 30% on the drug cost was still unsatisfactory (US$ 1,14 per pill). Methods Comparison of prices and case study aproach. The reference price of comparison was the last proposed by Merck for Brazil in 2007 of US$ 1,14 per pill. The total savings presented exclude the 1,5% of royalties that Brazil paid due to the Compulsory Licence. Results The government strategies to maintain a sustainable coverage of treament for those in need allowed firstly to issue a compulsory licence to import generic versions of EFZ, and thereafter to estimulate local production by the government industries. The savings with EFZ 200mg, purchased of international generic supliers, were of US$ 1.042.568,99; with EFZ 600mg, imported of international generic suplies, of US$ 63.992.537,16 and with EFZ 600mg locally manufactured of US$ 29.763.749,72. Amounting to a total saving of US$ 94.798.855,87 from 2007–2011. Conclusion The economic savings that were enabled with the compulsory licence were essential for the increased access to Efavirenz in Brazil. It is important to emphasize that the adoption of mechanism also boosts the strenght of the government to negotiate prices of other medicines and to stimulate the capacity of national pharmaceutical production and the transferring of technology., Background Morocco is facing a rising HIV epidemic among people using drugs (PUD). HIV prevalence among PUD ranks from 7% to 38% according to recent studies as HIV prevalence in general population is estimated to be 0.1%. This major change in epidemic pattern led Moroccan stakeholders to pay more attention to PUD. A first national harm reduction (HR) strategic plan (2008–2011) has allowed some needles and syringes programs as well as methadone for 80 people out of other HR services. But PUD are facing legal and social barriers acting as potential barriers for access to HIV prevention, care and treatment. Country is in need to assess those barriers in order to design a more comprehensive approach to mitigate and reverse HIV among PUD. Methods National HIV/AIDS community based organization ALCS has managed a cross sectional study in 3 North cities. 300 PUD recruited through outreach programs were asked to answer a questionnaire including 9 questions designed to assess human right violation from police officers, health professional and closed environment. Human right violation was defined as a break in national endorsed civil rights or break in national health good practices. Results 99.8% of PUD have been victims of at least one of those 9 violations with following sub scores: 87% from police officers (eg. non legal custody) and 49% from health professional (eg. non access to emergency hospital units). 60% has faced situation closed to human exploitation with drug smugglers or other PUD (including sexual intercourse against drug). Famility is also a major cause of human right violations. Conclusion Human Right should be considered as a central component of HR interventions in Morocco. At a time the country is designing HR scaling up it could improve PUD access to health services and alleviate family burden., Background In Macedonia, sex workers are among the most discriminated communities. Due to self stigma and no trust in the system, our experience shows that SWs almost never report perpetrators or demand protection via litigation. This made us aware about the complexity of raising awareness to litigate cases of human rights breaches. In November 2008 a systematic human rights violation by state happened when 23 SWs were unlawfully arrested and forcibly tested for HIV/HepC. Seven SWs were found HCV positive and criminally charged. Encouraging sex workers to demand justice, HOPS developed a complex model of legal, psycho-social and media support. Methods After the incident, HOPS created intervention team of lawyer, outreach worker, social worker and psychologist for free information and support for emotional trauma and possible lawsuits. For the first time 13 SWs raised 2 court cases against institutions and media, and defended themselves in the criminal case. 3 years after, 2 cases finished, 1 is ongoing, but the SWs successfully resisted fears and remained motivated to follow through. Consequently, 7 criminally charged SWs were sentenced on parole, and the civil suit against state institutions was won. Results SW in Macedonia are at risk for rights violation. Strategic litigation is a powerful protection tool, and while free legal aid is crucial, effective support should address emotional and other aspects of marginalization and resisting the state without fearing victimization. Trusted outreach and social workers, skilled psychologists and peer support must be part of the supportive model, involving the media and allies to create supportive environment. Conclusion Promoting the success of this model nationally and regionally, in order for organizations working with marginalized groups to adopt it in motivating them to report violence and use disposable mechanisms, including litigation. These positive outcomes will empower SWs in our country to seek justice., Background HIV criminalization laws are championed as protecting women. But HIV-positive women are increasingly prosecuted under these laws, resulting in unique violations of their sexual, reproductive and parental rights. 38 U.S. states and territories have criminal HIV exposure and transmission laws that increase HIV stigma and hinder HIV testing. Yet few tools exist to support anti-HIV-criminalization advocates, especially women. Methods In 2011, the Positive Justice Project (PJP) - a consortium working to end abuses of the criminal law against HIV-positive people - conducted community forums focused on HIV-positive women in four states with active HIV-specific criminal law prosecutions: Louisiana, Kansas, Missouri, and Illinois. HIV-positive advocates, public health officials, and attorneys attended. Local advocates, especially HIV-positive women, engaged to reframe the HIV criminalization conversation. Panels of local and national experts opened each forum and provided legal advocacy tools - fact sheets, model legislation, and “know your rights” cards - to eliminate local HIV criminal laws. Participants then developed advocacy strategies. Result Since October 2011, 125 people have been reached through PJP forums; thousands more through PJP and partner websites. PJP forums increased community knowledge of the impact of HIV criminalization laws on women, and provided general and women-specific advocacy tools to build an infrastructure at the state level to monitor and challenge existing laws. With technical assistance from PJP, HIV-positive women founded local advocacy groups in the four forum states to eliminate state criminalization laws; began monitoring criminal prosecutions and discriminatory practices; and put a woman's face to the consequences of HIV criminal laws. Conclusion HIV-positive women's engagement in turning the tide of the epidemic by personally advocating for elimination of criminal HIV exposure and transmission laws has increased awareness of the breadth of the laws' harms. Further policy research and political will is needed to support advocates to fight discriminatory criminal laws., Background The established critique of criminalizing HIV exposure/transmission focuses on issues of public health impact and human rights. Although important, this critique offers little guidance on how to practically oppose criminalization in local settings. Successful advocacy requires developing a literature on the impacts of strategies undertaken by advocates in various jurisdictions. This paper contributes to that literature through an analysis of the social organization of criminal law reform in Ontario, the centre of Canadian HIV-related prosecutions. Methods This paper is based on the experiences of members of the Ontario Working Group on Criminal Law and HIV Exposure (CLHE), a key participant in advocacy against criminalization in the province. Drawing on a studies in the social organization of knowledge perspective (Smith, 1990), it systematically identifies the key factors shaping CLHE's activities and reflects on the outcomes of CLHE's principal strategies. Results CLHE has emphasized the dissemination of research and political lobbying to create a stronger presence, in the criminal justice system, of scientific evidence on factors that reduce HIV transmission risk (a key element of the legal test in cases of HIV non-disclosure). Four initiatives have been key: (1) The mobilization of criminal defence lawyers and the identification of qualified expert witnesses have resulted in favourable judicial decisions; (2) a campaign to establish prosecutorial guidelines has been an effective community mobilization tool, but has stalled at implementation due to lack of provincial buy-in; (3) a proactive media campaign has, for the first time in Canada, generated widespread favourable mainstream media coverage of opposition to criminalization; (4) political lobbying has helped prevent harmful interventions in 2 cases recently heard by the Supreme Court of Canada. Conclusion Science-based criminal law reform led by a community organization can enhance legal defense, mobilize allies and impact media coverage, but faces challenges of engagement with provincial criminal justice authorities., Background The HIV epidemic has raised new and complex legal challenges, leading to a wide range of judgements on HIV-related matters. Given the diversity of issues and the quickly evolving science, judges need more opportunities to take stock of developments relevant to the cases before them. If properly informed and supported, the judiciary can help create the legal and social environment necessary to roll back the HIV epidemic. Methods An advisory committee of sitting and retired judges, judicial trainers, and legal experts from around the world was constituted to inform the scope, format and content of the handbook. Issue experts prepared chapter outlines and draft texts which were shared with the advisory committee for detailed feedback. The final text includes case summaries, key principles, plain language explanations of the science and treatment of HIV, statistics, and factors to consider when adjudicating cases. Results The result is a comprehensive and user-friendly handbook for the judiciary, suitable for use as a reference manual and in judicial training sessions throughout the world. Issues addressed include: discrimination, criminalization of HIV exposure, sexual assault and domestic violence, drug policy and the rights of people who use drugs, women's rights in family and property law, HIV-related treatment and healthcare, key populations at higher risk of HIV exposure, and judging during the HIV epidemic. Conclusion The handbook for judges is a unique resource with significant potential to provide judges with a contextualized understanding of key HIV-related issues, and thus improve rights protections for people living with and affected by HIV. This potential will be maximized through judicial training sessions and commitment by governments to include the judicial sector in strategies to attain universal access. The tools and training needed by judges are distinct from existing HIV-related resources therefore targeted, sensitive approaches are needed., Background It is well-documented that discrimination in women's access to property and inheritance hinders an effective response to HIV. However, in southern Africa, where HIV prevalence still remains high, numerous laws on property and inheritance rights explicitly discriminate against women. Law reform efforts are slow and in many cases have been ineffective resulting in discriminatory laws remaining in place. Approaching courts through litigation as a means of striking down such laws is underutilized in southern Africa. Methods In an attempt to accelerate the revision and/or striking down of laws discriminating against women in property and inheritance rights, we are using litigation before domestic courts to effectively strike down laws that discriminate against women with respect to property and inheritance in southern Africa. Results A number of cases have been filed. A case challenging a customary law rule denying women the opportunity to inherit from their father's estate is in the Botswana High Court; the Lesotho Constitutional Court will hear a challenge to a law denying women the right to succeed to chieftainship; and the Malawi Constitutional Court is expected to issue a decision on whether courts are permitted to only take monetary contribution to property into account when determining property distribution at the time of divorce. In each of these cases, the relief sought is a change in the discriminatory law. In all cases, the countries have constitutional provisions protecting women from discrimination. Decisions in the cases are expected by June 2012. Conclusion Law reform measures are critical to revise laws that facially discriminate against women with respect to property and inheritance rights. However, for relatively fast and effective reform, more advocates should approach courts asking them to strike down discriminatory laws., Background The HPTN 052 study authors randomized 1763 HIV-serodiscordant couples ( HIV infected partner CD4 count of 350–550/mm3) in 9 countries (8 LMIC) from June,2007–May, 2010 into an “early-therapy group” (median CD4=442, treatment started at enrollment,) and a “delayed-therapy group”(median CD4=428, treatment delayed until CD4 count ≤250 or development of AIDS).Subjects with a current/previous AIDS defining illness were excluded.WHO Stage 3 subjects were eligible; baseline viral load was not an exclusion criterion. Results were released, based on data collection to February 21, 2011 with 90% of couples enrolled a median 1.7 years. The study was designed and occurred while ARV initiation guidelines were evolving giving rise to 2 questions: researchers′ duty to offer subjects treatment at trial onset or mid-trial according to current guidelines and use of the word “early” to describe the study results. Methods The dates and recommendations of country /international guidelines for ARV initiation were cross checked against the study period, inclusion /exclusion criteria and triggers for “delayed-therapy group” treatment. The 052 study protocol was assessed against recognized international research guidelines. Results Tables 1 and 2 show that during the 052 study period, contemporaneous country/international guidelines for ARV initiation recommended substantially earlier triggers for treatment than those used in the 052 “delayed-therapy group”. The use of the 052 word “Early” relative to recommended treatment triggers is not reflective of those contemporaneous guidelines. Table 3 shows that the 052 study protocol may be inconsistent with international research ethics guidelines.Table 1ARV Country Guidelines052 Country GuidelineYearARV Initiation RecommendationGuideline Met for 052 “Delayed-Therapy Group”Botswana2008WHO Stage 3NoBrazil2008Clinically significant symptoms suggestive of advanced disease (not AIDS) or CD4 200–350 when VL > 100,000NoIndia2007WHO Stage 3 with no CD4 Consider if WHO Stage 3 and CD4 < 350NoKenya2005WHO Stage 3 and CD4 < 350NoMalawi2008WHO Stage 3 regardless of CD4NoSouth Africa2010CD4 < 350 + TBCannot DetermineThailand2010Asymptomatic with CD4 < 350 HIV-related symptomatic (not AIDS) with CD4 of any valueNoUnited States-DHHS2009All patients with CD4 < 350NoZimbabwe2007WHO Stage 3 with no CD4 Consider treatment with WHO Stage 3 and CD4 < 350No Table 2ARV International GuidelinesInternational GuidelineYearARV Initiation RecommendationGuideline Met for 052 “Delayed-Therapy Group”International AIDS Society-USA20082010All patients CD4 < 350All patients CD4 < 500NoNoWHO/UNAIDS2010All patients CD4 < 350No Table 3Research Ethics GuidelinesReseach Ethics GuidelinesEthics Guidelines/Recommendations052 Compliance with Guidelines/RecommendationsWMA Declaration of Helsinki-Ethical Principles for Medical Research Involving Human Subjects (2008)- Research subject wellbeing takes precedence over all other interests.- When research combined with medical care, research study will not adversely affect health of research subjects.NoUNAIDS/WHO Guidance Document: Ethical Considerations in Biomedical HIV Prevention Trials (2007)Internationally recogznized treatment regimens, including ARVs, must be accessible to subjects who become HIV-infected during a trial.Cannot determine treatment availability and follow-up of 052 subjects who sero-converted during trial.UNAIDS Guidelines for Biomedical HIV Prevention Trials (2010 Draft and 2011 Final Version)Research teams may need to modify their HIV care and treatment access plans in line with updated national guidelines.No Conclusion The 052 “delayed-therapy group” did not receive ARVs in accordance with national/international guidelines. The 052 descriptor “Early” is inaccurate relative to standard ARV initiation guidelines. According to contemporary research ethics standards the wellbeing of subjects should be paramount, requiring provision of the current standard of treatment to clinical trial subjects-in this case to the “delayed-therapy group”., Background HIV testing is a major part of HIV prevention efforts across the globe. In US and World Health Organization (WHO) HIV testing guidelines, opt-out testing has replaced voluntary confidential testing as a means of combating low rates of HIV testing. The success of opt-out testing is not assured, particularly due to financial, legal, operational, and cultural barriers, such as limited reimbursements for testing, obstructive laws that require written consent, limited access to healthcare, and poor compliance by care providers in testing patients perceived to be low-risk for HIV infection. Alternative methods of promoting HIV testing warrant analysis in comparison to opt-out testing. Methods HIV testing policies were hypothesized empirically and identified in the scientific and popular press. Each method was analyzed for consistency with WHO policy on HIV testing, which emphasizes the '3 Cs' of proper human rights-centered HIV testing. These conditions require that HIV testing must be: confidential, complemented by counseling, and informed, voluntary consent. Results We identified incentivized testing, anonymous mandatory testing, and names-based mandatory testing as alternatives to voluntary confidential and opt-out testing. Incentivized testing, in which a person's “willingness” to be tested is rewarded, e.g., with money, is voluntary but potentially coercive to those of lower socioeconomic status. Incentivized testing is in limited use but large-scale implementation would need to be names-based in order to avoid significant fraud. Anonymous mandatory testing using de-identified codes that allow verification that a person has undergone HIV testing preserves confidentiality but is involuntary. Names-based mandatory testing violates confidentiality and volition. Conclusion Though each HIV testing policy provides counseling, opt-out testing remains the only ethical approach for the promotion of HIV testing as it avoids coercion and loss of privacy. Financial, legal, operational, and cultural barriers to greater uptake of opt-out testing must be removed so that ethically unacceptable HIV testing policies are avoided., Background Study participants are reimbursed for transport costs incurred when travelling for clinic visits. Reimbursement also compensates for time spent in the clinic and is important for participant motivation and retention. In impoverished communities, determining adequate reimbursement is challenging. Under-compensation leads to low recruitment/retention rates, high mortality and missed trial endpoints. Ethical Committees cap reimbursements as overcompensation leads to undue influence. We sought to examine reimbursement practices, their impacts on costs and study participation in an ongoing tuberculosis vaccine trial. Methods Mothers in rural Western Kenya were approached to recruit their infants. Once enrolled, they come for seven scheduled visits and an average of two unscheduled/sick visits in a span of two months. Reimbursement was set at a rate of $4 per visit regardless of distance and cost incurred. Distances to clinic were measured by study staff. Furthest distance covered is 30km costing $6. Where the reimbursement rate was unacceptable to the mother given cost or critical study visits would be missed, mothers were ferried to clinic by designated vehicles at a cost of $18 per subject. Results Of 144 participants enrolled after 7 months, 57(40%) were under-compensated when compared to the costs incurred in attending study visits and expressed dissatisfaction with amounts reimbursed. Of these, retention rate was 99%.118 of sick participants attended clinic and 30(20%) sought care elsewhere due to cost. Participant satisfaction was not measured. Conclusion High retention rates were achieved despite under-compensation but at a cost three times higher compared to cost of directly reimbursing the mothers. Given the challenges of conducting trials in areas with limited infrastructure, there's need for continuing dialogue between investigators and Ethical Committees regarding amounts given to participants which may be based on a gradient of reimbursement according to distances travelled. There's room for educating mothers/participants on research ethics and non monetary research participation benefits., Background Ensuring informed consent is a complicated component of research, particularly with HIV prevention research conducted in poor settings. An inherent challenge characteristic of the informed consent process for HIV prevention studies is making sure that subjects understand that participation does not increase exposure to HIV and does not necessarily protect them from HIV. It is important to continuously monitor the informed consent process. Methods In June- September, 2011, gender-specific in-depth interviews (n=20) were held with interviewees who had been purposively selected from participants who had exited a vaginal HIV prevention study in Harare, Zimbabwe. An interview guide was used to elicit views around the informed consent process. Discussions were conducted in mother tongue and audio-recorded. Audio-recorded data were transcribed, translated verbatim into English, coded using NVivo 8 and analysed using grounded theory principles. Results Key information about study was given, as subjects articulated study aims well. However, it appeared that the informed consent process had been rushed and some participants had not had enough time to decide. Moreover, some participants reported that due to both excitement and anxiety, they had felt pressured to sign consent forms before comprehending some aspects of the study. Some mentioned that they had found it difficult to ask questions about the study. Both the study procedure and duration had not been fully explained. There were mixed feelings on importance of male partner involvement in decision-making around study participation, with some feeling that spouses should have been involved and others stating that partner consultation did not matter. Conclusion This study elicited some of the issues that characterise the informed consent process for clinical trials conducted in poor settings. It also highlighted the need for researchers' ingenuity in order to come up with strategies that tailor the informed process to suit the specific needs and circumstances of individual participants., Background Conducting community-based research with people living with HIV requires maintaining both individual and collective ethical standards. Research teams need to be cognisant of individual and community conceptions of informed consent, risks and benefits, and confidentiality. Although much has been written about challenges to obtaining ethics approval for HIV CBR, there have been fewer opportunities to describe ethical issues which emerge over the 'life' of these projects. This presentation addresses this gap by describing the ethical tensions which emerged during an HIV CBR study conducted in a hospital setting. Methods Using a case study analysis, this presentation draws on field notes, minutes from team meetings, and reflexive memos to offer a critical chronology of decisions made to improve ethical practice in one HIV CBR study. Various disciplinary (nursing, social work, public health) and stakeholder (clinician, coordinator, researcher, participant) perspectives are highlighted and contrasted to show how 'ethics' was understood and negotiated. Results We discuss the range of issues that emerged at the intersections of HIV, drug use, negotiating clinical space, and piloting innovative arts-based methods. Issues of cognition and HIV required the use of a multi-step informed consent process. Research team members balanced the need to support participants with reminders while being conscious of not creating undue pressure to participate. Maintaining confidentiality proved challenging because of the way space and time are managed in a clinical setting. The sensitive nature of the study and proposed group data collection necessitated changing the study design from group to individual data collection techniques to protect confidentiality. Interestingly, this happened despite having undertaken preliminary community consultations to determine the best approach. Conclusion Our findings highlight the importance of understanding and integrating both individualistic and communitarian ethical concerns, remaining flexible about design issues, and maintaining clear and open lines of communication between all project stakeholders., Background The implementation of this model comes from the minimum interventions of the Peruvian health system towards HIV/AIDS positive children and adolescents. The objective is to establish a program that provides children and adolescents with a caring, quality and confidential service. The model would contribute to reduce stigma and discrimination towards this specific HIV/AIDS positive population in South Lima. Methods The implementation of the model required training sessions to HIV positive children and adolescents of poor families, family members of low educational level, some quechua speakers and teachers from local schools. The topics of the trainings were the following: 1) human rights, stigma and discrimination, 2) self-care for children and adolescents, 3) diagnosis management, 4) psychotherapeutic issues with family members. Teachers and community leaders participate on a specific training on sensitization and advocacy. Results 31 HIV positive children and adolescents were trained on self-care and human rights. 28 families of HIV positive children received psychosocial support and their capacities and knowledge have been strengthened. 45 community leaders are more knowledgeable and sensitive on topics related to HIV/AIDS stigma and discrimination and can reproduce the training. 73 teachers are trained on topics related to HIV and children, stigma and discrimination and reproduced training to students, family members, in order to reduce rejection of HIV positive children and adolescents within their communities. Conclusion HIV/AIDS positive children and adolescents are more assertive and self-confident towards stigma and discrimination. Families and fathers of HIV positive children and adolescents are prepared to assume responsibilities, self-care and care of their children. An informed community and school would strengthen the process of reduce stigma and discrimination and reinforce adherence to treatment., Background In the 2000s, France's policy on illegal drug users has become increasingly stringent. The National AIDS Council wanted to assess the impact of this punitive policy on risk reduction policy targeting drug users, notably injection drug users. Methods Around thirty hearings were held with representatives of the relevant authorities (Ministries of Home Affairs, Justice, and Health), HIV/AIDS control associations, associations specialized in addiction and related issues, and drug user self-help groups. A review of the literature was also undertaken. Results Policies on illegal drugs have focused on strengthening sanctions against drug users. From 2001 to 2007 the number of arrests for drug offences increased by 106%. Accusations relating to drug use represented 85% of all offences during the period in question. Consequently, the cost of this punitive policy, estimated at 590 million Euros in 1995, is now much higher. In comparison risk reduction policy seems to be underfunded. Risk reduction centers have a budget of 30 million Euros and are only present in three-quarters of French counties (départements). Furthermore, this punitive framework means risk reduction tools, notably those targeting women, young people, people in detention, vulnerable users, and injection drug users have not been sufficiently diversified. Conclusion The punitive policy on drug users has been made a top policy and budget priority, with risk reduction policy relegated to second place. This policy has hindered the development of pragmatic risk reduction measures, such as medically supervised injection centres, or prison-based needle exchange programs, adapted across the country to support the most vulnerable populations., Background In 2003, France adopted a law against procuring and soliciting in order to discourage the practice of prostitution. The National AIDS Council wanted to assess its impact on sex workers in terms of prevention. Methods Around thirty hearings were held with representatives of the relevant authorities (Ministries of Home Affairs, Social Affairs, and Health), specialist police units and associations involved in the subject: associations campaigning and working on health and community health, social reintegration, abolition of prostitution, and sex workers' unions. A field investigation was also carried out within a community health association. Finally, all gray literature was analyzed. Results The 2003 law has undermined sex workers, the majority of whom are foreigners, without directly protecting the victims of procuring. Accusations against sex workers multiplied twenty-fold in the first half of the 2000s, before dropping slightly. There has been no increase in accusations for procuring. The activity has shifted to more isolated locations, under clandestine conditions with greater exposure to violence. The prevention work carried out by community health associations has become increasingly difficult, partly due to uncertainties regarding the availability of subsidies. The police and health authorities have not managed to cooperate effectively. Conclusion The introduction of a punitive law has complicated prevention work targeting sex workers. In a hostile legislative context, it seems important to support and reinforce community health actions by means of a comprehensive approach combining prevention, access to health care, social and human rights., Background HIV infection is higher among sex workers than in the general population, yet sex workers often lack access to HIV prevention services. A police practice that interferes with HIV prevention is using condoms as evidence of prostitution. Methods A multi-method investigation of the practice of using condoms as evidence of prostitution was conducted in New York City, Washington, D.C., Los Angeles and San Francisco between October 2011 and April 2012. In-depth interviews with hundreds of sex workers, their advocates, outreach workers, police, prosecutors, judges, and public health officials were conducted, combined with legal and policy analysis. Results Police engage in the routine and widespread practice of using the presence of condoms on individuals to profile them as prostitutes, to threaten arrest and as a basis for arrest on charges related to prostitution. In San Francisco, police and city regulators use condoms as a basis for arrest in clubs frequented by transgendered persons, in massage parlors and other businesses. In New York City, prosecutors introduce condoms into evidence to support prostitution charges. In Washington D.C. police confiscate condoms found on persons they identify as sex workers. In Los Angeles, sex workers follow what they believe to be the “three-condom rule”, fearing arrest for exceeding a routinely enforced limit. In each city these practices take place in a wider context of police harassment and abuse of sex workers and those perceived to be engaging in sex work, including verbal and physical degradation and other misconduct. Transgendered women and LGBT youth are particularly targeted. Conclusion Human rights abuses make some sex workers less likely to carry condoms, particularly those most vulnerable to arrest, such as undocumented immigrants. The criminalization of condoms interferes with the right to health and undermines public health objectives of universal access to disease prevention., Background Many jurisdictions continue to inappropriately prosecute people living with HIV (PLHIV) for non-disclosure of HIV-positive status, alleged exposure and non-intentional transmission. Although most HIV-related criminal cases are framed by prosecutors and the media as being cases of ′deliberate′ HIV transmission, the vast majority have involved neither malicious intent nor has transmission actually occurred or the route of transmission been adequately proven. Methods This global overview of HIV-related criminal laws and prosecutions is based on latest data from GNP+ Global Criminalisation Scan and media reports collated on criminalhivtransmission.blogspot.com. Final ranking will be based on the total number of prosecutions by July 1 2012 per 1000 PLHIV. Results At least 63 countries have HIV-specific criminal laws and at least 48 countries have used HIV-specific (n=19) or general laws (n=31) to prosecute HIV non-disclosure, exposure or transmission. Despite growing national and international advocacy, prosecutions have not diminished, particularly in high-income countries, with the greatest numbers in North America. Since 2010, prosecutions have taken place in Belgium and Republic of Congo for the first time. In 2011, although HIV-specific laws were suspended in Denmark and rejected in Guyana, Romania passed a new HIV-specific criminal statute. In Africa, the continent with the most HIV-specific criminal laws but with few known prosecutions, Guinea, Togo and Senegal have revised their existing HIV-related legislation or adopted new legislation in line with UNAIDS guidance. Conclusion Given the lack or inadequacy of systems to track HIV-related prosecutions in most places, it is not possible to determine the actual number of prosecutions for every country in the world. These data should be considered illustrative of a more widespread, but generally undocumented, use of criminal law against people with HIV. Improved monitoring of laws, law enforcement, and access to justice is still required to fully understand impact on HIV response and PLHIV., Background In Canada, the exposure and/or transmission of HIV is punishable by criminal law. The objective of this study was to investigate the impact of HIV/AIDS criminalization on awareness, prevention, and stigma as outlined in the literature and from the perspectives and experiences of stakeholders in the HIV sector in Ontario, Canada. Methods For the scoping review, we searched 11 databases, and reviewed (in duplicate) the results for any articles addressing topics related to HIV criminalization. We then identified stakeholders (policy/content experts, executive directors and frontline workers from community-based HIV/AIDS organizations) and invited a purposive sample to participate in one-on-one, semi-structured interviews. Results The search yielded 1301 results; 147 articles were included, most of which were case reports, editorials, commentaries and essays (n=136), with only 11 primary studies. Interviews explored perspectives on criminalization and its impact on prevention efforts, community awareness of prosecutions, and stigmatization of people living with HIV/AIDS. Findings highlight confusion regarding behaviours constituting “significant risk,” resulting in difficulties in the application of legal precedent, as well as uncertainty regarding HIV knowledge in the general public. Findings also highlighted uncertainty regarding the behavioural changes attributable to criminalization, but suggest that it contributes to disincentives for testing and disclosure, fears of secondary disclosure and false accusation, strained therapeutic relationships, HIV related stigma, and barriers for promoting shared responsibility for safer sex. Participants recommended guideline development to ensure optimal use of criminal law in case related to HIV/AIDS non-disclosure. Conclusion This study provides further insight into the impact of HIV/AIDS criminalization in the community. Further research is necessary to characterize the impact from the perspective of people living with HIV/AIDS and to inform ongoing policy discussions., Background Sociologists have recently become interested in the rise in prosecutions across the country under criminal HIV disclosure statutes. These law vary in their specifics, but generally make it a crime for HIV-positive individuals to have sex without first disclosing their HIV-positive status. Yet, despite a number of sociological explorations of how HIV-positive individuals relate to these laws, we know very little about how these laws are actually applied on the ground. This paper addresses this gap by exploring how legal actors in Michigan trial courts struggle to frame disclosure cases in terms of medicine and/or the law. Methods Using a database of prosecutions provided by the Michigan State Police, this study analyzes court transcripts from forty prosecutions for HIV non-disclosure. The police dataset included the sentencing dates, counties, and the court′s disposition for cases prosecuted between 1992 (the year the law first was prosecuted) and 2010. In order to request their corresponding court transcripts, these data were cross-referenced with local news reports in order to identify the defendants. This research design was reviewed (and deemed exempt from further review) by the University of Michigan′s Institutional Review Board. Results I argue that these cases can ultimately be understood as a contest to frame the disease as disease or crime. Prosecutors frame defendants as what Thomas Shevory has called “HIV monsters” using legal discourses of negligence, harm, and morality. Their accusers, on the other hand, are framed as undeserving and helpless victims. Defense attorneys attempt to diffuse these arguments by relying on medical discourses that frame disease as victimless and deserving of treatment, not punishment. Conclusion This analysis is the first empirical study to show how HIV disclosure cases are legally argued on the ground. Moreover, this study demonstrates empirically how medical problems become transformed into crime, a poorly understood social process., Background Laws criminalizing certain behaviors, and HIV non-disclosure, exposure and transmission are resurgent in developed and developing countries around the world. This study set out to understand how laws impact health seeking behavior and what coping mechanisms result amongst different key populations and to recommend policy changes. Methods A qualitative four-part questionnaire was developed and used in 27 focus groups carried out by community members during August and September 2011 in all regions of the world. More than 240 participants (51% PLHIV) from 32 countries, selected by their affiliation with a key population, took part in the study. Participants were asked non-identifying information such as HIV status, associated population group, gender, and housing situation. The hundreds of pages of feedback were analyzed for common themes across geographic region and population grouping. Common trends were then verified to develop key findings. Results Results show that individuals are being deterred from seeking health services when their behavior is criminalized. Evidence revealed that laws criminalizing HIV and certain behaviors promote the persecution of people living with HIV. HIV-specific criminal laws are reinforcing or increasing the stigma and discrimination that inhibit access to health services and undermine treatment. Evidence also demonstrated that legal protections for people living with HIV and key affected populations are insufficient or unenforced. Conclusion The current goals of accessing HIV prevention, treatment and care services are being undermined where the legal environment is unable to enforce laws protective of individuals at high risk of or living with HIV. Measures to be taken include: supporting anti-stigma and HIV education campaigns, specifically within the judicial system and amongst law enforcement; opposing and repealing HIV criminal laws; and promoting access to legal aid. Quantitative prevention research on HIV criminal laws and rates of HIV testing would be useful in statistically proving what was discussed in this study., Background In 2010, Action for Health Initiatives (ACHIEVE), Inc. conducted a research wherein evidence was found that the broad language of national anti-prostitution and anti-trafficking laws hinder effective HIV prevention initiatives among sex workers in the city. Considered as “victims”, sex workers are “rescued” while establishments are raided by police authorities using condoms as evidence of prostitution or trafficking. These hamper condom distribution and outreach activities of HIV prevention workers. Methods To address this issue, ACHIEVE, in partnership with the Quezon City Health Department (QCHD), held a series of consultative workshops, individual meetings and interfacing meetings with the Philippine National Police (PNP) officers, Quezon City Police Department (QCPD) officials and the local entertainment establishment organization in January 2011. The consultations sought to build partnership by forming memorandum of agreement (MOA) between QCPD and QCHD to end the conflicting law enforcement practice of using condom as evidence of prostitution. Results Bureaucracy, strict hierarchy within the Police Department and the very fast turnover of officials were identified as constraints in partnership-building with the police. However, the support given by the Quezon City Health Department and the sex work establishment owners association and the community help in convincing police officers and sensitizing them during the process despite their strong moral positions against sex work. After seven months, a MOA was drafted subject for adoption by PNP Chief of Police. Conclusion While the MOA was refused to be signed by the PNP Chief of Police, the process opened many doors for partnerships and for alternative next steps. These include increased support from the Quezon City STI/AIDS Council and garnered support from police officials of various QCPD and PNP offices who were not previously partnered with. The Quezon City Committee on Health also committed to provide support in implementing rights-based and issue-based HIV education among frontline police officers., Background The moralisation and criminalisation of sex work in Zimbabwe creates serious barriers to sex workers realising their rights. This research sought to examine the specific role played by the police in violating the rights of sex workers. The lack of rule of law means police have extensive powers and often act with impunity. This research sought to highlight the impact of the behaviour of law enforcement on the health and human rights of sex workers, particularly around the issue of condoms used as evidence of sex work. Methods Twenty-one sex workers and six outreach workers were interviewed in Bulawayo, Zimbabwe. The research considered the relationship between police and sex workers, specifically the confiscation of condoms. Results All 21 sex workers interviewed characterised their relationship with the police as bad, as 17 of the 21 sex workers cited harassment and intimidation from the police.17 of 21 sex workers said they had been arrested on charges related to sex work.Sex workers said that the police practice of confiscating and destroying condoms or harassing and arresting sex workers with condoms had affected their ability to negotiate condom use in a variety of ways.5 of 21 sex workers said police had confiscated their condoms.Those who had condoms taken from them, reported between 2 and 9 such encounters with police during the previous 12 months. Conclusion The Ministry of Justice should encourage interaction and dialogue between sex workers and organisations working with sex workers and law enforcement agents.The results also reflect the importance of ensuring that sex workers and organisations working with sex workers participate in the development of Zimbabwe's national HIV/AIDS Strategy.A government working group should be created to explore the decriminalisation of sex work., Background A significant body of work has examined the impacts of laws criminalizing commercial sex on sex workers’ health and safety. However, the impacts of laws criminalizing clients and third parties (i.e. managers, receptionists, cleaning staff …) on sex workers have hardly been documented. In Canada, sex work is criminalized through provisions against being found in a bawdy-house, running a bawdy-house, living on the avails of prostitution and communication for the purposes of prostitution. These are used to arrest sex workers, clients and third parties. Methods Stella is an organization by and for sex workers. The analysis of the impact of the different legal provisions criminalizing commercial sex on the health and safety of female and transgender sex workers specifically based on the street and in drug venues (i.e. crack houses, shooting galleries...) arises from available documentary data, reports on violent incidents through our aggressors’ list and also from our observations and personal experience. Results The criminalization of clients under the ‘communicating’ law places sex workers based on the street and in drug venues at greater health and safety risks by limiting their choice of clients and ability to negotiate safer sex, and causing displacement to dangerous and isolated areas far from HIV prevention and outreach services. The provisions against bawdy- houses create a greater risk of homelessness as it is grounds for eviction, including from social housing. Conclusion Often justified as “protecting” sex workers, the laws against clients and third parties actually place sex workers at greater risk, especially as they preclude the opening of safe indoor spaces. Take note that drug use legislations also increase these risks when discriminating sex workers., Background Food insecurity and HIV are part of a vicious and self-perpetuating cycle. In 2009, the World Health Assembly mandated the World Health Organization to report on global nutrition and HIV activities. However, the literature lacks definitional consensus for food insecurity in the context of HIV. Methods Using a standard literature review methodology, the aim was to describe and evaluate current definitions of food insecurity and measurement tools in the context of HIV. This study critically reviewed: operational definitions of food insecurity and its subtypes;clinical and survey measurement tools to assess food insecurity;program monitoring and evaluation tools to assess performance of food security interventions at the population-level. Results Epidemiologically validated tools have been used to measure food insecurity, hunger, and dietary diversity at the individual, household, and community levels. Some of these have been developed and validated in HIV-endemic countries. Examples of tools used with HIV-positive populations include household food insecurity scales and nutritional assessment measures such as dietary intake. Food safety, however, is seldom addressed in the HIV literature. Increasingly, there is a global movement towards integrating food security and HIV indicators across multiple organizations to strengthen program performance. With HAART expansion, profiles of food insecure people living with HIV/AIDS are shifting and measurements must reflect individual, social, and cultural factors such as over/under nutrition, resource constraints, food supplementation, literacy, and addiction. Conclusion Further research is needed to harmonize definitions of food security and its indicators in order to facilitate comparisons. Measurement tools need to be validated in both low and high resource settings, with different ethnic populations and genders and with HIV-positive populations to build a more comprehensive knowledge base., Background Ugandan guidelines recommend 6 months of exclusive breastfeeding (EBF) for HIV-infected women with continued breastfeeding (BF) for at least 1 year. Food insecurity has been posited to be a barrier to adherence to infant feeding recommendations. We therefore explored if greater food insecurity was associated with sub-optimal breastfeeding (BF) practices. Methods Data on food insecurity and BF practices and beliefs were collected among HIV-infected pregnant and BF women on antiretroviral therapy (ART) participating in the PROMOTE trial (NCT00993031) in Tororo, Uganda. Food insecurity was assessed using the Household Food Insecurity Access Scale (HFIAS). BF practices were determined using monthly maternal reports from a prospective cohort of 143 PROMOTE infants born between March 6, 2010 and October 9, 2011. Beliefs about food insecurity and BF were assessed using a purposive sample of 32 BF PROMOTE subjects who participated in in-depth interviews (IDIs) in July and August 2011. Results Food insecurity was very high; 82.5% were from severely, 14.7% moderately, and 2.1% mildly food insecure households. Median (inter-quartile range) HFIAS score was 17 (12–22). The prevalence of EBF was 89.5% and 66.9% at 3 and 6 months respectively; the prevalence of BF at 12 months was 84.1%. In multivariate logistic regression adjusting for socio-demographics and HIV-stage, the odds (95% confidence interval) of EBF at 6 months was 0.16 (0.03–0.86) for women in severely food insecure households compared to those in non-severely food insecure households. Consistent with this, IDIs revealed that BF participants associated insufficient nutritional intake with difficulties adhering to infant feeding recommendations: 75.0% were concerned about adequate breast milk production and 46.9% reported experiencing problems while EBF, e.g. unsatisfied baby. Conclusion Severe food insecurity is associated with suboptimal EBF. The mitigation of food insecurity may increase the duration of EBF among HIV+ women in rural Uganda., Background In resource limited settings (RSL) such as Haiti, people living with HIV/AIDS face great challenges in maintaining adequate nutrition.The evaluation of the benefits of nutritional supplementation(NS) programs on HIV clinic attendance among HIV infected subjects in developing countries is limited.This abstract focuses on the assessment of the rate of timely antiretroviral therapy (ART) visit attendance for a cohort of patients before food assistance, while receiving food assistance, and after receiving food assistance by using electronic pharmacy visit data. Methods Our study population included 2654 patients that received at least 6 months of ART prior to receiving NS between October 2007 and January 2011 at the GHESKIO Centers. Using pharmacy visit data, we calculated the number of late visits (at least 6 days after the scheduled visit date) during the 6 months before receiving NS from the World Food Program (WFP), during the approximate 6 months of WFP supplementation , and the 6 months after the receipt of WFP supplementation. Results Among 2654 patients, from a total of 4098 scheduled visits for the period : November 2007- December 2011: there were 1625 late visits during the 6 months period prior to NS which indicates that 39% of the scheduled visits were late visits , there were 1291 late visits during the 6 months of NS ie 31% of the scheduled visits were late visits, and 1135 late visits during the 6 months after NS ie 27% of the scheduled visits were late visits. Conclusion Our findings demonstrate that food assistance plays a key role in the regularity of the visits to the pharmacy, which is associated with ART adherence. NS should be part of the package of care and support offered to all patients on ART, particularly those with advanced immunodepression who are so desperately in need., Background UNHCR and its partners aim to ensure that refugees have similar access to HIV prevention, care and treatment services to that of local surrounding populations, and that HIV status is not used to discriminate against refugee rights to asylum, protection and assistance. HIV-related information is monitored systematically to ensure adequate protection and assistance to refugees. Methods HIV indicators collected routinely at the health facility level through UNHCR's Health Information System implemented in 21 countries where refugees live in camps, as well as review of indicators collected annually through HIV focal points at field level were analysed from 2008–2011. Results By 2011, 81% of pregnant women had access to PMTCT programmes compared with 53% in 2008. 89% of countries had camps with satisfactory universal precautions. 78% of countries were implementing interventions addressing at least one high risk group. The six UNHCR programmes directly managing a blood bank reported 100% of blood screened before transfusion. Fifteen countries reported implementing clinical management of rape survivors; 77% of survivors received PEP within 72 hours. The proportion of countries in Africa, Asia and South America where refugees have similar access to ART as host populations reached 91% by end of 2010. Advocacy against mandatory testing for HIV and for inclusion of refugees in country HIV National Strategic Plans remained stable. Conclusion Access to protection, prevention, care and treatment has increased in most of the 21 countries hosting refugees in camps. HIV programming in emergency and protracted situations is possible and effective., Background Given the importance of adherence to HAART for treatment success, our objective was to evaluate if refugees and the local host community attending a rural refugee camp clinic had acceptable adherence and virologic outcomes. Methods We conducted a cross-sectional survey among refugee and host community ART clients (≥18 years) in a rural camp-based clinic in Kakuma, north-western Kenya. Data sources included a structured questionnaire, a pharmacy-based measure of HAART prescription (Rx) refills over 24 months prior to study start, and HIV viral loads measured on dried-blood spots. Key outcomes were unsuppressed viral load (≥1000 copies/mL) and optimal adherence (≥95% Rx refill rate). Results In refugees and host clients, 85% (n=73) and 86% (n=86), respectively, of all clients not lost to follow-up (≥6 months without HAART Rx refill) participated. Median age (years, IQR) was 36 (31–41) vs. 32 (27–38) (p=0.02),% females was 67 vs. 66 (p=0.91), median time on HAART (weeks, IQR) was 156 (43–264) vs. 139 (34–225) (p=0.43), first available CD4 (IQR) was 196 (136–320), n=61 vs. 198 (119–289), n=76 (p=0.28). Most clients (63%) were taking zidovudine, lamivudine, and nevirapine (twice-daily). Similar proportions of refugee and host clients on treatment for≥25 weeks had unsuppressed viral load (88% vs. 89%, p=0.92; 89% overall). The proportion optimally adhering to pharmacy claim schedule was 79% overall (85% vs. 75%, p=0.14). In multivariable analyses, refugee status was not independently associated with unsuppressed viral load. A longer time since HIV diagnosis (ORadj=6.81, 95% CI 1.20–38.58, p=0.02) and≥8 household members (ORadj=0.10, 95% CI 0.02–0.55, p=0.01) were independent risk factors. Conclusion When available, virologic measures are valuable for monitoring program effectiveness. No differences in treatment outcomes were detected between refugee and host clients; however, levels of viral suppression were unacceptable. Possible reasons include past adherence lapses. Detailed investigations exploring reasons for the poor virologic outcomes are underway., Background There are few data evaluating adherence to HAART and virologic outcomes in clinics attended by urban refugees. Our primary objective was to evaluate if urban refugee and host community clients were maintaining acceptable treatment outcomes. Methods We conducted a cross-sectional survey among adult clients (≥18 years) receiving HAART from a public clinic in Kuala Lumpur, Malaysia. Data sources included a structured questionnaire with self-reported adherence measures, a pharmacy-based measure of HAART prescription (Rx) refills over 24 months prior to study start, and HIV viral loads. Key outcomes were unsuppressed viral load (cut-off, Background For HIV-positive persons, optimal adherence (≥95% of tablets taken as prescribed) to highly active antiretroviral therapy (HAART) is required to prevent development of drug resistance and treatment failure. Forcibly displaced populations such as refugees and internally-displaced persons may face unique challenges with respect to adherence and succeeding on HAART. To this end, we performed a systematic review of the literature on adherence to HAART and treatment outcomes in conflict-affected and forcibly displaced populations, assessed the quality of the evidence, and make suggestions for future research. Methods MEDLINE, EMBASE, and Global Health databases for 1995–2011 were searched using the OVID platform. A backwards citation review of subsequent work that had cited the OVID results was performed using the Web of Science database. ReliefWeb and MSF websites were searched for additional grey literature. Results We screened 297 records and identified 17 reports covering 15 quantitative and two qualitative studies. Three-quarters (11/15) of the quantitative studies were retrospective studies based on chart review; five included, Background HIV has multidimensional effects that pose unique challenges to development in Cambodia. One effect is a large number of orphans and vulnerable children (OVC). Many OVC are less likely to access regular schooling and have low levels of social, financial and psychological support as well as wider community support. KHANA provides a program of community based care and support including social welfare, nutrition and schooling support for these children. Methods KHANA collected data among OVC reached by community based care and support to assess changes in nutrition and schooling as well as care and community support between 2009 and 2011. The sample size was 194 in 2009 and 316 in 2011. Both surveys used cluster sampling with a take-all approach, using health center catchment areas as clusters and the same data collection tools. Chi-square test was used to detect changes in schooling, nutrition and community support. Results There was a significant increase in OVC regular access to schooling (83.1% vs 96.2%, p-value, Background The question of the potential role of income support in an ARV treatment programme is of particular relevance in South Africa, where individuals too ill to work qualify for a specific form of income transfer, or, as it is called in South Africa, a social welfare grant, namely the disability grant (DG). ARV patients face the dilemma of trading off a stable source of income against their current and/or future health and adhering sub-optimally to ARV treatment so as to not lose the grant. Methods This paper employs a pooled longitudinal, panel dataset from two Free State cohort studies of public sector ARV clients to determine how disability grant terminations may impact on virologic and immunologic treatment outcomes. Linear and logistic multivariate random-effects (RE) regression models are employed to assess the impact of grant terminations on CD4 counts, viral load (RNA) and viral suppression. Results The findings suggest that the termination of access to a disability grant does in fact translate into poorer treatment outcomes, particularly in the first year of ARV treatment. Disability grants impact negatively on viral suppression regardless of treatment duration [OR 0.253, 95% CI 0.087–0.733]. Disability grant terminations at the outset of ARV treatment initiation impacts negatively on CD4 counts [−103.8, 95% CI −164.6−43.0], log of viral load [ 4.07, 95% CI 2.58–5.56] and viral suppression [OR 0.019, 95% CI 0.002–0.181] at 3–12 months on ARV treatment. Conclusion Social welfare officers and health care teams, in particular physicians considering applications for the renewal of a disability grant, should take particular care when deciding to refuse applications for the renewal of a short-term grant in the early phases of the ARV treatment career. In the longer term, healthy ARV clients should be referred to welfare-to-work programmes to eliminate dependency on social welfare grants. Abstract Coding Guide Example: MOAA01=(Weekday) MO – (Session type) AA – (Session order) 01 Weekdays: SU (Sunday), MO (Monday), TU (Tuesday), WE (Wednesday), TH (Thursday), FR (Friday) Session types: oral abstract sessions – AA (Track A), AB (Track B), AC (Track C), AD (Track D), AE (Track E), AX (Cross-Track), LBA (Late Breaker Track A), LBB (Late Breaker Track B), LBC (Late Breaker Track C), LBD (Late Breaker Track D), LBE (Late Breaker Track E), LBX (Late Breaker Cross-Track); oral poster discussions sessions – PDA (Track A), PDB (Track B), PDC (Track C), PDD (Track D), PDE (Track E) PDX (Cross-Track) Session order: 01, 02, 03, 04, etc.
- Published
- 2012
16. Is the promise of methadone Kenya's solution to managing HIV and addiction? A mixed-method mathematical modelling and qualitative study
- Author
-
Rhodes, T., primary, Guise, A., additional, Ndimbii, J., additional, Strathdee, S., additional, Ngugi, E., additional, Platt, L., additional, Kurth, A., additional, Cleland, C., additional, and Vickerman, P., additional
- Published
- 2015
- Full Text
- View/download PDF
17. Decentralisation of tuberculosis treatment from the main hospitals to the peripheral health units and in the community within Machakos district, Kenya
- Author
-
Jk, Kangangi, Kibuga D, Muli J, Dermot Maher, Billo N, N'gang'a L, Ngugi E, and Kimani V
- Subjects
Rural Population ,Treatment Outcome ,Ambulatory Care ,Humans ,Patient Compliance ,Community Health Services ,Rural Health Services ,Kenya ,Tuberculosis, Pulmonary ,Program Evaluation - Abstract
A rural district, Machakos, in Kenya, facing decreasing national resources for health and an increasing tuberculosis (TB) caseload fuelled by the human immunodeficiency virus (HIV).To evaluate the impact on district TB programme performance of decentralising TB treatment by providing ambulatory care in the hospital and peripheral health units and in the community.A comparative study of district TB programme performance before and after the decentralisation of TB services at the end of 1997. To facilitate ambulatory care, ethambutol replaced streptomycin in the new treatment regimen.The number of patients registered in the control period (1996) was 1141, of whom almost 100% were admitted during the intensive phase of TB treatment, and in the intervention period (1998 and 1999), it was 3244, of whom only 153 (4.7%) required admission in the intensive phase. Of 3244 TB patients (all forms) registered in the intervention period, the number (%) choosing the different options for directly observed treatment (DOT) supervision were: hospital clinic 1618 (49.9%), peripheral health unit 904 (27.9%), community volunteer 569 (17.5%) and hospitalisation 153 (4.7%). The options were found to be acceptable to patients, their families and health staff. The treatment outcomes among new sputum smear-positive pulmonary TB patients were similar in the intervention and control cohorts, with treatment success rates of 88% vs. 85% and death rates of 4% vs. 6%, respectively. Treatment completion was significantly higher among new sputum smear-negative and extra-pulmonary TB patients in the intervention than in the control cohort (79% vs. 48%, respectively).The decentralisation of the intensive phase of TB treatment resulted in maintenance of good TB programme performance, while Machakos hospital closed its TB wards. A separate paper describes the cost-effectiveness of this approach. The National Tuberculosis Control Programme plans to adopt this approach as national policy.
- Published
- 2003
18. Female sex workers in Africa: Epidemiology overview, data gaps, ways forward
- Author
-
Ngugi, E. N., primary, Roth, E., additional, Mastin, Theresa, additional, Nderitu, M. G., additional, and Yasmin, Seema, additional
- Published
- 2012
- Full Text
- View/download PDF
19. Assessment of Changes in Condom Use Among Female Sex Workers in a Prospective Cohort Study Introducing Diaphragm Use for Disease Prevention
- Author
-
Gallo, M. F., primary, Warner, L., additional, Bell, A. J., additional, Wiener, J., additional, Eschenbach, D. A., additional, Bukusi, E. A., additional, Sharma, A., additional, Njoroge, B., additional, Ngugi, E., additional, and Jamieson, D. J., additional
- Published
- 2010
- Full Text
- View/download PDF
20. Trends, treatment outcomes, and determinants for attrition among adult patients in care at a large tertiary HIV clinic in Nairobi, Kenya: a 2004–2015 retrospective cohort study
- Author
-
Mecha JO, Kubo EN, Nganga LW, Muiruri PN, Njagi LN, Ilovi S, Ngethe R, Mutisya I, Ngugi EW, and Maleche-Obimbo E
- Subjects
HIV ,Antiretroviral therapy ,attrition ,lost to follow up ,risk factors ,Kenya ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Jared O Mecha,1 Elizabeth N Kubo,1 Lucy W Nganga,2 Peter N Muiruri,3 Lilian N Njagi,1 Syokau Ilovi,1 Richard Ngethe,2 Immaculate Mutisya,4 Evelyn W Ngugi,4 Elizabeth Maleche-Obimbo1 1Department of Clinical Medicine & Therapeutics, University of Nairobi School of Medicine, Nairobi, Kenya, 2The Palladium Group, Nairobi, Kenya, 3Kenyatta National Hospital, Nairobi, Kenya, 4Division of Global HIV and TB (DGHT), US Centers for Disease Control and Prevention (CDC), Nairobi, Kenya Background: Understanding trends in patient profiles and identifying predictors for adverse outcomes are key to improving the effectiveness of HIV care and treatment programs. Previous work in Kenya has documented findings from a rural setting. This paper describes trends in demographic and clinical characteristics of antiretroviral therapy (ART) treatment cohorts at a large urban, referral HIV clinic and explores treatment outcomes and factors associated with attrition during 12 years of follow-up. Methods: This was a retrospective cohort analysis of HIV-infected adults who started ART between January 1, 2004, and September 30, 2015. ART-experienced patients and those with missing data were excluded. The Cochran–Armitage test was used to determine trends in baseline characteristics over time. Cox proportional hazards models were used to determine the effect of baseline characteristics on attrition. Results: ART uptake among older adolescents (15–19 years), youth, and young adults increased over time (p=0.0001). Independent predictors for attrition included (adjusted hazard ratio [95% CI]) male sex: 1.30 (1.16–1.45), p=0.0001; age: 15–19 years: 1.83 (1.26–2.66), p=0.0014; 20–24 years: 1.93 (1.52–2.44), p=0.0001; and 25–29 years: 1.31 (1.11–1.54), p=0.0012; marital status – single: 1.27 (1.11–1.44), p=0.0005; and divorced/separated: 1.56 (1.30–1.87), p=0.0001; urban residence: 1.40 (1.20–1.64), p=0.0001; entry into HIV care following hospitalization: 1.31 (1.10–1.57), p=0.0026, or transfer from another facility: 1.60 (1.26–2.04), p=0.0001; initiation of ART more than 12 months after the date of HIV diagnosis: 1.36 (1.19–1.55), p=0.0001, and history of a current or past opportunistic infection (OI): 1.15 (1.02–1.30), p=0.0284. Conclusion: Although ART uptake among adolescents and young people increased over time, this group was at increased risk for attrition. Single marital status, urban residence, history of hospitalization or OI, and delayed initiation of ART also predicted attrition. This calls for focused evidence-informed strategies to address attrition and improve outcomes. Keywords: antiretroviral therapy, attrition, lost to follow-up, risk factors, electronic medical records, adolescents, urban
- Published
- 2018
21. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.
- Author
-
Rowland-Jones, S L, primary, Dong, T, additional, Fowke, K R, additional, Kimani, J, additional, Krausa, P, additional, Newell, H, additional, Blanchard, T, additional, Ariyoshi, K, additional, Oyugi, J, additional, Ngugi, E, additional, Bwayo, J, additional, MacDonald, K S, additional, McMichael, A J, additional, and Plummer, F A, additional
- Published
- 1998
- Full Text
- View/download PDF
22. Focused Peer-Mediated Educational Programs Among Female Sex Workers To Reduce Sexually Transmitted Disease And Human Immunodeficiency Virus Transmission In Kenya And Zimbabwe
- Author
-
Ngugi, E. N., primary, Wilson, D., additional, Sebstad, J., additional, Plummer, F. A., additional, and Moses, S., additional
- Published
- 1996
- Full Text
- View/download PDF
23. International Aspects of the AIDS/HIV Epidemic
- Author
-
Kimball, A M, primary, Berkley, S, additional, Ngugi, E, additional, and Gayle, H, additional
- Published
- 1995
- Full Text
- View/download PDF
24. Rapid Progression To Disease In African Sex Workers With Human Immunodeficiency Virus Type 1 Infection
- Author
-
Anzala, O. A., primary, Nagelkerke, N. J. D., additional, Bwayo, J. J., additional, Holton, D., additional, Moses, S., additional, Ngugi, E. N., additional, Ndinya-Achola, J. O., additional, and Plummer, F. A., additional
- Published
- 1995
- Full Text
- View/download PDF
25. Health care-seeking behavior related to the transmission of sexually transmitted diseases in Kenya.
- Author
-
Moses, S, primary, Ngugi, E N, additional, Bradley, J E, additional, Njeru, E K, additional, Eldridge, G, additional, Muia, E, additional, Olenja, J, additional, and Plummer, F A, additional
- Published
- 1994
- Full Text
- View/download PDF
26. Human Immunodeficiency Virus Infection among High-Risk Seronegative Prostitutes in Nairobi
- Author
-
Willerford, D. M., primary, Bwayo, J. J., additional, Hensel, M., additional, Emonyi, W., additional, Plummer, F. A., additional, Ngugi, E. N., additional, Nagelkerke, N., additional, Gallatin, W. M., additional, and Kreiss, J., additional
- Published
- 1993
- Full Text
- View/download PDF
27. Cofactors in Male-Female Sexual Transmission of Human Immunodeficiency Virus Type 1
- Author
-
Plummer, F. A., primary, Simonsen, J. N., additional, Cameron, D. W., additional, Ndinya-Achola, J. O., additional, Kreiss, J. K., additional, Gakinya, M. N., additional, Waiyaki, P., additional, Cheang, M., additional, Piot, P., additional, Ronald, A. R., additional, and Ngugi, E. N., additional
- Published
- 1991
- Full Text
- View/download PDF
28. Identification of molecular markers linked to a gene conferring resistance to coffee berry disease ( Colletotrichum kahawae) in C offea arabica.
- Author
-
Gichuru, E. K., Agwanda, C. O., Combes, M. C., Mutitu, E. W., Ngugi, E. C. K., Bertrand, B., and Lashermes, P.
- Subjects
COFFEE diseases & pests ,COFFEE berry borer ,GENETICS ,COFFEE anthracnose ,SEEDLINGS ,SEED crops - Abstract
Coffee berry disease (CBD) caused by Colletotrichum kahawae is a major constraint to Arabica coffee ( Coffea arabica) production in Africa. One source of resistance to the disease is a natural interspecific hybrid between C. arabica and C. canephora and its derivatives. This study is aimed at deciphering the genetic basis of the host resistance and identification of molecular markers associated with it. CBD is a mature stage disease and in the absence of a mature mapping population, early detection of disease reaction phenotypes of mapping individuals is required. Two F
2 populations from crosses of cv. Catimor (resistant) and cv. SL28 (susceptible) were screened for resistance by a two step procedure. First, half of each population was screened 6 weeks after germination by inoculating hypocotyls with the pathogen. The surviving seedlings (G1) were considered to be resistant and were raised in a nursery together with the other unscreened halves (G2). Secondly, after one year, all the seedlings (G1 + G2) were screened by inoculation. Analysis of 57 microsatellites and 31 AFLP markers in 56 and 95 seedlings from G1 and G2, respectively, were performed. Eight AFLP and two microsatellites markers linked tightly to the resistant phenotype were identified and mapped to one unique chromosomal fragment introgressed from C. canephora. The gene conferring the resistance was localized within an 11 cM segment. It is concluded that the locus carries a major resistance gene designated Ck-1, which is likely to be synonymous to the T gene described in previous studies. [ABSTRACT FROM AUTHOR]- Published
- 2008
- Full Text
- View/download PDF
29. Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial.
- Author
-
Richardson, B A, Lavreys, L, Martin, H L Jr, Stevens, C E, Ngugi, E, Mandaliya, K, Bwayo, J, Ndinya-Achola, J, and Kreiss, J K
- Published
- 2001
- Full Text
- View/download PDF
30. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection.
- Author
-
MacDonald KS, Fowke KR, Kimani J, Dunand VA, Nagelkerke NJD, Ball TB, Oyugi J, Njagi E, Gaur LK, Brunham RC, Wade J, Luscher MA, Krausa P, Rowland-Jones S, Ngugi E, Bwayo JJ, Plummer FA, MacDonald, K S, Fowke, K R, and Kimani, J
- Abstract
Certain human leukocyte antigens, by presenting conserved immunogenic epitopes for T cell recognition, may, in part, account for the observed differences in human immunodeficiency virus type 1 (HIV-1) susceptibility. To determine whether HLA polymorphism influences HIV-1 susceptibility, a longitudinal cohort of highly HIV-1-exposed female sex workers based in Nairobi, Kenya, was prospectively analyzed. Decreased HIV-1 infection risk was strongly associated with possession of a cluster of closely related HLA alleles (A2/6802 supertype; incidence rate ratio [IRR], 0.45; 95% confidence interval [CI], 0.27-0.72; P=.0003). The alleles in this supertype are known in some cases to present the same peptide epitopes for T cell recognition. In addition, resistance to HIV-1 infection was independently associated with HLA DRB1*01 (IRR, 0.22; 95% CI, 0.06-0.60; P=.0003), which suggests that anti-HIV-1 class II restricted CD4 effector mechanisms may play an important role in protecting against viral challenge. These data provide further evidence that resistance to HIV-1 infection in this cohort of sex workers is immunologically mediated. [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF
31. Risk factors for genital ulcerations in Kenyan sex workers. The role of human immunodeficiency virus type 1 infection.
- Author
-
Kaul R, Kimani J, Nagelkerke NJ, Plummer FA, Bwayo JJ, Brunham RC, Ngugi EN, Ronald A, Kaul, R, Kimani, J, Nagelkerke, N J, Plummer, F A, Bwayo, J J, Brunham, R C, Ngugi, E N, and Ronald, A
- Published
- 1997
- Full Text
- View/download PDF
32. Human immunodeficiency virus, human papillomavirus, and cervical intraepithelial neoplasia in Nairobi prostitutes.
- Author
-
Kreiss, Joan K., Kiviat, Nancy B., Plummer, Francis A., Roberts, Pacita L., Waiyaki, Peter, Ngugi, Elizabeth, Holmes, King K., Kreiss, J K, Kiviat, N B, Plummer, F A, Roberts, P L, Waiyaki, P, Ngugi, E, and Holmes, K K
- Published
- 1992
33. Condom use prevents genital ulcers in women working as prostitutes. Influence of human immunodeficiency virus infection.
- Author
-
Cameron, D. William, Ngugi, Elizabeth N., Ronald, A. R., Simonsen, J. N., Braddick, M., Bosire, M., Kimata, J., Kamala, J., Ndinya-Achola, J. O., Waiyaki, P. G., Plummer, F. A., Cameron, D W, and Ngugi, E N
- Published
- 1991
34. Utilization of dried blood spot specimens can expedite nationwide surveillance of HIV drug resistance in resource-limited settings.
- Author
-
Guoqing Zhang, Joshua DeVos, Sandra Medina-Moreno, Nicholas Wagar, Karidia Diallo, R Suzanne Beard, Du-Ping Zheng, Christine Mwachari, Carolyn Riwa, Boniface Jullu, Ngugi Evelyn Wangari, Mary S Kibona, Lucy W Ng'Ang'A, Elliot Raizes, and Chunfu Yang
- Subjects
Medicine ,Science - Abstract
INTRODUCTION:Surveillance of HIV drug resistance (HIVDR) is crucial to ensuring the continued success of antiretroviral therapy (ART) programs. With the concern of reduced genotyping sensitivity of HIV on dried blood spots (DBS), DBS for HIVDR surveillance have been limited to ART-naïve populations. To investigate if DBS under certain conditions may also be a feasible sample type for HIVDR testing in ART patients, we piloted nationwide surveys for HIVDR among ART patients using DBS in two African countries with rapid scale-up of ART. METHODS:EDTA-venous blood was collected to prepare DBS from adult and pediatric ART patients receiving treatment during the previous 12-36 months. DBS were stored at ambient temperature for two weeks and then at -80°C until shipment at ambient temperature to the WHO-designated Specialized HIVDR Laboratory at CDC in Atlanta. Viral load (VL) was determined using NucliSENS EasyQ® HIV-1 v2.0 kits; HIVDR genotyping was performed using the ATCC HIV-1 Drug Resistance Genotyping kits. RESULTS:DBS were collected from 1,368 and 1,202 ART patients; 244 and 255 these specimens had VL ≥1,000 copies/mL in Kenya and Tanzania, respectively. The overall genotyping rate of those DBS with VL ≥1,000 copies/mL was 93.0% (95% CI: 89.1%-95.6%) in Kenya and 91.8% (87.7%-94.6%) in Tanzania. The turnaround times for the HIVDR surveys from the time of collecting DBS to completing laboratory testing were 6.5 months and 9.3 months for the Kenya and Tanzania surveys, respectively. CONCLUSIONS:The study demonstrates a favorable outcome of using DBS for nationwide surveillance of HIVDR in ART patients. Our results confirm that DBS collected and stored at ambient temperature for two weeks, and shipped with routine courier services are a reliable sample type for large-scale surveillance of acquired HIVDR.
- Published
- 2018
- Full Text
- View/download PDF
35. Associations between grain yield and carbon isotope discrimination in cowpea
- Author
-
Ngugi, E. C. K., Austin, R. B., Galwey, N. W., and Hall, M. A.
- Published
- 1996
- Full Text
- View/download PDF
36. A review of HIV-1 in Africa
- Author
-
Allan Ronald, Ndinya-Achola, J. O., Plummer, F. A., Simonsen, J. N., Cameron, D. W., Ngugi, E. N., and Pamba, H.
- Subjects
Acquired Immunodeficiency Syndrome ,Cultural Characteristics ,Africa ,HIV-1 ,Humans ,Research Article ,Disease Outbreaks ,Forecasting - Abstract
As the AIDS epidemic reaches a dramatic stage of development, the time for African countries to establish effective control programs has come. The history of AIDS in Africa is different from that other regions of the world. The disease developed among heterosexual communities. By 1987, over 8,000 cases of AIDS had been reported from 37 of the 47 nations of Africa. Over 2,000 of these cases were found in Uganda. However, under-reporting and under-representation of the number of actual cases is still a problem. In many cases, there has been a failure to recognize the disease. The demographic and geographic distribution of seroprevalence is discussed. Because of the inaccuracies in AIDS reporting in Africa, epidemic forecasting is difficult. If 5 million are currently infected, a potential 50 million Africans may be infected by 1993. A further discussion of the risk factors for HIV-1 holds that promiscuity is the major problem. Cures and inexpensive treatments for the infection are years away. Energy, resources, and national committees in Africa and the world must be coordinated to combat the ultimate crisis of this century.
- Published
- 1988
37. Breeding for resistance against some of the major insects of cowpea and pigeon pea.
- Author
-
Ngugi, E. C. K., Shakoor, A., and Omanga, P. G. A.
- Published
- 1985
- Full Text
- View/download PDF
38. Condom use prevents genital ulcers in women working as prostitutes. Influence of human immunodeficiency virus infection
- Author
-
Cameron, D. W., Ngugi, E. N., Allan Ronald, Simonsen, J. N., Braddick, M., Bosire, M., Kimata, J., Kamala, J., Ndinya-Achola, J. O., and Waiyaki, P. G.
39. Personal digital assistants for HIV treatment adherence, safer sex behavior support, and provider training in resource-constrained settings
- Author
-
Kurth, A. E., Walter H. Curioso, Ngugi, E., Mcclelland, L., Segura, P., Cabello, R., and Berry, D. L.
40. Cofactors in male-female sexual transmission of human immunodeficiency virus type
- Author
-
Plummer, F. A., Simonsen, J. N., Cameron, D. W., Ndinya-Achola, J. O., Kreiss, J. K., Gakinya, M. N., Waiyaki, P., Cheang, M., Piot, P., Allan Ronald, and Ngugi, E. N.
41. Isolation of Human Immunodeficiency Virus from Genital Ulcers in Nairobi Prostitutes
- Author
-
Kreiss, J. K., primary, Coombs, R., additional, Plummer, F., additional, Holmes, K. K., additional, Nikora, B., additional, Cameron, W., additional, Ngugi, E., additional, Achola, J. O. N., additional, and Corey, L., additional
- Published
- 1989
- Full Text
- View/download PDF
42. Retrospective Seroepidemiology of AIDS Virus Infection in Nairobi Populations
- Author
-
Piot, P., primary, Plummer, F. A., additional, Rey, M.-A., additional, Ngugi, E. N., additional, Rouzioux, C., additional, Ndinya-Achola, J. O., additional, Veracauteren, G., additional, D'Costa, L. J., additional, Laga, M., additional, Nsanze, H., additional, Fransen, L., additional, Haase, D., additional, van der Groen, G., additional, Brunham, R. C., additional, Ronald, A. R., additional, and Vezinet, F. B., additional
- Published
- 1987
- Full Text
- View/download PDF
43. Breeding for resistance against some of the major insects of cowpea and pigeon pea
- Author
-
Ngugi, E. C. K., primary, Shakoor, A., additional, and Omanga, P. G. A., additional
- Published
- 1985
- Full Text
- View/download PDF
44. Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection.
- Author
-
Plummer, F A, primary, Simonsen, J N, additional, Chubb, H, additional, Slaney, L, additional, Kimata, J, additional, Bosire, M, additional, Ndinya-Achola, J O, additional, and Ngugi, E N, additional
- Published
- 1989
- Full Text
- View/download PDF
45. Evidence to HIV among continuously exposed prostitutes in Nairobi, Kenya
- Author
-
Plummer, F.A., Fowke, K., Nagelkerke, N.J.D, Simonsen, J.N., Bwayo, J., and Ngugi, E.
- Subjects
Prostitutes -- Health aspects ,HIV infection -- Physiological aspects - Abstract
AUTHORS: F.A. Plummer 1,2, K. Fowke 1, N.J.D. Nagelkerke 2, J.N. Simonsen 1, J. Bwayo 2, E. Ngugi 2 et al. 1 Department of Medical Microbiology, University of Manitoba, Winnipeg, [...]
- Published
- 1993
46. Invasive pneumococcal disease in a cohort of HIV-1 infected female prostitutes in Nairobi
- Author
-
Gilks, C.F., Ojoo, S., Paul, J., Brindle, R., Batchelor, B., Kimari, J., Were, J.B.O., Waiyaki, P.G., Plummer, F., Ndinya-Achola, J., Ngugi, E., and Warrell, D.
- Subjects
Pneumonia, Pneumococcal -- Statistics ,HIV infection -- Complications ,Nairobi, Kenya -- Health aspects - Abstract
AUTHORS: C.F. Gilks(1), S. Ojoo(1), J. Paul(1), R. Brindle(1), B. Batchelor(1), J. Kimari(2), J.B.O. Were(1), P.G. Waiyaki(2), F. Plummer(3), J. Ndinya-Achola(3), E. Ngugi(3) and D. Warrell(4). (1) Kenya Medical Research [...]
- Published
- 1992
47. The HAART cell phone adherence trial (WelTel Kenya1): a randomized controlled trial protocol
- Author
-
Ball T Blake, Ngugi Elizabeth, Estambale Benson, Nguti Rosemary, Barasa Samson, Karanja Sarah, Habyarimana James, Jack William, Chung Michael, Ritvo Paul, Kariri Antony, Mills Edward J, Lester Richard T, Thabane Lehana, Kimani Joshua, Gelmon Lawrence, Ackers Marta, and Plummer Francis A
- Subjects
Medicine (General) ,R5-920 - Abstract
Abstract Background The objectives are to compare the effectiveness of cell phone-supported SMS messaging to standard care on adherence, quality of life, retention, and mortality in a population receiving antiretroviral therapy (ART) in Nairobi, Kenya. Methods and Design A multi-site randomized controlled open-label trial. A central randomization centre provided opaque envelopes to allocate treatments. Patients initiating ART at three comprehensive care clinics in Kenya will be randomized to receive either a structured weekly SMS ('short message system' or text message) slogan (the intervention) or current standard of care support mechanisms alone (the control). Our hypothesis is that using a structured mobile phone protocol to keep in touch with patients will improve adherence to ART and other patient outcomes. Participants are evaluated at baseline, and then at six and twelve months after initiating ART. The care providers keep a weekly study log of all phone based communications with study participants. Primary outcomes are self-reported adherence to ART and suppression of HIV viral load at twelve months scheduled follow-up. Secondary outcomes are improvements in health, quality of life, social and economic factors, and retention on ART. Primary analysis is by 'intention-to-treat'. Sensitivity analysis will be used to assess per-protocol effects. Analysis of covariates will be undertaken to determine factors that contribute or deter from expected and determined outcomes. Discussion This study protocol tests whether a novel structured mobile phone intervention can positively contribute to ART management in a resource-limited setting. Trial Registration Trial Registration Number: NCT00830622
- Published
- 2009
- Full Text
- View/download PDF
48. Association between HIV and cytomegalovirus and neurocognitive outcomes among children with HIV.
- Author
-
Neary J, Chebet D, Benki-Nugent S, Moraa H, Richardson BA, Njuguna I, Langat A, Ngugi E, Lehman DA, Slyker J, Wamalwa D, and John-Stewart G
- Subjects
- Humans, Male, Female, Child, Child, Preschool, Infant, Kenya, DNA, Viral blood, Cohort Studies, Cytomegalovirus, Anti-Retroviral Agents therapeutic use, Viremia, Viral Load, Cytomegalovirus Infections complications, Cytomegalovirus Infections psychology, HIV Infections drug therapy, HIV Infections psychology, HIV Infections complications
- Abstract
Objectives: Children with HIV may experience adverse neurocognitive outcomes despite antiretroviral therapy (ART). Cytomegalovirus (CMV) is common in children with HIV. Among children on ART, we examined the influences of early HIV viral load and CMV DNA on neurocognition., Design: We determined the association between pre-ART viral load, cumulative viral load, and CMV viremia and neurocognition using data from a cohort study., Methods: Children who initiated ART before 12 months of age were enrolled from 2007 to 2010 in Nairobi, Kenya. Blood was collected at enrollment and every 6 months thereafter. Four neurocognitive assessments with 12 domains were conducted when children were a median age of 7 years. Primary outcomes included cognitive ability, executive function, attention, and motor z scores. Generalized linear models were used to determine associations between HIV viral load (pre-ART and cumulative; N = 38) and peak CMV DNA (by 24 months of age; N = 20) and neurocognitive outcomes., Results: In adjusted models, higher peak CMV viremia by 24 months of age was associated with lower cognitive ability and motor z scores. Higher pre-ART HIV viral load was associated with lower executive function z scores. Among secondary outcomes, higher pre-ART viral load was associated with lower mean nonverbal and metacognition z scores., Conclusion: Higher pre-ART viral load and CMV DNA in infancy were associated with lower executive function, nonverbal and metacognition scores and cognitive ability and motor scores in childhood, respectively. These findings suggest long-term benefits of early HIV viral suppression and CMV control on neurocognition., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
49. Brief Report: Group-Based Trajectory Modeling to Determine Long-Term HIV Viral Load Trends Among Children With HIV in Kenya.
- Author
-
Neary J, Njuguna I, Wagner AD, Richardson BA, Chebet D, Langat A, Ngugi E, Benki-Nugent S, Moraa H, Hawes SE, Overbaugh J, Slyker JA, Lehman DA, Wamalwa D, and John-Stewart G
- Subjects
- Humans, Kenya epidemiology, Male, Female, Child, Child, Preschool, Infant, Longitudinal Studies, Medication Adherence statistics & numerical data, HIV Infections drug therapy, HIV Infections virology, Viral Load, Anti-HIV Agents therapeutic use
- Abstract
Background: Identifying determinants of longitudinal HIV viral load (VL) trajectories using group-based trajectory modeling (GBTM) can inform clinical strategies and mechanisms of nonadherence among children., Methods: Children under 12 months old who were newly diagnosed with HIV were enrolled in the Optimizing Pediatric HIV therapy cohort (NCT00428116) from 2007 to 2010. Children initiated antiretroviral therapy at enrollment, and VL was assessed every 3 months for 24 months post-antiretroviral therapy and every 6 months thereafter up to 8 years old. VL trajectory groups were defined using GBTM. Fisher's exact and Kruskal-Wallis tests were used to determine the correlates of each trajectory group compared with the sustained-low VL group., Results: Five VL trajectory groups were identified among 89 children with 522 VL visits from 6 to 24 months: sustained-low (63% of children), sustained-very-high (16%), sustained-high (9%), low-to-high (7%), and high-with-periods-of-low (6%). Children in the sustained-high group were more frequently on a first-line protease inhibitor (PI)-based regimen (63% vs 38%; P = 0.03) and had younger caregivers (median: 22 vs 28 years; P = 0.02). Among 54 children with 560 VL visits followed from 48 to 96 months, 5 trajectory groups were identified: sustained-low (74%), mid-range (4%), periods-of-low (7%), high-to-low (7%), and sustained-high (7%). Those in the high-to-low group had younger caregivers (21 vs 29 years; P = 0.01)., Conclusions: GBTM identified unique VL patterns among children with unsuppressed VL. Caregiver and regimen-related characteristics were associated with patterns of nonsuppression. Younger caregivers may benefit from tailored counseling to help them support child antiretroviral therapy adherence. Palatable regimens are necessary for viral suppression among children with HIV., Competing Interests: The authors have no funding or conflicts of interest to disclose., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
50. Retrospective longitudinal analysis of low-level viremia among HIV-1 infected adults on antiretroviral therapy in Kenya.
- Author
-
Aoko A, Pals S, Ngugi T, Katiku E, Joseph R, Basiye F, Kimanga D, Kimani M, Masamaro K, Ngugi E, Musingila P, Nganga L, Ondondo R, Makory V, Ayugi R, Momanyi L, Mambo B, Bowen N, Okutoyi S, and Chun HM
- Abstract
Background: HIV low-level viremia (LLV) (51-999 copies/mL) can progress to treatment failure and increase potential for drug resistance. We analyzed retrospective longitudinal data from people living with HIV (PLHIV) on antiretroviral therapy (ART) in Kenya to understand LLV prevalence and virologic outcomes., Methods: We calculated rates of virologic suppression (≤50 copies/mL), LLV (51-999 copies/mL), virologic non-suppression (≥1000 copies/mL), and virologic failure (≥2 consecutive virologic non-suppression results) among PLHIV aged 15 years and older who received at least 24 weeks of ART during 2015-2021. We analyzed risk for virologic non-suppression and virologic failure using time-dependent models (each viral load (VL) <1000 copies/mL used to predict the next VL)., Findings: Of 793,902 patients with at least one VL, 18.5% had LLV (51-199 cp/mL 11.1%; 200-399 cp/mL 4.0%; and 400-999 cp/mL 3.4%) and 9.2% had virologic non-suppression at initial result. Among all VLs performed, 26.4% were LLV. Among patients with initial LLV, 13.3% and 2.4% progressed to virologic non-suppression and virologic failure, respectively. Compared to virologic suppression (≤50 copies/mL), LLV was associated with increased risk of virologic non-suppression (adjusted relative risk [aRR] 2.43) and virologic failure (aRR 3.86). Risk of virologic failure increased with LLV range (aRR 2.17 with 51-199 copies/mL, aRR 3.98 with 200-399 copies/mL and aRR 7.99 with 400-999 copies/mL). Compared to patients who never received dolutegravir (DTG), patients who initiated DTG had lower risk of virologic non-suppression (aRR 0.60) and virologic failure (aRR 0.51); similarly, patients who transitioned to DTG had lower risk of virologic non-suppression (aRR 0.58) and virologic failure (aRR 0.35) for the same LLV range., Interpretation: Approximately a quarter of patients experienced LLV and had increased risk of virologic non-suppression and failure. Lowering the threshold to define virologic suppression from <1000 to <50 copies/mL to allow for earlier interventions along with universal uptake of DTG may improve individual and program outcomes and progress towards achieving HIV epidemic control., Funding: No specific funding was received for the analysis. HIV program support was provided by the President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Centers for Disease Control and Prevention (CDC)., Competing Interests: We declare no competing interests. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.